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Recently, in  v it ro  production o f in te rle u k in -2  receptor induced by mitogens have 
been shown to be impaired in  autoimmune d isorders includ ing organo-specific autoimmune 
diseases. The aim o f th is  study was to investiga te  serum leve ls o f soluble in te rle u k in -2  
receptor in  20 untreated pa tien ts  w ith Graves' disease and to fo llow  up th e ir  changes in 
re la tio n  to  c l in ic a l p ic tu re  and TSH-receptor-, a n ti- th y ro g lo b u lin - , anti-microsomal as w ell 
as anti-eye muscle antibodies. Soluble in te rle u k in -2  receptor leve l was s ig n if ic a n t ly  in ­
creased in  newly-diagnosed Graves' patients compared to  con tro ls  (667+270 vs. 205+45 U/ml) 
(P <  0.001). Among the pa tients sera those w ith ac tive  in f i l t r a t iv e  ophthalmopathy had higher 
soluble in te rle u k in -2  receptor leve ls  than those w ithout eye symptoms (810+313 vs. 525+180 
U/ml). Soluble in te rleuk in -2  receptor leve l was normalized in  Methimazole-treatment-induced 
remission in  the m ajority o f pa tients  except those w ith  ophthalopathy. In f iv e  pa tie n ts  the 
soluble in te rle u k in -2  receptor leve ls  were studied a f te r  in te rru p tio n  o f th y ro s ta tic  therapy; 
an increase was observed in  three pa tients ; the rea fte r hyperthyrosis relapsed in  two cases. 
Furthermore, a corre la tion  was found between soluble in te rle u k in -2  receptor le ve ls  and TSH- 
receptor antibod ies, however, the association w ith  other immune parameters examined was not 
s ig n if ic a n t. In  conclusion, an enhanced leve l o f soluble in te rleuk in -2  receptor was detected 
in  pa tients w ith untreated Graves' disease. This fin d in g  might play a s ig n if ic a n t ro le  in  
regulation o f impaired cell-mediated immune mechanism and has a prognostic value fo r  relapse 
o f autoreactive processes.
Keywords : Graves' disease, soluble in te rle u k in -2  receptor, TSH-receptor antibod ies, 
Graves' ophthalmopathy, antimicrosomal antibodies, a n ti-th y ro g lob u lin  antibodies, anti-eye 
muscle antibodies.
O ffp r in t requests should be sent to : Cs. Balázs, I I I .  Department o f Medicine, Teach­
ing H ospita l, H-4043 Debrecen, Bartók B. u. 4, Hungary
Akadémiai Kiadó, Budapest
4 CS. BALÁZS, N .R . FARID
In tro d u c tio n
The importance of autoimmunity in  the pathogenesis of Graves ' 
disease has been well established, and a dysfunction in  both humoral and 
c e llu la r  immunity has been extensively reviewed /26, 28/. TSH receptor 
(TSH-R) antibodies have been shown to be involved in  induction and per­
petuation of thyrotoxicosis and have presented diagnostic as well as pre­
d ic tiv e  values /17 /. Despite the indisputable the importance of TSH-R 
antibodies, the concept of imbalance of immunoregulatory T lymphocytes as 
primary ae tio log ic  facto r in  the pathogenesis of th is  disease has been as­
sumed /1 2 /. Reduction of TSH-R-specific T suppressor a c tiv ity  and a c t i­
vation of T lymphocytes in  both the p e rife ra l and thyroid gland have been 
published /2 , 7, 11/. Recent advances in  immunology have provided evidence 
fo r a ro le  of cytokines in  cell-mediated immunity. Interleukin-1 (IL -1 ) 
produced by macrophages and various other c e lls ,  including thyrocytes, 
might play an important ro le  in  activa tion  of autoreactive clone(s) in  
organ-specific  autoimmune diseases /8 , 13/. Furthermore, i t  has become 
c lear tha t the key factors in  activa tion  processes are in te rleuk in -2  
( IL -2 ) and the expression of IL-2 receptor on the T c e ll surface /2 3 /. 
IL-2 production is  confined to CD4 T ce lls  and i t  exerts p le io trop ic  e f­
fe c t via an up-regulated spec ific  receptor. The in teraction  of IL-2 with 
IL-2 receptor (IL-2R) having been assumed to be involved in  the patho­
genesis of autoimmune diseases, has a ttracted  the attention of im­
munologists /9 / .  C onflic ting  data have been published on production of 
IL-2 by mitogen-induced peripheral mononuclear c e lls  and on the density 
of IL-2R on the surface of lymphocytes in  various autoimmune disorders 
/18, 19/. Recently, IL-2 in  v itro  production and IL-2-R expression have 
been shown to be impaired in  Graves' disease and insulin-dependent d ia­
betes m e llitus  /4 , 6 /. On the contrary, other authors have found enhanced 
leve ls  of soluble IL-2R (sIL-2R) in supernatant of activated mononuclear 
c e lls  as well as sera of patients with thyrotoxicosis /3 , 10, 14/.
This study was undertaken to determine whether sIL-2R could be 
changed due to impaired T c e ll function in  Graves' patients in re la tio n  to 
thy ro id  function, immunological parameters and Methimazole therapy.
INTERLEUKIN-2 RECEPTOR IN  SERA OF PATIENTS
P a tie n ts  and Methods
Subjects: twenty patients (19 female and 1 male) w ith  untreated hyperthyroid Graves' 
disease (aged 23-54 years, on the average 44.1 years) were diagnosed. A ll pa tients presented 
w ith cardinal features o f Graves' hyperthyroidism, seven had in f i l t r a t iv e  ophthalmopathy 
according ATA (American Thyroid Association) c r i te r ia .  Thyrotoxicosis was supported by a high 
leve l tr iiodo thyron ine  (12 .3jk3.2 nmol/1, normal range 1.5-3.0 nmol/1) and thyroxine 
(211+22 nmol/1, normal range 66-169 nmol/1) and suppressed TSH (1.1+0.3 mU/1, normal range 
1.5-3.0 mU/1) measured by radioimmuno-assay. A ll pa tien ts  were treated w ith  Methimazole 
(30-40 mg/day) fo r 12 months and s te ro id  therapy (Prednisolone average dose 50.0 mg/day) 
introduced in  seven patients with in f i l t r a t iv e  ophthalmopathy. Prednisolone treatment was 
tapered in re la tio n  to  the a c t iv ity  o f ophthalmopathy. Serum sIL-2R, TSH-R-, an ti-m icro - 
somal-, a n ti-th y ro g lo b u lin - and anti-eye muscle antibodies were measured before and at 
3-month in te rva ls  u n t i l  d iscontinuation o f treatment. Five pa tients were followed up a fte r  
stopping Methimazole therapy u n t il 10 month and tested fo r teh above-mentioned parameters 
every th ird  month.
TSH-R an tibod ies : were determined bv radioreceptor assay (TRAK assay, Henning, 
Chemie und Pharmawerk, B erlin ) and expressed in  U / l.  The values above 10.0 U /l were con­
sidered p os itive .
A n ti-th y ro g lo b u lin - and anti-microsomal an tibod ies: were tested by a passive haemag- 
g lu tin a tio n  technique (Thymune-T, Thymune-M, Wellcome).
sIL-2R: was measured by enzyme immunosorbent assay (ELISA). B r ie f ly ,  96-well m icro- 
t i t e r  plates were coated overnight w ith  100 yu l o f p u r if ie d  a n ti-ta c  in  PBS (pH 7 .4 ). A fte r 
washing, 50 u l  o f sample was added to  antibody-coated wells in  t r ip l ic a te .  Standard wells 
were prepared w ith  soluble human IL-2R at 0, 100, 400 and 1600 U/ml concentrations. 1000 U 
was defined as the amount o f relesed sIL-2R in  1.0 ml o f preparation o f supernatant from 
PHA-stimulated periphera l lymphocytes (T Cell Science In c . Cambridge, MA. USA). A fte r 2 h 
incubation at 37 C the plates were washed w ith Tween-PBS and 100 u l  horseradish peroxidase- 
-conjugated 7G7B6 antibody was added to each w e ll. A fte r 2 h incubation 100y j l  o f o-phenylene- 
diamine resuspended in  bu ffer containing c i t r ic  acidmonohydrate, Na^HPO ,^ 30% H^0 (pH 6.3) 
was incubated fo r 30 min at room temperature. The average absorbance at 490 nm o f each well 
and each p a tie n t' sample were read using Biorad m ic ro tite r  p la te  reader. The detection l im it  
o f sIL-2R in  our labora to ry was 50 U/ml, in tra-assay v a ria tio n  ranged between 3.8 and 4.9; 
interassay c o e ff ic ie n t o f va ria tion  was between 11.0 and 12.8%.
Anti-eye muscle antibodies: determined by modified method o f Faryna e t a l.  /1 ,  5 /.
AEMA was calculated as fo llows: I-p ro te in -A  counts bound by eye muscle membrane in  the
presence o f p a tie n ts ' serum per counts bound by muscle membrane in  the presence o f con tro l 
sera. AEMA index o f  1.2 was considered p o s itive .
S ta tis t ic a l analyses: the re su lts  were expressed as mean +SD. The data were analysed 
w ith  Student's t - te s t  and linear co rre la tio n  c o e ff ic ie n t ( r ) .
Results
The m ajority  of the untreated Graves' patients showed high sIL-2R 
levels (667+270 U/ml) compared to controls (205+_45 U/ml) (P < 0.001). 
In te res ting ly , remarkably higher values were observed in  patients with in ­
f i l t r a t iv e  eye symptoms (010_+313 U/ml) than in  absence of ophthalmopathy 
(F ig. 1). In euthyroid stage induced by Methimazole, mean value of sIL-2R 
was found to be higher (273+72 U/ml) than tha t of contro ls, however, th is
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Fig.' 1. Investiga tion  o f soluble in te rle u k in -2  receptor (sIL-2R) in  sera o f hyperthyroid and 
eu thyro id  pa tients  w ith Graves' disease. sIL-2R was measured by ELISA technique in  20 pa tients 
before and a fte r  12 weeks treatment w ith Methimazole (30-40 mg/day). In  con tro l group con­
s is ted  o f 20 healthy volunteers sIL-2R was 205+45 U/ml. In  sera o f hyperthyroid pa tien ts  w ith 
ophthalmopathy as w ell as without ophthalmopathy sIL-2R was s ig n if ic a n t ly  increased: 010+313 
U/ml (P <  0.001) and 605+210 U/ml (P < 0 .0 1 ) ,  respective ly . A fte r Methimazole treatment in  
eu thyro id  patients without ophthalmopathy the sIL-2R was normal i t  remained elevated w ith 
ophthalmopathy (394+78) (P <  0.05) despite therapy w ith Prednisolone (average dose 50 mg/day
fo r  4-12 weeks)
d iffe rence  was not s ig n ific a n t mathematically. When seven patients with 
ophthalmopathy were studied separately s ig n if ic a n tly  enhanced leve ls of 
sIL-2R were found at the end of the period of observation compared to pa­
tie n ts  w ithout ophthalmopathy despite th e ir  euthyroid stage (P <  0.05). No 
co rre la tio n  was found between anti-microsomal-, an ti-thyrog lobu lin  a n ti­
bodies and sIL-2R. Undoubtedly, the c ircu la tin g  antibodies to human eye 
muscle antigen were higher in  patients with active eye disease, the corre­
la t io n  between sIL-2R and anti-eye muscle antibodies proved to be low 
(r=0.21) (Fig. 2). Thereafter, we studied the time-dependent changes of 
TSH-R antibodies and sIL-2R at three-month in te rva ls . We found that the de-
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crease o f sIL-2R was more rapid than that of TSH-R antibodies. In addition, 
the t i t r e  of sIL-2R normalized e a r lie r  than other immunological and hormon­
a l parameters. In five  pa tien ts  we made follow-up study fo r 18 months. The 
tendency of decrease of sIL-2R and TSH-R antibodies was s im ila r to that 
found in  a l l  patients, however, 6 months a fte r Methimazole treatment had 
been ceased, an apparent rap id  increase of sIL-2R leve ls was observed in 
three patients succeeded by e levation of TSH-R antibodies, and at the end 
of period of study the hyperthyrosis relapsed in  two cases (Fig. 3).
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Discussion
In  the present report we studied the sIL-2R sera of untreated 
Graves' patients and found i t  to be s ig n ific a n tly  higher than in  control 
samples. Previously, sIL-2R had been shown to be elevated in  lymphopro­
l i fé r a t iv e  and systemic autoimmune diseases /7 , 14/, therefore, i t  seems to 
be not a disease-specific marker, instead, i t  re fle c ts  the activa tion  of 
autoreactive lymphocytes involved in the pathogenesis of Graves' disease 
/2 , 26/. Our findings appear to contradict some in  v it ro  observations con­
cerning autoimmune diseases, fo r  an impaired p ro life ra tio n  réponse to T- 
c e ll-s p e c if ic  mitogens in  systemic lupus erythematosus, rheumatoid a r th r i­
t i s  and Sjögren's syndrome has been published, and i t  was explained by a 
decreased capacity of helper T ce lls  to produce IL -2 , since exogenous IL-2 
reversed in  part the d e fic ie n t lymphocyte re a c tiv ity  /9 , 20, 22/. At f i r s t  
glance the well-known find ings that autoimmunity resu lts  from general 
hype rac tiv ity  of the immune system is  incompatible w ith deficiency of IL-2 
production. This contrad iction  could be explained by various mechanisms 
based on experimental data, however, a precise proof is  missing. The f i r s t  
p o s s ib il i ty  is  that periphera l T lymphocytes are in  transient exhaustion of 
IL -2  secretion. This is  supported by in vivo observations: glycocorticoids 
and cyclosporin A improve IL-2  secretion /27 /. The a lte rna tive  p o s s ib ility  
might be an increased leve l of sIL-2R and IL-2R-positive ce lls  which resu lt 
in  a decrease of IL-2 concentration. Eisenstein et a l.  /3 / have found s ig­
n if ic a n t  deficiency in  mitogen-induced in  v it ro  cultures of Graves' mono­
nuclear ce lls  and concluded tha t production and response to IL-2 by mono­
nuclear ce lls  were poor due to  an impaired receptor expression which was 
restored by thyrosta tic  treatment. In contrast, Lai e t a l. have observed an 
increased IL-2 production in  response to pokeweed mitogen-stimulated cu l­
INTERLEUKIN—2 RECEPTOR IN  SERA OF PATIENTS 9
tures of Graves' patients w ith ophthalmopathy /10 /. Nevertheless, these 
co n flic tin g  data on in v itro  IL-2 production in  Graves' desease imply that 
reasonable caution should be necessary in  an extrapolation to the in  vivo 
s itua tion . The elevated sIL-2R re fle c ts  the activa tion  of autoreactive 
lymphocytes due to impaired TSH-R-specific suppressor function 2, 24/. 
This finding is  in  connection with our observation concerning the 
presence of the TSH-R antibodies is  a characte ris tic  humoral immune 
parameter of Graves' disease these antibodies could have been in  corre­
la tio n  with sIL-2R as a sensitive  and early marker of lymphocyte a c t i­
vation. In addition, the fa c t tha t the highest sIL-2R has been observed in  
patients with active in f i l t r a t iv e  ophthalmopathy is  in accordance w ith con­
cept of association of two e n tit ie s  of Graves' disease, i .e .  thyro tox icosis 
and ophthalmopathy, consequently, with higher number of activated auto- 
reactive lymphocytes /26, 28/. This assumption is  supported by other f in d ­
ings, that neither anti-eye muscle-, an ti-thy rog lo bu lin -, nor anti-m icro ­
somal antibodies have showed co rre la tion  with sIL-2R leve l, fo r these 
parameters have lower pred ictive values than TSH-R antibodies /17, 21, 29/. 
Although we fa ile d  to detect serum IL-2 during Methimazole treatment, the 
progressive and more rapid decrease of sIL-2R level than of TSH-R a n ti­
bodies serve an ind irec t evidence fo r the gradual in h ib itio n  of c e llu la r  
overac tiv ity  an autoimmune mechanism. Taken together, we have found a 
remarkable increase in  the sIL-2R level in  untreated Graves' patien ts and 
a rapid decrease in  re la tion  to Methimazole treatment and enhance before 
relapse of thyrotoxicosis. Therefore, sIL-2R seems to be a se n s itiv ie  
marker of autoimmune c e llu la r processes of Graves' disease and might be a 
valuable parameter fo r prediciton of recurrence of thyrotoxicosis.
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CO№ARATIVE STLDY ON IgG AND IgA ANTIBODIES AGAINST HUMAN 
THYROID AND EYE-MUSCLE ANTIGENS IN GRAVES' OPHTHALMOPATHY
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I l l r d  Department of Medicine of Kenézy Hospital, Debrecen,
Hungary
(Received: A p ril 18, 1991)
C ircu la ting  IgG and IgA a n ti-th y ro id  and an ti-eye  muscle antibodies were investiga ted  
in  07 pa tients with Graves' disease (60 cases w ith  ophthalmopathy). The ELISA method was used. 
Both IgG and IgA antibodies were demonstrated against human thyro id  and eye-muscle membrane or 
cytoso l antigens. Anti-eye-muscle antibodies o f the IgA type were observed more frequen tly  
than those o f the IgG type (25 cases vs. 10 were demonstrated with membrane antigens and 37 
cases vs. 23 with cytoso l antigens). The respective  d is tr ib u tio n s  fo r thy ro id  antigens the 
cytoso l frac tion  were 55 cases vs. 13 and 10 cases vs. 36. A s ig n ific a n t d iffe rence  was ob­
served in  the a n ti- th y ro id  IgG levels and the anti-eye-msucle membrane or cytoso l le ve ls  be­
tween the patients w ith  Graves' disease and those in  con tro l group (P <  0.001). The d iffe rence  
in  the IgA antibody to  thyro id  and eye-muscle antigens was s ig n ific a n t between the pa tien ts  
w ith  and without ophthalmopathy (P <  0.002). The strong co rre la tion  between the le ve ls  o f IgA 
antibodies to thyro id  and those to the eye-muscle cytoso l fractions might be connected w ith 
the theory o f the common aetio logy of the th y ro id  and eye diseases in  Graves' ophthalmopathy 
(P <  0.001). C ircu la ting  IgA anti-human th y ro id  and eye-muscle antibodies seemed to  have a 
d iagnostic relevance in  the development o f ophthalmopathy in  Graves' ophthalmopathy.
Keywords : IgG antibodies, IgA an tibod ies, human eye muscle antigen, human thyro id  
antigen, Graves' ophthalmopathy
Abbreviations: GO: Graves' disease, GO: Graves' ophthalmopathy
O ffp rin t requests should be sent to  I ld ik ú  Molnár, I l l r d  Department o f Medicine of 
Kenézy H ospita l, H-4043 Debrecen, Dorottya u . 2, Hungary
Akadémiai Kiadd, Budapest
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In tro d u ctio n
Graves' ophthalmopathy (GO) was generally considered to be an auto­
immune disorder /1 , 3 /. Many studies have been aimed at detect autoanti­
bodies against eye-muscle membrane and cytosol in  Graves' disease (GD) /6 , 
10, 13/. High levels of anti-eye-muscle autoantibodies were a ttributed to В 
c e ll p ro life ra tio n  th a t was observed in  GO /1 9 /. Ihe role of the eye 
disease in  the development of IyG and IgM antibodies to extraocular muscles 
was studied /14 /. An enhanced level of serum immunoglobulins was described 
in  GO and other autoimmune diseases (myasthenia gravis, systemic lupus 
erythematosus, insulin-dependent diabetes m e llitu s ) /8 / .  Ihe elevation in  
tears of Graves' patients was in  good co rre la tion  with the severity of the 
eye symptoms /11 /.
In the present study i t  was investigated whether c ircu la ting  IgA 
antibodies to human thyro id  and eye-muscle antigens are involved in  the 
pathogenesis of GO and might have a diagnostic relevance.
P atien ts  and Methods
1. Patients
Serum samples from 87 treated patients (16 males, 71 females; from 19 to 72 years, 
mean age 44+14 years) w ith  GO were examined: S ixty o f the pa tien ts  had ophthalmopathy (average 
duration 4.5+3.8 years, from the onset o f hyperthyroidism t i l l  13 years o f disease). Oph­
thalmopathy was c la s s if ie d  according to the NOSPECS c r i t e r ia  o f the American Thyroid Associ­
a tion  /22 , 23/. Soft tissue  involvement (class 2) was found in  7 pa tients , proptosis (c lass 3) 
in  29 patients and an impaired m o t il ity  o f extraocular muscles (class 4) in 21 pa tien ts . Only 
two pa tients  with corneal involvement (class 5) and one p a tie n t w ith  s igh t loss (class 6) were 
g iven. The current th y ro id  stage was the fo llo w in g : 36 pa tients  were hyperthyroid, 45 
euthyro id  and 5 hypothyroid. F o rty -s ix  had elevated TSH receptor antibody leve ls  (51.9+90.76 
U / l,  range 0.3 to 405 U / l)  a t the time o f the in v e s tig a tio n . A lymphocyte in f i l t r a t io n  was 
confirmed by fine-needle biopsy in  23 patients.
The levels o f immunoglobulins (IgG, mean +S.D., 12.43+3.42 g/1, range 5.4 to  20.03 
g /1 ; normal 10-15 g/1) and IgA 2.17+1.11 g/1, range 0.46 to  5.76 g/1; normal 1.7+2.5 g /1) were 
measured by Hyland Laser PDQ TM nephelometer. High le ve ls  o f IgG (16.7+1.6 g/1, range 15.4 to  
20.03 g/1) and IgA (3.29+1.02 g /1 , range 2.54 to 5.76 g /1) were found in  7 and 9 p a tie n ts , 
respective ly .
Twenty-five healthy subjects (11 males, 14 females, from 30 to 62 years o f age; 
mean age: 46+9 years) w ithou t autoimmune endocrine, in fe c tio u s  and cancer disorders were 
tested  as contro ls.
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Methods
1. Preparation of human thyro id  and eye-muscle fra c tio n s
The human thyro id  tissue  was obtained a t surgery from tw  patients w ith GO. The human 
eye-muscle tissue was removed w ith in  4-6 h a fte r  death from pa tients who had not su ffered from 
tumour, endocrine and in fe c tio us  disease. The tissue homogenates were centrifuged atBOOxg and 
frac tio n s  were prepared w ith  cen trifuga tion  to separate the d iffe re n t subce llu la r compart­
ments. The p e lle t o f 3000 x g, 10 000 x g or 100 000 x g were ca lled frac tions I ,  I I - o r  I I I ,  
respective ly . Fraction I I  consisted o f mainly m itochondria l compartments (estab lished by 
electronmicroscope) and fra c tio n  I I I  was remarked as a microsomal frac tio n . The supernatant o f 
the 100 000 x g gave fra c tio n  IV. The pro te in  concentration was measured by Lowry ' s method 
/1 5 /. The frac tio n s  (w ithout protease in h ib ito rs )  were stored a t -40 C.
2. In d ire c t enzyme-linked immunosorbent assay
A n ti- th y ro id  and anti-eye-muscle antibodies were measured by the in d ire c t ELISA 
technique: a m odification o f V o lle r 's  method w ith antigen-coated enzyme-plate (Propylene GM, 
Pécs), 96 w e lls /p la te  /2 1 /. The | '  IV , 30
(.diluted i : iu u ;  was added to  each _ _ _ _ _ _  _ jnd IgA
antibodies conjugated w ith horseradish peroxidase (Human In s t itu te ,  Hungary) were chosen fo r 
detection o f  antibody binding (d i lu t io n  1:1000). The re s u lts  were given as an index, the ra t io  
o f sera O.D. o f t r ip l ic a te d  p a tie n t's  samples to the c o n tro ls ' mean O.D. value. An antibody 
leve l was defined elevated i f  the ELISA index exceeded the (mean +S.D.) value fo r  the con tro l 
group tested concurrently.
3. Determination o f the leve ls  o f thyro id  hormone and TSH receptor antibodies
The leve ls  o f thyro id  hormones were determined w ith radioimmunoassays (T3-RIA 
(normal 1 .2-3 .0  nmol/1), T4-RIA (normal 52-154 nmol/1) (Isotope In s t itu te , Budapest)). The 
TSH hormone and TSH receptor antibodies were determined by Byk M allincrodt (normal 0.6-3 .8  
mU/1) and TRAK (normal c  14 U /l)  (Henning, B e rlin , Germany) k i ts ,  respective ly . T3-uptake 
(normal 0 .8-1.15) was measured by a te s t developed in  our laboratory.
S ta t is t ic a l Analysis
S ta t is t ic a l analysis was performed by means o f Student's paired _t-test and the c h i-  
square te s t .  Linear co rre la tio n  was used to assess the re la tio n sh ip  between the le ve ls  o f IgG 
and IgA antibodies to the thy ro id  and eye iruscle cytoso l fra c tio n s .
The IgG and IgA antibodies against human thyroid and eye muscle 
fractions were investigated in  GO. The sera of the patients with GO were 
reacted w ith two fractions of eye muscle tissue (Table I)  and a l l  frac tions  
of thyro id  tissue (Table I I ) .  The differences in  the levels of IgG a n ti­
frac tio n s serum
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Table I
IgG antibodies to human eye-muscle fra c tio n s  ( I- IV )  
in  Graves' disease (ELISA)
Groups
ELISA index3 o f an ti-eye  jnu; 
F raction
scle IgG antibodies
I I I I I I IV
GO1 AC 0.6 + 0.27 1.89 _+ 0.48х 0.56 + 0.21 1 .4 + 0 .7 5 * *
Bd 0 17 0 16
GD2 A 0.71+ 0.21 2.17 ±  0.44* 0.73 + 0.22 1.45+ 0.51**
В 0 14 0 6
c3 A 1 +0.25 1 + 0 .5 6 1 +0.33 1.02+ 0.41
В 0 1 0 0
GO'*' : Graves' disease w ith  ophthalmopathy (n=50)
2
GD : Graves' disease w ithout ophthalmopathy (n=25)
C3 : Control group (n=25)
A^ : mean +_ S.D.
B° : number o f pa tients  w ith  c irc u la tin g  IgG anti-eye-muscle antibodies
ELISA Index“ : the ra t io  o f mean O.D. o f t r ip l ic a te d  p a t ie n t 's  samples to  the c o n tro ls ' mean
O.D. value. Elevated index means a value exceeding the mean +_ 2 S.D. fo r  the con tro l 
group tested concurrently.
Fraction*5: I  -  p e lle t o f 3000 x g; I I  -  p e lle t o f 10 000 x g; I I I  -  p e lle t o f 100 000 x g; 
IV -  supernatant o f 100 000 x g
* ’ **p  <0.001 compared to  con tro l
Table I I
Detection o f IgG antibodies to human th y ro id  frac tions ( I- IV )  
in  Graves' disease by ELISA
ELISA Index3 o f a n ti- th y ro id  IgG antibodies 
Groups F raction
I  I I  I I I  IV
GO1 AC 1.93+ 1.72* 1.05 + 0.81 1.06 + 0.46 1.59+ 0.72**
Bd 17 6 22 26
GO2 A 2.27+2.98* 0.76 + 0.57 0.99 + 0.66 1 .85+ 0 .4* *
В 8 3 5 24
c3 A 1 + 0.39 1 + 0.33 0.99 + 0.06 1 + 0 . 23
В 1 1 1 0
See footnote to  Table I ; * ’ **P c  0.001 compared to  c o n tro l
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P< 0.001 
3- I------------
P< 0.001
I---------------------------1
GO1 GD2 C3 GO GD C 
Fraction llb Fraction IVb
Fig- 1. IgA antibodies to human eye-muscle membrane (fra c tio n  I I )  and cy toso l 
1 ( fra c tio n  IV ) (ELISA)
GO :^ Graves' disease w ith ophthalmopathy (n=60)
GÇ : Graves' disease w ithout ophthalmopathy (n=27)
C : Control group (n=17)
ELISA Index : the ra t io  o f mean O.D. o f tr ip l ic a te d  p a tie n t's  samples to  the 
con tro ls ' mean O.D. value. Elevated index means a value exceeding 
the mean +_2 S.D. fo r the co n tro l group tested concurrently 
Fraction : I I  -  p e lle t o f 10 000 x g; I I I  -  p e lle t o f 100 000 x g;
IV -  supernatant o f 100 000 x g
bodies against eye-muscle-membrane (31 cases) and cytosol (22 cases) a n ti­
gens were s ig n ifica n t between the GD patients and the con tro l group 
(P <0.001).
C ircu la ting IgG antibodies against human thyroid tissue were de­
tected in  fractions I I I  and IV. High leve ls of IgG antibodies against 
thyro id  cytosol (fra c tio n  IV) were observed in  24 (96%) patien ts without 
eye disease and in  26 (52%) cases w ith ophthalmopathy. Twenty-two patients 
w ith GO showed c ircu la ting  IgG antibodies against thyroid fra c tio n  I I I .
S ign ifican t differences were found in  the presence of IgA antibodies 
against eye-muscle fractions I I  and IV between the patients w ith and w ith­
out ophthalmopathy (P <0.001) (Fig. 1). IgA antibodies against eye-muscle 
cytosol were found in  31 patients and IgG antibodies in only 16 patients 
w ith GO.
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GO1 GD2 C3 GO GD C 
Fraction lllb F raction IV b
F ig . 2. Detection o f  IgA antibodies to human th y ro id  membrane (fra c tio n  I I I )  
and cy toso l ( fra c tio n  IV) antigens by ELISA .
See footnote to  F ig . 1
3. 5 -
3.0-
2.5-
2 .0-
1. 5-  
10 -  
0.5 -
0
IgA antibodies
Y=0.02*Q93*X 
r =0.7333 P<0.001
05  TO 15 Z0 25  
Elisa index of thyroid cytosol
3.0
F ig . 3. Linear co rre la tio n  between the ELISA indices o f  a n t i- th y ro id  and anti-eye-muscle 
IgA antibodies aga inst cytosol antigens in  Graves' ophthalmopathy.
See footnote to  F ig . 1
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IgA antibodies to thyroid fra c tio n  I I I  were detected in  43 patients 
vs. 16 cases with the presence of a n ti-th y ro id  fraction  IV antibodies (Fig. 
2). The difference in  the levels of these an ti-thyro id  IgA antibodies was 
s ig n if ic a n t between the patients with GO and the control group (P <  0.001). 
The occurrence of an ti-thy ro id  and anti-eye-muscle IgA antibodies in  GO was 
higher than that of IgG. S ign ifican t differences were found in  the levels 
of IgA antibodies to thyroid and eye-muscle antigens between the patients 
with and without ophthalmopathy (P <  0.002).
An association was confirmed in  the study of linear regression of 
IgA antibodies to thyroid and eye-muscle antigens (Fig. 3). There was a 
s ig n if ic a n t corre la tion between the thyro id  and eye-muscle IgA antibodies 
(r=0.7333, P <  0.001), but no signficance was found (r=0.0029, N.S.) with 
IgG antibodies.
Discussion
The results reported in  th is  study indicate that IgA anti-eye-muscle 
antibodies might have relevance in  the pathogenesis of GO. C on flic ting  data 
on IgG antibodies against extraocular muscle antigens have been published 
/12, 20/. No significant difference was detected in  the levels o f IgG an ti- 
eye muscle antibodies between the patients with and without in f i l t r a t iv e  
ophthalmopathy /16 /. Surprisingly, the IgA anti-eye-muscle and a n ti-th y ro id  
antibodies showed signficant differences between the groups w ith and w ith­
out eye disease (P <c 0.002).
Van der Gaag et a l. /19/ described alterations in  the serum IgA 
leve ls tha t were depended on the degree of the eye involvement and the 
thyro id  function. A common aetiology between the thyroid and eye disease 
might be demonstrated the strong co rre la tion  that was found between the 
a n ti-th y ro id  and anti-eye-muscle cytosol IgA antibodies (P <  0.001).
There is  much evidence fo r existence of Fc-receptor (FceCR) of IgA 
on lymphocytes, monocytes and polymorphonuclear leukocytes /2 , 4, 5/. 
Synergistic e ffects between secretory IgA and IgG antibodies were published 
in  ADCC and phagocytosis /9 , 17, 18/. Recent data on the ro le  o f IgA has 
suggested that IgA antibodies might be of more importance in  the immuno- 
regulation of the development of autoimmune diseases than i t s  loca l pro­
tec tive  ro le  /6 /.  Our findings established a diagnostic relevance of high 
leve ls of IgA an ti-thyro id  and anti-eye muscle antibodies in  GO. Further
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investiga tions have to be carried out to c la r i fy  the mechanism of IgA a n ti­
bodies in  the ophthalmopathy.
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The aim o f our present study was to examine the ADCC reaction against l iv e r  c e l l  in  
various chronic l iv e r  diseases on ttie basis o f in d ire c t evidence. Forty-nine l iv e r  patients 
and one hundred and twenty-three healthy con tro ls  were examined. Anti-LSP autoantibody was 
determined on ra t l iv e r  membrane by using the in d ire c t immunofluorescent method. On the other 
hand, K i l le r - c e l l  a c t iv ity  against human erythrocyte target c e lls  was established in  the 
lymphocytes o f peripheral blood. Anti-LSP autoantibodies were demonstrated in  seven patients 
and were associated with the high K i l le r - c e l l  a c t iv i t y  in  s ix cases. S pec ific  ADCC reaction 
to l iv e r  c e ll  membrane can be assumed i f  anti-LSP autoantibody presence is  topped w ith  in ­
creased K i l le r - c e l l  a c t iv ity .
Keywords: L iver immunology, ADCC, LSP, anti-LSP autoantibody
In tro d u c tio n
Ample evidence is  available that c e ll in ju ry  induced by antibody 
dependent c e llu la r  cy to to x ic ity  (ADCC) reaction to l iv e r  c e ll membrane may 
play an important role in  the process and etiopathogenesis of chronic liv e r  
diseases /4 , 5, 6, 11/.
In 1972 Meyer zum BLischenfelde and Miescher isolated the liv e r  
spec ific  plasma membrane lipopro te in  (LSP) /15 /. LSP dispersion on paren-
Abbreviations: ADCC: antibody dependent c e llu la r  c y to to x ic ity , LSP: l iv e r  sp e c ific  
membrane lip o p ro te in
O ffp r in t requests should be sent to  R. Schnabel, H-1137 Budapest, Pozsonyi ú t 7,
Hungary
Akadémiai Kiadó, Budapest
24 R. SCHNABEL e t  a l .
chyma ce lls  is  d iffuse . I t  can be found simultaneously on the cytoplasmic 
and plasma membrane, or so le ly  on the plasma membrane /8 / .  In fact LSP is  an 
antigen complex, numerous determinants of which have been recognized, e.g. 
i t  contains approximately 0.25 per cent hepatic le c t in ,  called also asia lo­
glycoprotein /12, 24/. This component was also id e n tif ie d  on the hepato­
c e llu la r  membrane of various species. Accordingly, animal derived - ra t, 
ra b b it -  hepatocytes can be used for LSP studies /18, 20/. Anti-LSP auto- 
antibody production can be induced by hepatocellu lar destruction developing 
on the e ffec t of some damaging agent, since l iv e r  c e ll membrane fragments 
tha t enter c ircu la tion  become immunogens or, in  cases of v ira l in fec tion , 
when expression of the v irus  antigen by hepatocytes occurs near the LSP 
antigen determinant, furthermore, i f  antibodies in  response to some antigen 
challenge inc iden ta lly  cross-react with LSP. Characteristics of LSP have 
been reported in  d e ta il among others by Japanese authors, Morichika et a l. 
and w i l l  not be discussed in  the present paper /1 7 /. Anti-LSP autoanti­
bodies were demonstrated f i r s t  by Hopf et a l. /9 / .  The anti-LSP autoanti­
bodies are not species sp e c ific , as cross-reaction with LSP of other 
species occurs /18 /. The appearance of anti-LSP autoantibodies is  a pre­
condition of the sp e c ific  ADCC reaction against l iv e r  c e ll.  The Fab frag ­
ment of anti-LSP binds to the LSP antigen determinant, while the Fc frag ­
ment binds the К-c e lls ,  the actual causers of cy to ly s is . The power of ADCC 
reaction substantia lly  depends on the cyto tox ic  a c t iv ity  of К-ce lls  and 
degree of activation.
In the present paper we report on our studies concerning the as­
sumed ro le  of ADCC reaction by the demonstration of anti-LSP autoantibodies 
and the cytotoxic capacity of К-ce lls  based on in d ire c t evidence.
P atien ts  and Methods
Patients
Forty-nine pa tien ts  (30 males and 19 females) w ith  various l iv e r  diseases have been 
examined. The mean age amounted to  53,3 years (27-81 yea rs). D is tr ib u tio n  according to  the
diagnosis was as fo llow s:
Liver c irrh o s is  18 m
Fatty liv e r  12
Acute a lcoho lic  h e p a tit is  8
Postnecrotic f ib ro s is  4
Chronic active h e p a tit is  3
Chronic pers is ten t h e p a tit is  2
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Drug (INH) induced to x ic  h e p a tit is  1
Chronic reactive  h e p a tit is  1
The diagnoses were based on complex laboratory examinations (SGOT, SPGT, gamma-GT, 
a lk a lic  phosphate, e lectrophoresis , LDH, L E -ce ll, serum b i l i r u b in ,  complete blood count, 
complete urine analysis, antinuclear antibody, anti-DNA, a lpha -fe top ro te in , serum cho lin ­
esterase, HB Ag), as w e ll as on abdominal ultrasonography and h is to logy , in  add ition  to 
c l in ic a l examinations. Occasionally isotope scin tig raphy and computer tomography have also 
been performed.
К- c e l l c y to to x ic ity  was determined in  123 healthy volunteers (55 males and 60 
females) w ith a mean age o f 56.2 years. In add ition  the anti-LSP autoantibody examination was 
carried  out on 16 (2 males and 14 females) healthy con tro ls .
In d ire c t immunfluorescent study o f autoantibodies against l iv e r  c e ll  plasma membrane
a) Target c e lls  were obtained from young (12-week o ld) healthy male CFY ra ts . Hépato­
cytes were separated according to Schaffer and Kessler /1 9 /. Rats were k i l le d  by decapitation. 
To obtain to ta l ischemia the exposed liv e r  was perfused w ith iso ton ic  so lu tio n , then removed 
and placed in to  Parker's so lu tio n . Homogenisation was performed in  Ca- and Mg-free PBS so l­
u tion  and larger l iv e r  fragments were removed by f i l t r a t io n .  The f i l t r a t e  was then washed 4x 
in  PBS so lu tion  at 600 g by cen trifuga tion  and incubated in  a 5 per cent CO^  environment for 
10 min at 37 C. A fte r repeated cen trifuga tion  the sediment was homogenized in  Parker's so l­
u tion  by mild magnetic s t i r r in g .  From th is  c e ll suspension the in te g r ity  and v i t a l i t y  of c e lls  
was established by tryptan  blue s ta in ing . Had re s u lts  not been sa tis fa c to ry  the procedure^was 
repeated from PBS washing through u n t i l  success. The cell-suspension was adjusted to  3x10 /ml 
c e ll  count. 30yul were^removed and the hepatocytes placed by means o f a cytocentrifuge  on a 
s lid e  and dried at +4 C. Suspension o f c e lls  was carried out under s te r i le  conditions.
b) A fte r the 1:10 d ilu t io n  w ith PBS o f the sera the hepatocytes were placed on s lides 
and incubated in  thermostat fo r  30 min. The aspec ific  bounds were removed by repeated washing 
w ith PBS. The preparate was incubated again w ith  FITC-labelled anti-humang IgG rab b it serum 
fo r 30 min and was followed by repeated PBS-washing.
c) Evaluation: The preparations were studied by fluorescence microscopy. Results were 
considered pos itive  (an ti-LS P -pos itive ) i f  fluorescence appeared on the surface o f the hepato­
cytes .
К- c e l l a c t iv ity  of lymphocytes in  peripheral blood
Antibody dependent cy to tox ic  a c t iv ity  was studied in  anti-human eryhtrocyte  te s t. 
Urbaniak's basic method modified by Garam and Bakács /7 , 22/ has been used. I t  is  based on the 
enzyme k in e tic  model o f Zeijlemaker e t a l.  and Thorn and Hanney /20 , 25/. According to  the 
la t te r  lymphocyte c y to to x ic ity  also depends on the number o f ta rget c e lls ,  i . e .  the cyto tox ic  
mechanism is  s im ila r to  ce rta in  enzyme reactions.
Separation o f lymphocytes was carried out from 20 ml heparinized blood. The mono­
nuclear c e lls  were separated by F icoll-U rom iro gradient cen trifuga tion  according to  Böyum /3 / .  
"0" (R , R ) human erythrocytes served as ta rge t c e lls .  The ta rge t c e lls  were washed, i n ­
cubated w ith 2 per cent papain fo r 10 min at room temperature, then labe lled  w ith  200 uCi Cr 
isotope (Na-chromate, Amersham, England) at 37 C fo r  120 min. A fte r incubation the c e lls  and 
the required concentrations were placed in  RPMI-FCS n u trie n t f lu id .  Anti-D-immunglobulin (Na­
tio n a l In s t itu te  ^of Haematology, Budapest) a t 6000x d ilu t io n  was used as antibody. S eria l 
d ilu t io n s  o f 1x10 to 14x10 /m l concentration were prepared from the ta rge t c e lls .  From these 
d ilu t io n s  o f 50 u l  were p ipetted in to  the "V" shaped openings o f the m icrodish. 50 u l lympho­
cyte o f the 2x10 /ml concentration were p ipetted in to  each cu ltu re  and 50 u l  an ti-D  serum was 
added and the to ta l volume replenished w ith 50 u l  medium to 200 ^ i l .  The te s t m ixture was in ­
cubated in  a 5 per cent CO^  environment thermostat a t 37 C fo r 18 n.
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Calculation of c y to to x ic ity . The spec ific  release per cent was calculated on the 
basic o f  fo llow ing formula:
Supernatant "cpm" -  spontaneous release "cpm"
------------------------------------------------------------------------------------------------------ X 100
Total incorporated a c t iv i t y  "cpm" -  spontaneous release "cpm"
From th is  cyto tox ic  capacity, which is  epxressed by the maximum o f ta rge t c e lls  destroyed by a 
u n it  u f  lymphocyte can be ca lcu la ted  by the formula:
Number o f sa tu ra ting  ta rg e t c e lls  x re lated sp ec ific -re lease  %
100
The sa tu ra ting  target c e ll number is  the smallest number o f ta rg e t c e lls  at which the peak 
a c t iv i t y  o f lymphocytes is  measured. In  each of the lymphocyte and ta rg e t c e ll  combinations 
two p a ra lle l samples were used. Their mean represented the basic o f the ca lcu la tion , which was 
performed w ith  a program from the U n ive rs ity  of C a lifo rn ia  Los Angeles Biomedical Department.
The Student's two sample _ t-tes t was used fo r the c a lcu la tio n  o f s ign ificance between 
the two groups.
Results
Anti-LSP autoantibody studies
Anti-LSP autoantibody p o s it iv ity  has not been found in  the group of 
16 healthy controls.
From the 49 pa tien ts  with l iv e r  diseases findings were highly 
p o s itive  in  4 cases and moderately positive in  3 patien ts. Data and K-cell 
a c t iv i ty  of lymphocytes in  the peripheral blood fo r these 7 patients are 
shown on the Table I .
К- c e l l  a c t iv ity  studies
К-c e ll a c tiv ity  was determined in  a l l  the patients with l iv e r  
disease and mean values were calculated fo r the group (mean x 10 +S.D.)
(2.38x10^+1.47x10^). Based on detectable anti-LSP autoantibody two sub­
groups were formed and mean К-c e ll a c tiv ity  fo r  la t te r  calculated. K-ce ll 
c y to to x ic ity  was 1.95x10^+1.43x10^ in the 123 healthy volunteers. Results 
can be seen on Table I I .
K -ce ll a c tiv ity  in  patien ts with l iv e r  disease and in the anti-LSP 
autoantibody negative group (2.09xl06+0.82xl06) showed no substantial d i f ­
ference from the findings in  the control group.
K-celi a c t iv ity  in  the anti-LSP autoantibody positive group
(3.85x10^+1.32x10^) was s ig n if ic a n tly  higher when compared to controls, as 
w e ll as to the findings in  the anti-LSP autoantibody negative group (P< 0.001).
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Table I
Main data o f pa tients w ith anti-LSP pos itive  l iv e r  diseases
Patient Age Diagnosis H istory
A n ti-
LSP
C yto tox i­
c i t y  X 10
1. B.L. 57 Chronic pers is tent 
h e p a tit is
A lcohol:0
HB AG:0 
s
++ 3.95
2. SZ.S. 57 L iver c irrh o s is  
(Signs o f a c t iv ity :  
piecemeal necrosis)
A lcoho l:+
HB AG:0 
s
++ 4.20
3. F.GY. 60 l,ive r c irrh o s is  
(Signs o f a c t iv ity :  
piecemeal necrosis)
A lcoho l:+
HB AG:0 
s
+++ 4.66
4. V.CS. 54 Drug induced 
h e p a tit is  (INH)
Alcohol:0 
HBsAg:0
++ 0.92
5. P.GY. 59 Chronic active 
h e p a tit is
A lcohol:+
HBsAg:0
+++ 4.07
6. V.J. 51 Chronic active  
h e p a tit is
A lcohol:0
HB AG:0
s
+++ 4.55
7. M.L. 50 Reactive h a p tit ls  
(v iru s  in fe c tio n )
A lcoho l:+ 
HB^Ag:0
+++ 4.70
Meaning o f the symbole
Table I I
К- c e l l  c y to to x ic ity  in  pa tients w ith  l iv e r  diseases based on 
detectable anti-LSP autoantibody
Groups № o f cases
C y to to x ic ity  
mean x 10 +_ S.D.
1. Total o f pa tients 49 2.38 + 1.47
2. Anti-LSP negative patients 42 2.09 + 0.82
3. Anti-LSP p o s itive  pa tients 7 3.85 + 1.32
4. Control group 123 1.95 + 1.43
S ig n ifica n t d iffe rences: Between group 2 and 3: P <  0.001;
between group 3 and A: P <  0.001; 
between group 2 and 4: N.S.
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Discussion
As already mentioned in  the introduction, an important ro le  was a t­
tr ib u te d  to the ADCC reaction , as well as to the anti-LSP autoantibody as 
the spec ific  antibody of the ADCC reaction in  the pathogenesis of the 
various chronic l iv e r  diseases considered presently of autoimmune o rig in .
According to Ventoi e t a l. au toreactiv ity in  h epa titis  A, B, and 
non-A, поп-B virus in fe c tio n  might be of e tio lo g ic a l importance /23 /. 
Mondelli et a l. found tha t ADCC played a s ig n if ic a n t part in  the develop­
ment o f non-A, non-B v irus hepatitis-induced chronic hepa titis  /16 /. In a 
substan tia l part of a lcoho lic  l iv e r  diseases an increased non-T-cell cyto­
to x ic ity  against autologous hepatocytes - presumably К-c e ll cy to to x ic ity  - 
has been confirmed /1 / .  Experimental studies confirmed that c ircu la ting  
antibodies against l iv e r  c e l l  membrane appear on the e ffec t of ethanol 
/2 / .  Cell in ju ry on the e ffe c t of ADCC reaction occurs p rim arily  in  the 
p o rta l region and was confirmed in  various l iv e r  diseases by Vergagni et 
a l.  /2 3 /. In autoimmune chronic active hepa titis  (CAH) detection of a n ti- 
LSP autoantibodies and th e ir  change of t i t e r  showed close corre la tion  with 
the remission or relapse o f the disease /1 3 /. IgG liv e r  c e ll membrane 
autoantibodies were found at a high per cent (LMA) in  various liv e r  
diseases^: e.g. in  autoimmune CAH 83%, cryptogenic chronic active liv e r  
disease 47%, primary b i l ia r y  c irrhos is  42%, HBsAg positive  and HBsAg 
negative but anti-HBc p o s itive  chronic active l iv e r  diseases 11% were LMA 
p o s itive  /14/. By means of the monoclonal antibody technique Kakumu et a l. 
demonstrated anti-LSP antibodies in  acute and chronic l iv e r  diseases. I t  
seems noteworthy that la t te r  authors found anti-LSP autoantibodies in  13 
o f the 16 patients with active  l iv e r  c irrhos is  /1 0 /.
Results of our anti-LSP autoantibody studies are in  lin e  with the 
mentioned reports. From the 7 positive cases 2 corresponded to autoimmune 
CAH (Table I ,  case Nos 5 and 6), in which, to our knowledge, the occur­
rence of anti-LSP autoantibodies is  high. Anti-LSP antibody p o s it iv ity  in  
p a tie n t No. 1 with chronic persistent hepa titis  was neither surprising. In 
th is  case i t  may be assumed tha t the process has been induced by a former 
v i r a l  in fection , eventually non-A, поп-B virus in fe c tio n , though no d irec t 
evidence was available. P o s it iv ity  in the two c ir rh o t ic  cases showing ac­
t i v i t y  (patients Nos 2 and 3) was in  agreement w ith data reported in  
l i te ra tu re .  Anti-LSP autoantibody production in  pa tien t No. 4 (drug in ­
duced INH hepatitis ) was probably induced by l iv e r  in ju ry . In patient No.7
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antibodies e lic ite d  by a common virus in fec tion  did probably cross-react 
inc iden ta lly  with the LSP antigen determinant.
I t  should be emphasized that К-c e ll a c t iv ity  essentia lly  exceeded 
normal values in  6 of the 7 patients revealing anti-LSP autoantibody 
p o s it iv ity .  Contrariwise, no such increase (2 -fo ld  of normal) occurred in 
the anti-LSP autoantibody negative and control groups. Although the 
present is  only in d ire c t evidence on the ro le  of ADCC reaction against 
l iv e r  c e ll membrane, corre la tions may serve as additional data. In patient 
No. 4 the anti-LSP autoantibody p o s it iv ity  has not been associated to high 
К-c e ll a c t iv ity . Because of the early diagnosis of a mild l iv e r  in ju ry  
(detected during a regular check-up) we assume that the autoreactive pro­
cess, i .e .  ADCC reaction had not been induced besides anti-LSP autoanti­
body production, which might be an in te rp re ta tion  of the low K-cel ac­
t iv i t y .
Although the number of patients according the d iffe re n t diagnoses 
was re la tive ly  low, we believe that the 65 cases (49 patients and 16 
contro ls) permit conclusions, the more so, because in  almost each of the 
7 anti-LSP autoantibody pos itive  cases ( in  6 from 7 К-c e ll a c t iv ity  has 
been extremely high. This corre la tion  (also s ta t is t ic a lly  of high s ig ­
n ificance) served as in d ire c t evidence on the ro le  of ADCC reaction. We 
assume that our resu lts , i .e .  the ind irec t evidence of ADCC reaction might 
promote knowledge on immune processes in  l iv e r  diseases and w i l l  be he lp fu l 
in  the decision of therapy.
REFERENCES
1. A c tis , G., M ie li-Vergagni, G., Portmann, В ., Eddieston, A.L.W.F., Davis, M., W ill ia rs , 
R.: Lymphocyte c y to to x ic ity  to  autologous hépatocytes in  a lcoho lic  l iv e r  disease. L ive r 
2 , 0-12 (1903)
2. Anthony, R.S., Farguharson, M., MacSween, R.N.: L ive r membrane antibodies in  a lcoho lic  
l iv e r  disease. I I .  Antibodies to e thanol-a ltered hépatocytes. J. C lin . Pathol. 36, 
1302-1308 (1903)
3. Bdyum, A.: Separation o f lymphocytes from blood and bone marrow. Scand. J . C lin . Lab. 
Invest. 21, 77-89 (1968)
4. Cohrane, A.M.G., Thomson, A.D., Moussours, A ., Eddieston, A.L.W.F., W illiam s, R.: A n ti­
body-dependent cell-mediated (К- c e l l)  c y to to x ic ity  against iso la ted  hepatocytes in  
chronic active h e p a tit is . Lancet 2 . 441-444 (1976)
5. Eddieston, A.L.W.F.: Immunology o f chronic active  h e p a tit is . Quart. 3. Med. 55, 191-198 
(1985)
6. Eddieston, A.L.W.F., M ondelli, M.: Immunpathological mechanism o f l iv e r  c e l l  in ju ry  in  
chronic h e p a tit is  В v iru s  in fe c tio n . J. Hepatol. 2> 17-23 (1906)
30 R. SCHNABEL e t  a l .
7. Garam, T ., Bakács, T ., Varga, M., Petrányi, Gy.: Entieri lymphocyták humán vörösvérsejtek
e l le n i cytotoxicus kapacitásának vizsgálata. Orv. h e t i l .  121, 1705-1708 (1980)
8 . H e lin , H., Uibo, R., Paronen, I . ,  Krohn, K .: Immunohistochemical lo c a liz a tio n  o f human 
l iv e r  specific  pro te in  using ra b b it antisera and the a v id in -b io tin  complex technique. 
C lin .  Exp. Immunol. 59 , 371-376 (1985)
9. Hopf, U., Meyer Zum Büschenfeide, K.H., Arnold, W.: Detection o f a liver-membrane auto­
antibody in  HB^Ag-negative chron ic  active h e p a tit is . N. Engl. 3. Med. 294. 578-582 (1976)
10. Kakumu, S., Yoshioka, K ., Tsubouchi, A.: Antibody to  l iv e r -s p e c if ic  lip o p ro te in  in  acute 
and chronic l iv e r  diseases. I t s  quantita tive  assay w ith  monoclonal antibody, but w ithout 
the use o f l iv e r -s p e c if ic  lipop ro te ins . G astroentero l. Jpn. 20, 216-221 (1986)
11. Jensen, D.M., McFarlane, I .G . ,  Portmann, В., Eddieston, A.L.W.F., W illiam s, R.: Detection 
o f  antibodies d irected aga inst a liv e r -s p e c if ic  membrane lip o p ro te in  in  pa tients w ith 
acute and chronic ac tive  h e p a t it is .  N. Engl. J. Med. 229, 1-9 (1978)
12. McFarlane, I.G ., McFarlane, B.M., Major, G.N., T o lley , P ., W illiam s, R.: Id e n tif ic a tio n  
o f  the hepatic as ia lo -g lyco p ro te in  receptor (Hepatic le c t in )  as a component o f l iv e r  
s p e c if ic  membrane lip o p ro te in  (LSP). C lin . Exp. Immunol. 55^ , 347-354 (1984)
13. McFarlane, I.G ., Hegarty, J .E . ,  McSorley, C.G., McFarlane, B.M., W illiam s, R.: Antibodies 
to  liv e r -s p e c if ic  p ro te in  p re d ic t outcome o f treatment withdrawal in  autoimmune chronic 
a c tive  hepa titis . Lancet 954-956 (1984)
14. M elicon i, R., S tancari, M .V., Garagnani, M., B a ra ld in i, M., S te fan in i, G .F., M ig lio , F ., 
G asbarrin i, G.: Occurrence and significance o f IgG l iv e r  membrane autoantibodies (LMA) 
in  chronic l iv e r  disease o f  d if fe re n t aetio logy. C lin . Exp. Immunol. 5^, 565-571 (1983)
15. Meyer zum Büschenfelde, K .H ., Miescher, P.A.: L ive r s p e c if ic  antigens: p u r if ic a tio n  and 
characteriza tion. C lin . Exp. Immunol. 1£, 89-102 (1972)
16. M ondelli, M., A lb e r t i,  A ., Tremolada, F ., W illiam s, R., Eddieston, A.L.W.F., Realdi, G.: 
In  v it r o  cell-mediated c y to to x ic ity  fo r autologous l iv e r  c e lls  in  chronic non-A, non-B 
h e p a tit is . C lin . Exp. Immunol. 63_, 147-155 (1986)
17. Morichiaka, S., Arima, T .,  Nagashima, H.: P u r if ic a tio n  and characteriza tion o f a l iv e r  
c e l l  membrane sp e c ific  an tig en . Gastroenterol. Jpn. 2^, 471-478 (1986)
18. Perperas, A., McFarlane, B.M ., McSorley, C.G., McFarlane, I.G ., W illiam s, R.: Species 
c ross -re ac tiv ity  o f anti-LSP antibodies in  acute v i r a l  h e p a tit is . J. C lin . Lab. Immunol. 
19, 25-30 (1986)
19. Schaffer, W.J., Kessler, D .J .: In Methods in  C e ll B iology. Acad. Press. New York-San 
Francisco-London, 21/B, 457-469 (1980)
20. Sípos, J ., McFarlane, B.M., McSorley, C.G., Gove, C.D., W illiam s, R., McFarlane, I.G .: 
Irrmunhistochemical demonstration o f the as ia log lycoprote in  receptor in  ra t l iv e r  by a 
sens itive  a v id in -b io tin  technique. J. o f Pathology 158, 247-252 (1989)
21. Thorn, R.M., Hanney, C .S .: K ine tics  analysis o f ta rg e t-c e ll destruction by e ffe c to r T 
c e lls .  J. Immunol. 119, 1973-1979 (1977)
22. Urbaniak, S .J.: Lymphoid c e l l  dependent (К- c e l l)  ly s is  o f human erythrocytes sensitised 
w ith  Rhesus a lloan tibod ies . B r i t .  J. Haematol. УЬ_, 409-413 (1976)
23. Ventoi, S., McFarlane, 8 .M ., McSorley, C.G., R an ie ri, S ., G iu lia n i-P ic c a ri, G., Dal- 
Monte, P.R., Verruchi, G ., W illiam s, R., Chiodo, F ., McFarlane, I .G .: L iver autoreactiv­
i t y  in  acute v irus  A, В and non-A and non-B h e p a tit is .  J. C lin . Lab. Immunol. 25, 1-7 
(1988)
AUTOANTIBODY AGAINST LIVER CELL MEMBRANE 31
24. Vergagni, D., M ie li-V ergagn i, G., M ode lli, M., Portmann, B ., Eddleston, A.L.W .F.: Immun­
g lobu lin  on the surface o f iso la ted  hepatocytes in  associated w ith antibody-dependent 
cell-mediated c y to to x ic ity  and l iv e r  damage. L ive r 307-315 (1987)
25. Zeijlemaker, W.F., Van Oers, R.H.J., De Boede, R .E .J ., Schellenens, P.Th.: C ytotoxic ac­
t i v i t y  o f human lymphocytes. Q uantita tive analysis o f T c e ll and К- c e l l  c y to to x ic ity ,  
revealing enzymlike k in e tic s . 0. Immunol. 119, 1507-1513 (1977)

A c ta  M e d ica  H u n g a r ic a ,  V o l .  4 8 / 1 - 2 ,  p p .  3 3 -4 3  (1 9 9 1 )
ENDOCRI NOL OGY
BIOLOGIC BLOOO MARKERS REFLECTING THYROID HORMONT EFFECT 
AT PERIPHERAL TISSUE LEVEL IN PATIENTS RECEIVING 
LEVOTHYROXINE REPLACEMENT FOR HYPOTHYROIDISM
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Plasma fib ro n e c tin , serum proco llagen-III-pep tide  and sex-hormone-binding g lobu lin  as 
non-specific  markers of thyro id  hormone effect a t periphera l tissue  le ve l were determined and 
th e ir  values were re la ted  w ith serum leve ls  o f TSH, free -thyrox ine  and triiodo thyron ine  
during lévothyroxine sodium replacement therapy fo r hypothyroidism. Low leve ls  o f b io log ic  
markers ch a ra c te ris tic  o f hypothyroidism were normalized in  consequence o f hormone replace­
ment and a negative c o rre la tio n  between th e ir  serum le v e ls , and TSH concentration was de­
monstrated in  most subjects. However, in  some patients a discrepancy in  the response to lévo­
thyroxine between the p itu ita ry  and other target organs was revealed. A dd itiona l evidence was 
disclosed tha t the p itu ita ry  thyrotroph sensitizes a minor decrease in  serum thyroxine le ve l, 
which would not be recognized by other target organs. Furthermore, i t  was revealed tha t dur­
ing L-T^ replacement therapy in  a large frac tio n  o f pa tien ts  w ith  subnormal serum TSH con­
centra tion blood leve ls  o f the measured markers often exceeded the upper l im it  o f the normal 
range ind ica ting  a p o s s ib il ity  o f "tissue" thy ro tox icos is , besides the p itu ita ry ,  in  other 
ta rge t organs, too. According to the present study, which takes in to  consideration markers 
re fle c tin g  end-organ responsiveness to  thyro id  hormones, i t  is  reconmended to  adjust the dose 
o f lévothyroxine to maintain serum TSH in  the normal range. For pa tients  w ith subnormal TSH 
concentration a close fo llow-up is  ob liga tory  and in  case o f concomitantly raised free- 
thyroxine leve l the reduction o f the lévothyroxine dosage is  proposed.
Keywords : Thyroid hormones, peripheral tissue le v e l,  lévothyroxine, hypothyroidism
In tro d u c tio n
The choice of lévothyroxine sodium (L-T^) as the most appropriate 
form of thyro id hormone replacement therapy fo r hypothyrodism has been 
well documented. However, the fine  adjustment of the L-T^ replace­
ment doses frequently presents a challenging problem. I f  the preparation
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is  administered in  an inadequate dosage, subclin ica l hypothyroidism may be 
l e f t  over or subclin ica l hyperthyroidism may be induced. In the la tte r  
case TSH secretion is  already suppressed, while serum thyro id  hormone 
le v e l is  s t i l l  w ith in the normal range and the patien t seems to be 
c l in ic a l ly  euthyroid /14, 19/.
Measurement of serum TSH concentration applying a sensitive method 
which can distinguish normal from subnormal levels is  considered the most ac­
curate te s t fo r optimizing long-term L-T^ replacement therapy /6 , 9, 
16-18/. I t  is  widely accepted tha t normal TSH concentration is  an in ­
d ica to r of appropriate hormone replacement, while a subnormal leve l refers 
to excessive L-T^ dosage. However, according to some observations each 
subject has a unique TSH se tpo in t, thus, the attainment of a "normal 
range" TSH value during replacement therapy may not re lia b ly  denote a 
s ta te  o f euthyroidism in  every patient /1 6 /. Furthermore, experimental 
data /7 /  indicate that the p itu ita ry  is  more sensitive to serum T  ^ than 
other ta rge t organs and th is  has led to the assumption that serum TSH 
le v e l does not represent the assessment of overtreatment w ith L-T^. Thus, 
a suppressed TSH secretion would not indicate the induction of "tissue "- 
thyro tox icos is  re lia b ly .
Late ly some sensitive but not specific  methods have been developed 
which re f le c t  the e ffec t of thyro id  hormones at peripheral tissue leve ls. 
Plasma fib ronectin  (pFn), serum procollagen-III-peptide (P -III-P ) and sex- 
hormone binding globulin (SHBG) determinations are included in  the 
category of these tests /2 , 3, 8, 10-12/. Assessment of these b io log ic 
markers in  blood may point to  the various peripheral tissue responses to 
th y ro id  hormones. The present study was undertaken to detect by these 
markers the peripheral responses to L-T^ replacement in  patients with 
hypothyroidism and to reveal a possible re la tionship between th e ir  serum 
leve ls  and TSH concentration. Furthermore, from the resu lts  of th is  in ­
ves tiga tion  we intended to provide evidence of the appropriateness cf 
L-Тд dosage.
P a tie n ts  and Methods
Two groups of patients w ith  primary hypothyroidism were studied. In to  the f i r s t  
group 18 untreated female pa tients (age 20-6t^^pars) were enro lled . The th y ro id  gland fa ilu re  
resu lte d  from Hashimoto's th y ro id it is  and I  therapy or su rg ica l treatment o f Graves' 
hyperthyroidism  or tox ic  nodular g o ite r . A fte r the establishment o f the diagnosis lévo­
thyrox ine  replacement treatment was s ta rte d  (L -lhy rox in , Henning) w ith an in i t i a l  dose of
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25-50 yjg/day. Blood samples were taken at the end o f each month and i f  i t  was necessary the 
L-T^ dose was increased by 25 ug/day increments each month t i l l  the maintenance dosage was 
a tta ined . Before the in i t ia t io n  o f the hormone su b s titu tio n  and a fte r adm in is tra tion  o f a 
constant maintenance L-T dose a t least fo r 3 months, serum leve ls o f free -thyrox ine  (FT^), 
free -triiod o th y ron in e  (FT ) ,  TSH, P -II I-P , SHBG and pEn were determined. Having received 
L-T^ fo r replacement, each pa tient became c l in ic a l ly  euthyroid and the serum le v e l o f TSH 
was w ith in  the normal range.
Patients in  the second group were referred to  the thyro id  outpatient c l in ic  o f the 
F irs t Department o f Medicine o f our U n ivers ity . This group comprised o f 113 hypothyroid 
female subjects (age: 20-60 years) who had received Thyranon (Organon) or E ltro x in  (Glaxo) 
fo r s u b s titu tio n  therapy and la te r  these preparations were changed to L-Thyroxin (Henning). 
At the time o f the investiga tion  a l l  patients were c l in ic a l ly  euthyroid and had been rece iv ­
ing a constant maintenance dose o f L-Thyroxin fo r a t least 3 months. According to  th e ir  
serum TSH leve l tha t pa tients  were c la ss ifie d  in to  3 subgroups: a) normal serum TSH: 0.3-3.0 
mU/l; b) subnormal TSH concentration: < 0 .15  mU/1; c) high serum TSH: >  3.0 mU/1. Patients 
with an intermediate serum TSH value (0.15-0.3 mU/1, so-ca lled "gray zone") were dropped out 
o f th is  study.
For the measurement o f serum hormone le ve ls  commercially available k i t s  were used: 
Free-thyroxine (FT^; Anerlex M FT^; Amersham; norm, range: 9.5-24.5 pmol/1); f re e - t r i io d o -  
thyronine (FT ; Amerlex M FT^; Amersham; norm, range: 3.5-9.3 pmol/1); TSH (IRMA-mat TSH; 
Byck-Sangtek; norm, value: 0.3-3.0 mU/1). For the assessment o f thyro id  hormone e ffe c t at 
periphera l tissue leve l the fo llow ing methods were applied: 1. plasma fib ro n e c tin : Blood was 
taken o f f  in to  EDTA containing tubes and pFn was determined w ith the Boehringer tu rb id im e tric  
te s t k i t s  adapted to H itach i 704/c; norm, value: 300-550 ug/ml; 2. P roco llagen-III-pep tide : 
RIA-giost P - II I-P  (Bdhring); norm, value: 0.3-0.8 U/ml; 3. SHBG: sex-hormone b ind ing  g lobu lin  
assay k i t  (Farmos); normal value: 30-90 nmol/1 (untreated females; age: 20-60 years).
Student’ s unpaired ta te s t and one way ana lysis o f variance were used in  s ta t is t ic a l 
analysis. Mean +^S.D. are presented in  the Tables.
Results
Data fo r 18 patients with primary hypothyroidism are demonstrated 
in Table I .  I t  is  noteworthy that p rio r to in it ia t io n  of replacement L-T^ 
therapy among the markers related to the peripheral responses to thyroid 
hormones the pFn and SHBG levels were low, while the mean value of P -III-P  
approached the lower l im it  of the normal range. During hormone replacement 
therapy the mean serum or plasma levels of TSH, FT^, FTj, pFn, P - III-P  and 
SHBG were unanimously normalized.
Table I I  shows the serum TSH, FT^, FT^, pFn, P -III-P  and SHBG levels 
of 113 patients with hypothyroidism receiving L-T. fo r hormone replace­
ment. The subjects were c lass ified  in to  3 categories on the basis of the ir 
serum TSH concentration. The test resu lts  of the groups with subnormal or 
high TSH levels were correlated with the data obtained in the group with 
normal TSH leve l. In the subnormal TSH group the mean FT  ^ leve l was 
s lig h t ly  raised while in  the high TSH group i t s  value was lower than that 
found in  the group with normal serum TSH concentration (P < 0.001); how-
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Table I
Test re s u lts  (means ~S.D.) o f pa tients (n-lB ) w ith  primary hypothyroidism p r io r  to  
treatm ent and fo llow ing  lévothyroxine sodium replacement therapy (means -dà.O.). 
In  brackets are given the reference ranges of the te s ts . Asterisks denote s ig ­
n if ic a n t d iffe rences from values p r io r  to  therapy 
(S tudent's unpaired t_-test)
P rio r to 
treatment
During L-T^ 
replacement treatment
TSH mU/1 
(0 .3 -3 .0 )
51.8 + 28.4 1.3 + 0.9***
FT pmol/1 
(9 .5 -24 .5 )
4.8 + 3.0 1 7 .7 + 2 .8 ** *
FT pmol/1 2.8 + 1.2 5.6 + 0.9***
(3 .5 -9 .3 )
F ibronectin  yjg/ml 
(300-550)
252.3 +59.6 415.8 +93.7***
Procollagen I I I  
peptide U/ml 
(0 .3 -0 .8 )
0.33+ 0.09 0.64+ 0.12***
SHBG nmol/1 
(30-90)
27.7 +10.3 51.9+17.1***
***P  < 0 .0 0 !
every, th e ir  values were s t i l l  w ith in the wide normal range. In a l l  3 
groups FTj levels were equally normal, though, a s ign ifican t d ifference 
was demonstrated between th e ir  mean values. In the group with subnormal 
serum TSH content the mean values of pFn, P - II I-P  and SHBG compared to 
those in  the group with normal TSH, were s ig n if ic a n t ly  (P <  0.001) elev­
ated, but only the mean pFn leve l exceeded the upper l im it  of the normal 
range. At la s t i t  is  shown tha t in the group w ith a s t i l l  raised TSH con­
cen tra tion  the mean serum levels of P -III-P  and SHBG became already 
normal, and th is  is  va lid  also fo r pFn, but i t s  mean level remained s ig ­
n if ic a n t ly  lower than that in  the normal TSH group (P <  0.01).
Figures l /а, 1/b, 1/c show the ind iv idua l pFn, P -III-P  and SHBG values 
fo r L-T^-treated patients recruited to groups w ith normal, subnormal or 
s t i l l  high serum TSH concentration and cases w ith normal or raised FT  ^
leve ls  are presented separately. FT  ^ values were elevated only in  4 cases 
in  the group with low TSH leve l. Conversely, the FT  ^ levels were higher
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Table I I
Serum leve ls  (means ~S.D.) of TSH, free -Тд , free-T -, and b io log ic  markers from 
113 hypothyroid pa tients  receiving a constant dose of lévothyroxine sodium and 
categorized according to serum TSH concentrations.Asterisks denote s ig n if ic a n t 
d ifferences from group w ith normal TSH (one wav ANOVA)
Subjects c la s s if ie d  by serum TSH leve l
TSH subnormal TSH normal TSH high
(n=32) (n=63) (n=18)
TSH mU/1 0.15*** 1.80 +1.21 15.18 + 7.14***
FT^ pmol/1 20.54 + 3.94*** 16.78 + 3.81 12.42 + 1.56***
FTj pmol/1 6.97 .2 .7 1 * * 5.34 + 1.09 4.39 +_ 0.98*
F ibronectin yug/ml 590.5 +183.0*** 426.4 +100.0 322.5 +88.9**
Proco1lagen-111-pept ide 0.78 + 0 .28*** 0.59 + 0.9 0.48 + 0.18
U/ml
SHBG nmol/1 75.6 + 3 5 .5 *** 48.6 + 2 0 . 6 36.1 + 1 3 .4
*P < 0 .05 ; **P <  0.01; ***P <  0.001
Plasma
fib ronectin
fjg /m l
Fig. 1/a.
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Procollagen-III peptide 
U/ml
than normal in  15 subjects o f the 32 patients w ith undetectable TSH con­
centra tions and in  6 cases of the 63 patients with normal TSH leve ls .
Of the 32 patients with subnormal TSH concentrations in  21 cases the 
pFn, in  16 subjects the P -III-P  and in  9 patients the SHBG levels exceeded 
the upper l im it  of the normal range. This re fers especially to patients 
w ith concomitant raised FT^levels. I t  is  noteworthy, however, that out of 
63 p a tien ts  with normalized TSH leve l in  10 cases the pFn, in  11 subjects 
the P - II I-P  and in 9 cases the SHBG levels were higher than normal. On the 
other hand, in  the group with elevated TSH concentration (n=18) in  8 cases 
the pFn, in  5 the P -III-P  and in  6 subjects the SHBG values were lower 
than normal.
Figure 2 demonstrates tha t in  5 cases of the group with subnormal 
serum TSH concentration the high pFn values decreased s ig n if ic a n tly  
fo llow ing  the reduction of the L-T replacement dose, when the serum TSH 
le ve l returned to the normal range.
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F ig , l /а ,  1 /b, 1 /c . PJos'ia fib ro n e c tin , serum p roco llagen-III-peptide  a i J sex-hormone binding 
g lo b u lin  leve ls  o f pa tients receiving a constant lévothyroxine sodium replacement dose fo r 
hypothyroidism (n=113). The subjects are categorized by th e ir  serum TSH le v e ls . C la s s if i­
ca tion marks; ^  TSH subnormal; 'MSH high; 0 FT^ w ith in  the normal range, •  ra ised  FT 
le v e l. Broken lin e s  ind ica te  the reference range o f the b io log ic  markers
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Plasma fibronectin  
|ug/ml
1100-
1000-
9 0 0 -
8 0 0 -
7 0 0 -
6 0 0 -
5 0 0 -
4 0 0 -
3 0 0 -
200 -
dose A dose B
F ig . 2 , Plasma f ib ro n e c t in  le v e l be fo re  and a f te r  a re d u c tio n  o f  lévo thyrox in e  sodium dose. 
P a tie n ts  had a subnormal serum TSH concentra tion nn dose A and a normal TSH value on dose В
Discussion
In the presence o f thyroid gland fa i lu re  signs ind icative of 
"tissue"-hypothyroidism might be discovered. In accordance with th is  ob­
servation blood leve ls o f the biologic markers re fle c tin g  thyroid hormone 
e ffe c t at peripheral tissue  level are usually lower than normal. In th is  
regard present find ings are corroborating previous data /2 , 3, 8, 11/. 
Ihe goal of our fu rth e r studies was to reveal a change in  the blood levels 
of these markers during L-T^ replacement therapy and to find out a re l­
a tionship between th e ir  serum levels and ISH concentration.
In most patients receiving hormone su b s titu tio n  normal serum ISH 
leve ls  have been detected and the value of FT^ occasionally exceeded the 
upper l im it  of the normal range. In th is  group of patients hormone re­
placement with L -l^  seemed to be successful, as fo r  the most part of these
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subjects the blood levels of the b io log ic markers were w ith in  the normal 
range. I t  is  remarkable, however, that in  some cases the serum leve ls of 
the measured markers were s lig h t ly  higher than normal, ind ica ting  a d is ­
crepancy in  the response to  L-Тд between the p itu ita ry  and other target 
tissues.
Some c lin ic a lly  euthyroid subjects who were on a stable dose of 
L-Тд had a high TSH le ve l, apparently due to under-replacement or non- 
compliance. Our observations indicate tha t serum Тд leve l gains an access 
to the wide normal range a fte r a lower dose of hormone replacement than i t  
is  needed to normalize TSH secretion. This find ing proves tha t fo r the 
fine  adjustment of the replacement dose a single FT  ^ determination is  not 
enough. In the m ajority of these patients serum levels of the measured 
b io log ic markers were already w ith in the normal range in  contrast with the 
s t i l l  elevated TSH concentration. This observation is  in  agreement with 
e a rlie r data suggesting that the p itu ita ry  thyrotroph sensitizes even a 
minor decrease in  serum Тд to a value that is  s t i l l  w ith in  the normal 
range, which would not be recognized by other target organs /15, 16/. Con­
versely, in  other subjects the serum levels of the b io log ic markers re­
mained s t i l l  low, ind ica ting  subsistent "tissue"-hypothyroidism. This, 
taken together with high serum TSH concentration, recommends an increase 
of the hormone-replacement dose.
The evaluation of patients with subnormal serum TSH concentration 
during L-Тд replacement therapy is  s t i l l  debatable. To fin d  out whether 
doses of L - Т д  s u ffic ie n t to suppress TSH secretion cause "tissue "-thy ro - 
toxicosis also in  other organs, some authors have recently used additional 
methods fo r the estimation of peripheral tissue responses to thyroid 
hormones /4 , 5, 12, 13/. In the present study based upon the measurement 
of some b io log ic markers, we demonstrated a high ind iv idua l v a r ia b il i ty  
of tissue s e n s it iv ity  to thyroid hormones. Nevertheless, i t  was shown that 
in a large frac tion  of patients with subnormal serum TSH concentration the 
blood levels of b io log ic  markers re fle c tin g  thyroid hormone e ffe c t at 
peripheral tissue leve l exceeded the upper l im it  of the normal range. In 
th is  group of patients, however, a s t r ic t  corre la tion  between serum FT  ^
leve l and the development of "tissue"-thyro tox icos is  could not be revealed, 
as the serum levels of the b io log ic markers were elevated in  some patients 
with "normal" range РТд le ve l, too. I t  seems plausible that in  some in ­
dividuals serum FT  ^ levels which are s t i l l  w ith in  the broad normal range, 
but are already capable of suppressing p itu ita ry  TSH secretion may induce
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changes in  other target organ functions s im ila r to , but less marked than, 
those recorded in overt hyperthyroidism. At the same time, i t  can be 
sta ted that pFn and P -III-P  values were frequently elevated in those pa­
t ie n ts  with subnormal TSH concentrations who had concomitantly s lig h t ly  
ra ised serum FT  ^ leve ls, re fe rr in g  to a generalized tissue overexposure to 
thy ro id  hormones. In th is  group of patients such a re lationship between 
the b io log ic  markers and serum FT  ^ was not detectable. At la s t, our data 
ind ica te  that in some pa tien ts  with subnormal serum TSH content the high 
pFn le ve l tru ly  reflected "tissue "-thy ro tox icos is , as i t s  plasma leve l de­
creased s ig n ifica n tly  a fte r  a reduction of the replacement hormone dose.
Present observations which take in to  consideration the markers 
re f le c t in g  end-organ responsiveness to thyro id  hormones are in accordance 
w ith  e a r lie r  studies and show the superio rity  of a sensitive TSH assay 
over FT^ or FTj measurement in  iden tify ing  patients receiving excessive 
L-T^ doses /4, 5, 12, 13/ and to a l l  p ro b a b ility  in  a large frac tion  of 
pa tien ts  subnormal serum TSH leve l may denote the development of "tissue "- 
thyro tox icos is  beside the p itu ita ry  in other ta rge t organs, too. In the 
event o f undetectable serum TSH as a second-step the determination of serum 
FT^ is  ju s t if ie d  and i f  i t s  value is  raised a reduction of the L-T^ dose 
is  necessary. Furthermore, patients who have suppressed TSH secretion 
despite "normal"-range serum FT  ^ value should be closely followed-up in  
the long-term, too.
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The authors have reviewed the sex ra t io  in  353 o ffsp rin g  o f adolescent partu rien ts  
based on a 5-year m ateria l o f th e ir  department. The 174 males and 179 females provided a sex 
ra t io  o f 97.2; less than the usual ra t io  o f 106. In te re s tin g ly , females are prevalent not 
only among low -b irth-w eight but also among average-birth-weight babies o f adolescents. The 
hypothesis is  presented th a t the anatomy of the cerv ix  and the chemical composition o f the 
ce rv ica l mucus may a ffe c t the sex ra t io  in  some manner.
Keywords : Adolescent mothers, sex ra tio
In tro d u ctio n
The question of sex ra tio  in  re la tion  to maternal age has been a 
controversial subject in  the lite ra tu re  during the past several decades. 
In many obste tric  complications and also in  cases involving perinata l 
death, the number of males appears to exceed that of females. Noting the 
opinion that teenage gestations involved increased perinata l r is ks , we 
f e l t  that the sex ra t io  of the offspring in  these gestations deserved in ­
vestigation . •
O ffp r in t requests should be sent to  Ä.A. Jakobovits, H-5600 Békéscsaba, Berzsenyi u. 
1, Hungary
Akadémiai Kiadű, Budapest
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P a tie n ts  and Methods
We investigated the 5-year m ateria l o f our department between January 1, 1985, and 
December 31, 1989. We sought to  c la r i f y  the to ta l number o f adolescent mothers, the pro­
p o rtio n  o f  such mothers in  our e n t ire  o b s te tr ic  population and the sex ra tio s  (number o f boys 
per 100 g ir ls )  in the investiga ted  m ateria l. The sex ra t io  o f newborn babies o f adolescent 
mothers was compared w ith th a t o f  a l l  ot£ier pregnancies. The s ign ificance  o f the d ifferences 
was investiga ted  s ta t is t ic a lly  by the X  te s t.
Results
During the quoted study years, 351 parturien ts were less than 18 
years old at the time of the delivery. Some adolescent g ir ls  gave b ir th  
more than once during the 5 study years. Since during the same time 7567 
women delivered in the department, the ra tio  of adolescents was 4.64 per­
cent. Two adolescents gave b ir th  to twins. Each pa ir belonged to the same 
sex. Thus, the to ta l number of neonates was 353, including 174 males and
179 females sex ra tio : 97.2. The sex ra tio  in  the to ta l population was 
2
106. The difference (X = 0.66) was not s ig n ifica n t.
In the adolescent group, the most frequent age was 16-17 years (Table 
I ) .  The youngest pa rtu rien t was 12 years old.
Table I
Sex ra t io  o f neonates according to  maternal age
Maternal age
(years)
Number o f 
cases
Per cent Boys G ir ls Sex ra t io
12-13 3 2 1
14-15 46 25 21 119.0
16-17 304 86.12 147 157 93.6
Total 353 174 179 97.2
There were no ch a ra c te ris tic  differences of sex ra tio  according to 
the gestation length at the time of the de livery (Table I I ) .  The sex 
ra t io  was re la tive ly  high when delivery occurred between 31 and 32 and be­
tween 37-38 weeks. The ra t io  was the lowest between 35 and 36 weeks.
The b irth  weights o f neonates ranged between 500 and 4850 grams 
(Table I I I ) .  The sex ra t io  tended to increase with increasing b irth  
weights of the neonates.
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Table I I
Sex ra t io  o f neonates according to gestation length a t b ir th
Gestations age 
(weeks)
Number of 
cases Per cent Boys
G irls Sex ra t io
23-24 3 2 1
25-26 1 1 0
31-32 6 4 2
33-34 7 3 4
35-36 17 7 10 70.0
37-38 64 18.13 35 29 120.7
39-40 212 60.06 104 108 96.3
41-42 43 18 25 72.0
Total 353 174 179 97.2
Table I I I
Sex ra t io  of neonates according to b ir th  weights
Body weight
(g)
Number of 
cases Per cent
Boys G irls Sex ra t io
500- 999 4 3 1
1000-1499 3 1 2
1500-1999 6 4 2
2000-2499 34 13 21 61.9
2500-2999 103 29.18 45 58 77.6
3000-3499 137 38.81 68 69 98.6
3500-3999 53 15.01 32 21 152.4
4000-4499 12 7 5 140.0
4850 1 1 0
Total 353 174 179 97.2
s t i l l b i r t h s and s ix n e o n a ta l d e a th s w i t h in two day:
delivery occurred during the five  years. Of these fetuses and neonates, 
seven were males and one was female.
Discussion
According to our current understanding, the sex of the offpsring  is  
determined by the fe r t i l iz in g  spermatozoon. The Y-chromosome-carrying 
androspermatozoa have smaller head, longer t a i l ,  and move fas te r than X- 
carrying gynospermatozoa /9 /. Furthermore, i t  appears that the andro­
spermatozoa are more vulnerable than gynospermatozoa, insofar as in con-
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nection with cryopreservation, the sex ra tio  is  as low as 75-77; consider­
ably lower than the usual 105-107. After a r t i f i c ia l  insemination resu lting  
from the use of fresh sperm, the noted sex ra t io  is  91.6-92 /1 , 8 /. Some 
authors have found that vaginal inflammations decreased the sex ra tio  
because the gynospermatozoa were more resistant of v a g in itis  on spermatozoa 
/6 , 7 /. We did not found any case of c o lp it is  in  the documentation of our 
re levan t material. In con trast, in  cases of in  v it ro  fe r t i l iz a t io n ,  when 
the spermatozoa do not need to pass through the gen ita l canal, the sex 
ra t io  is  as high as 183, presumably due to the fa c t tha t the spermatozoa 
escape the vicissitudes associated with passage through the female gen ita l 
t r a c t  /10 /. A d iffe re n t in te rp re ta tio n  was presented by James /5 / who 
a ttr ib u te d  the high male ra t io  to the induced high estrogen levels as­
sociated with the assisted reproduction.
• In previous pub lica tions, we reported a high proportion of female 
o ffsp rin g  among low-b irth-weight neonates /3 , 4 /. A s im ila r observation, 
in vo lv ing  a sex ra tio  of 92.2 of low-birth-weight neonates was reported 
from Aberdeen, Scotland, fo r  the years 1961-1979. Interestingly, in  Soct- 
land a t large, between 1973 and 1979, the sex ra t io  showed close re la tio n ­
ship and decreased with gestation length at b ir th  (136.6 before the 27th 
week and 104.6 by the 40th week). This conclusion was based on an exten­
s ive  review that involved a to ta l of 169 631 b irths  /2 / .
In our material, the sex ra tio  was low between 2.500 and 3.499 g 
b ir th  weight. One may speculate that in  the adolescent age group the 
progress of androspermatozoa along the genita l tra c t is  hindered by some 
as yet unc la rified  mechanism.
In our experience, ne ither parental age nor b ir th  order is  a s ig ­
n if ic a n t  factor, per se, w ith  regard to the determination of the gender of 
the o ffsp ring . However, i t  is  conceivable, that the mechanism of trans­
p o rta tio n  plays a lim ited  ro le  by hindering in  adolescents the passage of 
Y carry ing  spermatozoa. I t  is  understood tha t the transportation of 
spermatozoa is  influenced by a variety of facto rs , which are hormonal, 
rheolog ic and, perhaps, also mechanical or chemical in  nature. Relevant 
fa c to rs  appear to be the patency of the cervica l canal, the chemical com­
p o s itio n  of the cervica l mucus, vaginal f lu id  and, possibly, some other 
fac to rs  that could conceivably be related to  previous ch ild b irth s .
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In order to  examine the prognostic value o f d if fe re n t cardiopulmonary variab les in  
adu lt resp ira to ry d is tre ss  syndrome the data o f 30 pa tients  w ith th is  i lln e s s  were studied 
re trospec tive ly . The pa tients  were divided in to  3 groups: Group A: survivors (9 cases, 40 
examinations), Group B: ea rly  stage nonsurvivors (8 cases, 37 examinations), Group C: la te  
stage nonsurvivors (19 cases, 89 examinations). In  6 nonsurvivor pa tients a few measurements 
were done in  the ea rly  and la te  stage, too. There were h igh ly  s ig n if ic a n t d iffe rences between 
Groups A and C (mean pulmonary a r te r ia l pressure, pulmonary a r te r ia l d ia s to lic  pressure minus 
pulmonary c a p illa ry  wedge pressure, le f t  v e n tricu la r stroke work index, systemic and pulmon­
ary vascular resistance, insp ired oxygen fra c t io n , a r te r ia l oxygen tension per inspired 
oxygen fra c tio n , mixed venous oxygen sa tu ra tion , pulmonary shunt fra c tio n , and oxygen 
d e live ry , but the d iffe rences in  re la tio n  to  other groups were less prominent. Using a step­
wise d iscrim inant ana lys is , i t  was found th a t the oxygenation parameters alone determined the 
outcome co rrec tly  in  68-75%. Extending the analysis to haemodynamic variab les the re s u lt im­
proved (72-80%). S im ila r p red ic tion  was obtained when parameters po ten tiona lly  measurable by 
noninvasive methods were analysed (69-80%). These re s u lts  suggest th a t i t  is  possible to  pre­
d ic t  the outcome o f ARDS co rre c tly  without any invasive monitoring technique.
Keywords : Prognosis p red ic tion , ARDS, haemodynamics, oxygenation, discrim inant
analysis
Abbreviations: ARDS : adu lt resp ira to ry  d is tre ss  syndrome, Cl : cardiac index, CVP : 
cen tra l venous pressure, DO : oxygen de live ry , FiO^: fra c tio n  o f inspired oxygen, LVSWI: le f t  
v e n tricu la r stroke work inœ x, MPAP: mean pulmonary a r te r ia l pressure, MSAP: mean systemic 
a r te r ia l pressure, O^ER: oxygen extraction ra t io ,  PADP-PCWP: pulmonary a r te r ia l d ia s to lic  -  
pulmonary c a p illa ry  wedge pressure, PaO^: a r te r ia l oxygen tension, PCWP: pulmonary ca p illa ry  
i«edge pressure, PEEP: p o s itive  end expiratory pressure, PVR: pulmonary vascular resistance, 
Qs/Qt: re igh t to le f t  shunt, RPP: rate pressure product, RVSWI: r ig h t v e n tricu la r stroke work 
index, SV: stroke volume, SvO^: mixed venous oxygen sa tu ra tion , SVR: systemic vascular 
resistance, VO^: oxygen consumption
O ffp rin t requests should be sent to : T. Gondos, H-1135 Budapest, Szabolcs u. 35,
Hungary
Akadémiai Kiadó, Budapest
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Introduction
Outcome prediction has a great importance in  the treatmeet of c r i t i ­
c a lly  i l l  patients. Shoemaker et a l.  /2 , 17, 19, 20/ developed a predic­
t iv e  index based on nonparametric multivariance analysis of the cardio­
resp ira to ry  data of c r i t ic a l ly  i l l  surgical patients. In patients with 
ARDS Smith and Gordon /24/ described a simple index to predict outcome, 
invo lv ing  only 3 parameters (age, airway pressure, a lveo lo -a rte ria l oxygen 
gradient) to determine the "v e n tila to r score". The disadvantage of th is  
method was that a real d iscrim ination between survivors and nonsurvivors 
became possible only from the 9th day of the ve n tila to r therapy. Hankeln 
e t a l.  /9 /  used a complex cardiorespiratory prognostic index in ARDS, 
re su ltin g  in  a useful way to  pred ic t outcome but only in  the la te  stage. 
For outcome prediction several other studies /4 , 6, 22, 29/ proposed that 
the VO2  is  the main parameter of the prognosis, because i t s  leve l depends 
on the function of d iffe re n t organs. Recently, however, th is  statement has 
been disproved /10, 27/. The prognostic value of V02 has not improved even 
by i t s  entering in to  the SAPS (S im plified  Acute Physiologic Score) system. 
Knaus e t a l. /11/ developed the Acute Physiologic and Chronic Health 
Evaluation (APACHE I I )  system containing also resu lts  on the oxygenation. 
I t  is  a useful and sensitive index to graduate the severity of the illn e ss  
and thus predict the outcome. Much of the score re lie s  upon time-consuming 
laboratory data. I t  has a lim ite d  use as a too l fo r re p e tit ive , hour to 
hour evaluation. The aim of. the present retrospective study was to evalu­
ate the prognostic role of the d iffe re n t cardiorespiratory data in  pa­
tie n ts  w ith ARDS of d iffe re n t aetiology.
Patients and Methods
T h ir ty  patients (16 females, 14 males, aged 14-71, mean 48 years) w ith  ARDS o f 
various o r ig in s  were included in  the study. Each pa tien t met the c r i te r ia  fo r the diagnosis 
o f ARDS: 1_) an acute, progressive resp ira to ry  fa ilu re  w ithout p re -ex is ting  lung and heart 
diseases, 2) FiO higher than 0.4 necessary to  maintain PaO  ^ above 60 mmHg a t zero le v e l o f 
PEEP, 2 )  necessity o f more than 72 h o f mechanical v e n tila t io n , 4) d iffu s e , b ila te ra l pulmon­
ary in f i l t r a t e s  on chest X-ray, and 5) w ithout evidence o f l e f t  ve n tricu la r fa ilu re  (PCWP 
less than 15 mmHg).
Associated conditions were: sepsis in  12, thoracic  surgery in  10, abdominal surgery 
in  9, pulmonary embolism in  4, m u ltip le  in ju ry  in  2 and paraquat in to x ica tio n  in  one cases.
For the study the pa tients were divided in to  3 groups: Group A: survivors (9 cases, 
40 measurements) who had been weaned from resp ira to ry  support and recovered, Group B: non- 
su rv ivo rs , early  stage group (8 cases, 37 measurements) who died during the treatm ent, but
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the measurements were done up to 5 days before death, and Group C: nonsurvivors, la te  stage 
group (19 cases, 89 measurements) where the measurements were done during the la s t  5 days of 
the l i f e .  In 6 pa tien ts  the measurements were repeatedly performed before and a f te r  the lim it  
time (5 days) between Groups 8 and C, so the sum o f cases o f the groups exceeded the number 
o f the studied pa tie n ts . During the examination period each pa tient was given mechanical 
v e n tila tio n  and the same therapeutical p ro toco l was applied. Pulmonary haemodynamics were 
measured w ith Swan-Ganz catheters (7F Edwards). Cardiac output was determined by the thermo- 
d ilu t io n  method (S irecust 404, Siemens, FRG). Each measurement was performed a t least in 
t r ip l ic a te s  w ith the mean taken as cardiac ou tpu t. To characterize the haemodynamic status 
o f the patients the fo llow ing  parameters were used: MSAP, MPAP, PCWP, CVP, PADP-PCWP, Cl, 
LVSWI, RVSWI, PVR, SVR and RPP.
A rte r ia l and mixed venous oxygenation parameters were measured w ith  a blood gas ana­
lyser (Radiometer ABL 300, Copenhagen, Denmark). To characterize the oxygenation status of 
the pa tients, the fo llow ing  parameters were used: SvO^, PaO^/FiO^, DO ,^ O^ER, V0^, Qs/Qt. At 
derived parameters we used conventional equations /8 / .
S ta t is t ic a l analysis used means +S.D., m u ltip le  ta te s t, and the d isc rim inan t analysis 
te s t o f the SPSS s ta t is t ic a l software package. This analysis was a stepwise va riab le  selec­
tio n  w ith the se lec tion  ru le  minimized by W ilk 's  lambda value.
Results
The summarized cardiorespiratory data of the patients are shown in 
Table I .  There are s ig n ifica n t differences between Groups A and in MPAP, 
PADP-PCWP, CI, SV, LVSWI, SVR, PVR, Fi02, Pa02/F i02, Sv02, Qs/Qt, and D02- 
The data of Group В take an intermediate position between survivors and 
late-stage nonsurvivors. C lin ica lly  important differences between Groups A 
and j) are only in Cl, PVR, and D02, and between Groups В and Jl in  Pa02/Fi02, 
Sv02 and Qs/Qt.
To determine the prognostic ro le  of oxygenation parameters in ARDS, 
the follow ing variables were entered in to  the discrim inant analysis: V02, 
D02, 02ER, Sv02, Qs/Qt and Pa02/F i0 2. Taking Groups A and ]3, D02 and 
Pa02/F i02 were included in to  the analysis with mean c la s s if ic a tio n  value 
of 68% (Table I I ) .  Dsing the same parameters, the d iscrim ination  between 
Groups A and £  was higher: 75%. The re su lt was sim ilar in  Groups В and C 
(mean c la ss ifica tio n  value: 74%), but the involved parameters changed for 
Qs/Qt, Pa02/F i0 2. In the next step, a l l  of the examined parameters were 
entered in to  the analysis (Table I I I ) .  Analysing the data of Groups A and Д 
the discrim inating variables (Cl, PVR, Pa02/F i02) changed and th e ir  aver­
age discrim inant function increased to 74%. The best re su lt was achieved 
between Groups A and (1 (Fig. 1). The involved Cl, PADP-PCWP and Pa02/F i02 
variables correc tly  c lass ified  the data in  80%. The d iscrim ination  between 
Groups В and £  was 72% and the included parameters changed fo r SVR,V02 and 
Pa02/F i02. F in a lly , the prognostic function of the d iffe re n t potentianally
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Table I
Summarized card iorespiratory data o f survivors (Groups A ), e a rly  stage nonsurvivors 
(Group B), and la te  stage nonsurvivors (Group C)a
.. ., Group A Group В Group C
n l S n=40 n=37 n=89
MSAP mmHg 108 + 15 102 + 16 100 + 19*
MPAP mmHg 23 + 8 26 + 7* 28 + 8***
PCWP mmHg 11 + 5 12 + 4 11 + 4
CVP mmHg 5 + 2 5 + 3 5 + 3
PADP-PCWP mmHg 3 + 4 5 + -jXX 6 + .XXX4 о
Cl 1/min/m2 4.3 + 1.2 3.4 + 0 .8 *** 3.5 + j  jXXX
S V ml 78 + 20 68 + 14* 57 + 23***
LVSWI gxm/m2 58 + 15 50 + 20* 43 + 20***
RVSWI gxm/m2 9 + 3 9 i 4 9 + 4
SVR dynxsec/cm^ 1146 + 358 1361 + 305** 1395 + 452**
PVR dynxsec/cm2 150 + 102 233 + H 0 **x 272 + 150***
RPP mmHg/min/1000 15.1 + 3.5 13.6 + 3.5 13.4 + 3.6*
Pi02 0.5 + 0.1 0.5 + 0.2 0.7 + 0.2*SS
Pa02/F i0 2 mmHg 326 + 92 339 + 99 216 + in .*xx106OOO
Sv02 0, 81 + 9 81 + 7 76 + ln xxxIO000
Qs/Qt 0, 18 + 10 18 + 10 28 + n CXXX15ooo
oo2 ml/min/kg 17.2 + 5.0 13.5 + 4 .0 *** 13.9 + 4 .0***
0 ER % 20.5 + 8.0 20.6 + 7.0 23.3 + 9.0
vo2 ml/min/kg 3.3 + 1.3 2.7 + 1.1* 3.2 + 1.2
aData are expressed as mean +S.D. A s te risks  (x) indicate s ig n if ic a n t d ifferences between Group 
A and Group B, or G roup A and Group C. C irc les  (o) ind icate  s ig n if ic a n t  differences between 
Group В and Group C.
*P <  0 .05 ; **P < 0 .01 ; ***P <  0.001; °P <  0.05; °°P < 0 .01 ; P <0 .001
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Table I I
C la ss ifica tio n  resu lts  o f oxygenation parameters
Actual groups n
Predicted group
(1)
membership Л /
(2)
Parameters
included
Group A (1) 40 26 /65 / 14 /35/ o o 2
Group В (2) 37 11 /30 / 26 /70/ Pa02/F i0 2
Group A (1) 40 31 /78 / 9 /22/ o o 2
Group C (2) 89 23 /26 / 66 /74/ Pa02/F102
Group В (1) 37 26 /70 / 11 /30 / Qs/Qt
Group C (2) 89 22 /25 / 67 /75/ Pa02/F i0 2
Table I I I
C la ss ifica tio n  resu lts  o f ca rd io resp ira to ry  parameters
Actual groups n
Predicted group
(1)
membership / V
(2)
Parameters
included
Group A ( l) 40 29 /73/ 11 /27/ C l, PVR
Group В (2) 37 9 /24 / 28 /76/ Pa02/F i0 2
Group A (1) 40 33 /83/ 7 /17/ C I, PADP-PCWP
Group C (2) 89 19 /21 / 70 /79/ Pa02/F i0 2
Group В (1) 37 25 /68 / 12 /32/ SVR, V02
Group C (2) 89 23 /26 / 66 /74/ Pa02/F i0 2
Table IV
C la ss ifica tio n  resu lts  o f po ten tio n a lly  noninvase parameters
Actual groups n
Predicted group
(1)
membership / V
(2)
Parameters
included
Group A (1) 40 24 /60 / 16 /40/ c i ,  v o 2
Group В (2) 37 8 /22 / 29 /78/ Pa02/F i0 2
Group A (1) 40 33 /83 / 7 /17 / CI
Group C (2) 89 19 /21/ 70 /79/ Pa02/F i0 2
Group 8( (1) 37 25 /68 / 12 /33/ Qs/Qt
Group C (2) 89 23 /26 / 66 /74/ PaC2/F i0 2
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S t a n d a r d i z e d  C a n o n i c a l  
D i s c r i m i n a n t  F u n c t i o n  
C o e f f i c i e n t s :
FUNC 1
Cl  5 6 7 5 0
Pa 02 / Fi  02 7A 736
PADP-PCWP -  -18552
Group C e n t r o i d s :
Gr oup  1 -960
Gr oup 2 -  .A31
Al l  - g r o u p s  s t a c k e d  H i s t o g r a m
C a n o n i c a l  D i s c r i m i n a n t  F u n c t i o n  1
12-
8 -
A-
X
2
2
2 2 
2 2 
2 2 2 2 
2 22222 22 2
2 2 2 2 2 2 2 2 2 2  2 
222 222222212 1 22
222222222221121 12 
222222222221121211  1 
2212222122221111211  11
22 21 221 21 1 221 1 1 1 1 1 1 1 2 1 1 1 1 1 1 
1----------------------1---------------------1--------------------1---------------------1--------------------- «------------------- i—
Out -  3 0 -2.0 -1.0 0 1.0 2.0 3.0 Out
C l a s s  2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1  11 
Cent  ro i ds  2 1
Gr o u p  1 :  S u r v i v o r s ,  / G r o u p  А/
G r o u p  2 ;  L a t e  s t a g e  n o n s u r v i v o r s  / G r o u p  Cl
F ig . 1. The resu lt o f  the d iscrim inant analysis in  respect o f survivors and la te-stage 
nonsurvivors in v o lv in g  a l l  o f the examined ca rd io re sp ira to ry  parameters
noninvasive measurable parameters was analysed (Table IV). The VO2 , Cl, 
Qs/Qt and Pa02/Fi02 were taken as noninvasive parameters. The ra tio  of 
co rre c tly  c lass ified  data was 69% between Groups A and J3 and the included 
parameters were C l, VC^, and Pa02/Fi02- Between Groups A and JT, Cl and 
PaÜ2 /F iÜ 2  correctly discrim inated the data in  80%. The resu lt of the d is ­
crim inant analysis between nonsurvivors (Groups В and Ç) was correct in  
72%, included Qs/Qt and PaÜ2/Fi02 into the analysis.
4
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Discussion
Several cardiorespiratory variables of survivors and nonsurvivors 
were found to be s ig n if ic a n tly  d iffe re n t in  the patients w ith ARDS. Due to 
the random sampling, we fa ile d  to continuously fo llow  the changes of the 
d iffe re n t parameters, in  contrast with temporal prognostic analysis of 
others /2 , 24/. However, assessment of the patients in to  three groups (sur­
v ivors, early and la te  stage nonsurvivors) resulted a good se lection  of the 
nonsurvivors, too. In both groups of nonsurvivors, the flow  related 
parameters changed p rim arily  (CI, SV, LVSWI, 00£ decreased and PVR, SVR 
increased). This is  a typ ica l feature of nonsurvivors in  ARDS and other 
diseases /3 , 5, 9, 16, 27, 28/. In the la te  stage of nonsurvivors, a sig­
n if ic a n t pulmonary hypertension and an impaired oxygenation developed which 
were characterized by decreased Pa02/FiÜ2, SVO2  and increased FÍO2 , Qs/Qt. 
High PAPD-PCWP gradient was measured in  Group C, s im ila rly  to the results 
of Sibbald et a l. /2 1 /, that may indicate a fa ta l outcome. The VO2  was 
maintained by an increase in O2 ER. These changes are universal hallmarks 
of ARDS /15, 28, 30/, nevertheless th e ir  prognostic ro le  is  ambiguous 
because they discrim inate survivors and nonsurvivors only in  la te  stage. 
Our discrim inant analysis, using inhomogeneous d is tr ib u tio n  of data base, 
resulted in  a detachment of 70-80% p ro b a b ility , which is  closely comprable 
to the resu lts of others /2 , 13, 20, 25/. The most important variable was 
Pa02/Fi02 which took part in  the d iscrim ination of each group. Langhi et 
a l. /12 / emphasize the importance of a s im ila r respiratory index (alveolo- 
a r te r ia l oxygen gradient normalized by Pa0 2 ) in  the prognosis of post- 
traumatic ARDS. Their study demonstrated that the re la tionsh ip  between 
resp ira tory index and Qs/Qt was s ig n if ic a n tly  increased in cases of fa ta l 
ARDS, compared with those who did not develop ARDS, or with those whose 
ARDS resolved. In our study Qs/Qt played a discrim inant ro le  only in  the 
data of early and la te  stage nonsurvivors. To discrim inate between sur­
vivors and nonsurvivors, in  addition to Pa02/Fi02, Cl or i t s  closely re l­
ated parameter D02 was included in to  the analysis, both re in fo rc ing  the 
early prognostic ro le  of Cl /3 , 16, 27, 28/. The best resu lt was achieved 
by analysing the data of survivors and la te  stage of nonsurvivors. The 
prognostic p robab ility  was 80% when e ithe r of the noninvasively measurable 
parameters alone or the extended cardiorespiratory variables were used. In 
the la t te r  case the PAPD-PCWP and, analysing the data of survivors and 
early stage nonsurvivors, the PVR were involved in to  the discrim ination
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with regard to the s ig n if ic a n t role of pulmonary c ircu la tion  in  the 
development of ARDS /21, 25, 28/.
We should like  to emphasize that the re su lts  of the applied d is­
crim inant analysis based on an occasionally pooled inhomogeneous data base, 
were s im ila r  to the conclusions drown by others, when the regularly meas­
ured parameters /2 , 9, 13, 17/ were applied. Namely, Qs/Qt, PVR, PAPD-PCWP 
grad ien t, Cl and PaÛ2/Fi02 were the most important variables in  view of 
the outcome.
Contrary to the early  suggestion that VO2  was an important d is­
c rim ina to r between survivors and nonsurvivors /2 , 4, 6, 17, 22, 29/, in  our 
d iscrim inant analysis VO2  was entered only in  two occasions: in  d is c r i­
m inating data of early- and late-stage nonsurvivors using potentionally 
noninvasive parameters, and in  making d iscrim ination between survivors and 
early-stage nonsurvivors using a l l  cardiorespiratory parameters. In an 
e a r lie r  study we compared the tissue oxygenation parameters (VO2 , DO2 , 
O2 ER) o f survivors and nonsurvivors /8 /. Using 3-dimensional representation 
method / 7 /  we could separate survivors and la te  stage nonsurvivors at 73% 
p ro b a b ility , which is  equivalent to the present re s u lt of the discrim inant 
analysis of the oxygenation parameters.
I t  was an in te resting  observation that data, p o ten tia lly  measurable 
w ith  noninvasive techniques, did not decrease the prognostic value of sur­
v iv a l,  compared to the a l l  invasive ly measured cardiorespiratory variables. 
M onitoring VO2  by d irec t measurement in respirated pa tien t, the Pa02/FiÜ2 
by blood gas analysis, the Qs/Qt by inert gas method or blood gas analysis, 
the Cl by several noninvasive method (bioimpedence /1 , 15, 18/, echocardio­
graphy /1 4 /, oesophageal Doppler /23/, sys to lic  time in te rva ls  /26/) may 
allow a continuous supervision without any r is k  of the r ig h t heart cath­
e te r iz a tio n . The PC-processed data provide enough information fo r early 
in te rven tions to correct dysfunctions and to co rre c tly  estimate the prog­
nosis in  80% of the cases. Application of th is  method may decrease the 
frequency of the indwelling pulmonary a rte r ia l catheters.
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Sixteen middle-aged, normotensive, s lig h t ly  overweight male pa tients w ith  previous 
myocaridal in fa rc tio n  were studied during Holter-checked s ile n t myocardial ischaemia. As 
reference, stress and la te  201-T1 scintigraphy served fo r comparison w ith C ard io lite -M IB I 
s ile n t  ischaemic perfusion scan, both carried  out in  planar mode. The c ircum fe ren tia l pro­
f i le s  d iffe re d  in  9 cases, on region o f in te re s t basis the segment number d iffe rence  was 10, 
but the la te  d is tr ib u tio n  segment number was near to  both ischaemic numbers. The q u a n tita tive  
scores were d is t in c tiv e  ( ra t io  133-128/103) ind ica ting  the s ile n t ischaemia appeared in  the 
p e r i- in fa rc t  area. The s i le n t  ischaemic MIBI and stress 201-T1 ischaemic score d iffe rence  was 
reduced by means o f repeated SPECT inves tiga tion . With gated radionuclide ventriculography 
there was -4.3% d iffe rence between the le f t  ve n tricu la r e jec tion  fra c tio n s , measured w ith 
f i r s t  pass MIBI technique during s i le n t  ischaemia and afterwards in  basal s ta te . The im pair­
ment o f the le f t  ve n tricu la r function was re flec ted  on the stroke pattern o f our Holter-based 
radiocyclogram, as w e ll. Taking the 43.7-48.0=-4.3% "ischaemic s h if t "  in to  consideration i t  
was a close co rre la tion  (r=0.90) between the two kinds o f e jec tion  fra c tio n  determ ination. 
The major rhythm fa ilu re s  (occurring during the 24 h H olter monitoring) decreased to  a higher 
degree the le f t  ve n tricu la r e jec tion  fra c tio n  than s ile n t  ischaemia or s ile n t  ischaemia and 
minor rhythm fa ilu re  together (38-42-50%).
Keywords : H o lte r-con tro lle d  s ile n t  ischaemic periods on po s tin fa rc tio n  pa tie n ts , 
99m-Tc m ethoxy -iso b u ty l- iso n itrile  inves tiga tions , myocardial perfusion, le f t  v e n tric u la r  
e jec tion  fra c tio n , radiocyclographic contraction dynamic analysis
Abbreviations: MIBI: C a rd io lite  m e th o xy -iso b u ty l- iso n itrile ; RNV: 99m-Tc rad ionuc lid  
ventriculography; LV-EF: le f t  v e n tric u la r g lobal e jec tion  fra c tio n ; p-MI SMI: s ile n t
ischaemia on pos tin frac tion  pa tien ts ; T l:  tha llium
O ffp rin t requests should be sent to : M. Horváth, H-8231 Balatonfured, P.O.Box 13,
Hungary
Akadémiai Kiadó, Budapest
62 M. HORVÁTH e t  a l .
In tro d u ctio n
I t  is  a fundamental fac t that the (p a in fu l)  angina is  preceeded by 
myocardial perfusion imbalance producing e lectrophysio log ica l events, i .e .  
ECG-changes /14 /. H o lter monitoring shed l ig h t  yet on more types of 
ischaemia episodes. The painless form is  ca lled  s ile n t myocardial ischemia 
(SMI) /22/.
SMI can occur in  asymtomatic ind iv idua ls , in  patients with angina 
pectoris  and a fte r myocardial in fa rc tion  (p-MI SMI) /4 / .  The hypothesis 
th a t the p-MI SMI is  a special en tity  has been refuted /26 /.
One of the main trends of the SMI research is  to compare the ra tio  
o f the ST-segment changes during stress and Holter monitoring. I t  is  very 
important to define the SMI c r ite r ia  from the c l in ic a l as well as technical 
po in t of view co rre c tly , fo r SMI diagnosis depends on the correct per­
formance of the te s t ( >  0.1 mV ST-depression 80 ms a fte r the point 0 fo r 
more than 30 S /25 /.
The diagnosis is  supported by the VEST-like nuclear probes combined 
w ith  Holter-monitoring, estimating together w ith the ST-change the re­
duction of the stroke volume and of the LV-EF during SMI /19, 27/. Con­
vincing evidence can be a new or extending myocardial perfusion defect 
during SMI, but the simultaneous determinations are rare ly feasib le . What 
can be performed, i t  is  the detection of the perfusion defect at a l l ,  
ca rried  out by d if fe re n t radiopharmaca. 201-T1 is  the c lassica l radio- 
pharmacon. More recently  the new is o n it r i le  deriva tive  RP-30 C ard io lite  
methoxy-isobutyl is o n i t r i le  (MIBI) has proved to be useful, too /15 /. MIBI 
gives two preferences: 1) being non-red istribu tive  radiopharmacon, i t  holds 
"frozen" the myocardial perfusion s itua tion  p reva iling  the SMI period /8 / ,  
2) MIBI is  suitable fo r  measuring at the same time the myocardial perfusion 
and the le ft-v e n tr ic u la r  function /13/. I f  PET (=positron emission computer 
tomograph) is  ava ilab le , 18-F deoxyglucose may be considered the best 
ischaemic marker /2 , 21/ and important inform ation can s t i l l  be got about 
the aerobe metabolism of the heart by 11-C acetate as well /1 /.
Our c lin ic a l goal was to detect SMI myocardial perfusion of a small 
Holter-cheked pos tin fra c tio n  group with MIBI in  comparison with 201-T1 
stress myocardial perfusion d is tr ib u tio n k moreover, to compare the SMI 
LV-EF with basal LV-EF as w e ll, in planar presentation.
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P atie n ts  and Methods
Sixteen middle-aged pa tients were selected from our po s tin fa rc tio n  re h a b ilita t io n  
cataster and studied w ith th e ir  informed consent a fte r  permission o f the competent e th ica l 
commission. The pa tien ts  aged between 36 and 58 years (average, 51 years), they were s l ig h t ly  
overweight (body mass excess: 10-12 kg), and normotensive. In fa rc t lo ca lisa tio n s : non-Q:2, 
p o s te r io r i ,  in f e r io r s ,  anteroseptal:5 and extensive an terio r:2 . A ll had undergone previous 
combined H olter-m onitoring and 113m-In radiocardio-cyclography a t about 15 min la s tin g  s ile n t  
ischaemia.
The in jec ted  ra d io a c t iv it ie s  were: 25mCi 99m-Tc M I8I, 12mCi 99m-Tc RNV, 2mCi 201-T1. 
The la b e llin g  y ie ld  o f 99m-Tc MIBI was 95%. C lin ic a l side e ffe c t o f MIBI was not observed and 
a t a l l .
We used 24 h H olter monitor o f the type Marquette Laser 8000/T.
On the casette o f th is  device we developed a specia l combined beat-to-beat ECG and 
radiocyclogram analogue technique /5 /  to synchronize the inform ations got by the radiopharma- 
con, in jected even in  the SMI period.The Holter tape continued a fte r  the SMI event served fo r 
fu rth e r analysis, beside the ST changes i t  checked rhythm fa ilu re s . The SMI lasted about 
15 min, presenting more or less ST-changes and 1 monofocal and 1 polymorphous v e n tricu la r 
extrasysto le as w e ll. Minimal SMI c r ite r io n  was ST depression somewhat more than 0.1 mV, but 
three major 0.2m V ST-depressions also occurred a t the end o f observation, jo ined w ith  s lig h t 
oppression. Major arrhythmia c r ite r io n  meant short runs, ve n tricu la r tachycardia o r, in  1 
case, f ib r i l la t io n ,  polymorphous ven tricu la r ex trasys to le , while minor arrhythmias were Lowi 
I —I I  grade rhythm fa ilu re s , mostly monomorphous, un ifoca l extrasysto le . Except the two ex tra - 
systoles during the SMI period, the rhythm fa ilu re s  were fixed  on the 24 h Holter tape.
The MIBI myocardial perfusion examination followed 1 h post in je c tio n , the ergometric 
stress Tl-scan and gated 99m-red blood c e ll RNV in  the subsequent week.
For SMI MIBI LV-EE determ ination, we used necessarily  f i r s t  pass LV-EF technique /2 0 /.
Nuclear ca rd io lo g ica l imaging was carried  out on a computer-assisted s c in t i l la t io n  
gamma camera (Gamma Works, Budapest MB 9100-9101), using mostly the softwares elaborated by 
The Medical School o f Nuclear Medicine, Szeged (in c lu d ing  c ircum fe ren tia l p ro f ile s  o f myo­
ca rd ia l perfusion MIBI and T l, moreover the gated RNV programme). For more precise q u a n t if i­
cation we used region o f in te re s t (ROD sporing: 4 most severe hypoperfusion defects, 0 
normal s itu a tio n . From each o f AP, LAO 45 and LAO 70 d irec tio n s  4 segments were separated, 
but because o f 2 common regions in  2 d irec tions , the in d iv id u a l segment numbers were only 10, 
instead o f 3 d irec tio n s  x 4 segment = 12 in d iv id u a l character. Typical le f t  coronary supply 
dominance being considered, the a n te r io r, the a n te ro - la te ra l, the in fe ro -a p ic a l, the proximal 
and (J ista l septal segments belong to  the le f t  an te rio r descending (LAD), the s e p ta l+ in fe r io r , 
the infero-diaphragmatic and the posterobasal to  the r ig h t  coronary supply, while the 
posterobasal is  a circum flex (CX) area. This topography helped us to  fasten the ischaemic re ­
action to the in fa rc t- re la te d  c u lp r i t  a rte ry .
For c la r if ic a t io n  o f MIBI and TL myocardial perfusion segment and score discrepancies, 
we requested 7 pa tien ts  fo r SPECT examination, which has carried  out w ith  Ganma Works MB 9300 
gantry and w ith Ketronic-Siemens Medax N tomo-programme.
S ta t is t ic a l evaluation was not possible because o f the small number o f the pa tien ts .
Results
For demonstration of our technical fa c i l i t ie s ,  we present Figs 1, 2, 3. 
The myocardial perfusion data of the 16 p-MI SMI patients are sum­
marized with MIBI and T l, during SMI and stress (Table I ) ,  moreover fo r 
comparison the la te  3 h Tl re d is tribu tion  data.
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F ia - 1■ Hnlter completed w ith beat to  beat radiocyclographic programme, developed in  Balaton- 
fu red . Top: T. Caunt m in ia turized C s l/T l detector w ith  p ream plifie r and w ithout photo­
m u lt ip l ie r  tube(PHT); bottom: our old RCG-system w ith  collim ated N al/T i s c in t i l la t io n
c rys ta l
F ig . 2 . 99m-Tc C ard io lite  myocardial perfusion scan. The back part o f the c ircum fe ren tia l 
p r o f i le  033 on low leve l under the normal sca tte r corresponds la rg e r ly  to  in f .  post, reg ion. 
The defect arises p a rtly  from p o s tin fa rc tio n  scar, p a rt ly  from ischaemic hypoperfusion
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Fig. 3. Comparative planar (bottom) and SPECT (top ) p ictures on the same p a tie n t as on the 
F ig. 2 w ith TBI ( te r t ia ry  bu ty l is o n i t r i le ) .  The transaxia l short s lic e s , th e ir  histograms 
and circle-segments unequivocally present the large defect in  the in f .  post, region
Table I
Summarized myocardial perfusion data o f 16 p o s tin fa rc tion  PTS 
(2 non-0, 3 post., 4 i n f . ,  5 ant. sep t., 2 ex t. a n t.)
Hypoperf. Hypoperf.
segment Nr. defect score
H o lte r-con tro lled  SMI 
C a rd io lite
49 133
Ergometrie stress 
201-T1
44 128
3 h la te  re d is tr ib u t iv e  
201-T1
42 103
SMI MIBI and stress T1 segment number d iffe rence  -  10 but because o f 8 MIBI>T1 
and 2 T1 =■ MIBI cases the f in a l re s u lt is  only 49/44
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The direction of the SMI ST change was e levation only in  1 case, i t  
was depression in  a l l  otherá (both in major and minor cases). Major ST de­
pressions occurred in  ext. p o s t., post, and in f .  pa tien ts , major arrhytmias 
in  1 pos t., 1 in f . ,  3 a n t.,  septal and 1 ext. ant. patients. The majority 
o f the massive defects came from the ant. sept, and ext. ant. group. 
Discrepancies between the SMI MIBI and stress T1 segment numbers were 10, 
inc lud ing  1 ext. an t., 3 ant. sept., 1 non-Q, 3 post, and 2 in f .  lo c a li­
sa tions . Being the affectued segments MIBI >  T1 8, T1 > MIBI 2 cases, 
the re fo re , is  only 49/44 r a t io .
133-128=5 SMI and s tress T1 score differences spread among the seg­
ments. The MIBI incongruence diminished on SPECT in  the in fe r io r  lo c a li­
sa tion  and, what is  more, w ith te r t ia ry -b u ty l- is o n it r i le  ( IB I) . Ihe d is ­
tu rb in g  factor by the is o n i t r i le  investigations is  the l iv e r -a c t iv ity  
o ve rla p •on the lower heart regions. The SPECT correction with TBI is  con­
v inc ing  because the TBI l iv e r  kinetics is  slower than that of MIBI.
The non-ischaemic T1 segment number, 42, is  very near to the 
ischaemic value and, at the same time, there ex is ts  a s ig n ifica n t score 
d iffe rence : 120-128/103, which means that the two kinds of ischaemia ap­
peared mostly in the p e r i- in fa rc t  area.
The evaluation of the LV-EF followed two aspects: a) according to 
the Holter-ischaemia and rhythm data, b) according to the p-MI lo c a li­
za tions . The average LV-EF during SMI detected w ith the f i r s t  pass 
technique was lower than in  non-ischaemic "basal sta te" detected with 
gated RNV. Otherwise, the LV-EF was mainly affected in  patients who had 
major arrhythmia during continuous Holter monitoring. Ih e ir  loca liza tions 
was mostly ext. ant. and an t. sept. Gable I I ) .
The in fa rc t lo c a liz a tio n  of the major arrhythmic patients was mostly 
ex t. ant. and ant. sept. The LV-EF of mixed minor ischaemic and minor ar­
rhythm ic group shared between severe arrhythmia and the major ST-depres- 
sion group (38.5-42-50%). The minor ST-depressions occurred, surpris ing ly , 
among the post. in f .  pa tien ts  (true, the ir LV-EF was only s lig h tly  d i­
minished) .
In each loca lisa tion  group, there existed an "ischaemic s h if t " ,  with 
o v e ra ll -4.3% SMI Д . Regression equation was obtained with r=0.90 
(Table I I I ) .
EFSMI,MIBI-FP ‘ 0-88 + 9-5 = EFRESI GATED RNV
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Table I I
L e ft ven tricu la r e lec tion  fra c tio n  (EF%)
SMI f i r s t  pass MIBI Gated RNV basal
SMI ST4< 0.1 mV 42 47
minor rhythm fa ilu re
SMI ST- 1  0.2 mV+ 50 55
Maior rhythm fa ilu re  24 h 38.5 42
+
To th is  groups belonged post. in f .  lo c a liz a tio n
Table I I I
Le ft ven tricu la r e jec tion  fra c tio n  (EF%)
SMI f i r s t  pass MIBI Gated RNV basal
In fa rc t lo c a liz a tio n
2 Non -  Q 57 61
3 P osterior 47 50
4 In fe r io r 49 53
5 Anteroseptal 36 42
2 Extensive an te rio r 29 35.5
-  4.3%
43.75 + 9.5 48.0 + 0.6
Controls 66.62%
effb-m ib i
0.88 + 9.5 = Gated RNV basal 
c o rre l. coe ff. г  = 0.90
In other group of lo  p-MI SMI patients who belonged to NYHA I I I - IV  
severity, as markers of the le f t  ven tricu la r function, the fast and mean 
ejection, the fa s t and mean f i l l in g  ve lo c itie s  were found s ig n ifid a n tly  de­
creased already at rest and th e ir radiocyclographic pattern was s im ila r to 
those detected during SMI monitoring.
We tested also milder p-MI SMI cases (NYHA I - I I  severity groups) 
during ergometric dynamic, handgrip isometric and arithmetic psychological 
stress. Being our radiocyclographic technique quite ind iv idua l, we do not 
give absolute values, only scatter grade: P <  0.05 (Table IV).
Our d iffe re n t exercise data are in  congruence with the observations 
carried out on coronary heart disease patients and control subjects with 
VEST /12, 24/.
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Table IV
P o s tin fa rc tim  s ile n t  myocardial ischaemic pa tien ts  radlocyclographic (RCG) 
contraction dynamics times and In te rv a l ra tlo s
Stress Handgrip Psychological
te s t
Cycl. time s s s
Systo le p .c . s s ns
D iasto le  p .c . s s s
Fast f i l l in g / d ia s t . ns ns ns
Fast/s low  e jec tion ns ns ns
Blood pressure s s ns
P a tien ts  belonged to the: 1st seve rity  
NYHA I - I I
2nd severity  
NYHA I I
3rd se ve rity  
NYHA I I
P ostin fa rc tion  s ile n t  myocardial ischaemic patients
10 -  10 -  10 were selected in  3 groups
Ergometrie stress forced handgrip bearing l x l
30 -  60 -  90 V endurance psychological te s t
1st s e v e rity  
NYHA I - I I
2nd seve rity  
NYHA I I
2nd severity  
NYHA I I
Radiocyclographic (RCG) contraction dynamics ve lo c itie s
Stess Handgrip Psychological
te s t
Blood pressure s s
Mean e je c tio n s ns ns
Maximal e je c tio n s s ns
Mean f i l l i n g ns ns ns
Maximal f i l l i n g s s ns
Fast f i l l i n g ns s ns
Slow f i l l i n g ns ns ns
Cycle time s s s
Contraction dynamics analysis o f p-MI SMI pa tien ts  a t t  re s t, and during d if fe re n t 
m u lt i- to o ls .
s : s ig n if ic a n t P*=0.05 
ns: non-s ign ifican t
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Discussion
The fe a s ib i l i ty  of the firs t-p a ss  LV-EF determination has been con­
vincingly v e rif ie d  /10, 13/. Our data about the derangement of the le f t -  
ventricu lar function agree with the lite ra tu re , mostly with non-imaging 
technique-detected impairment during short-ischaemic periods /24, 27/. The 
examination of the le ft-v e n tr ic u la r function during SMI can be extended, of 
course, on the regional wall motion analysis, too /8 /.  Our observation that 
the LV-EF was mostly affected in p-MI SMI patients with major rhythm dis­
order, correlates with less favourable prognosis of SMI patients with 
ventricu lar ectopy /22 /.
The s itu a tio n  with the myocardial perfusion analysis is  a more com­
plicated problem. F irs t of a l l ,  In MIBI publications the time re la tion  of 
the in jec tion  to SMI, and the character of SMI as grade, duration, etc. are 
not discussed. Comprehensive study was dealing with the methodological as­
pects of symptomatic and s ile n t myocardial ischaemia, including high-resol­
ution surface electrocardiography among others /6 /.
The conclusion is  that both T1 and MIBI SPECT can be used. With 
planar scan the scatter is  wider, compared to the more objective SPECT 
d is tr ib u tio n  images /2 3 /. Only concordant positive or negative SPECT and 
ST-changes can be accepted in  s c ie n t if ic  publications. In our study the 16 
positive Tl-scans served fo r reference, major ST-changes were 3, minor ones 
12 and stress ST-depressions were more than 0.2 MV in  number 2. I t  is  
worthy of note that in  normal subjects the perfusion increment in  exercise 
is  at least 2.1 times that of rest perfusion /18 /. The perfusion scan can 
be carried out also in  combination with dipyridamole infusion /1 6 /, helping 
to a better understand the underlying by means of d ila ta tiv e  and, in  severe 
stenotic cases, steal-producing e ffe c t.
The myocardial perfusion determining factor in  the p e r i- in fa rc t area, 
in  the region of in fa rc t-re la te d  c u lp r it  artery is ,  without doubt, the col­
la te ra l c irc u la tio n . I t  depends rather on the absence of c o lla te ra ls  and 
duration of occlusion than on the extent of the ischaemic myocardium /17/. 
In patients w ith good co lla te ra ls , stress-induced transient enlargement of 
the perfusion defect occurs in those with poor co lla te ra ls , however, the 
enlargement did not occur /7 /.
99m-Tc MIBI and 201-T1 correlated well in both planar and SPECT 
images /11 /, in  respect to the id e n tif ic a tio n  of patients w ith coronary 
artery disease a ffec ting  the ind iv idua l a rte ries , the presence and severity
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of perfusion defects and the assessment of defect re v e rs ib il ity .  The 
precise quantifica tion  of confluent scar and ischaemic areas in  patients 
w ith  p r io r  myocardial in fa rc tio n  is  a hard task and i t  needs special b u ll 's  
eye technique and m athem atica l-sta tistica l apparatus as receiver operation 
ch a ra c te r is tic  (ROC) method /3 / .  ROC improved cut s p e c if ic ity  fo r detection 
in  the LCX (40%) and in  RCA (20%) te r r ito r ie s , having no e ffec t in  12% LAD. 
The 201-T1 SPECT was more accurate for detection o f CAD in  the noninfarct 
region than the c lin ic a l and/or stress ECG responses.
Our planar scans were fixed  in 64x64 matrix and evaluated circum­
fe re n t ia l ly  from 3 d irections and 4 segment/directions. In 120x128 matrix 
and SPECT, the segment scores could be somewhat d if fe re n t.
As we also found, some plus information fo r  MIBI ( in  contrast with 
T l) could be exist independently of detection problem, since the reversible 
hypoperfused segments were detected 104 with 201-T1 and 134 with MIBI 
SPECT.
That the myocardial perfusion can assume during long-lasting  SMI in  
the p e r i- in fa rc t zone ischaemic character is  lo g ica l on the base of several 
common electrophysio logical issues. The question remains, however, s ta t­
is t i c a l ly  open.
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The e ffe c ts  o f d a ily  0.5 g vitamin C on plasma urea n itrogen, u ric  ac id , cho les te ro l 
and t r ig ly c e r id e  leve ls  were recorded over a period o f one month. There was a s ig n if ic a n t 
reduction in  plasma cho lestero l leve l (P <  0 .05). There was no s ig n ifica n t e ffe c t o f vitam in 
C on plasma urea n itrogen , u r ic  acid and tr ig ly c e r id e  le ve ls  (P >  0.05). I t  was a placebo- 
con tro lled  t r i a l .  The research and contro l groups were formed o f 105 and 47 vo lunteer un iver­
s ity  students, respective ly . In these groups the mean ages were 20 +_ 0.33 (mean +_ S.E.M.) aod 
20 +_ 0.49 years, respec tive ly . Mean body mass ind ices were 22.2 + 0.13 and 22.3 +_ 0.19 kg/in , 
respective ly .
Keywords : Ascorbic acid, cho les te ro l, tr ig ly c e r id e s , u ric  acid, urea n itrogen
In tro d u c tio n
Very high doses of vitamin C ( >  1 g) have been claimed to prevent or 
to be e fficacious in  treating hypercholesterolaemia and atherosclero­
s is  /17 /.
Ginter /6 /  found that acute vitamin C deficiency in guinea pigs led 
to an increase in  cholesterol synthesis and a reduction in  conversion of 
cholesterol to b ile  acid and that these changes led to an increase in 
carcass cholesterol. An increase in  plasma and liv e r  cholesterol levels 
was detected, concomitant with a decrease in  the fractiona l rate of tu rn-
2 2
Abbreviations: BMI = Body mass index (weight/Cheight) ) as kg/m ; F = Female; M = 
Male; NS = Not s ig n if ic a n t;  V it .  C = Vitamin C
O ffp r in t requests should be sent to : Erdal Beser, Karadeniz Technical U n ive rs ity , 
TR-61080 Trabzon, Turkey
Akadémiai Kiadó, Budapest
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over o f to ta l body cholesterol levels, in d ica tin g  a diminished b ile  acid 
synthesis /6 / .  A positive  corre la tion between rate of b ile  acid synthesis 
in  and concentration of ascorbic acid in  the l iv e r  was also reported /1 0 /. 
These possibly indicate an ind irec t e ffec t on microsomal 7-alpha-hydroxyl­
ase /3 , 7 /. Evidence of atherogenesis in  scorbutic animals and i t s  p a r t ia l 
prevention by vitamin C administration was also presented /26, 27/.
Dobson et a l. recorded a 14% reduction of plasma cholesterol when 
1 g o f vitamin C per day was given for 6-12 months to each of 4 men and 6 
women of mean age 58 years /4 / .  »
Since the prevalence of low ascorbic acid concentrations increase 
w ith age, the p o s s ib ility  tha t an age-related r is e  in  plasma cholesterol 
may be secondary hypovitaminosis C has been examined /11, 14/.
S p itt le  recorded tha t in  healthy people under the age of 25 years, 
cho leste ro l levels tended to f a l l  when 1 g of vitam in C per day was added 
to th e ir  otherwise normal d ie t /22 /. Ginter reported a s ign ifican t reduc­
tio n  of plasma cholesterol when hypercholesterolaemic patients were given 
1 g o f vitamin C per day fo r twelve months /9 / .
When high da ily  doses of vitamin C ( >  1 g) are ingested regu la rly  
over a period of months or years, adverse e ffe c ts  may occur such as u r i-  
cosuria , reduced bacte ric ida l a c tiv ity  of leukocytes, secondary hyperoxal- 
aemia in  hemodialysis pa tien ts , enhanced m obiliza tion  of bone calcium, im­
paired blood coagulation time, lowered plasma B-12 levels, in te rrup tion  of 
pregnancy, reduced in su lin  production and in terference with anticoagulant 
therapy /1 , 2, 12, 15, 17, 19-21, 23, 24/.
The purpose of th is  study was to investiga te  the effects of short­
term, small da ily  doses of vitamin C (0.5 g/day, fo r one month) on plasma 
BUN, u r ic  acid, cholesterol and tr ig lyce rid e  leve ls .
Subjects and Methods
The research population consisted o f 105 vo lunteer u n ive rs ity  students. They took 
d a ily ,  fo r  one month, 0.5 g o f vitam in C o ra lly .  The co n tro l population consisted o f 47 
vo lun teer u n ive rs ity  students. They took placebo fo r one month. I t  was a p lacebo-controlled 
t r i a l .  Plasma BUN, u r ic  acid , cho lestero l and tr ig ly c e r id e  le v e ls  were measured tw ice before 
and a f te r  taking vitamin C and placebo in  respective groups.
A l l  the pa rtic ipan ts  were under the age o f 24 years, healthy non-smokers who had not 
had any in fe c tio n  in  the previous two months and had no fa m il ia l h is to ry  of a the rosc le ro tic  
vascular disease /5 / .  None o f them had taken any drug or v itam in  preparation fo r a t le a s t one 
month p r io r  to  the in ve s tig a tion . None of the p a rtic ip a n ts  took regular exercise. A l l  par­
t ic ip a n ts  consumed a normal d ie t ( th a t is ,  no extra food containing vitamin C, u r ic  ac id ,
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cho lestero l and tr ig ly c e r id e s ) . A l l  were liv in g  in  dorm itory accommodation and, the re fo re , 
were consuming the same kind o f food in  the student's  ca fe te r ia  (tab le  d 'h îte ) .
Biochemical Tests
Plasma urea n itrogen , u r ic  acid, to ta l cho lestero l and tr ig ly c e r id e  leve ls  were de­
termined by rou tine  biochemical enzymatic methods (urease, uricase, cholestero l oxidase and 
lipase , respe c tive ly ).
I t  was reported /2 5 / th a t an craldose o f some 2 g vitam in C does not a ffe c t cho les te ro l
values.
S ta t is t ic a l Analysis
The chi-square te s t,  s ign ificance te s t fo r the d iffe rence  o f two means and the paired 
observation s ign ificance  te s t were used.
Results
The characte ris tics  of the control and research groups are shown in  
Table I .  There was no difference between the two groups (P >0 .05) (except 
in  vitamin C leve ls  at the end of the study).
Table I
о
C haracte ris tics o f the con tro l and the research groups
Group
No. o f Sex of Mean age
Mean BMI4 Plasma le ve l o f V i t .  C (mg/dl)
subjects subjects 
M F
(years) S ta rt o f 
study
End of 
study
S ta rt o f 
study
End o f 
study
Control 47 25 22 20+0.49° 22.3+0.19 22.2+0.19 1.20+0.05 1.23+0.05
Research 105 57 48 20+0.33 22.2+0.13 22.1+0.13 1.19+0.03 2.31+0.01
°mean +_ S.E.M.
X 2 2
BMI = body mass index (w e ight/(he ight) ) as kg/m ; M = male; F = female
The comparison of double measurements of plasma urea nitrogen, u r ic  
acid, cholesterol and tr ig lyce rid e  leve ls , between the measurement re- 
corded at the s ta r t of the study and that recorded at the end of the study 
(tha t is  at the beginning and end of the one-month period) fo r respective 
groups are shown in  Table I I .  There was no difference in the plasma leve ls  
of four biochemical determinations between the control and the research 
groups at the s ta r t of the study (fo r both sexes) (P >0 .05 ). There was no
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Table I I
Comparison of double measurements of plasma urea n itrogen , u ric  acid, cho lestero l and 
tr ip lv c e r id e  le ve ls  at the s ta r t  and a t the end o f the study
Control Group Research Group
(M=25, F=22) (M=57, F=48)
S ta rt o f End o f study P S ta rt o f End o f study P 
study (placebo) study (V it  C)
UREA NITROGEN M 1 2 .9 3 ^ 0 .9 1  12.90 + 0.95 NS 12.88 + 0.69 12.15 + 0.64 NS
F 12.97 +_ 0.95 12.91 + 0.96 NS 12.78 + 0.74 12.20 + 0.69 NS
(7-21 mg/dl) M+F 1 2 .9 1 + 0 .7 1  12 .92+ 0 .71  NS 1 2 .99 + 0 .4 8  1 2 .11 + 0 .4 3  NS
URIC ACID M 4.63 + 0.15 4.67 + 0.15 NS 4.95 +.0.11 4.74 + 0.11 NS
F 4 .5 8 + 0 .1 7  4 .6 3 + 0 .1 6  NS 4 .5 0 + 0 .1 1  4 .7 0 + 0 .1 2  NS
(3-0  m g/dl) M+F 4 .6 9 + 0 .1 1  4 .6 8 + 0 .1 1  NS 4 .6 5 + 0 .0 9  4 .7 1 + 0 .0 8  NS
CHOLESTEROL M 1 6 7 .4 1 + 6 .8 3  168.99+6.21 NS 168 .45+4 .39  151.88 + 4.49 <  0.05
F 1 6 9 .4 1 + 7 .2 9  170 .21+7.09  NS 170.00+4.91  153.10 + 4.97 c  0.05
(112-270 mg/dl) M+F 168.98 + 4.93 169.01 + 4.33 NS 169.72 + 3.12 1 5 2 .1 7 ^ 3 .4 3 ^ 0 .0 5
TRIGLYCERIDES M 126.01 + 7.35 125.87 + 7.05 NS 126.19 + 4.67 125.99 +^4.56 NS
F 124.32 + 7.57 123.99 + 7.35 NS 1 2 5 .0 1 ^  4.91 124.98 ^ 4 .7 7  NS
(25-170 mg/dl) M+F 125.87 + 5.23 125.03+5.11 NS 125 .99+3 .39  125 .34+3 .28  NS
A l l  values are mean +_S.E.M. 
NS = Not s ig n ifica n t 
M = male; F = female
Biochemical S ta rt 
Determ inations o f sub­
n o rm a l ranges) jec ts
d iffe rence  ( i )  in  the plasma levels of four biochemical determinations on 
the measurements recorded at the beginning of the study and on the meas­
urements recorded at the end of the study fo r the control group, (tha t is  
a t the beginning and the end of the one-month period) (fo r both sexes) 
(P >  0.05) and ( i i ) in  the plasma levels of urea nitrogen, u ric  acid and 
tr ig ly c e rid e s  in  the measurements recorded at the beginning of the study 
and in  the measurements recorded at the end of the study fo r the research 
group ( fo r  both sexes) (P >  0.05). However, there was a s ig n ifica n t d i f ­
ference in  the plasma cholesterol levels recorded at the beginning of the 
study and those recorded at the end, in  the research group ( fo r  both 
sexes) (P < 0.05). There was no difference between females' and males' 
biochemical determinations in  the control and research groups.
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Discussion
We observed tha t taking low doses of vitamin C (0.5 g/day) fo r  one- 
month s ig n if ic a n tly  decreases the leve l of plasma cholesterol (P <  0.05). 
We found no s ig n ific a n t e ffec t of vitam in C on plasma BUN, u ric  acid and 
tr ig ly ce rid e  leve ls (P >  0.05).
I t  has been suggested that taking high doses of vitamin C (such as 
1 g) over a period of months decreases plasma cholesterol le ve l /4 , 9, 
22/. Ingestion of high doses of vitamin C ( >  1 g) over a period of months 
or years is  not recommended /1 , 2, 12, 15, 17, 19-21, 23, 24/. In our 
study the research group took a small d a ily  dose of vitamin C (0.5 g/day) 
over a short-term period (1 month). G in te r's  resu lts are s im ila r to ours. 
Ihe reported mean reductions of 15-70 mg/dl when three groups o f hyper- 
cholesterolaemic subjects (ri= ll-24) w ith i n i t i a l  mean cholesterol levels 
of 255-355 mg/dl were given, 0.3-0.45 g/day vitamin C /8 /.
Conversely, some investigations ind ica te  continuing increase in  
cholesterol levels in  the group receiving the higher ascorbic acid supple­
ment /13 , 16/. When Peterson et a l. administered 4 g/day to 9 hyperchol- 
esterolaemic persons fo r two months, plasma cholesterol levels remained 
unchanged /18 /.
These resu lts  are perhaps the most rewarding in th is  ra ther con­
fusing f ie ld  and, at least, they provide some encouragement fo r  fu rthe r 
c lin ic a l t r ia ls .
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STUDY OF THE EFFECT DF SUPEROXIDE DISMUTASE 
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Warm ischaemia was provoked by occlusion o f the le f t  renal a rte ry  in  dogs narcotized 
w ith Nembutal and i t  was studied whether a small (0.5 mg/kg body weight /п=6 /) or a large 
dose (5 mg/kg body weight /n=7/) o f superoxide dismutase (SOD) improves rena l function  during 
90 min reperfusion, compared to  the con tro l group (n=6). In  the f i r s t  period a fte r  release of 
occlusion (min 0-15) the GFR and cPAH values reached 10-20H o f those in  the contra la te ra l 
kidney w ith normal c irc u la tio n . The GFR and cPAH values as w e ll as urine flow , sodium and 
potassium excretion were not d iffe re n t in  the three groups. Renal function  s ig n if ic a n t ly  
improved in  a l l  groups during reperfusion. At the early  stage o f reperfusion the malondial- 
dehyde (MDA) concentration exceeded that before occlusion. Such an increase could not be 
seen when superoxide dismutase (SOD) treatment was applied. Our resu lts  show th a t SOD tre a t­
ment does not improve renal function at the ea rly  stage o f acu terly  stage o f acute renal 
fa ilu re  o f ischaemic o r ig in .
Keywords : Acute rena l in su ffic ie n cy , free ra d ica l, superoxide dismutase
In tro d u c tio n
Certain c l in ic a l conditions occur in  the medical p ractice when 
transient tissue ischaemia is  followed by reperfusion.
Ischaemia depending on the s e n s it iv ity  of d iffe re n t organs and la s t­
ing fo r a c r i t ic a l  period of time ce rta in ly  leads to ir re ve rs ib le  damage 
of the tissues, and any intervention carried out in  due time to improve 
c ircu la tion  serves fo r the preservation of v ita l functions.
Abbreviations: MDA: malondialdehyde, FR: Free ra d ic a l, SOO: superoxide dismutase 
O ffp rin t requests should be sent to : L. Kónya, H-1088 Budapest, S z e n tk irá ly i u. 46,
Hungary
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Recent data emphasize the r isk  of res ta rting  tissue blood flow /5 /.  
I t  seems lik e ly  that the degree of tissue damage a fte r reperfusion depends 
both on ischaemia and the in ju ry  caused by reperfusion /7 / .  More and more 
workers stress the importance of free radicals of oxygenous o rig in  in  th is  
type o f tissue damage /1 , 8, 10, 12, 17/. These rad ica ls are also formed 
in  the course of natural v i t a l  processes; th e ir  importance is  denoted by 
th a t ^.1 aerobi organisms have a defence system against them, in  which one 
o f the most s ign ifican t enzymes is  SOD /18/. Acute ischaemic renal fa ilu re  
is  o f great c lin ic a l importance because of i t s  frequent occurrence, and 
increasing m orta lity . That is  why free radicals and the protecting e ffec t 
o f antioxidant treatment are widely investigated in  th is  context /3 , 7, 
10, 21, 22/. From our t r ia ls  we got contradictory resu lts , so the question 
needed further study. Such t r ia ls  on dogs can be found in  small number in 
the l ite ra tu re , therefore, we performed our experiments on dogs. Reactive 
free  rad ica ls are formed in  a large quantity at the early stage of reper­
fus ion  f i r s t  of a l l  due to the a c tiv ity  of xanthin oxidase of endothelial 
o r ig in ;  th e ir impact is  instantaneous; that is  why we followed the changes 
in  the control group and in  those treated with d iffe re n t doses of SOD in 
the same period.
Methods
Experiments were performed on mongrel dogs o f e ith e r sex w ith a body mass o f 10-34 kg. 
The animals were narcotized w ith  Nembutal (sodium pentobarb ita l, 30 mg/kg body mass i . v . ) ,  
steady narcosis was provided w ith  3 mg/kg body mass of i . v .  maintenance doses. A cuffed endo­
tra c h e a l tube was inserted, continuous a r t i f i c ia l  resp ira tio n  was maintained (re sp ira to r 
RO-5, Moscow, USSR) and regu lar c o n tro l o f blood-gas analysis was performed during the t r i a l .  
Surgery was performed on a heatable operating tab le , re c ta l temperature was maintained be­
tween 37 and 38 C. With the aim o f g iv in g  in fusion, taking blood and measuring blood pres­
sure , a jugu la r vein and both femoral a rte rie s  and veins were catheterized. Urine was ob­
ta in e d  through catheters from u re te rs  by a median laparotomy. Venous blood from the kidney 
was obtained through the v . spermatica or ovarica w ith the help o f a catheter led in to  the 
l e f t  v . re n a lis . The le f t  rena l a rte ry  was exposed, w ith  the rena l nerves le f t  in ta c t.  On 
f in is h in g ,  the operation, sa line  in fu s io n  was administered (20 ml/kg body mass) in  30 min, 
which was then followed by 10 m l/kg body mass/h u n t i l  the end o f the t r i a l .  With the aim o f 
measuring GFR and e ffe c tive  rena l plasma flow, in u lin  and paraaminohippuric acid in  saline 
s o lu tio n  was infused in to  the v . ju g u la r is  to  reach 30-50 mg/100 ml and 1-3 mg/100 ml plasma 
concentra tion , respective ly, tw ice  depending on the animal's body weight (0.21-0.58 m l/m in). 
A f te r  the operation, a 60 min e q u ilib ra t io n  period was maintained, then urine was collected 
a t 15 min in te rva ls . A fte r two co n tro l periods the le f t  rena l a rte ry  was occluded fo r 45 min 
and u rin e  was collected from the r ig h t  kidney alone. During the occlusion period the quantity 
o f the in fus ion  was halved. Follow ing the release of the occlusion urine was co llected from 
both kidenys fo r fu rther s ix  periods. To measure the MDA concentration in  the plasma 5 ml of 
venous blood was taken from the kidney 5 min before the s trangu la tion  o f the renal a rte ry  and
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5, 15 and 30 min a fte r  i t s  release. A r te r ia l blood samples were taken in  the middles o f the 
periods.
Blood pressure, measured w ith a Statham P 23 db pressure transducer, was continuously 
recorded (Rikadenki, В 301, Tokyo, Oapan).
The fo llow ing  groups were examined: 1) Control (n=6) Animals given sa line  alone. 
2) Small dose SOD group (n=6) 0.5 mg/kg body mass SOD in fus ion  was started 1 min before re -  
perfusion and given continuously fo r 10 min. 3) Large dose SOD group (n=7) 5 mg/kg body mass 
SOD was administered as above.
The in u lin  and PAH concentration in  the plasma and the appropriately d ilu te d  u rine  
samples were measured w ith  anthrone and diphenylamine method. Sodium and potassium concen­
tra t io n  were measured w ith  a Flapho 4 type flame photometer (Carl Zeiss, Jena, Germany). The 
MDA concentration in  the renal venous blood was determined w ith  spectrophotometry as de- 
scibed by O ttolenghi /2 0 /. The Tables contain mean values o f kidney parameters expressed fo r  
100 g wet kidney +_ S.E.M. The groups were compared w ith  analysis o f variance.
Results
In the course of s ta t is t ic a l data processing the parameters of 
ischaemic kidney and that with in tac t circulation were compared w ith in  one 
group of animals at d iffe re n t periods of time and the values of ischaemic 
kidney were compared between the groups.
In Table I  the data fo r three stressed periods of time are shown. 
They show that T5 min a fte r the release of the renal artery occlusion fo r 
45 min the GFR and cPAH values (the la t te r  approximating e ffec tive  renal 
plasma flow) reached 10-20% of the control value and a fte r 1.5 h reper­
fusion i t  was s ig n if ic a n tly  lower than those in  the in tac t kidney. Potas­
sium excretion of the ischaemic kidney was lower in a ll of the three groups 
at the beginning of reperfusion than in the other one with normal c ir c u l­
a tion. Diuresis and sodium excretion were s ig n ifica n tly  lower in  the 
large-dose group a fte r reperfusion. Both d iuresis  and sodium + potassium 
excretion of the ischaemic kidney were lower in  a l l  of the three groups 
than those of the in ta c t kidney both at the beginning and in  the la s t 
periods of reperfusion (75-90 min), but the difference was s ta t is t ic a l ly  
not s ig n if ic a n t. However, i t  can be stated that prolonged reperfusion 
resulted in  better parameters in  a l l  groups. At given periods of time the 
parameters of the ischaemic kidney never d iffe red  in the three groups or 
the degree of decrease in  the examined parameters was s im ila r in  a l l  
groups when compared to those of the contro l kideny. The MDA concentration 
values of the venous blood of the kideny are summarized in Table I I .  The 
MDA concentration s ig n if ic a n tly  exceeded the baseline value at min 5 and 
30 of reperfusion in  the control group. No changes in  the MDA concentra­
tion  were observed with any of the two SOD doses.
Table I
The e ffe c t o f small (0.5 rng/kg body mass) and large dose (5 mg/kg body mass) of superoxide dismutase (SOD) on renal function and 
a r te r ia l blood pressure in  narcotized dogs a fte r  45 min u n ila te ra l warm renal ischaemia
before ischaemia 0-15 min a fte r  ischaemia 75-90 min a fte r  ischaemia
Control small dose large dose Control small dose large dose Control small dose large dose
n=6 m=6 o f SOD n=7 П=6 m=6 o f SOD n=7 n=6 n=6 o f SOD n=7
V, ml/min C: 1 8_+ 0.4 1.9+ 0.5 1 8+ 0.3 1. 7+ 0.4 1 0+ 0.3 1 7+ 0.3 2.3+ 0.6 1.4+ 0.3 1 7+ 0.5
I : 1 8j+ 0.4 2.1+ 0.6 1 9+ 0.3 0. 8+ 0.2 0.4+ 0.1 0.6+ 0.2 1.4+ 0.3 0.6+ 0.1 1 3+ 0.3
GFR, ml/min C: 65 + 5 7 7 + 6 80 + 5 61 + 5 65 + 7 66 + 5 6 6 + 4 82 + 7 82 + 6
I : 63 + 5 7 5 + 6 76 1  4 13 7  3C 12 + 4C 6 I 2 C 39 + 4C 40 7 6С 32 ± 5 C
cPAH, ml/min C: 157 + 8 219 +13 237 +22 154 + 5 145 +20 172 +12 160 +12 189 +13 213 +12
I : 155 + 6 204 +14 223 +17 44 +nc 35 +12C 17 + 5C 91 +10b 106 +14U 86 i l l C
U V, omol/min C: 276 +57 365 +90 302 +60 175 +41 149 +38 214 +26 253 +61 211 +37 205 +34
I : 319 +93 383 +95 308 +54 118 +38 48 +14 73 +27a 165 +46 78 +10 163 +34
U V,^umol/min C: 67 + 8 79 +12 50 + 6 66
± 6 b
48 +12 47 ± 9b 7 6 + 8 84 +17 53 +10
I : 70 + 9 77 +11 49 + 6 28 + 6 14 + 5C 8 + 2° 58 +10 42 +_ б3 44 + 7
BP, mmHg 130 + 7 133 + 7 123 + 5 150 + 8 139 + 7 132 + 7 139 + 4 138 + 6 131 + 4
Abbreviations: C: con tro l ( r ig h t ) ,  I :  ischaemic ( le f t )  kidney; 
a: P *= 0.05; b: P -=0 .01 ; c: P *=0.001
The data (mean ;+ S.E.M.) are expressed fo r 100 g wet kidney weight
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Table I I
The e ffe c t o f small (0.5 mg/kg) and large (5 mq/kq) dose of Superoxid dismutase (SOD)
a fte r 45 min u n ila te ra l warm ischaemia
before ischaemia a fte r ischaemia
5 min 15 min 30 min
Control (n=6) 8.2 + 1.7 29.0 + 17.0b 21.4 + 3.4 25.7 + 2.5a
Small dose o f S00 14.2 + 2.6 12.1 + 2.1 13.7 + 2.7 12.1 + 2.2
(n=6)
Large dose o f SOD 21.9 + 4.8 26.6 + 5.8 21.4 + 3.4 25.7 + 2.5
(n=7)
S ig n ifica n t d iffe rence  V.S.: con tro l: a = P ^  0.05, b = P <  0.01 compared to  co n tro l
(mean + S.E.M.)
Discussion
To approach the pathogenetic role of free radicals we had two a lte r­
native ways in  our t r ia l :  (a) examining whether kidney function improves 
on antioxidant treatment a fte r reperfusion and (b) fo llow ing the changes 
of MDA concentration in the blood. Many workers have studied the e ffe c t of 
d iffe re n t doses of SOD; Baker et a l. found that the serum-creatinine level 
was lower in  ra ts treated fo r 1 h w ith 3.25 mg/kg body mass of SOD fo llow ­
ing ischaemia of the kidney on the f i r s t  days a fte r operation than in  the 
untreated contro l group, however, la te r  no difference could be seen in 
m o rta lity ; w ith double dose (6.5 mg/kg b.m.) of the enzyme a l l  the animals 
survived /3 / .  Koyama et a l. fa ile d  to fin d  any protective e ffe c t with
0.2-2 mg of -the enzyme given in to  the renal artery of pigs fo llow ing a 
cold-warm ischaemia modelling kidney transplantation, while on administ­
ra tion  of 20 mg of the enzyme creatinine-clearance improved /1 5 /. With 
small dose of SOD, tissue damage was experienced in  v it ro ,  th is  can be 
explained by that the incomplete transformation of the superoxide radical 
formed during reperfusion fa c il ita te s  the production of a more tox ic  root 
/1 4 /. In th is  t r ia l  we examined the e ffe c t of 0.5 mg/kg and 5.0 mg/kg body 
mass of SOD enzyme; kidney function parameters showed a s lig h t impairment 
compared to untreated animals. I t  is  common practice to measure the MDA 
leve l in  the course of the study of reactions caused by free rad ica ls.
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Though MDA Is  not a spec ific  marker of the peroxidation of membraneous 
l ip id s ,  i t  is  considered to corre late with i t s  degree /9 /. Contradictory 
resu lts  were obtained during the examination of the venous blood from the 
kidney and of the MDA leve l of homogenized tissue /3 , 15, 19, 22/. In our 
t r i a l  the MDA concentration in  the blood samples from the renal vein was 
elevated a t min 5 and 30 of reperfusion in  the con tro l group, while no in ­
crease was observed in  treated animals. Dur resu lts  correspond to those of 
Joannidis e t a l . ,  who found a s ig n ifica n t increase in  the arterio-venous 
d iffe rence at the early stage of reperfusion a fte r  45 min ischaemia, while 
an tiox idant treatment fa ile d  to improve renal function during 60 min re- 
perfusion /1 3 /. So one of the in d ire c t evidence in  our t r ia l  indicates the 
p o s s ib il ity  of reactions caused by free rad ica ls while the in e ffe c t iv ity  
of antiox idant treatment speaks against th is  p o s s ib il ity .  On the basis of 
the re su lts  described above, i t  is  not un like ly  tha t the protective e ffe c t 
of applied therapy is  manifested at a la te r  period of reperfusion or 
e ithe r large dose of SOD enzyme or combined antioxidant treatment is  
needed to protect against reperfusional damage.
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EXOGENOUS SUPEROXIDE DISMUTASE UPTAKE BY THE MYOCARDIUM AND 
KIDNEY IN AN ISCHAEMIC REPERFUSION MODEL IN DOGS
L . KÓNYA,  A . F Ü L Ö P + , I L D I K Û  B A R T F A I  ,
G.  S Z É N Á S I
2nd Department of Medicine, in s t i t u te  of Biology, Semmelweis U n iversity 
Medical School, Budapest, Hungary
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The renal and cardiac tissues o f dogs were examined w ith autoradiographic method in  
ischaemic reperfusion t r ia ls  w ith  the aim o f studying the access o f exogenous superoxicte d is- 
mutase (SOD) enzyme to the c e lls .  Penetration o f S00 in to  the c e lls  was demonstrated. The 
enzyme showed special a f f in i t y  to  the mitochondira and myofilaments in  the myocardium and i t  
was seen both in  the glomeruli and the tubules in  the kideny. In both organs the uptake of 
the enzyme was most abundant in  the ischaemic regions than in  tissues with in ta c t c irc u la tio n
Keywords : Superoxide dismutase, reperfusion, autoradiography
In tro d u c tio n
Substances carrying unpaired electrons on the ir outer o rb its  are 
called free radicals. Such highly reactive compounds may appear during 
natural v ita l processes mainly during oxygen reduction. Aerobic organisms 
have established an e ffec tive  defence system against them /5 , 13/. Super­
oxide dismutase (SOD) seems to be an important enzyme in th is  system. In 
ischaemic,reperfusion conditions fo r free radicals of oxygenous o r ig in  are 
often formed e.g. xanthine oxidase enzyme, during the function of ac­
tiva ted  leukocytes or the metabolism of arachidonic acid, due to the auto­
oxidation of catecholamines and the abnormal functioning of mitochondria.
Abbreviations: LAD: le f t  an te rio r descending coronary a rte ry , SOD: Superoxide d is ­
mutase
O ffp r in t requests should be sent to : L. Kónya, H-1088 Budapest, S z e n tk irá ly i u . 46,
Hungary
Akadémiai Kiadó, Budapest
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Recently i t  has been stated by many authors that such radicals play 
an important role in  the tissue damage in  reperfusion /12 /. D iffe rent com­
pounds have been examined in  view of th e ir  impact on diminishing these 
damages. The impact l ie s  partly  on dim inishing the appearance of free 
rad ica ls , partly  on inac tiva ting  the developing ones. The e ffect of SOD 
has been examined in  th is  context. The investiga tions gave contradictory 
re su lts  /2 , 3, 6, 9, 16/. The question has arisen how the large molecules 
o f SOD — being widely applied in the prevention of reperfusion-caused 
damages — can penetrate the ce lls  and whether th is  enzyme has an in t ra ­
c e llu la r  protective e ffe c t.
Our objective was to  study th is  problem. As reperfusion of the heart 
and the kidney is  of great c lin ic a l importance ( in  the thrombolytic tre a t­
ment of myocardial in fa rc tio n , organ transp lanta tion  and revasculari- 
za tiona l operations), we performed our t r ia ls  on the heart and the kidney.
M a te ria ls  and Methods
Experiments were performed on mongrel dogs o f both sexes w ith a body mass o f 10-34 
kg. The dogs were narcotized w ith  30 mg/kg sodium pen toba rb ita l i . v . ,  steady narcosis was 
maintained w ith 3 mg/kg supplementary i . v .  doses. A cu ffed  endotracheal tube was inserted 
in to  the trachea and a r t i f i c i a l  resp ira tion  was applied during the t r i a l  (resp ira to r RO-5, 
Moscow, USSR). Operations were performed on a heatable operating tab le ; rec ta l temperature 
was maintained between 37 and 37.5 C. Haemodynamic balance was maintained w ith adm in istra tion 
o f sa lin e  infusion and/or Rheornacrodex adm inistration. The le f t  renal a rte ry was dissected 
from two dogs a fte r median laparotomy without damaging the rena l nerves, then i t  was oc­
cluded fo r 45 min with an atraum atic s i lk  snare. There was an in ta c t c irc u la tio n  in  the r ig h t  
kidney. One min before repe rfus ion  S00 enzyme was administered in  doses o f 0.5 mg or 5 mg/kg 
body mass (50% in  bolus, th e re a fte r  the remainder in  i . v .  in fu s io n  over ten min).
Samples were taken from the cortex and medulla o f  the l e f t  (ischaemic) kidney and o f 
the r ig h t  (non ischaemic) one a f te r  20 min reperfusion. Thoracotomy was performed in two other 
dogs, where the le f t  a n te r io r  descending (LAD) coronary branch under the f irs t  septal a rte ry  
was dissected a fte r pericard io tom y. Regional ischaemia was produced by 30 min occlusion. One 
min before reperfusion 0.5 mg o r 5 mg/kg body mass la b e lle d  SOD enzyme was administered in to  
the l e f t  atrium through a cannula in  a s im ila r way as in  the f i r s t  t r i a l .  A fte r 20 min 
repe rfus ion , samples were taken from the endo- and e p ic a rd ia l regions o f the myocardium w ith 
both ischaemic and in ta c t c ir c u la t io n .  Exogenous SOD (Peroxinorm, Grünenthal Germany) was iod- 
irriarl by the special method o f  Fraker and Spec /4/, in  which the reaction occurs a t +4 C in  a 
polypropylene (Eppendorf) w e ll.  The process was the fo llo w in g : 500 ug I0D0-GEN vas dissolved 
in  500 u l  chloroform, then d ried  on the wall o f the reac tion  w e ll by c ircu la tin g  p u r if ie d  
n itro g e n . Then 185 MBq (5mCi) I-Na (12 u l)  (code: IMS. 300, Amersham In t .  p ic . ,  UK) and 
50 mg (500y j l )  S00 enzyme d isso lved in  0.05 M sodium phosphate bu ffe r (pH: 7.5) were added. 
The compound was mixed fo r  5 min in  a magnetic m ixer. The process was stopped by sucking up 
the wet phase o f the reaction  compound from the so lid  IODO-GEN phase. The la t te r  was washed 
tw ice in  200 yul phosphate b u ffe r .  The e ffic iency o f iod ine  in take was determined w ith th in  
f i lm  chromatography (K iese lge l F ^ /M e rc k ) , e luent: acetone aldehyde (Reanal, Budapest). 
Labe lling  e ffic iency : 95-98%, s p e c if ic  a c t iv ity  o f the la b e lle d  enzyme: 3.5-3.6 kBq/ug.
EXOGENOUS SUPEROXYDE DISMUTASE UPTAKE 89
Autoradiography was performed as fo llow s. The semi-thin sections were covered with 
photoemulsion ILFORD G5 w ith immersion method. Photos were taken a fte r a four-week exposure, 
gra in  counting was performed a fte r seven weeks o f exposure. Development was performed on 
paper, then the sections were stained w ith to lu id in e  blue and covered w ith  Canada balm. The 
gra ins were counted in  squared frames in  1600-fold enlargement with the help o f an immersion 
lens. In  each preparation the grains were counted in  every 14-16 f ie ld  and the groups were 
characterized w ith the mean grain-count and standard e rro r . Superthin sections were covered 
w ith  emulsion ILFORD L4 w ith immersion, they were developed a fte r four month exposure with 
the developing method Kodak B19. Tie photos were taken w ith a P h ilips  300 type transmission 
electronmicroscope.
S ta t is t ic a l evaluation o f  uata was performed by analysis o f variance. Mean +_ S.E.M. 
are shown on the Table I .
R esults
Exogenous SOD was detected in  the examined tissues p a rtly  quantita­
t iv e ly .  The data are summarized in  Table I .  The SOD uptake by ischaemic 
tissues per u n it microscopic (high powerfield 1600 x) area exceeded that 
by the tissues with in tac t c ircu la tio n . In the kidney the uptake was s ig ­
n if ic a n t ly  higher than that of the tissues with in tact c irc u la tio n  both 
w ith low and high doses (P < 0.001) compared to the heart, where i t  was 
dose dependent. A fter treatment with the higher SOD dose the enzyme uptake 
by the ce lls  was higher both in  the heart and the kidney than w ith a low 
dose (P <  0.001). However, the increase does not compare to  the tenfold 
d ifference in  the concentration applied in  the treatment (the increase of 
the enzyme concentration was 70% in  the kidney and 60% in  the heart).
The qua lita tive  analysis of the autoradiographic examinations done 
by electronmicroscope gave the fo llow ing results. Grains were be seen 
above the basement membrane in  the kidney. They were also seen in  the 
cytoplasm and the nuclei of the e p ith e lia l ce lls  of the c o lle c tin g  tubules, 
in  the cap illa ry  lumen, above the mitochondira of the tubular e p ith e lia l 
c e lls  and in  or under the brush border of the e p ith e lia l c e lls  of the 
proximal tubule as well as on the basement membrane and the podocytes of 
the glomeruli. Grains were also found above the filaments in  the cytoplasm 
o f the transient e p ith e lia l ce lls .
In the myocardium, grains frequently occurred on the myofilaments 
and the mitochondria. In some cases grains were seen above the endoplasmic 
reticulum , the basement membrane and/or the extrace llu la r region. Some 
typ ica l s ites can be seen on Figs 1-3.
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Table I
Exogenous SOD content of the kidney and myocardium
Ischaemic tissue Non ischaemic tissue
Mean _+ S.E.M. Mean +_ S.E.M.
SOD Kidney medulla 13.8(15) + 0.8 0(10)
0.5 mg/kg b.m. cortex 8.6(15) + 0.8 2.9(14) + 0.2
Heart-endocardium 12.7(14) + 1.3 8.6(27) + 0.9
-epicardium 13.5(15) + 1 .2 6.2(15) + 0.6
SOD Kidney medulla 12.8(14) + 1.8 6.9(18) + 0.9
5 mg/kg b.m. cortex 25.3(15) + 1.5 21.9(15) + 1.2
Heart-endocardium 18.9(30) + 0.8 13.5(13) + 0.2
-epicardium 16.9(14) + 1.9 12.4(14) + 0.9
Values are means o f counted g ra ins  +S.E.M. numbers in  parentheses ind ica te  the number o f 
f ie ld s  studied.
F ig . 1. Myocardium a fte r reperfus ion  (treated with SOD, 5 mg/kg). There are grains ( la b e lle d  
SOD enzyme) in  the myofilaments (<f) and m itochondria ( f r ) . (X 30 000)
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F ig . 2, Kidney a fte r reperfusion (treated w ith SOD, 5 mg/kg). There are several gra ins (♦ ) in  
the brush border o f e p ith e lia l c e lls .  (X 30 000)
F ig . 3, Kidney a fte r  reperfusion (treated w ith S00 5 mg/kg). There (ф) is  a gra in  in  the 
basement membrane kof the g lom eru li. (X 39 000)
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Discussion
Various SOD enzymes can be found in  aerobs. Eukaryotes involve an 
SOD of approximately 33 000 Dalton Cu and Zn content in the cytosol and 
the mitochondria and a 85 000 Dalton SOD with Mn content in  the m ito­
chondria. In the plasma a kind of SOD with s ig n if ic a n tly  larger molecule 
can be found in  a low concentration /11, 13/. The enzyme seems to be an 
extremely specific  transformer .of the superoxide radical and i t  has no 
other b io log ica l func tion . The protective e ffe c t of the enzyme has been 
examined in  the ischaemic-reperfusion t r ia ls  in  tissues of d iffe re n t 
animals /1 , 2, 7, 10/. Recently human recombinant SOD has been in ­
vestigated in  c l in ic a l t r ia ls  too /3 , 18/. The pharmacological a p p lica b il­
i t y  of SOD is  influenced by several fac to rs , such as c ircu la tion  time, 
penetration in to  the c e lls ,  in tra c e llu la r lo ca liza tio n  and organ s p e c ific ­
i t y .  SOD soon disappears from the c irc u la tio n . In d iffe re n t species i t  can
be shown in  large amount in  the kidneys w ith in  10-30 min, but i t  is  also
accumulated in  the pulmonary system and the myocardium /11, 15/. E a rlie r 
the access of exogenous SOD to the ce lls  was doubted because of i t s  macro- 
molecular structure /5 , 13/. As the perm eability of the ischaemic c e ll 
membrane can be a ltered (release of macromolecules from ischaemic not
necrotiz ing ce lls  was v e r if ie d ) , the enzyme may penetrated the c e lls  but 
there i t s  impact on the microvascular system is  also possible /1 , 8, 14/. 
Studying the access of exogenous SOD to d if fe re n t ce lls  (monkey's kidney, 
Ehrlich  ascites, hamster fib ro b la s t, human erythrocytes) in v itro  Michael- 
son and Puget found tha t i t s  0.04% was fixed a fte r incubation in  sub­
stances containing SOD on fa r greater concentration than in  the ce lls  with 
the simultaneous penetration of its  50% through the c e ll membrane. On 
examination the in tra c e llu la r  loca liza tion  of SOD encapsuled in  the l ip o ­
somes i t  was found tha t i t s  25% was bound to the mitochondria or the 
nucle i /15 /.
The aim of our t r i a l  was to answer the fo llow ing questions: Is  the 
exogenous SOD able to  penetrate the ce lls?  What is  the difference between 
the SOD uptake by ischaemic tissues and by those with in tac t c ircu la tion?  
Which are the organelles tha t the enzyme shows a f f in i ty  to in  the ce lls?  
How does the exogenous SOD content of the c e lls  a lte r in  response to 
treatment with d iffe re n t doses?
On the basis of the results gained w ith autoradiographic technique 
and the use of labe lled  SOD we conclude, tha t the exogenous SOD can
EXOGENOUS SUPEROXYDE DISMUTASE UPTAKE 93
qucikly penetrate the ce lls  during reperfusion. I t  was seen in  large 
amount on the basement membrane in  the kidney, which can be due to  i t s  
f i l t e r in g  function: the labelled SOD molecules are retained on th is  
b a rrie r. I t  also could be detected in  large amount in or under the brush 
border of the ep ith e lia l c e lls  in  the tubules, which have a reabsorptive 
function . The enzyme seems to have special a f f in ity  to d iffe re n t f i l a ­
ments: most frequently i t  could be observed above the myofilaments in  the 
myocardium but i t  also occurred in  the filaments of the trans ien t ep i­
th e lia l ce lls  of the kidney. Light-microscope showed tha t ischaemic 
tissues contained exogenous SOD in  s ig n if ic a n tly  higher quantity than 
those with in ta c t c ircu la tio n ; the d ifference may be due to the easier 
access of the enzyme through the membrane with altered perm eability. How­
ever, the access is  lim ited . This is  proved by the fact tha t tissues 
treated with tenfold SOD concentration produced less than ten fo ld  amount 
of grains. I t  is  known that free rad ica ls can penetrate ce lls . Thus, i t  is  
important that the exogenous antioxidant SOD also enters ce lls  under con­
d itio n s  of ischaemia and reperfusion. Tanaka et a l. investigated the fa te  
of exogenously administered SOD in  ra t myocardium and cultured bovine 
endothelium. They found (w ith an immunohistochemical method) a s ig n if ic a n t 
amount of SOD in the ce lls  (endothelia l uptake by endocytosis) /1 7 /. This 
is  somewhat s im ila r to our resu lts . Our new findings are: we observed that 
the enzyme sp e c ifica lly  binds to certa in  organelles and that a moderate 
quantity of the SOD can enter non-ischaemic c e ll.
Our investigations were performed with bovine SOD enzyme on the 
basis of the Cu-Zn content. Further studies are needed with other enzyme 
products (e.g. human recombinant) in  other species and organs on ischaem­
ic-reperfusion models in  d iffe re n t time-schedules.
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P A T HOP H Y S I OL OGY
EFFECT OF PULSED MAGNETIC FIELDS ON HEALTHY MICE,
A STUDY THROUGH CELLULAR ELECTROPHORESIS OF THYMIC CELLS
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An exposure o f adu lt mice to a pulsed magnetic f ie ld  (PMF) increases thymus weight. 
In  th is  work, thymic lymphocytes were studied by c e llu la r  electrophoresis because the pro­
l i fe ra t io n  and maturation o f these c e lls  is  lin ke d  to  an increase in  th e ir  e le c tropho re tic  
m ob ility  (EM). Fifteen-week-old female Swiss mice were exposed for 30 min to  a 6 mT PMF, 
12 or 460 Hz in  frequency, according to d if fe re n t  m oda lities. The EM o f the thymic c e lls ,  
suspended in  sa line were measured from 0 to 96 h a f te r  the end ofthe exposure. For some of 
the mice the whole body, fo r others the head on ly or the body without the head was exposed; 
the animals were awaken or narcotized, prepared or not w ith  6-hydroxydopamine. The m od ifi­
cations o f the EM are in  favour o f an action o f  the PMF on the thymus through the cen tra l 
nervous system.
Keywords : C e llu la r e lectrophoresis, pulsed magnetic f ie ld s , mice thymus
In tro d u c tio n
In normal healthy mice thymus invo lu tion  begins as early as 6 weeks 
of age and is  demonstrable by a decrease in  weight /7 /. In a previous ex­
periment /1 / we had shown that the exposure of 15-week-old mice to a 
pulsed magnetic f ie ld  0.6 or 6 mT in  in te n s ity , 12 or 460 Hz in  frequency 
increased the thymus weight. The va ria tio n  was the most s tr ik in g  24 h 
a fte r a 30 min expopsure. An e ffec t on the thymic ce llu la r content was 
taken in to  account.
Abbreviations: EM: e lectrophoretic m o b ility ,  6-0H0A: 6-hydroxydopamine, PMF: pulse 
magnetic f ie ld
O ffp r in t requests should be sent to : A. B e llo s s i, 2, Avenue du Pr. Léon Bernard, 
F-35043 Rennes Cedex, France
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Sabülovic and Dumont /8 /  observed an increase of e lectrophoretic 
m o b ility  of thymic lymphocytes during th e ir  p ro life ra tio n  and maturation. 
The EM of cortisone-resis tan t ce lls  were found to  be the fastest. There­
fo re , a ce llu la r electrophoresis has been undertaken to determine i f  the 
exposure to PMF modifies the qua lity  of the thymic ce lls .
M a te r ia ls  and Methods
Fifteen-week-old female Swiss mice were used. For the exposure they^were put in to  
an a ltu g la s  para lle lop iped ic conta iner divided in to  compartments 29x29x100 mm in  s ize . Ihe 
mouse, one in  each compartment, was unable to  move about.
The magnetic generator (Magnobiopulse -  Société A tla s , Paris, France) delivered a 
pulsed magnetic f ie ld .  The f ie ld  was created from two independent discs, each 12 cm in  
d iam eter. They were put on the top o f the container hold ing the mice. The centre o f a com­
partment fo r  a mouse was placed a t a distance o f 18 mm from the surface of an em itter d isc . 
The f ie ld  strength measured a t the em itter surface was 6 mT. Twelve and 460 Hz were the 
frequencies used.
For experiments: the co n tro ls  and mice to be exposed were taken at random and put in  
the same conditions, but the con tro ls  were not exposed to  magnetic f ie ld .  The exposure 
las ted  30 min ju s t once. At given times a fte r the eno o f  the exposure, the mice were de­
ca p ita te d , the thymuses were removed and weighed. In  each experiment 2 mice were used. The 
2 thymuses were torn to  pieces together. Then 3 ml o f a 0.15 M NaCl so lu tion , pH 7.7 
( s a l in e ) ,  was added. About 1-min a f te r  shaking the c e ll suspension was put in to  the measure 
room o f a Zeiss cytopherometer a t 25 C. The time o f m igra tion o f a c e ll was measured in  two 
ways by the reversal o f the e le c t r ic  f ie ld .  With a few exceptions, 100 ce lls  or more were 
taken in to  account in  each experiment. The experimenter was not informed about the group o f 
mice the thymuses belonged to .
EM were determined in  re la t io n  to  the EM o f e ry th rocytes. Before and a fte r the thymic 
c e lls  were measured, measures were done with the ery th rocytes o f  a mouse. Here, in  the 
s a lin e  used, the EM o f a mouse was considered to  be 1.10 u . sec- -*-. V- -*-. cm- -* /5 / .
In  each case, the values obtained fo r the exposed mice were compared with the c o n tro l 
va lues. The measuring fo r each parameter (frequency, and time a fte r  exposure) were repeated 
from 5 to  20 times. Groups o f mice were treated as fo llow s:
(1 ) Whole-body exposure o f wide-awake mice; measuring were done 0, 3, 24, 48, 72 or 
96 h a f te r  the end o f the exposure; (2) mice narcotized fo r  the time o f exposure by an i . p . ,  
in je c t io n  o f 1.5 mg o f pentobarb ita l dissolved in  0.3 ml o f s a lin e ; (3) exposure o f the head 
o f wide-awake mice the res t o f the body being shielded by a ferromagnetic tube; measuring 24, 
48 and 72 h a fte r  the end o f the exposure; (4) exposure o f the body of wide-awake mice, the 
head being shielded by a ferromagnetic tube; (5) whole-body exposure o f wide-awake axotomized 
mice. To produce peripheral axotomy, we in jec te jl mice w ith  0.2 ml 6-hydroxydopamine (6-OHDA) 
(Sigma Chemical Co.) (d a ily  dose: 100 mg_j kg body mass) fo r  10 days /6 / .  6-OHDA was d is ­
solved in  sa line  containing 0.1 mg . ml ascorbic ac id . The mice were exposed seven days 
a f te r  the la s t  6-OHDA treatment. Measuring were done 24 h a f te r  the end of the exposure.
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Results
(1) Wide-Awake mice
The mean EM _+ standard deviation (S.D.) data are given in  the 
Table I .  A variance ra tio  tes t with the d iffe re n t control groups, from 0 
to 96 h, showed no s ig n ifica n t heterogeneity. However, there was a s lig h t 
increase in  the EM from the 3rd h a fte r the end of the exposure in  re­
la tio n  to the EM of the very controls which had not stayed in  the con­
ta ine r; the mean EM at the 72nd h was even s ig n if ic a n tly  d iffe re n t from 
the mean EM of the very controls (P <  0.02).
Table I
Awaken mice: mean EM -  S.D. expressed in  a -sec .V  . cm * o f the thymic 
c e lls  exposed to the ind icated f ie ld  frequencies 
Time o f measuring: hours a fte r  the end o f the exposure, n = sample size
Time of measuring 
h
Mice having put in  container Controls 
not put in  
containerControls 12 Hz 460 Hz
0.835 0.842 0.848 0.832+0.032
0 +0.030 +0.041 +0.032 n = 20
n=10 n=10 n=10
0.842 0.863 0.862
3 +0.038 +0.032 +0.032
n= ll n=10 n=10
0.840 0.878 0.862
24 +0.021 +0.036 +0.052
n=13 n=20 n=10
0.852 0.840 0.862
48 +0.022 +0.038 +0.035
n=10 n=20 n=10
0.854* 0.878 0.872
72 +0.026 +0.038 +0.043
n=14 n = ll n=10
0.855 0.871 0.867
96 +0.031 +0.026 +0.046
n=10 n = ll n = ll
P <  0.02 vs. the con tro ls  not put in  container
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Table I I
Awake mice : mean EM ±  S. D. expressed in  и . sec . V . cm . Sums o f the values obtained 
fo r  the thymic c e lls  the values a t 3, 24, 48, 72 and 96 h a f te r  the end o f the exposure 
( fo r  12 Hz, the values at the 48th h have been discarded) 
n = sample size
Frequency (Hz) Contro ls 12 Hz 460 Hz
Mean 0.849 0.873 0.863
+S.D. 0.028 0.033 0.041
n 58 52 51
Variance ra tio  te s ts  with the d iffe re n t groups exposed e ither to 
12 Hz or to 460 Hz gave s ig n ific a n t heterogeneities. A ll the average EM 
values from the exposed mice, with the exception of the average EM of mice 
exposed to 12 Hz 48 h a fte r  the end of the exposure, were superior to the 
average EM values of the contro ls. But, w ith the exception of the mice 
exposed to 12 Hz and measured 24 h and 72 h a fte r  the end of the exposure, 
no s ig n ifica n t d ifference appeared between the exposed mice and the 
con tro ls . This may be due to  the small sample sizes and the heterogenei­
t ie s  o f the populations. However, in  consequence of the same magnitude of 
the values, the values from the 3rd to the 96th h of each series were put 
together, with the exception of the values from the 48th h of the 12-Hz 
exposed mice. The resu lts  are shown in Table I I .
A variance ra t io  te s t comes to the conclusion that the 3 means are 
s ig n if ic a n tly  heterogeneous. Student's t - te s t  is  in  favour of s ign ifican t 
d ifferences between the con tro ls  and the mice which had been exposed to 
12 Hz (P <  0.001) or to 460 Hz (P < 0.05); there was no s ig n ifica n t d i f ­
ference between mice exposed to d iffe ren t frequencies.
(2) Asleep mice
The mean EM + S.Ü. values are shown in  Table I I I .
There was no d iffe rence  between the re su lts . Gathering a l l  the 
values obtained at d if fe re n t times a fter the end of the exposure gave the 
mean values shown on Table IV.
There was no d iffe rence between the exposed mice and the controls.
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Table I I I
. -1 -1 -1 
Narcotized mice: mean EM — S.D. expressed in  p. sec . у . cm .
Thymic c e lls  exposed to the ind icated f ie ld  frequencies.
Time o f measuring: hours a fte r  the end o f the exposure.
n := sample size
Time o f measuring Mice put in  container Controls not put in
(h a fte r exposure) Controls 12 Hz 460 Hz container
0.829 0.819 0.826 0.824
0 ++0.017 +0.023 +0.016 +0.019
n=5 n=5 n=5 n=5
0.830 0.824 0.838
3 +0.035 +0.025 +0.016
n=5 n=5 n=5
0.844 0.840 0.826
24 +0.019 +0.042 +0.021
n=5 n=5 n=5
0.835 0.834 0.813
48 +0.046 +0.024 +0.022
n=5 n=5 n=5
0.825 0.848 0.829
72 +0.022 +0.012 +0.031
n=5 n=5 n=5
0.844 0.810 0.839
92 +0.027 +0.044 +0.026
n=5 n=5 n=5
Table IV
-1 -1 -1
Asleep mice: mean EM±S. D. expressed in  и . sec . V cm .
of the values obtained fo r  the thymic c e lls  examined a t d if fe re n t  1
a fte r  the end of the exposure
n = sample size
Frequency (Hz) Controls 12 Hz 460 Hz
Mean 0.834 0.833 0.829
+S.D. 0.028 0.033 0.023
n 30 « 30 30
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(3 ) Body exposure of wide-awake mice
The mean EM +_ S.D. values are shown in  Table V.
There was no d iffe rence  between the exposed mice and the controls.
Table V 1
Body-exposed awaken mice: mean EM±S.D. in n  •s e c ’*’. V ■ cm '''fo r the thymic c e lls  
exposed to the Indicated f ie ld  frequencies. Time o f measuring: hours a fte r the end
o f the exposure 
n = sample size
Time o f measuring (h) Controls
Exposure to  
12 Hz 460 Hz
0.846 0.834 0.831
24 +0.017 +0.035 +0.040
n=5 n=10 n = ll
0.838 0.824 0.837
48 +0.019 +0.028 +0.027
n=5 n=10 n= ll
0.859 0.838 0.852
72 +0.032 +0.022 +0.026
n=5 n=10 n=10
(4) Head exposure of wide-awake mice
The mean EM + S.D. values are shewn in  the Table VI.
Table VI
Head-exposed awaken mice: mean EM±5.D. expressed in^iu. sec \  V \cm  \  Thymic c e lls  
exposed to the indicated f ie ld  frequencies. Time o f measuring: hours a fte r the end
o f the exposure 
n = sample size
Exposure to
Time o f measuring (h) Controls 12 Hz 460 Hz
0.835
+0.013
0.864
+0.043
0.863
+0.039
n=5 9 n = ll n=10
0.843 0.869 0.847
+0.025 +0.025 +0.036
n=5 n=15 n=17
0.825 0.869 0.865
+0.018
n=5
+€.021
n=5
+0.037
n = ll
72
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(5) Axotomized mice
The mean EM + S.D. values are shown in  the Table V II.
There was no difference between the exposed mice and the con tro ls .
Table V II
Axotomized mice: mean EM±S.D. expressed in ^u . sec \  V ^cm Thymic c e lls  exposed 
to the ind ica ted  f ie ld  frequencies. 24 h a f te r  the end of the exposure
Exposure to
Controls 12 Hz 460 Hz
0.828 0.841 0.832 
+0.034 +0.030 +0.041 
n=19 n=18 . n=20
Discussion
The stay of wide-awake mice in  the container induced a s l ig h t ,  but 
obvious, increase in  the ce llu la r EM. I t  appeared as soon as the 3rd h and 
became more pronounced about the 48th h. This can only be a consequence of 
the handling of animals and of the re s tra in t stress due to the stay in  the 
container.
The modifications of the EM a fte r the exposure at 460 Hz followed 
the same lin e  as those of the controls but were more marked than those of 
the la t te r  and appeared as early as the end of the exposure. The d i f fe r ­
ence between the e ffects  of 460 Hz and the e ffects of 12 Hz consists of a 
temporary return to low EM at the 48th h.
As the EM values for the anesthetized mice did not increase, a l l  
happened as i f  the exposure to the PMF had accelerated and am plified  the 
reaction of the organism to the stress. Boranic et a l. /2 / reported that 
in  case of stress the CNS, and also the autonomic nerves can influence the 
lymphatic organs. Barbiturates can produce a l l  sorts of degrees of depres­
sion of the CNS and selectively depress the transmission in  autonomic 
ganglia /4 / .  So, an e ffec t of the PMF via the nervous system may be taken 
in to  account.
In fac t no e ffe c t appeared, i f  the mice's heads were shielded during 
exposure. I t  may therefore be suggested tha t the encephalon played an es­
sen tia l ro le  in  the action of the PMF on the thymic ce lls . Furthermore,
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when only the head was exposed, an increase in  the EM was observed. How­
ever, the EM at the 48th h fo r the exposure a t 12 Hz and the exposure a t 
460 Hz were exactly reversed vs. to the values obtained for a whole-body 
exposure: an absence of acceleration was observed fo r the exposure to  460 
Hz compared to the exposure to  12 Hz.
Axotomy suppressed the increase of EM at the 24th h. According to  
Felten e t a l. /3 / the developing thymocytes would be the suspected ta rge t 
c e lls  o f the noradrenergic fib e rs  d is tribu ted in  the thymic cortex. 6-PHDA 
is  a neurotoxic agent tha t destroys noradrenergic sympathetic nerve 
te rm ina ls . Therefore, the e ffe c t of the PMF must be transmitted to  the 
thymus through the noradrenergic fibres in case of both of the frequencies 
12 Hz and 460 Hz.
Hence, an exposure óf the CNS is  absolutely necessary to an e ffe c t 
of the PMF on the thymic c e lls ,  and an action on the peripheral nervous 
system must also be taken in to  account.
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A simple method based on rocket and crossed Immunoelectrophoresis was adapted fo r 
detection o f cC AT-HNE complexes in  8ALF: Agarose gel w ith  anti-Ot^AT combined w ith  in te r ­
mediate gel containing anti-HNE was used fo r detection and evaluation o f the r a t io  o f com­
plexes w ith  HNE to the free form o f ot^ AT. BALF samples from 31 pa tients d iv ided  in to  5 
groups su ffe ring  from various resp ira to ry  tra c t diseases were tested. I t  was found th a t 3 out 
o f 8 patients w ith inflammatory pulmonary diseases showed the presence o f both forms o f 
AT, 7 out o f 13 patients su ffe ring  from cancer showed both forms, whereas the complexed form 
was not detected in  any o f 8 pa tients w ith asthma bronchiale. I t  is  suggested th a t the 
presence o f AT-HNE complex may re f le c t ,  to  some exten t, the p ro te o ly tic  s ta tus o f pulmonary 
t is s u e .
Keywords: a -a n titry p s in , neutroph il e lastase, bronchoalveolar lavage, Immuno­
electrophoresis, proteinase-antiproteinase complex
In tro d u c tio n
A lpha-l-an titryps in  (a^AT), a lte rn a tive ly  called alpha-l-prote inase 
in h ib ito r  ( c L P I ) ,  seems to inactiva te  a l l  the human serine proteinases 
tested by now. Besides, being responsible fo r about 90% of the to ta l tryp ­
sin inh ib ito ry  a c t iv ity  /3 , 9, 10, 16/, i t  is  known as the main physiolo­
g ica l in h ib ito r of human neutrophil elastase /5 , 6, 16/. The protective
Abbreviations: g  AT : a lp h a -l-a n titry p s in , cx^PI: a lpha-l-proteinase in h ib ito r ,  a^M: 
alpha-2-macroglobulin, HALF: bronchoalveolar lavage f lu id ,  HNE: human n e u troph il elastase, 
PMN: polymorphonuclear leukocyte
O flprint requests should be sent to : Wladysiaw Pajdak, Department o f Imnunology, 
Nicolas Copernicus Academy o f Medicine, 18 Czysta S tre e t, 31-121 Kraköw, Poland
Akadémiai Kiadó, Budapest
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e ffe c t of oljAT against e la s to ly tic  a c tiv ity  is  known to exist in  many 
organs and tissues, but elastase- об^ АТ imbalance is  p a rticu la rly  spectac­
u la r and dangerous in  some pulmonary diseases /5 , 6, 14/.
The a ttraction  of leukocytes in to  a ir  spaces of the diseased lung 
is  regulated by many chemoattractants. Among others, leukotriene B^, 
in te rle u k in -1 , C5a — (a peptide generated during activa tion  of the comple­
ment cascade),cigarette smoke /6 , 16/, some peptides --  degradation pro­
ducts of connective tissue /15 / — and also the alpha-l-antitrypsin-human 
neutroph il elastase ( oC^ AT-HNE) complex i t s e l f  /1 / .  Once in it ia te d , .pul­
monary accumulation of leukocytes proceeds as a self-perpetuating process.
Leukocyte granules contain a broad spectrum of hydro lytic enzymes, 
among others elastase, which is  a 33-kD single-chain polypeptide contain­
ing about 12% carbohydrate /1 7 /. Discharged during phagocytosis or a fte r 
c e l l  death, i t  is  ready to attack e lastin  of the surrounding tissues i f  
not inactivated by an appropriate in h ib ito r.
oi.^ AT, being small enough (53 kD) to penetrate in tra c e llu la r spaces, 
has also been found in  the bronchoalveolar f lu id .  I t  seems that the pro­
portion  of o(^AT-elastase complex to the free form of the in h ib ito r re­
f le c ts  the important part o f p ro teo ly tic  balance in  the respiratory tra c t.
We present here a simple method — rocket immunoelectrophoresis with 
intermediate gel containing antibodies to HNE — to  detect both free and 
complexed forms, of ot^AT. No attempts were made in  th is  work to deter­
mine precise concentrations. However, the method is  read ily  adaptable fo r 
th is  purpose.
M a te r ia ls  and Methods
Bronchoalveolar lavage f lu id  (BALF) was obtained from 31 pa tien ts . The patients were 
d iv ided in to  5 groups in respect o f  th e ir  main disease.
Group 1 — 13 patients (2 women and 11 men) w ith lung cancer. Mean age: 60.9 years, 
range: 49-69 years.
Group I I  — 2 patients w ith  cancer not connected w ith  the resp ira to ry  tra c t (1 woman 
w ith cancer o f ovary, aged 51 years and 1 man w ith prosta te  cancer, aged 67 years).
Group I I I  — 8 pa tients  (2 women and 6 men) w ith  various inflammatory pulmonary 
diseases, mean age: 47.5 years, range: 35-69 years.
Group IV — 6 pa tients (3 women and 3 men) w ith asthma bronchiale, mean age: 49.2 
years, range: 31-74 years.
Group V — 2 patients (1 woman aged 55 years and 1 man aged 27 years) w ith sarcoidosis.
Bronchoalveolar lavage was performed through a f ib e ro p tic  bronchoscope w ith the 
method o f  W ile rley  & Barl e t t ,  w ith  m od ifica tion  o f Owsihski /1 2 / to  prevent the samples from 
being contaminated with o ra l microorganisms. Within 2 h a f te r  c o lle c tio n  the samples were 
cen trifuged  a t 4 C, 20 000 g^ fo r 15 min to  remove the c e lls  and occasionally present membrane 
fragments, and stored at -18 C u n t i l  assayed.
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Detection o f Ot^AT and O^AT-HNE complexes.
We measured the ra t io  o f free to complexed forms o f Ot AT by the means o f rocket and 
crossed Immunoelectrophoresis using rabb it immunoglobulins to  human Ot^AT (D ifco ) and sheep 
anti-HNE produced in  our laboratory by vaccinating sheep w ith human neutroph il elastase 
iso la ted  according to Baugh & Travis /2 / .  Anti-HNE antibodies were p u rif ie d  according to 
McKinney & Parkinson /1 1 /. Jn b r ie f ,  the BALF samples (10 yu l each) were jun on 1% agarose 
p lates containing 0.1 u l/cm  o f anti-CL AT or a combination o f 0.2 u l/cm  o f anti-HNE and 
a n t i-  OCjAT (F ig . 1).
a) b)
F ig. 1. Agarose p la tes used fo r a) crossed and b) rocket immunoelectrophoresis
The separation was performed in  0.1 M T ris-verona l bu ffe r o f pH 8.6 a t 50V, over­
n ig h t. In the case o f crossed immunoelectrophoresis the BALF samples (20 u l )  were f i r s t  
separated on 5% polyacrylalm ide gel rods, according to  Clarke /4 /  and then the gels were cut 
lo n g itu d in a lly  in to  halves. One o f them was stained w ith  Coomassie b r i l l ia n t  blue G-250, and 
the other was electrophoresed (perpendicularly to  the f i r s t  run) in to  agarose gel containing 
the proper concentration o f the antibody (antibodies) as described above.
A fte r the run, the agarose plates were pressed, d ried , and stained w ith Coomassie 
b r i l l ia n t  blue R-250.
Results and Discussion
BALF from 13 patients with lung cancer, 8 patients with inflammatory 
diseases of the lower respiratory tra c t and 6 patients su ffering  from 
asthma bronchiale were tested fo r the presence of cCjAT-HNE complexes. 
A typ ica l resu lts  of rocket immunoelectrophoresis of a sample containing 
both: free and complexed forms of (X^ AT is  shown in Fig. 2. The lower peak 
represents O^ AT-HNE complex while the upper one — the free (uncomplexed) 
form of the in h ib ito r . Peak heights of the complexed form (lower) and the
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a b
F ig . 2. Rocket immunoelectrophoresis patterns o f BALF samples containing a) both forms o f 
(X^AT (uncomplexed and in  complex w ith HNE) and b) only one -  uncomplexed form.
Arrow ind ica tes the complexed form
free  one (higher) of HNE were measured and the proportion сС^ АТ-HNE/OC^ AT 
was calculated. I t  is  known tha t HNE liberated from polymorphonuclear 
leukocytes (PMNs) is  immediately complexed and inactivated, mostly by 
OC-j^ AT. Small amounts of HNE complexed by alpha-2-macroglobulin (O^M) and 
other plasma inh ib ito rs  /1 4 / are neg lig ib le . The proportion of the lower- 
to-upper peak (complexed to  free in h ib ito r)  varies by patien t, ranging 
form 0 to 0.54 (Table I ) .  P a ra lle lly  a l l  samples were analysed by two- 
d ire c tio n a l (crossed) immunoelectrophoresis against anti-O^AT. The 
presence of free and complexed forms of OC^AT was c lea rly  shown in  each of 
the m aterials exhib iting both forms of OC^AT found by means of rocket im­
munoelectrophoresis with intermediate gel, whereas only the free form was 
present in  samples exh ib iting  one peak in  rocket immunoelectrophoresis 
(F ig . 3a and 3b). In some patien ts additional peaks were found represent­
ing OC^AT complexes with p ro te o ly tic  enzymes other than PMN elastase (the 
most suspected one was leukocytic collagenase), however, the concerning 
problems were not studied in  d e ta il.
None of 8 asthma bronchiale patients exhibited the presence of 
detectable amounts of complexed forms of Ot^ AT in  BALF, moreover, most of 
them showed only traces of free OC^ AT.
Dut of 8 patients w ith inflammatory diseases 3 showed the presence 
of both forms of AT while the remaining 5 showed only the free form.
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Table I
The ra t io  o f OC^ AT-HNE (alpha-1-antitrypsin-Human neutrophil elastase) 
complex to free o^ AT (a lp h a - l-a n titrv p s in )  in  BALF samples
Patient Diagnosis (main disease)
OCjAT-HNE
OUT
WG Cancer (lung, larynx) 0.09
BK Cancer (ovary, marnia, p leura) 0.12
BH Cancer (lung, bronchi) 0.23
PM Bronchiectasis, purulent pneumonia 0.24
KS Cancer (lung, bronchi) 0.24
MG Cancer (lung) 0.32
JG Cancer (lung, bronchi) 0.37
GJ Bronchiectasis 0.44
LS Bronchiectasis, b ro n ch itis 0.45
Л Cancer (lung) 0.54
F ig . 3. Crossed immunoelectrophoresis patterns o f  BALF samples containing a) both forms o f 
(XjAT (uncomplexed and in  complex w ith HNE) and b) only one -  unconplexed form.
Arrow indicates the complexed form
I t  is  d i f f ic u l t  to say whether the low proportion or even absence of the 
(XjAT-HNE complex in  BALF is  a ru le  in  patients with lower resp ira to ry  
tra c t inflammatory disease showing almost normal level of white blood 
ce lls .
I t  has been suggested recently tha t the upper part of the resp ira­
tory tra c t is  protected against leukocytic elastase action by a so-called 
low-molecular bronchial in h ib ito r , while the lower part mostly by OC-^ AT /14/ 
Seven out of 13 patients su ffe ring  from cancer showed c le a rly  the 
presence of a complexed form of AT in  BALF. This high rate is  not sur-
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p ris in g , while i t  is  well established tha t PMN in f i l t r a t io n  is  involved in  
lung neoplasms. Elastase released from PMNs may penetrate surrounding 
cancer and healthy tissues and readily enter the BALF. I t  may enter th is  
compartment e ithe r in  free or complexed forms, depending on the enzyme-in­
h ib ito r  dynamic status.
I t  should be kept in  mind, however, tha t most of the main disease of 
the investigated patients were complicated by the presence of various 
bac te ria l stra ins in  the respiratory tra c t /7 / .  The influence of the con­
taminating microorganisms and the in teraction  of th e ir  p ro teo lytic  a c t iv i­
t ie s  are out of the scope of th is  study. Nevertheless, we are aware of the 
possible im plications of th is  fac t. An attempt of a preliminary assessment 
of these in teractions w i l l  be presented in  a separate paper.
I t  is  d i f f ic u l t  to say to what extent the ra t io  of the complexed to 
free form of oC-^ AT, when measured only once in  a given patient, re fle c ts  
the status of the disease and would help in  diagnosing and monitoring the 
inflammatory process in  the pulmonary tissue. Preliminary works comparing 
the elastase- (X^ AT complex in  the c ircu la tin g  blood and in the BALF /8 , 
13, 18/ seem to be very promising.
However, much more information would be drawn i f  the progress of the 
disease had been correlated with the dynamically measured changes of the 
concentration of free and complexed forms of CC^AT both in BALF and c i r ­
cu la ting  blood.
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CONTRIBUTION TO THE UNDERSTANDING 
OF DEGENERATIVE PATHOLOGY 
AND A PROPOSAL OF A GLOBAL THERAPEUTIC SOLUTION
J .P . WILLEM
The purpose of th is  paper is  to  consider the p o s s ib ility  of a 
g loba l solution to degenerative pathology by means of a simple, unique, 
ambulatory and to ta lly  innocuous procedure.
Degenerative pathology (canceration, atheromasia, m ultip le  sclero­
s is ,  schizophrenia and Alzheimer's) constitu tes the major agent of mor­
b id ity  and m orta lity . In th is  ro le , i t  took the place of v ira l pathology, 
suppressed by vaccination, and of in fec tious  pathology, eradicated by 
treatment with a n tib io tic s . I ts  progression has been res is tant to a l l  e f­
fo r ts  and no solution to any of these a ffections has yet been found.
However, b io lo g ic a lly , there are reasons to believe that a common 
so lu tio n  resides in  the drying up of the growth hormone in  the adult. 
Following are the reasons, a l l  of which are based on established b io lo g i­
ca l data.
F irs t of a l l ,  in  the subject whose growth has stopped, the growth 
hormone no longer serves any purpose.
Whether natural and taking place w ith age or provoked, i t s  drying 
up is  not accompanied in  the adult by e ith e r immediate or la te r  physio­
lo g ic a l or pathological e ffe c t. Once growth is  fin ished, the growth hor­
mone does not have any more purpose than the other remnants of the organo­
genesis which is  p a rtic u la r ly  slow in  the human species.
With no physiological in te rest remaining in  the adult, the growth 
hormone presents the inconvenience of maintaining the stim ulation of the 
immature remnants of the organogenesis and the c e lls  which, l ik e  cancerous 
ones, recover a status of immature ce lls .
This p ro life ra tiv e  stim ulation of the residual or regressive ce lls  
is  the major factor in  degenerative pathology, fo r  which we w i l l  consider 
the various expressions.
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CANCER
One cannot induce cancer in  an hypophysiolyzed animal (C o u r t ia l )
This in h ib it io n  o f carcinogenesis re s u lts  from the fa c t  th a t  the  
growth hormone is  a major fa c to r  in  the p ro li fe r a t io n  o f the embryonic 
c e l ls  or the c e l ls  which, l ik e  the cancerous ones, recover an embryonic 
s ta tu s .
The s e n s it iv ity  o f the cancerous c e l ls  to  the growth hormone can be 
seen as w e ll in  v i t r o  as in  v iv o . Moreover i t  co n stitu tes  the foundation  
fo r  the in d ic a tio n  of hypophysectomy, in  p a in fu l u ncon tro llab le  cancers , by 
generating  a quiescence o f the p r o li f e r a t io n  w ith  a consequent a n ta lg ic  
e f f e c t .
Considering the incidence o f c a n c é ris a tio n  in  general m o r ta l i t y ,  i t  
is  b e tte r  to  in h ib i t  carcinogenesis than to  f ig h t  against cancer. In  o ther 
words, i t  is  b e tte r  to  proceed w ith  the d ry in g  up of the growth hormone as 
soon as i t  does not serve anymore purpose than to  r is k  a c a n c é r is a tio n  to  
preserve an organogenetic remnant, which no longer serves any u s e fu l pur­
pose a t  ad u lt age.
AGEING
Genetic programming sets l i f e  d u ra tio n ; th is  maximal l i f e  d uration  
is  about 120 years in  the human species. This programming is  fundam entally  
conditioned  by the l im ita t io n  in  the number o f possible c e l lu la r  d iv is io n s .  
In  the human species, th is  " in t r in s ic  k in e t ic  p o te n tia l"  is  70 d iv is io n s  
( in  v i t r o  as in  v iv o ) of which 50 are used up during a d u lt m a tu ra tio n  of 
the organism and 20 are a v a ila b le  fo r  the re s t of the in d iv id u a l l i f e .
The precocious a b la tio n  of the hypophysis is  accompanied, in  animals 
by an increase of l i f e  d u ra tio n .
The reason fo r  th is  e f fe c t  is  the same as th a t which we considered  
fo r  cancerous c e l ls ,  i . e .  "the growth hormone has a s tim u la tin g  ac tio n  on 
t is s u la r  growth in  general and on th a t  o f tumors in  p a r t ic u la r "  ( S i b i l l y ) .
By s tim u la tin g  the m aturation  o f the stock of c e l ls  rem ain ing a t 
adulthood, the growth hormone hastens th e  exhaustion o f th is  " in t r in s ic  
k in e t ic  p o te n tia l"  o f the c e l lu la r  p o p u la tio n s , and thus reduces lo n g e v ity . 
G iants and acromegalics d ie  prem ature ly ; the premature d ry in g  up o f the 
growth hormone has an inverse e f fe c t .
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Of a l l  degenerative processes, the only inescapable one is  ageing, 
which sees the exhaustion of the genetica lly lim ite d  number of c e llu la r  
d iv is ions , indispensable in  replacing the c e lls  used up by the metabolism. 
The elim ination of the stim ulating hormone which hastens the exhaustion of 
th is  k ine tic  po ten tia l delays the terminal impoverishment of the paren­
chymas which leads to  na tu ra l death.
ATHEROMASIA
We have known since 1985 that a r te r ia l degeneration fundamentally 
re su lts  from a cancérisation of the a rte r ia l w a ll. This very cancérisation 
o f the vascular muscular ce lls  in it ia te s  the development of the athero­
matous deposit. A ll in te rna tion a l teams agreed (12th Symposium in  Kyoto, 
1988) with the new datum which was introduced in  France in  1986.
We can already notice  two essential po in ts . On the one hand, the 
most usual manifestations o f atheromasia (myocardial in fa rc t, hemiplegia) 
are both on the l i s t  o f the states of hypersecretion of the growth hormone; 
on the other hand, under yet the most atherogenous conditions, the athero­
matous evolution is  stopped by the drying up of the growth hormone 
(Sheehan's Syndrome).
Therefore we have a l l  bio logical reasons to th ink that, on the one 
hand, th is  drying up is  able to break the p o s itive  corre la tion between the 
growth hormone and atheromasia and, on the other hand, to in h ib it  the 
atheromatous evolution.
MULTIPLE SCLEROSIS
A French Government inquiry (Salpétrière 1980) seeking to define 
the corre la tion between m u ltip le  sclerosis and hypophyseal somatotrophic 
hormone reached the fo llow ing  conclusion: there has never been a case of 
an hypophysiolyzed in d iv id u a l who contracted m u ltip le  sc lerosis .
The explanation o f th is  phenomenon is  based on the fact that the 
nervous system is  not mature a t b irth . In e ffe c t, the nervous organogenesis 
is  extremely slow; i t  is  completed only at about fo r ty  or so and the 
myelinogenesis which conditions and re flec ts  the accession of the immature 
neuronal is le ts  to th e ir  function becomes discontinuous at the end of i t s
course.
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Sclerosis patches are scars of a v ir a l  in festa tion  of the myelinic 
ce lls  (oligodendrocytes) s a te llite s  of those is le ts  of tardy maturation. 
When v ira l m ye lin itis  occurs in a young adu lt whose neuronal organogenesis 
has become insu lar and discontinuous, the scars become nodular and ite ra ­
t iv e . By not allowing the maturation of these terminal residual is le ts  from 
adulthood, the drying up by hypophysiolyzis of the growth hormone does not 
allow th is  in fes ta tion  to be expressed and thus does not allow the disease 
to develop. That's why an hypophysiolyzed patient cannot get m ultip le  
sclerosis, which the research confirms.»
Since th is  drying up does not cost anything b io lo g ica lly , i t  is  
clear that i t  is  necessary to proceed w ith i t  as soon as the diagnosis of 
m ultip le sclerosis is  made.
Furthermore, to abstain from drying up of the growth hormone in  pa­
tie n ts  with m u ltip le  sclerosis, when one knows that the secretion of 
somatostatin which in h ib its  th is  hormone is  fa il in g  in  these patients, 
would represent a rea l problem of conscience.
SCHIZOPHRENIA
I t  is  s u ff ic ie n t to consult the tab le  of the hypersecretion's states 
of growth hormone to notice that schizophrenia is  found at the top of the 
l i s t , immediately a fte r acromegalia. Furthermore, these two a ffections en- 
certain close bounds which are manifested by the high frequency of acro- 
megaloid morphotype in  schizophrenia.
In add ition , there is ,  in  schizophrenia, there is  an abnormal secre­
tory response, as much from chemical as from hormonal s tim ula tion , in  the 
ce lls  which secrete the growth hormone (Cilad-Dickerman).
The drying up of the growth hormone, aiming to rupture th is  core- 
re la tion  binding the growth hormone and schizophrenia, is  absolutely es­
sentia l as i t  is  in  acromegalia.
As in  m ultip le  sclerosis, an understanding of the pathogenic 
mechanism is  based on the fact tha t the nervous system is  not mature 
at b ir th .
By e le c tive ly  stimulating the tardy immature neuronal remnants of 
cephalization because of th e ir abnormally low threshold of ac tiva tion , the 
growth hormone confers on them a prevalence which f in a lly  becomes dominant 
over the already organized sites of the in i t ia l  and fundamental cephali­
zation.
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Now, the in i t ia l l y  organized s ites  of the cephalization emit in fo r ­
mation shaped by re a lity  and educated by apprenticeship during two decades 
whereas terminal s ites  have no time to be shaped by confrontation w ith 
r e a l i t y .  I f  the information emitted by the term inal s ites , which is  normal­
ly  accessory and subordinate, becomes p r io r ita ry  and dominates over the 
main information, the hierarchy of the information is  ruptured and re ­
versed: that is  schizophrenia. I t  sees the progressive remoteness from 
re a l i t y  and prevalence of the uneducated and unbridled signals from the 
te rm ina l cephalization over the in i t ia l  signals durably shaped by re a l i ty .
This contamination is  progressive because i t  is  the ac tiva tion  of 
the pathways which conditions, anatomically by increasing th e ir  ca lib re , 
the speed of the signals having access to the fro n ta l in tegrator. The more, 
the term inal network is  active , the more i t s  fib e rs  are conductive and the 
more the princ ipa l network becomes functiona lly  frustra ted and anatomically 
in v o lu t iv e . The inversion of the hierarchy of information at the fro n ta l 
leads to  the ir re v a s ib il ity  o f the process.
ALZHEIMER'S DEMENTIA
Alzheimer's dementia is  to the aged adult what schizophrenia de­
mentia is  to the young adu lt. The two processes are fundamentally indent- 
ic a l.  They both resu lt from a p a ras itic  and f in a l ly  exclusive dominance of 
the inform ation emitted by the terminal s ites  of the cerebral organogenesis 
over th a t emitted by the in i t i a l  s ites .
Now th is  terminal information is  tha t which has been the least 
shaped by re a lity  and the least educated by a long apprenticeship of two 
decades. Under normal conditions, th is  term inal information is  subordinated 
to the main information, which is  p r io r ita ry , and lim ited  to influencing 
i t .  When th is  hierarchy in  information gets reversed, there is  a progres­
sive rupture  with re a lity ;  tha t is  dementia. Since i t  is  activation which 
conditions the trophism and co n d u c tib ility  of the networks, as soon as a 
dominance o f the terminal network s ta rts , i t  tends to become invasive, then 
ir re v e rs ib le  and f in a lly  exclusive. The information is  transferred from an 
ancient s tructure  which is  shaped by re a lity  towards a recent one which is  
to ta l ly  free  from experienced contingencies.
To describe schizophrenia and Alzheimer's is  to repeat oneself, ex­
cept the c l in ic a l expression d if fe rs  according to the age. In schizophrenia
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in  the young adult, the abnormal re ce p tiv ity  of the terminal neuroblasts to 
the growth hormone induce th e ir  hyperplasia with a unreal mental symptoma­
tology which generally is  productive, excessive and expansive, whereas in  
Alzheimer's, in  the aged adu lt, the premature disappearance of the large 
ce lls  of the in i t ia l  network makes the ancient and essential memorial data 
which are fixed in  i t  disappear, g iving free re in  to the accessory and un­
educated information of the terminal network. The fundamental memory 
regressess with the regresses of the fundamental cortex.
Based on th is  mechanistic id e n tity  the follows a single therapeutica l 
so lu tion which is  the drying up of the growth hormone.
In schizophrenia, th is  drying up prevents the maturation of the 
terminal pa ras itic  s ites .
In Alzheimer's, th is  drying up im plies the same precociousness, that 
is  to say several decades before the appearance of the disease, because i t  
appears at an age when the cerebral organogenesis is  to ta lly  rea lized . I t  
seeks to elim inate the subsequent competition of a terminal uneducated 
structure becoming p a ras itic  as soon as the large in i t ia l  neurones, which 
prematurely degenerate in  Alzheimer's, disappear. However, since i t  is  the 
functional activa tion  which maintains the troph ic ity  and su rv iva l of the 
networks, the impoverishment of the primary one is  hastened i f  p a ras itic  
pathways ex is t turning the information aside. Of course, the drying up does 
not re-establish the prematurely destroyed neurones but, on the one hand, 
i t  excludes the competition of an uneducated network carrying fac to rs  of 
dementia and, on the other hand, i t  prolongs the activation and thence the 
surviva l of the fundamental residual neuronal stock carrying the semantic 
memory.
There is  no other solution fo r  Alzheimer's. One cannot e ffe c tiv e ly  
count on a neuronal p la s t ic ity  which does not ex is t any longer a t th is  age 
in  a structure otherwise impoverished. I t  is  also il lu s iv e  to consider now 
the suppression of the m ultip le causal factors, among which are the neuro­
trop ic  poisons. They act in  minimal and cumulative doses since childhood 
and resu lt in reducing the longevity of the in i t ia l  neurones whereas the 
latecomers of the organogenesis, whose paras itic  a c t iv ity  needs to be 
prevented, escape because of th e ir tardy maturation.
As fa r as we know, a consultation of the records has not yet been 
done, which would demonstrate the inexistence of Alzheimer's in  aged adults 
hypophysiolyzed when they were young. But we already know tha t children
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treated with growth hormone run the r is k ,  o f which th e ir parents are 
warned, of contracting a dementia, decades la te r ,  at the Alzheimerian age.
F ina lly , degenerative pathology consists o f a parasitic  prevalence 
o f b la s tic  remnants (o r c e lls  which recover an embryonic status).
In an adult, they are physio log ically as useless as the growth 
hormone which stimulates them.
Degenerative pathology is  in  accordance with the Conheim's law , 
which has remained a standard though unexploited fo r the past century.
The drying up o f the growth hormone in  adults w i l l  prevail due to 
s im p lic ity  of the theory, experimental evidence, socio-economic necessity 
and, most of a l l ,  the benign ity of the procedure.
The e ffective  dose of radiation focused on the hypophysis is  well 
established (13.5 mCi) and is  su ffic ie n t to in h ib i t  exclusively the growth 
hormone, the secretion o f the other hypophyseal hormones being respected. 
I t  is  applied using a simple radiotherapeutic fla sh  by means of the helmet 
o f a Gamma Unit apparatus. This apparatus is  widely available and the d i f ­
f ic u l t y  presented by the procedure is  no more than that of a standard 
rad io log ica l examination.
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Neuroembryology: The Selected Papers of V iktor Hamburger with an 
Introduction by Rónai W. Oppenheim, pp. XV+420. Birkhäuser, 
Boston, 1990. Price: DM 138.-
This is  an in te res ting  co llection  of papers celebrating the 90th 
birthday of th e ir authôr, a well-known embryologist, Professor V. Ham­
burger. He began his resourceful research works on amphibian embryos in 
the early 1920's in  H. Speemann's laboratory, and a decade la te r he 
switched to chicken embryos in  F. L i l l ie 's  laboratory to pursue the 
problems of development on th is  model during the subsequent 50 years. He 
is  the only l iv in g  witness of the heroic epoch of experimental neuro- 
embryology in it ia te d  by R.G. Harrison and completed to a high perfection 
by S. Detwiler, G. Coghill, P. Weiss, R. Sperry and himself. He was at the 
cradle of the Nerve Growth Factor, which earned the Nobel Prize for Rita 
Levi-Montalcini and S. Cohen in  1986.
The selected papers are c lasssified  in  seven groups. The f i r s t  group 
contains 8 review papers on developmental neurobiology. In them, Professor 
Hamburger investigates the development of the nerveless amphibian limb, 
the princip les of neuroembryology in  terms of the then fashionable neuron­
a l s p e c if ic ity , and the natura lly  occurring c e ll death. In the second 
group, 4 papers are devoted to the problems of development of m o tility  and 
behaviour representing a beautifu l series of experiments performed mainly 
on chicken embryos. In the 4 papers of the th ird  group, the author gives 
comprehensive trea ties  on the h istory of neurogenesis, reaching back to 
the pioneering works of S. Ramon y Cajal and R.G. Harrison. The t i t l e  of 
the fourth group is  Developmental Genetics and Evolution. The 3 papers on 
th is  topic demonstrate Professor Hamburger's wide in te res t in  various 
aspects of development: as early as 1942, he investigated the mechanisms 
of hereditary developmental abnormalities. The f i f t h  group contains re­
views of 5 books in the f ie ld  of embryology and evolution. The s ix th  group 
comprises 2 biographies of H. Speemann and the re p rin t of his S. K uffle r 
lecture that he presented at the Harvard University with the t i t l e  The 
Rise of Experimental Neuroembryology. Two papers are lis te d  in  the la s t, 
Miscellaneous, group. One of them gives an account of his v is i t  to Japan, 
where he v is ited  Emperor H iroh ito 's  marine zoology laboratory among 
others. The second paper is  a most in te resting  comment on Goethe's work 
"Zur Farbenlehre". -  Unfortunately, two volumnious works by Professor Ham­
burger could not be f i t të d  w ith in the lim ited  space of the book. The 
Manual of Experimental Embryology was, and s t i l l  is ,  one of the books most 
favoured by those who have chosen the rough road of experimental embryo­
logy, and the second, A Series of Normal Stages in  the Development of the 
Chick Embryo, is  one of the most frequently c ited  papers in  biology.
I t  is  an in te lle c tu a l pleasure to page through the book and to spend 
time at selected pages. The book is  warmly recommended to neurobiologists 
and developmental b io log is ts  and to students interested in  the struggling 
l i f e  of a natural s c ie n tis t with a strong impact on the growth of our 
knowledge in  biology.
GEORGE SZÉKELY
Akadémiai Kiadó, Budapest
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N. Mrosovsky: Rheostasis: The physiology of chance, 
Oxford University Press, New York, Oxford, 1990. 
Price: Æ 40.0 •
Rheostasis, as defined in  Mrosovsky's own words, "re fers to a con­
d it io n  or state in  which, at any one instan t, homeostatic defenses are 
s t i l l  present but over a span of time there is  a change in  the regulated 
le v e l" .  Therefore, rheostasis includes a change in  se t-po in t, when i t  is  
used to  indicate a mechanism comprising negative feedback with a reference 
s ig n a l. Rheostasis may apply to both slow (gradual) and sudden changes, 
but the d is tinc tion  between slow and sudden changes is  not always clear.
Two circumstances in  which rheostasis occurs can be distinguished. 
Changes in  defended levels may be obligatory incerta in  phases of the l i f e  
cycle and may occur regardless of conditions. These referred to as ex­
amples of programmed rheostasis (1), are often though not necessarily 
c y c lic .  There also may be developmental, once-in-a-life tim e examples of 
rheostasis.
Reactive rheostasis (2) occurs in response to s tim u li that may or 
may not be encountered. Mrosovsky gives a set of examples of these two 
circumstances to explain the two types of rheostasis. Mrosovsky's book is  
indeed a very in teresting review of some exciting new concepts of physio­
lo g ic a l changes.
JENÖ MAJOR
WHO IARC-Biennal Report: 1988-1989 
(For the period 1 July 1987 to 30 June 1989) 
IARC, Lyon France 1989
Several successful p ro jects were finished or almost completed in  the 
Agency through June 1989, and the resu lts described in  the Biennium Report 
Some o f them are h igh ligh ted. While others are more detailed in  the 
repo rts . There is  a chapter dealing with the epidemiology of cancer to 
plan the beginning of the s ix th  Volume of Cancer Incidence on Five Con­
tin e n ts . This study includes 30 new centres including reg is te ries  in  
A frica  and the USSR. In the present studies the cancer incidence is  
analysed of Jewish immigrants to Israe l from d iffe re n t European, Aust­
ra lia n  and South American Countries. 17 European countries have been 
in it ia te d  to follow geographic and temporal trends in  the incidence of 
childhood leukaemia from 1980 to the 1990s. This study w i l l  allow the 
evaluation of whether there are changes related to exposures ot the ac­
c ident a t Chernobyl in  1986.
The Agency maintains large in te res t in  the id e n tif ic a tio n  of d i f ­
fe ren t occupational hazards. Cohort studies are in  progress on workers 
exposed to  s ilic a , v iny l ch loride and styrene.
The reports contain the epidemiology of the cancer r is k  fo llow ing 
chemotherapy. 14-fold increase on r is k  fo r leukaemia was found when 
therapy o f the MOPP type fo r Hodgkin's disease was continued. The large 
scale o f collaboration between c lin ic ia n s , epidemiologist and cancer 
researchers should make possible to id e n tify  what spec ific  type and extent 
of DNA damage induced by the a lky la ting  agents is  responsible fo r the
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chemotherapeutic and the long-term adverse e ffects . The possible re la tio n ­
ship between mutation and cancer is  also detailed here and the protective 
e ffects  of vegetables, vitamins and fib re s  are discussed. The increased 
r is k  of cancer in  the case of high meat consumption has been confirmed 
again.
Smoking as a cause of lung cancer is  conclusively established and 
the reports are pointing out to pay more attention to the increasing rate 
of smokers among young people and among women in developing countries.
SEARCH (Survellance of Environmental Aspects Related to  Cancer) 
programme is  an in ternational co llabora tive  programme which was estab­
lished to provide evidence on the relevant aetio log ica l hypotheses.
The f i r s t  SEARCH study was conducted on the aetiology of pancreas, 
gallbladder and b ile  duct cancer. That tobacco smoking increases the risk  
of pancreatic cancer was c learly  demonstrateds. In the fu ture other stud­
ies w i l l  be fin ished on the brain tumour development in  ch ildren and 
adults, leukemia and other haematological malignancies w i l l  be put on the 
projects in  collaboration with the European Organization fo r Reserach and 
Treatment of Cancer. The estimation of r is k  factors fo r ce rv ica l cancer 
and the HPV screening is  in progress also. Samples and questionnaires are 
being collected from 20 countries. Another project is  aimed to assess the 
ro le  of N-nitroso compounds themselves or in  conjugation w ith other fac­
to rs  in  the o rig in  of human cancer. The Agency has continued to help the 
evaluation of early detection and cancer prevention programmes fo r ex­
amples in  China and in  Philippines with regard to stomach cancer and in 
Czechoslovakia with regard to the lung cancer.
A chemoprevention fo r precancerous lesions of the stomach by using 
certa in  vitamins is  under consideration in  a h igh-risk population in 
Venezuela.
Variation in  individual s u s c e p tib ility  to cancer are also being in ­
vestigated by analysing and measuring individua l capacity to metabolize 
carcinogens by the use of the te s t drugs as o rfo rin , debrisoquine and 
antipyrine, which may allow the noninvasive investigation of P-450 iso­
enzymes .
Measurements of DNA adduct in  human tissues are now being assessed 
as a marker of exposure and th e ir  b io log ica l significance is  being ex­
plored. Experimentally, i t  was shown tha t levels of DNA adducts a fte r 
e ithe r single or repeated exposure(s) to N-nitroSodimethylamine are 
s im ila r in  the l iv e r  and in  lymphocytes. This finding supports the more 
general use of peripheral blood lymphocytes in the human population 
monitoring studies by GNA-adducts measurement indicating the to ta l body 
burden and can be used in  the b io log ica l dosimetry.
ANNA TOMPA
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WHO, IARC Cancer: Causes occurrence and control 
E d itor-in-C hief: L. Tomatis
Co-Editors: A. A it io ,  N.E. Day, E. Heseltine, 0. Kaldor, 
A.B. M ille r ,  D.M. Parkin and E. R ibo li 
IARC, S c ie n tif ic  Publications, NO 100, Lyon 1990
This Volume presented an easily-readable description of what is  
known about the incidence o f and morbidity from cancer and the actual pos­
s ib i l i t ie s  of cancer prevention This book gives Marginal picutre about the 
progress of cancer research and presents an update of the new hopes fo r 
the cancer prevention and contro l.
The book presents the available evidence of the preventab ility  of 
human cancer and describes i t s  occurrence. I t  gives information about the 
agents and risk  factors tha t have been causally associated with the 
development and early detection of human cancer and provides current in ­
formation that could lead to preventive in te rven tion  at the population 
le ve l.
Part I  contains information on the occurrence of the cancer around 
the world. The cancer incidence and m orta lity  are described and the geo­
graphical d ifférencies in  the occurrence of various types of cancer are 
also shown. Such descrip tive  epidemiology provides the global dimension to 
the cancer problem and provides the basis fo r hypotheses about the a e tio l­
ogy of cancer.
Part I I  begins w ith a discussion of how causes of cancer are id e n ti­
f ie d . The major part of th is  section deals with known environmental deter­
minants of cancer. This chapter describes agents th a t are recognized as 
being causally related to human cancer as well as those fo r which a causal 
re la tionsh ip  at present are p a r t ia lly  ve rified .
In Part I I I  the authors review the po ten tia l benefits of early de­
te c tio n . This is  the screening of individuals who have no overt symptom of 
the disease.
In the f in a l Part IV the book attempts to quantify extent to which 
primary prevention and early detection are feasib le  fo r the most common 
cancer.
In general, i t  is  a sad re a lity  that in  most part ot the world in ­
cluding Hungary the standards of the health care, prevention and tre a t­
ment of cancer are fa r from being optimal. For a l l  expert who would lik e  
to improve the s itu a tio n , i t  is  necessary to read th is  book to renew th e ir  
inform ation and to compare th e ir  s ituation to th is  summarized picture.
ANNA TOMPA
B io log ica l and toxin weapons today 
Edited by E. Geissler 
SIPRI, Oxford University Press, Stockholm
The change in  the view of the m ilita ry  value o f b io log ica l (BW) and 
tox in  weapons (TW), i .e .  th e ir  use mainly fo r aggression instead of te r ­
rorism and sabotage, th e ir  application by the Ira q i troops in  the Ira q i-  
Iranian War against the unarmed population and the threats by the Iraq i 
leaders in  the 1991 Gulf War support the sorrowful a c tu a lity  of th is book.
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The 20 contributors fo llow  the h is to ry  of the use of BWs and TWs 
from the f i r s t  BW attack by the Mongols in  1346 to the present and ou tline  
the development of the new-generation weapons and p a rticu la rly  the new- 
generation methods of protection as, e .g ., vaccination. The contribu tors 
consider the points of view of an aggressor or of a defender in  the 
strategy. They evaluate the theo re tica lly  and/or p ra c tica lly  available 
p o s s ib ilit ie s  and methods and also disucss the fa llacy  even of the defen­
sive BW programmes. The e ffects of BWs and TWs on the world health and en­
vironment are also dealt w ith in the book.
BWs and TWs and m ilita ry  doctrines of the USA and the ro le  of these 
weapons in  the new US strategy are surveyed in  a discrete chapter. I t  is  
very important that in  th is  strategy the US policy s t r ic t ly  "p roh ib its  the 
f i r s t  use of le tha l or incapacitating chemical munitions". I t  also pro­
h ib its  any use of BWs.
The contributors also deal with the in ternationa l conventions regu­
la tin g  and/or p roh ib iting  the use or misuse of BWs and TWs. Among these 
conventions probably the most important is  the 1972 "Convention on the 
Prohib ition of the Development, Production and S tockp illing  of Bacterio­
log ica l (B io log ica l) and Toxin Weapons and on th e ir Destruction", r a t i ­
fie d  by 103 states as of 1985, the f i r s t  rea l in ternationa lly-negotia ted 
measure of disarmament. I t  does not p ro h ib it, however, the work on "micro­
b ia l or other b io log ica l agents or toxins of types and quan tities  that 
have ju s t if ic a t io n  fo r prophylactic, protective or other peaceful pur­
poses" .
The "B io logical and Toxin Weapons Today" is  very he lp fu l fo r  those, 
who are interested in  the s c ie n tif ic  and legal questions of th is  threating 
problem.
JENŰ MAJOR
Control of sexually transmitted diseases 
Technical Report Series 
Editor is  not indicated 
World Health Organization (WHO), Geneva
The decrease of the frequency of sexually-transm itted diseases 
(STDs) a fte r World War I I  stopped in the la te  1960s and a strong increase 
to a disturbing leve l has been observed, despite the a v a ila b il ity  of w e ll- 
established treatment methods. The complications that may arise  at in ­
d iv idua l, family and community levels, alarmed the WHO to achieve the goal 
of public health problems including personal patients ' care, health edu­
cation, information and welfare services. Therefore, a s c ie n t if ic  meeting 
was organized by the WHO in Washington (USA) in April of 1982 to examine 
the problems of the present s itua tion . This book is  a b r ie f summary of the 
meeting.
The "book" deals with a wide selection of technical problems from 
the in i t ia l  planning steps, e.g. the estimation of the public health im­
portance of STDs in  a given country and the determination of the p r io r ity  
groups, to the programme management. The book also deals w ith the in te r­
vention strategies, the prevention including information and professional 
tra in ing  and the laboratory services. Appendices give information about 
the tests currently available fo r the early detection of STDs and also 
contain some prototype patient care protocols, e.g. u rethra l and vaginal 
discharge and gen ita l ulcers.
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The "Control of Sexually Transmitted Diseases" is  useful fo r the 
workers of public health services, the physicians of the everyday practice 
ra the r than for the sp e c ia lis ts  of STDs.
JENŐ MAJOR
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F E L L OWS H I P S
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER
World Health Organization 
Lyon - France
FELLOWSHIPS FOR RESEARCH TRAINING IN CANCER 
1992-1993
A p p lica tio n s fo r  t ra in in g  fe llow sh ips  in  1992-1993 are in v ite d  from  
ju n io r  s c ie n t is ts  w ishing to  be tra in e d  in  those aspects o f cancer 
research re la te d  to  th e  Agency's own programmes: epidem iology, b io s ta t ­
is t i c s ,  environm ental and v i r a l  carcinogenesis and mechanism o f c a rc in o ­
genesis.
Applicants should be engaged in research in  medical or a llie d  s c i­
ences and intend to pursue a career in cancer research.
Fellowships are awarded fo r one year and are tenable at the Agency 
or in  another suitable in s t itu t io n  abroad. Fellows w i l l ,  in  general, be 
selected from applicants with some postdoctoral research experience re l­
ated to cancer in  medicine or the natural sciences. Applicants requiring 
basic tra in ing  in  cancer epidemiology w i l l  also be considered. They must 
have an adequate knowledge, both w ritten and spoken, of the language of 
the country in  which th e ir  fellowship is  tenable.
Applications cannot be accepted from people already holding fe llow ­
ships enabling them to stddy abroad.
Stipends w i l l  vary according to the cost of l iv in g  in the country., of 
study. The cost of trave l fo r the applicant, and in  certain circumstances, 
that of one dependent, w i l l  be met.
This programme is  p a r t ia lly  supported by the Ita lia n  Association
fo r Research on Cancer.
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VISITING SCIENTIST AWARD 
1992-1993
This award is  in tended fo r  e s tab lis h e d  cancer research workers w ith  
a minimum o f f iv e  years postdoctora l experience who wish to  spend up to  
one year a t IARC working on the im plem entation o f a c o lla b o ra t iv e  research  
p r o je c t  re la te d  to  th e  Agency's own programnes: epidem iology, b io s ta t ­
i s t i c s ,  environm ental and v i r a l  carc inogenesis and mechanisms o f ca rc in o ­
g en es is .
Applicants must belong to the s ta f f  of a university or a research 
in s t itu t io n .  They must provide a w ritten  assurance that they w i l l  have a 
pos ition  to return to at the end of the period of award.
Candidates should submit th e ir applications a fte r consultation with 
an IARC s c ie n tif ic  s ta f f  member. Applications w i l l  be reviewed by the 
Fellowships Selection Committee each year.
There w il l  be an annual renumeration and the cost of trave l w i l l  
be met.
Fellowship app lication forms and more detailed information are
available from:
Education and Training Programme 
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER 
150 cours Albert-Thomas, 69372 Lyon Cedex 08 
France
A p p lica tio n s  must reach the Agency no la t e r  than 31 December 1991.
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NEUROLOGY
PARKINSON’ S SYNDROME: CRANIAL COMPUTED-TOMOGRAPHY FINDINGS.
THEIR DEPENDENCE DN SEX AND AGE
W. GRUNDL,  R. Z I EGLER,  K . - P .  WESTPHAL,  M. HUFNAGL,  
J . SZI RTES , H . H . K0RNHU8ER
Department of Neurology, University of Ulm, C lin ic  Dietenbronn,
Ulm, Germany
(Received: July 10, 1991)
Cranial Computed Tomography (CCT) find ings in  123 patients su ffe ring  from Parkinson’s 
syndrome were compared w ith a sex- and age-matched normal contro l group. Signs o f supra­
te n to r ia l atrophy — c o rtic a l and subco rtica l — were more s ig n if ic a n tly  marked in  the Parkinson 
group. In  both groups, signs o f atrophy were more prevalent in  men than in  women. Parkinsonian 
women also more frequently showed lim ite d  features, such as lacunar lesions, around the la te ra l 
ve n tric le s . Moreover, in  these pa tien ts  atrophy was marked in  the fro n ta l co rtex.
Keywords: Parkinson’ s syndrome, computed tomography, sex differences
In tro d u c tio n
Parkinson’ s syndrome is  an e n tity  characterized by three extra- 
pyramidal-motoric symptoms: hypo- to akinesia, r ig id ity  and tremor may be 
present to varying degrees. In addition psychic, apractic, vegetative and 
other disturbances may occur. With increasing age the proportion o f parkin­
sonian patients grows larger — the maximum frequency occurring in  the 8th 
decade of l i f e .  In view of primary (id iopa th ic ) and secondary aetiology 
(w ith in  variable fundamental diseases) d iffe re n t forms have to be d is t in ­
guished. Neuropathological destruction of the ganglia ce lls , espec ia lly  in 
the substantia nigra as well as in  the globus pallidus and other regions are 
demonstrable. Pathophysiological findings show a deficiency in dopamine as a
O ffp r in t requests shoulü be sent to  Wolfgang Grundl, University o f Ulm, Department of 
Neurology, Steinhövelstrasse, 7900 Ulm, Germany.
Akadémiai Kiadd, Budapest
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neurotransmitter and, accordingly, a preponderance of cholinergic trans­
m itted  functions.
Since the development and c lin ica l use o f computed tomography (CT), 
several studies, comparing CCT findings of parkinsonians and normals have 
been done /1—8, 10—16, 18/. The aim of th is  study is  to check the pub­
lish e d  results with regard to  sex sp e c ific ity .
Patients and methods
The relevant CCT examinations were carried out from Ju ly  1987 to July 1988 a t the 
Neurology C lin ic  of the U n iv e rs ity  o f  Ulm at Dietenbronn. A CT apparatus Somatom 2 (Siemens AG) 
was used. Seria l CT scans were performed pa ra lle l to  the orb itom eata l l in e .  In  a l l  cases the 
th ickness o f each layer was 2 mm in fra te n to r ia l and 8 mm su p ra te n to ria l.
During the above-mentioned period, 59 women and 64 men, diagnosed as su ffe rin g  from 
Parkinson’ s syndrome (but exc lud ing  cases caused by neu ro lep tics ) were admitted to  the Dieten­
bronn c l in ic  to  undergo a CCT examination. The age- and sex-matched con tro l group consisted o f 
persons whose CCT find ings  were considered regular (e s p e c ia lly  pa tients who complained o f 
headaches, dizziness or u n c h a ra c te ris tic  symptoms, and whose neuro log ica l examination and labo­
ra to ry  parameters led to  normal re s u lts )  (Table I ) .
Table I
Age and sex d is t r ib u t io n  in  the Parkinson and the con tro l group
Number o f a l l
Parkinsonians Contro l persons
men
114
women
114
men women
6th decade 13 7 13 7
7th decade 14 13 14 13
8th decade 23 33 23 33
9th decade 4 7 4 7
sum 54 60 54 60
Average age 68.28 73.08 68.58 73.66 years
The chosen CCT images were evaluated by three persons (eva luators). Each CCT series 
was c la s s if ie d  in to  three ca te go rie s : c o rtica l atrophy, w id th  o f the inner CSF spaces (supra­
te n to r ia l)  and signs o f in f r a te n to r ia l  atrophy. The two s u p ra te n to ria l categories were disposed 
in to  f iv e  and the in f ra te n to r ia l  category in to  three degrees. In  addition there was a 4th 
heading fo r lim ited fea tu res. For the s ta t is t ic a l ana lys is  pa tien ts  as normals were divided 
in to  fou r age-groups (50—59, 60—69, 70—79 and 80—89 years). The s ta t is t ic a l evaluation was 
based on the Wilcoxon Test.
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R esu lts
The three evaluators agreed in  the estimation of c o r t ic a l atrophy 
only s lig h t ly  be tte r than in the estimation of case ventricu lar w idth. There 
is  even greater correspondence a fte r  comprehension of degrees 1 w ith 2 and 3 
w ith 4 to one class each. Accordingly, there was greater disagreement in 
estimating in fra te n to r ia l atrophy.
Normal pressure hydrocephalus
Nine patients (5 women and 4 men), who came to our c l in ic  w ith  a diag­
nosis of Parkinson’ s syndrome and who were CT scanned while in  hosp ita l, 
were excluded from study. With CCT, the presence of NPH was suspected i f  
there was a d ifference in width o f the inner and the outer CSF spaces. This 
d ifference was judged by the three evaluators e ither >1.66 ( in  average of 
the three ra te rs ), or i t  lay between 1.0 and 1.66, two of the three eval­
uators reported very small c o rtic a l su lc i in  the upper p a rie ta l region. A ll 
these patients were furtheron c la s s ifie d  according to series cisternography, 
confirming the suspected diagnosis of NPH. The therapy in each o f these nine 
cases was neurosurgial in traven tricu la r shunt implantation.
Thus i t  was possible to compare the remaining 114 parkinsonians (54 
women and 60 men) with the normal contro l group.
Men vs. women (ove ra ll view)
I f  parkinsonians and normal persons of both sexes are compared, men 
in  each age group show higher atrophy scores than women — especia lly  in  the 
supratentoria l regions.
Table I I
C o rtica l atrophy — outer C5F spaces (sup ra ten t.) — in the Parkinson 
and the contro l group (mean o f three evaluators, range 3—15)
6th 7th Bth 9th decade
Parkinsonians, female 7.4 8.6 9.35 10.65
Parkinsonians, male 7.9 8.55 10.5 11.2
Control persons, female 5.2 6.6 6.95 9.3
Control persons, male 5.9 7.3 8.75 12
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Table I I I
V entricu lar w idth — Inner CSF spaces (sup ra te n t.) — in  the Parkinson 
and the c o n tro l group (mean of three eva lua to rs, range 3—15)
6th 7th 8th 9th decade
Parkinsonians, female 7 7.8 9.55 11.1
Parkinsonians, male 7.7 9.1 11.45 10.75
Control persons, female 4.7 5.7 7.1 8.5
Control persons, male 5 6.7 7.9 10.9
Parkinsonians vs. healthy contro l group
While there is  a steady increase in  the atrophy scores in  the parkin­
sonian group, there is  a sudden advance in  the course of the atrophy process 
in  the normal contro l group, there is  a growing by leap from the 8th to the 
9th decade of l i f e .  This tendency is  more pronounced fo r co rtica l atrophy 
than fo r ven tricu la r enlargement, and i t  is  more fo r men than fo r women 
(Tables I I  and I I I ;  Figs 1 and 2).
mean 
12 T
10 - •
A -L
-I-------------------1------------------- 1-------------------- 1
6 7 6. 9. decade of life
F ig . 1. C o rtica l atrophy — outer CSF-spaces (supra tent.) — o f the Parkinson and the co n tro l 
group (mean fo r  three evaluators, range 3—15).
■  Parkinson female, □  Parkinson male, •  co n tro l female, о contro l male
PARKINSON’ S SYNDROME: COMPUTED-TOMOGRAPHY FINDINGS 131
mean
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6 7 8 9 decade of life
F ig , 2. V en tricu la r w idth — inner CSF-spaces (sup ra te n t.) — o f the Parkinson and the con tro l 
group (mean fo r  three evaluators, range 3— 15). (Symbols as in  F ig . 1)
I f  the Parkinson group and the con tro l group are compared the atrophy 
scores of the male parkinsonians up to the 8th decade and also of women in 
the 9th decade of l i f e  are higher than in  the corresponding contro l group. 
Ihe scores fo r the parkinsonian patients are almost equal to the scores fo r 
the control group 10 or in  some cases 20 years la te r. Only the scores fo r 
male parkinsonians during the 9th decade o f l i f e  are the same as those fo r 
the control group (lab les I I  and I I I ;  Figs 1 and 2).
Women vs. men (contro l group)
In the contro l group, the scores of co rtica l atrophy and of ven- 
t ic u la r  width in  men c la r ly  correspond to the scores of the female contro l 
group one decade la te r . The resu lts  of ven tricu la r enlargement in  healthy 
women in  the 9th decade d e fin ite ly  exceed those of healthy men in  the 8th 
decade. The in fra te n to r ia l atrophy scores are approximately the same (Table 
IV; Fig. 3).
132 GRUNDL, W. e t  a l .
Table IV
In fra te n to r ia l signs o f atrophy in  the Parkinson and the 
con tro l group (mean o f three eva lua to rs, range 3—9)
6th 7 th 8th 9th decade
Parkinsonians, female 4.4 4.8 5.3 5.3
Parkinsonians, male 4.6 5.1 5.78 5.3
Control persons, female 4 4.3 5.2 5.95
Control persons, male 4.2 4.7 5.4 6.58
Women vs. men (Parkinsonians)
There are s im ila r resu lts  in  both female and male parkinsonians. The 
ten-year "advantage" of men in  the supratentoria l region is  not recognizable 
in  cases of c o rtic a l atrophy in  the 7th and 6th decade only; the ve n tricu la r 
w idth o f parkinsonian women w ith in  the 9th decade exceeds the scores fo r  men 
of the same age group. In the in fra te n to r ia l region, however, there are 
hardly any differences between the parkinsonian group and the normal con tro l 
group (Table IV; Fig. 3).
F ig . 3. In fra te n to r ia l signs o f atrophy o f the Parkinson and the con tro l group 
(mean fo r  three evaluators, range 3—9 ). (Symbols as in  F ig . 1)
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Parkinsonians: inner vs. outer CSF spaces
I f  the three evaluation c r ite r ia  of parkinsonian women are compared, 
the scores fo r c o rtic a l atrophy are nearly the same as those fo r ve n tr icu la r 
width. Male parkinsonians show a d ifference between co rtica l atrophy and 
ventricu lar width score > 1 in  the 7th decade only (Tables I I —IV; Figs 1—3).
Limited features
Limited features were observed in  33 o f 114 parkinsonians. (Cerebro-) 
Vascular-ischaemic lesions were prevalent. Moreover, there was a preponder­
ance of women w ith the disease (21 women, 12 men). In cases in  which c o r t ic ­
a l atrophy is  regional marked (mostly in  the fro n ta l regions), there is  also 
a preponderance of parkinsonian women (Table V).
Table V
Limited features CCT o f parkinsonians
Women Men Sum
54 60 114
P e rive n tricu la r patchy areas o f decreased a ttenua tion 11 4 15
Local p e riv e n tr ic u la r  lucencies — le f t  hemisphere 6 2 8
— r ig h t  hemisphere 1 0 1
Fahr's syndrome 6 3 9
Cavum sep ti p e llu c id i 0 1 1
24 10 34
Regional ( c o r t ic a l)  atrophic chances — fro n ta l 9 2
— temporal 1 0
— p a rie ta l 0 1
10 3 13
The above-mentioned differences between the Parkinson and the normal 
control group are s ig n ifica n t ( in  Wilcoxon’ s Test P < 0.05) fo r the fo llow ­
ing comparisons: in  women for c o rtic a l atrophy including the 9th decade, 
fo r ven tricu la r width t i l l  (and including) the 8th decade; fo r men w ith 
regard to c o r t ic a l atrophy u n t i l  the 6th, w ith regard to ven tricu la r width 
in the 8th decade, too. — Apart from sex differences between the sexes, the 
Parkinson and the normal group are s ig n if ic a n tly  d iffe re n t fo r both supra­
te n to r ia l c r i te r ia  (P < 0.05).
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Discussion
The results of th is  study show tha t in  the normal group as w ell as in 
the Parkinson group CCT reveals an increase in  the width of inner and outer 
CSF spaces during aging. Parkinsonians in  nearly a l l  decades show higher 
atrophy scores than the "normal" group. But the difference between the two 
groups is  much more marked in  the younger people than in  the advanced age 
groups.
So fa r these resu lts  confirm those o f e a rlie r publications /6 , 11, 
15, 18/. They do, however, d if fe r  from those o f Lichter et a t . ,  who do not 
mention differences between Parkinson patien ts and normals as regards CCT 
signs /1 2 /.
During the la s t age decade (80—89 years) parkinsonians, especia lly 
male ones showed lower supratentoria l atrophy levels than the con tro l per­
sons. Perhaps the re s tr ic te d  opportunités tha t Parkinson patients have to 
obta in  alcohol may help to explain th is  astonishing phenomenon. In both 
groups there are higher leve ls  in  men than in  women.
In our study there are no references to  declared differences between 
general co rtica l atrophy and ventricu lar w idth, which has had been described 
several times /2 , 3, 4, 7 /.
I f  there was a d ifference between inner and outer supratentoria l CSF 
spaces, and i f  the leve l of ventricu lar w idth surpassed c o rtic a l atrophy 
signs to  a certain extent, suspected NPH could be confirmed. Also in  th is  
respect ( id io p a th ic ), Parkinson’ s syndrome is  one of the most frequent fa lse  
diagnoses in  case of NPH.
Moreover, our resu lts  ve rify  the favoured atrophy of fro n ta l cortex 
in  parkinsonian women /1 / .  In addition female Parkinson patients frequently 
show lo ca l CCT pecu la ritie s , and, to a large extent, vascular lesions. I f  
th is  po in t underlines the importance of vascular diseases in  the pathogene­
s is  o f Parkinson’ s syndrome, the pecu la rities  in  women already mentioned 
should be a subject of fu rth e r examination.
From our resu lts  i t  is  not very l ik e ly ,  tha t the duration of Parkin­
son’ s syndrome has any influence on cerebral atrophy /6 , 7; in  contrary to 
3 /. In  younger patients there is  a more pronounced difference in  the supra­
te n to r ia l atrophy scores between Parkinsonians and normals than in  the old 
age groups. — Age and sex, p a rticu la rly  in  the younger age groups are not 
the most important parameters to explain inner and outer signs of atrophy in  
parkinsonians compared to  normals.
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In addition, there may well be another process (or processes) that 
leads to a loss of brain substance. In view of the sex-differences describ­
ed, Parkinson’s syndrome in  each patient may have various causes, which lead 
to the lack of homogeneity in  the Parkinson group.
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MYASTHENIA GRAVIS: TREATMENT WITH PLASMA EXCHANGE 
EXPERIENCES OVER 10 YEARS+
L . FORNÁDI ,  RITA HORVÁTH,  A.  SZOBOR 
Dept, of Neurology, Ferenc Jahn Teaching Hospital, Budapest 
(Received: November 5, 1991)
Evaluation o f the resu lts  o f plasmapheresis therapy is  reviewed on 160 pa tien ts  
su ffe rin g  from myasthenia g ra v is . This new therapeutica l procedure is  considered very valuable: 
improvement can be achieved in  63% of the pa tien ts  during the therapy, a fu rth e r improvement in  
30% a fte r  i t .  Plasmapheresis is  especia lly e ffe c tiv e  fo r  pa tien ts  in  resp ira to ry  c ris is -p ro n e  
s ta te , fo r  d rug -res is tan t cases and fo r preparation pa tien ts  fo r  surgery. Plasma exchange 
therapy may be combined w ith  other forms o f immunosuppression w ith  b e n e fit. Thymectomy and 
plasma exchange are considered to be the main therapeutica l procedures in  myasthenia g rav is .
Keywords: myasthenia, plasma exchange, thymectomy.
Plasma exchange (PEX) has occupied a worthy position among the meth­
ods of treating autoimmune disorders in  neurology /2 —5, 3, 7, 10/. We 
started with plasmapheresis therapy in  our neurological department — which 
is  now a centre fo r  the care of neuroimmune diseases — in  1981, shortly  
a fte r the f i r s t  successful applications of PEX in  myasthenia gravis (MG) by 
Pinching et a l. /1 3 /, Dau et a l. /4 / ,  and Newsom-Davis et a l.  /11, 12/. 
Since then, we have gained experience with the method in  MG, Lambert—Eaton— 
Rooke syndrome, acute and chronic forms of demyelinating polyneuropathies 
and multiple sc le ros is . Up to now, we have treated 240 patients (o f them 160 
w ith MG) with 450 PEX series.
Abbreviations: myasthenia gravis: MG, plasma exchange: PEX, pos itive  pressure in te r ­
m itten t resp ira to r: PPIR, D is a b ility  Status Scale: DSS
+0n the basis o f the platform presentation a t the Third Euro-Myasthenia Conference, 
Oxford, 1991.
O ffp rin t requests should be sent to  L. Fornádi, H-1204 Budapest, Köves S tr .  2—4.
Akadémiai Kiadó, Budapest
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Treatment of MG by PEX serves the follow ing purposes in  our practice: 
1. Enhancement of the remaining function by cholinesterase in h ib ito r  medica­
t io n .  — 2. Possible suppression of ACh-receptor antibody production. — 3. 
D ire c t removal of c ircu la tin g  antibodies and immunocomplexes. — 4. Prepara­
t io n  o f patients with serious MG fo r surgery. — 5. Treatment a fte r  surgery 
i f  the e fficacy of the operation is  not sa tis facto ry . A ll these aims are 
rea lized  by circumspect tim ing and planning in  our treatment protocol.
The most convincing improvements in  the myasthenic symptoms during PEX are a tta inab le  
in  the severe bulbar c r is is -p ro n e  cases. For th is  reason, we in s ta lle d  an automatic c e l l-  
separator (Dideco, I ta ly )  in  our in tens ive  therapeutic department, thus we can help immediately 
in  re s p ira to ry  c rises, often preventing the use o f a resp ira to r (PPIR). So the number o f the 
re sp ira te d  hours as w e ll as the time spent in  in tens ive  care decreases. The need fo r  a r t i f i c i a l  
re s p ira t io n  can be elim inated in  general by 2-3 PEX procedures.
Preparation fo r thymectomy by PEX is  advisable not only in  c r is is -  
prone cases, but the high-dose demand of cholinesterase in h ib ito rs  is  also a 
weighty reason fo r employing PEX therapy p rio r to thymectomy. Sometimes 
b ene fits  can be obtained in  cholinerg ic or mixed c r is is ,  in  the so-called 
o s c il la t in g  c r is is  /1 5 /. In th is  very complicated cases, the detoxicating 
func tion  of PEX also proves to be e ffe c tive  because there are no other 
p o s s ib il i t ie s  to solve the antagonistic problem of whether cho linerg ic  and/ 
or an ticho line rg ic  medication is  needed at the same time /15 /. Post-thymec­
tomy ocular and bulbar residual symptoms are also e ffe c tive ly  influenced and 
con tro lle d  by PEX, but i f  thymectomy is  performed a fte r a long existence of 
ocu lar symptoms, even PEX is  in e ffe c tive . PEX often has a bene fic ia l e ffec t 
in  immunosuppressive drug-resistant cases /8 , 15, 17/, on the other hand, 
immunosuppression is  essentia l during or a fte r PEX on the account of the 
r is k  o f rebound phenomenon. A fu rthe r frequent ind ication of PEX is  prepara­
t io n  o f the patient fo r s te ro id  pulse therapy /1 , 16, 17/. A fte r high-dose 
s te ro id  pulse therapy, however, there is  no reason fo r applying PEX, but i f  
i t  must s t i l l  be done because to prevent resp ira tory c r is is ,  i t  is  unsuc­
cessfu l in  the majority of the cases.
Plasmapheresis has a considerable ro le  in  c r is is  prevention in  pregnancy /9 /  and 
before  operations other than thymectomy /15, 17/. We usua lly  administer m aintaining procedures 
weekly o r monthly, employing c o rtico s te ro id s , too, i f  necessary. We have three forms o f 
plasmapheresis protocol from the p o in t o f view o f the removable plasma quan tity : 1. One plasma 
volume d a ily  fo r 5-6 days. — 2. One and a h a lf  volume every other day, 4 tim es. — 3. Two 
volumes every other day 3 tim es, over a seven day period. The three protocols are s im ila r  in  
e ff ic a c y .
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Use of immunoglobulin medication is  ra ther res tric ted  on the account 
of i t s  high cost, though we have found human immunoglobulins very e ffec tive  
in  selected cases, by removal of ACh-receptor antibodies, supposedly by 
binding them and checking th e ir  production. In anticholinesterase drug- 
res is tant cases, plasmapheresis is  more useful than other immunotherapies, 
the r is k  of exchange-dependency, however, is  also higher. Aged myasthenic 
patients to le ra te  the procedures w ell, respond to them remarkably, pa rtly  
because the removal of lipopro te ins improves oxygenization and general c i r ­
cula tion. Risk of dependency exis ts  in these cases, too, but l i f e  can be 
prolonged and the qua lity  of l i f e  can be improved.
MG tends to  combine w ith  other diseases or syndromes o f immunological or autoimmuno- 
lo g ic a l o r ig in , fo r  example, w ith  m u ltip le  sc le ros is , rheumatoid a r th r i t is ,  m yos itis , polymyo­
s i t is ,  dermatomyositis, immune thrombocytopenia, p s o ria s is , anaemia perniciosa, autoimmune 
diabetes m e llitu s , Sjögren-sicca syndrome, scleroderma, progressive sc le ros is , systemic lupus 
erythematosus, d isco id  lupus, e tc . In  these cases, in  add ition  to  MG, the concomitant or 
associated diseases or syndromes respond to  PEX w e ll. We have observed tha t the re s is ta n t 
ce rebe lla r, brain-stem, sphincter and other symptoms o f m u ltip le  sc le ros is  also improve in 
add ition  to  myasthenic weakness and fa t ig a b i l i t y ,  already during PEX treatment. L i t t le  or no 
reaction was seen in  the in te n s ity  o f pyramidal symptoms. Progressive myopathic cases (o f 
course, w ith myasthenic character) are generally re s is ta n t to  plasmapheresis, but sometimes 
the so-called "burnt out cases" o f MG resembling to myopathy can be influenced by PEX therapy 
w e ll.
Plasmapheresis is  generally useful in  patients a fte r thymectomy ( i f  
the resu lt of the operation is  not sa tis fa c to ry ). To avoid the rebound phe­
nomenon and to achieve a long-term e ffec t w ith plasmapheresis, we always 
use immunosuppressive therapies. As having the f i r s t  experience with immuno­
suppression therapy in  MG (15), we have been deeply convinced of the bene­
f ic ia l  e ffec t of th is  type of therapies. These methods are usually varied 
concerning both th e ir  types and combinations, as well as timing and duration 
of th e ir use. Two main drugs have been used in  most cases, v iz . stero ids ( in  
d iffe re n t forms) or azathioprine alone or in  combination, sometimes a lte r -  
natingly used. Levamisol or inosiplex are also used either alone or in 
various combinations, but never with azathioprine. Azathioprine and, ra re ly , 
levamisol are the drugs to be chosen, when a long-term therapeutical proce­
dure seems to be necessary.
Evaluation o f the c l in ic a l s ta tus o f the pa tie n ts  have been performed by using the 
D is a b ility  Status Scale (DSS) system /14 , 15/. In  th is  score system the higher the number o f 
the po in ts , the worse the p a tie n ts ’ cond ition .
Results achieved by PEX therapy in  MG are shown in  figures. The cor­
re la tion  of the types of immunosuppressive medication and the measure of
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DSS
F ig . 1. C lin ica l improvement o f MG patients in  re la tio n  to  the type o f immunosuppression
during PEX therapy.
OSS = D is a b ility  Status Scale, n .s . = not s ig n if ic a n t,  Mean +_ S.D. is  shown on the F ig .
DSS
F ig . 2. C lin ica l improvement in  re la tio n  to  the tim ing o f immunosuppression during PEX. 
В = Before PEX, A = Immediately a fte r, PEX, 1 MO = One month a fte r  PEX
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DSS
F iq. 3. Duration o f the therapeutic e ffe c t in  a one-year period a f te r  PEX, 
contained w ith  d iffe re n t immunomodulations
Crisis therapy P rae -  Post­ Reduction of Indications
thymectomy drug demand
therapy
F ig. 4, E fficacy  o f PEX in  pa tients w ith  d if fe re n t ind ica tions o f therapy. 
Mean + S.D. is  shown on the F ig.
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Immediately after PEX
F ig . 5. Improvement o f p a tie n ts  in  connection w ith the time elapsed since the s ta r t  o f PEX
c l in ic a l  improvement according to the DSS system are seen in  Fig. 1. The 
most s ig n ifica n t improvement was observed with combined azathioprine-steroid 
medication.
Relationship between the timing of immunomodulation and the e fficacy 
o f plasmapheresis is  shown in  Fig. 2. We fin d  no d ifference from the point 
o f view of c lin ic a l improvement between the various timings of immunosup­
pression, but the absence o f immunomodulation has usually caused rebound 
phenomenon.
The longest e ffe c t o f PEX was achieved in  the case of long-term ap­
p lic a t io n  of combined azathioprine-stero id medication, i t  sometimes lasted 
over one year (Fig. 3 ), but no s ign ifican t d ifference was seen concerning 
the d iffe re n t methods of immunosuppression.
C lin ica l improvement depends on the condition on which the ind ica tion  
o f PEX is  based (Fig. 4 ). The most s ign ifican t benefits can be obtained in  
myasthenic or cholinergic c r is is .  In these cases, PEX is  the therapy of 
choice. The best resu lts  a f te r  plasmapheresis are achieved on early thymec- 
tomized patients, who to le ra te  immunosuppressive drugs w ell, continuously 
fo r  years. Very ra re ly , su rp ris in g ly , long-lasting  remission a fte r PEX the­
rapy is  achieved even w ithout long-term immunomodulation.
D istribu tion  of temporal manifestation o f the therapeutic e ffec t of 
PEX in  percentage of pa tien ts  is  shown (Fig. 5 ). In 14 there is  no improve­
ment a fte r  PEX. There are some reasons for th is  low percentage, out of which 
we emphasize the la te  generalized ocular cases w ith  or without thymectomy,
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patients with rapid progressive myopathia and the drug-resistant cases. 
Patients who are susceptible to infections and malignancies can be reckoned 
to the same group. Improvement was observed in  63% of the patients during 
PEX therapy, mostly a fte r the f i r s t  or second treatment; 12% improve immedi­
a te ly  a fte r the treatment, 10% one month la te r.
Apart from the iso la ted ocular ( lo ca l) MG cases, PEX has not only a 
"buy-time ro le" before thymectomy, but can also better the l i f e  prospects 
and prolong the l i f e  of MG patients, using the r ig h t method at the r ig h t 
time. PEX is  a life -sa v in g  method in  cris is -therapy. "Qui habet tempus, ha­
bet vitám."
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FAMILIAL MYASTHENIA GRAVIS:
NINE PATIENTS IN TWO GENERATIONS
A. SZOBOR
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In  two generations o f a fam ily followed up fo r  15 years, nine pa tien ts  su ffe rin g  from 
myasthenia gravis were observed. The fam ily , being o f specia l genetic importance, is  unique in 
the l i te ra tu re .
Keywords: myasthenia, fa m il ia l occurrence, thymectomy.
In tro d u c tio n
We published a study on a family w ith two patients --  both females — 
suffe ring  from apparent myasthenia gravis 15 years age. Further four s is te rs  
in  the same fam ily proved to have provocable ( la te n t) myasthenia gravis. The 
oldest s is te r, however, and four brothers did not suffer from the disease, 
neither did the parents /1 , 8 /. Examinations concerning HLA antigens did not 
prove any spec ific  su s c e p tib ility , the ind iv idua l sex d is tr ib u tio n , however, 
might indicate the ro le  of an unknown fac to r, suggestive of sexbound suscep­
t i b i l i t y  /1 , 8 /. No iden tica l or s im ila r reports have been known in  the 
lite ra tu re , furthermore, we fa iled  to find  such a report w h ils t co llec ting  
our fa m ilia l cases and surveying the lite ra tu re  /2 , 3, 5 /. There was a fu r ­
ther characte ris tic  in  th is  fam ily: the severity of the manifest and provoc­
able myasthenia gravis state increased in  a negative co rre la tion  with the 
age of the patients. Thus, the illn e ss  of the two youngest s is te rs  were the
O ffp r in t requests should be sent to  A. Szobor, H-1204 Budapest, Köves S tr .  2—4.
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most severe, not only generalized, but also c ris is -p rone, thus, needed 
re la t iv e ly  urgent thymectomy.
The condition of the operated patients improved to such a degree and 
a t such a rate as i t  is  usual in  cases in  which thymectomy is  performed at 
the r ig h t  time, on the basis of proper ind ica tion . I n i t ia l ly  we were not 
ready fo r performing acetylcholine receptor antibody examinations. We could 
only say that no other immune disease or syndrome — which occurred in  21% 
in  our to ta l c lin ic a l m ateria l /4 / — associated w ith myasthenia gravis 
in  th is  fam ily.
Patients and methods
Every member o f the fa m ily  under study has been monitored, checked and con tro lled  
from tim e to  time, in  general in  every th ird  to  s ix th  month. Their complaints, symptoms, and 
th e ir  general and special s ta te  have been followed up and reg is te red . Meanwhile, thymectomy o f 
fu r th e r  fou r s is te rs  as w e ll as o f  a young male and a g i r l  o f the 3rd generation became neces­
sa ry . A l l  the thymectomies were performed v ia  median sternotomy (Dr Molnár, Dr Kas), thymic 
a c t iv i t y  was evaluated by the usual method, namely on the basis o f the presence, number and 
s ize  o f  germinative centres /6 ,  7 / .  In  the second series o f examination we determined a ce ty l­
ch o lin e  receptor antibodies, too . Eleven determinations were ca rried  out on 8 p a tie n ts , in  
th ree  cases both p rio r to  operation and therea fte r (Dr Szelényi). Treatment and a fte r-ca re  took 
place in  our Department o f Neurology in  every case, according to  the method described in  d e ta il 
elsewhere /6 / .
Results
The data fo r the members of the family are shown in  two genealogical 
tab les (Figs 1 and 2). The order and in i t ia ls  of the patients are iden tica l 
in  both tables, the fo llow -up-tim e has been 15 years (1976—1991). Myasthenia 
g ra v is , which had been only "provocable" (or la te n t) at f i r s t  in  the 2nd 
generation, became manifest in  a generalized form during the time of obser­
va tion . Furthermore, the disease proved to be cris is-prone in two cases on 
the account of resp ira tory d is tress. In the change or progression of the 
il ln e s s  the role of common factors such as resp ira tory in fections — were 
recognized. Unequivocal generalized myasthenia gravis became manifest in  a 
young male patient and in  a g i r l  in the 3rd generation. These two patients 
were thymectomized, meanwhile the drug therapy of the th ird  affected member 
o f the 3rd generation, a boy aged 3 years has been continued.
The oldest s is te r and a l l  brothers in  the 2nd generation neither 
became i l l  nor needed any therapy during the one and a ha lf decade of obser-
ge
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О  Manifest MG 
(^  Latent MG
7 8 9 10 11
O  <? ú  ù  □  Э
BZ 34 BM 33 BJ 31 BJ 30 BL 27 BV 26
®  Э  □  •  •
BE 25 ВТ 22 BA 21 BH 18 BJ 17
Thymectomy: 2 nd generation:cases 2,7,8,10, 11 
3 rd genera t ioncases 2/3, 8/1 
AChR-antibody positive cases 2,6 ,7  8,10, 11 
cases 2/3, 8/1
Fig. 1. and F ig. 2, Meirtiers o f the fam ily in  geneological tables
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va tio n . The other members o f the 3rd generation, including ch ild ren, adoles­
cent and young adults, are healthy, la ten t myasthenia gravis was not sus­
pected; they have needed no therapy, th e ir somatical development has been 
normal. Acetylcholine receptor antibodies were found in  a l l  the examined 
cases, but no s ig n ifica n t d ifference was found in  the cases in  which the 
te s t was repeated a fte r operation.
Discussion
The genetic score and the possible background of the fam ily under 
study was thoroughly discussed at the 3rd Euro-Myasthenia Conference held in  
Oxford (1991). This fam ily raised in te rest because i t  was considered to be 
unique: no sim ilar observations had been published in  the lite ra tu re  or 
encountered in the personal observation of the pa rtic ipan ts . In sp ite  of the 
fa m il ia l character of myasthenia gravis in th is  fam ily, the p o s s ib ility  of 
congenita l myasthenia can be excluded, furthermore, there is  no reason to 
suppose any form of sp e c ific  myasthenia syndrome.
Latent, undetected or only provocable form of myasthenia gravis and 
i t s  characteris tics were discussed in one of our previous papers 1 1 1 . This 
p o s s ib il i ty  led us in  the present case, too, when a fte r the two manifest 
instances of myasthenia g rav is , we applied curare provocation on the other 
members of the fam ily. We consider the d iffe re n t provocation procedures to 
be usefu l diagnostic to o ls  in  recognizing uncertain or la ten t myasthenia 
cases.
The family has specia l ind iv idua l characte ris tics , therefore, i t  
seems to  be worthwhile to  study a l l  of i t s  members (includ ing the healthy 
ones). I t  would be of in te re s t to  get fu rther unexpected experiences in  the 
2nd or 3rd generation, and to get know whether or not the sex difference 
would keep to disappear in  the fu rthe r generations.
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A to ta l o f 37 prenatal diagnoses were analysed: 10 observations in  which one o f the 
parents ca rried  a Robertsonian translocation and 27 observations in  which one a rec iproca l 
transloca tion  was ca rried  by one o f the parents. The segregations o f the in h e rite d  chromosome 
s tru c tu ra l rearrangements were analysed in  re la tio n  to  the methods o f ascertainment o f the 
anomaly in  the fam ily , and the types o f rearrangement. The mode of ascertainment proved to  be a 
very useful in d ica to r o f the r is k :  those cases ascertained through abnormal l iv e b ir th s  had a 
44% r is k  in  our se ries , but there was no unbalanced fe tus  in  the group ascertained through 
recurrent abortions.
Keywords : prenatal diagnosis, chromosome trans loca tions , cytogenetics.
In tro d u c tio n
The frequency of balanced chromosome translocations was estimated 
between 1 and 2 per 1000 in  newborns /3 , 5 /. Approximately ha lf of these are 
Robertsonian, the others are reciprocal translocations /1 /.  In the case of 
balanced chromosomal rearrangements the amount of genetic material is  not 
changed, and usually not accompanied by v is ib le  phenotypic e ffe c ts . However, 
these abnormalities represent a high r is k  to reproductive outcome of the 
balanced ca rrie rs . For th is  reason, parental balanced s truc tu ra l chromosome 
rearrangements are among the major ind ica tions for chromosome analysis in 
prenatal cytogenetic screening.
O ffp r in t requests should be sent to  A. Töth, H-1389 Budapest, Szabolcs u. 35.
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P a tie n ts  and methods
»
One part o f c a rr ie rs  was recognized during the cytogenetic study o f in f e r t i le  couples 
a t our department. The a ffected  parents asked fo r prenatal in vestiga tion  a t the beginning o f 
the subsequent pregnancy. Major p a rt o f the c a rr ie rs  was re fe rred  by several genetic labora­
to r ie s  to  our prenatal centre . The exact descrip tion o f karyotype and, in  c e rta in  cases a 
p ic tu re  o f the karyotype, was requ ired to  get a re lia b le  diagnosis. When the rearrangement in ­
cluded la rge  segments o f chromosomes, d ire c t chromosomal preparation o f chorion ic v i l l i  was 
c a rr ie d  out /4 / .  In  the cases o f smaller translocations cu ltu res  were set up, frequen tly  from 
both cho rion ic  v i l l i  and am niotlc f lu id  c e lls .  G- and Q-banding were used fo r  eva lua tion .
Thirty-seven prenatal in ves tig a tion s  were ca rried  out on 26 pregnants because o f 
c a rr ie rs h ip  o f a chromosome rearrangement. Six affected couples were investigated in  successive 
pregnancies.
Ten observations were analysed in  which one parent ca rried  a Robertsonian trans loca ­
t io n .  The d iffe re n t types o f Robertsonian transloca tion  are presented in  Table I .
Twenty-seven samplings were ca rried  out on 17 pregnants because o f rec ip roca l tran s ­
lo c a tio n  in  one of the parents. E ight cases were ascertained through a malformed in fa n t w ith  an 
unbalanced s truc tu ra l rearrangement, nine through a h is to ry  o f spontaneous abortions.
Results
There was no unbalanced offspring in  the group investigated fo r Ro­
bertsonian translocation. The fetuses were ca rrie rs  of a balanced rearrange­
ment in  4 cases (Table I ) .
Table I
Segregations in  Robertsonian transloca tions
Type o f rearrangement No. o f 
diagnoses normal
O f fs p r in g
balanced unbalanced
Involving 4 2 2
chromosome 21
Not involving
chromosome 21
Table I I
Risk o f rec iproca l trans loca tion  ca rrie rs  depending on the ascertainment
Ascertainment No. o f
inves tig a tion s normal
O f fs p r in g
balanced unbalanced
Malformed
ch ild 16 5 4 7
Recurrent
11abortion 6
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Investigating reciprocal translocations 7 unbalanced offsprings were 
found out of 16 samplings in  cases of couples ascertained through an un­
balanced o ffspring . There was no unbalanced in fan t in  the group w ith p rev i­
ous abortions (Table I I ) .
Discussion
Meiotic segregation of chromosome translocations produces gametes 
carrying d iffe re n t chromosome complements. For a given translocation several 
constitu tions could arise theo re tica lly . According to the cytogenetic studies 
of sperms of c a rr ie r men, most of the sperm complements represent a lte rnate  
(47%) or adjacent-1 (42%) segregations. Adjacent-2 and 3:1 segregations were 
much infrequent /9 / ._ A lternate segregation y ie lds normal o ffspring : theore­
t ic a l ly ,  one-half should have normal chromosomes, and the other h a lf should 
have the two balanced translocated chromosomes. Results from some studies of 
liveborn infants and fetuses with p rio r prenatal diagnosis have indicated an 
excess of balanced c a rr ie r fetuses /12 /. Our data show an excess of normal 
fetuses (18/14). I t  seems probable that the theore tica l 1:1 ra tio  which was 
confirmed by the cytogenetic analysis of sperms. /9 / is  va lid  in  la te r gesta­
tio n a l ages, too. The imbalances observed at b ir th  in  several pregnancies of 
the same ca rrie r nearly always resu lt from the same mode of segregation. 
This mode can be predicted from the pachytene diagram of the chromosomes in ­
volved in  the trans loca tion . The meiotic production of imbalances is  h ighly 
variable according to the translocation type, i t s  incidence ranging from 19% 
to 77% /11 /. The rate of imbalances in sperm is  always above (mean value 
36%) the one observed at term (10%), and at the prenatal diagnosis fo r 
ca rr ie r couples (11.6%) /1 / .  The spermatogenic fa ilu re  of men heterozygous 
fo r a translocation could resu lt from an in te rac tion  between the sexual 
b iva lent and the rearranged chromosomes, which can in te rfe re  with the XY 
inactiva tion  /7 / ,  or the pairing disruption around the breakpoints /8 / ,  but 
a prezygotic selection against unbalanced spermatozoa is  un like ly  /1 1 /. In 
contrast, postzygotic selection occurs, depending on the fa ta l i ty  of the 
imbalance.
90% of the pa te rna l-o rig in  imbalances resu lts  from adjacent-1 segre­
gation /6 / .  A p re fe ren tia l mechanism fo r th is  segregation seems to e x is t. 
Syntenic d isposition  of the homologous centromeres could promote an adja- 
cent-l-type segretation. The adjacent-2 and 3:1 segregations are transmitted
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almost exclusively maternally. The common characte ris tic  of these two types 
is  the nonsegregation of the homologous centrometers. Out of f iv e  fam ilies  
w ith  unbalanced fetuses three translocations were of maternal o r ig in . In 
con tras t to the lite ra tu re , a l l  of them resulted from adjacent-1 segrega­
t io n .  In  general, the maternal meiosis could be more w illin g  to chromosome 
nondisjunctions.
Though each reciprocal translocation is  associated with a p a rticu la r 
r is k ,  the e ffic iency of the natural selection fo r a given translocation 
depends on the gene dosage e ffe c t /6 / .  The v ia b i l i ty  of an unbalanced trans­
lo ca tio n  is  related to the size of the translocated segments and th e ir  
genetic contents. The smaller is  the imbalance the greater is  the r is k  of 
unbalanced liv e  b ir th  /2 / .  A good rough estimate can also be derived from 
the manner in  which the rearrangement has been ascertained. I f  there was a 
previous ch ild  with developmental malformations, there is  a higher possib i­
l i t y  fo r  survival with a ce rta in  chromosomal anomaly, and the r is k  o f re­
currence tends to be high in  about 20%. I f  the chromosome abnormality has 
been discovered while investiga ting  fo r the course of recurrent miscarriages 
then the majority of the anomalies are usually selected in  the f i r s t  t r i ­
mester, and consequently, the r is k  of an unbalanced aberration at the second 
tr im e s te r of the pregnancy is  less than 5% /10, 14/. This tendency is  well 
represented in our m ateria l, i .e .  there was no unbalanced o ffspring  in  the 
i n f e r t i l i t y  group. However, there were seven unbalanced fetuses (44%) in  the 
group ascertained through a previous abnormal ch ild . Cases w ith previous 
la te  spontaneous abortions where the fetus was abnormal and the parents 
turned out to be ca rrie rs  o f a chromosome translocation, also have a higher 
chance fo r surviva l. This find ing  ca lls  a ttention  to the importance of a 
thorough pathological investiga tion  of large fetuses and to the necessity of 
the cytogenetic analysis of suspected cases.
The rate of ca rr ie r mothers was not d iffe re n t from the ra te  of car­
r ie r  fa thers in case of the reciprocal translocation. The s im ila r ro le  of 
both parents in transm itting  the rearrangements was also found /13 /.
The commonest Robertsonian translocation is  the t(13ql4q) transloca­
t io n ,  in  which the r is k  of translocation trisomy 13 (Patau syndrome) in  the 
o ffs p r in g  of carrie rs is  less than 1%. On the other hand, i f  Robertsonian 
translocations are invo lv ing chromosome 21, the r is k  of translocation t r i ­
somy 21 is  about 15% when the mother is  the ca rr ie r. I f  th is  translocation 
was inherited  from the fa the r, then the r is k  would be much less. These
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resu lts  underline the importance of cytogenetic investigation o f newborns 
w ith Down’ s syndrome.
In conclusion, the study shows a high degree of v a r ia b il i ty  in  the 
incidence of unbalanced karyotypes. The resu lts  allow a pred iction  fo r the 
r is k  in  the o ffspring . According to the lite ra tu re  there is  a higher r is k  fo r 
couples with maternal balanced Robertsonian translocations invo lv ing chromo­
some 21, and fo r couples w ith reciprocal translocations ascertained through 
an o ffspring  with unbalanced karyotype. Cytogenetic survey of in fe r t i le  
couples and abnormal in fants or fetuses suspected of having a chromosomal 
anomaly makes i t  possible to recognize the s truc tu ra l rearrangements. When a 
fam ily member is  found to carry a transm issible chromosome aberration, i t  is  
the respons ib ility  of the loca l genetic services to in it ia te  studies in  
f i r s t  degree re la tives  to ensure that a l l  those who might be at r is k  of 
having affected offsprings are id e n tif ie d  and counselled. Detection of 
s tru c tu ra l rearrangements in  the ca rr ie r fam ilies and the p o s s ib il ity  of 
prenatal diagnoses w i l l  permit the affected couples to avoid the b ir th  of 
abnormal in fants.
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CARDI OL OGY
RETROGRADE (VENTRICULO-ATRIAL) CONDUCTION, PREMATURE BEATS, 
PSEUDOTRICUSPID REGURGITATION, SYSTOLIC ATRIAL SOUNDS AND PACEMAKER SOUNDS 
OBSERVED TOGETHER IN TWO PATIENTS WITH VENTRICULAR PACING
D. GELLÉRI
Jász-Nagykun Szolnok Cardiovascular Care Station,
Szolnok, Hungary
(Received: July 20, 1991)
Two pa tien ts  were found to  have retrograde a tr io v e n tr ic u la r  conduction w ith  premature 
beats during permanent v e n tric u la r pacing. In  both pa tie n ts  the auscultatory phenomena had been 
heard and recorded th a t had been described as independent signs, but a l l  together in  the same 
pa tien t had not been reported before.
In  one o f the pa tien ts  pseudotricuspid reg u rg ita tio n  was observed w ith  Doppler echo­
cardiography and the other was suspected having the same. I t  seems tha t pa tien ts  w ith  these 
symptoms deserve high preventive care and a tte n tio n .
Keywords: retrograde conduction, premature beat, rec iproca l beat, pseudotricuspid 
reg u rg ita tio n , s y s to lic  a t r ia l  sound, pacemaker sound.
In tro d u c tio n
Inh ib ited  ven tricu la r pacing is  the most popular pacing form nowa­
days, fo r the implantators have been using the dual chamber pacing modes 
less frequently than i t  was predicted in  the early ’ 80 s /12 /. Nevertheless, 
in  association w ith ven tricu la r pacing some unfavourable e lectrophysio logic
Abbreviations: AAI: A t r ia l pacing A tr ia l sensing In h ib ito ry  mode, cw: cannon wave, 
D00: Dual chamber pacing Dual chamber sensing Double response modes, DVI: Dual chamber pacing 
V en tricu la r sensing In h ib ito ry  mode, ECG: electrocardiogram, JVP: Jugular Venous Pulse, PCG: 
Phonocardiogram, PDE: Pulsed Doppler Echocardiography, PMC: Pacemaker C lick , PMS: Pacemaker 
Sound, RP in te rv a l is  the time la s tin g  from the paced R wave to  the P wave o f ECG, VVI: V e n tr i­
cu la r pacing V en tricu la r sensing In h ib ito ry  mode.
O ffp r in t requests should be sent to  D. G e llé r i ,  Dobó u. 25. 1 /7 ., H-5000 Szolnok,
Hungary
Akadémiai Kiadó, Budapest
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and haemodynamic e ffec ts , such as retrograde conduction, premature beats, 
re c ip ro ca l beats and pseudotricuspid regurg ita tion  may arise and some 
auscu lta to ry phenomena, such as sys to lic  a t r ia l  sounds and pacemaker sounds 
may come in to  being. The ECG, PCG, JVP tracings and the PD échocardiographie 
re g is tra t io n  of two patien ts in  whom these find ings were seen together are 
described here.
Case re p o rts
Case 1. The pa tie n t, a 51-year-o ld man, experienced dyspnoea, dizziness and tiredness. 
H is h e a rt frequency sometimes decreased to  43 beats min, and premature beats w ith  p o s it iv e  P 
waves on th e ir  ST segments were seen during ECG recording (F ig . 1 ). Since c l in ic a l symptoms and 
the ECG recordings revealed sinus-node dysfunction, the pa tien t received a Medtronic r ig h t -
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F ig . 1, Upper standard 3-channel ECG re g is tra tio n  — Sinus bradycardia (.43 beats/m in l. Every 
t h ir d  beat is  a ve n tricu la r premature beat w ith p o s itiv e  P wave on the ST segment. Lower 
3-channel ECG, JVP and PCG re g is tra t io n  — A d is t in c t io n  can be made between "A" and "B" types 
o f  sys to le s  produced by pacemaker and between "C" type o f sys to le , which is  a premature beat. 
The "x "  descents of 1VP are occupied by the large "a" waves. The accentuation o f the f i r s t  
h ea rt sound increases from "a" to  " c " .  Abbreviations: 1 4  2 = number o f heart sounds (4 = fo u rth  
heart sound, s y s to lic  a t r ia l  sound), ECG (1 11) = ECG lead I I
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Fig. 2. 3-channel ECG, JVP and PCG re g is tra tio n  — Every second nonpaced beat is  a premature beat w ith  la te  
s y s to lic  c lic k  during magnet mode, i f  the PR in te rv a l is  295 ms., so the pacemaker impulse f a l ls  in  the 
la te  s y s to lic  region ( to  the r ig h t  from the v e rt ic a l black l in e ) .  I f  the PR in te rv a l is  390 ms., the pace­
maker impulse f a l ls  ju s t a fte r  the f i r s t  heart sound and the pacemaker c l ic k  disappears ( to  the le f t  from 
the v e r t ic a l black l in e ) .  The pacemaker impulses fa l l in g  on the s y s to lic  cycle can generate no depolariza­
t io n  because o f the re fra c to ry  phase. On the le f t  side o f the fig u re , when the PR in te rv a l is  long (390 
ms.), the pacemaker impulse f a l ls  in  the middle o f e le c tr ic a l systo le , thus the e le c tr ic a l movement o f the 
pace increases above the is o e le c tr ic  le v e l; then i t  decreases im ita ting  depolariza tion. On the r ig h t side 
o f the f ig u re , when the PR in te rv a l is  shorter (295 ms.) the pacemaker impulse f a l ls  in  the negative apex 
o f the T wave, thus the e le c tr ic a l movement o f the pace rise s  only to  the is o e le c tr ic  le v e l, i . e .  does not 
im ita te  any depolariza tion. Abbreviations: see F ig. 1.
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v e n tr ic u la r  demand pacemaker w ith  Lith ium  battery a t the Department o f Cardiovascular Surgery, 
Semmelweis U n ive rs ity  Medical School, Budapest (September 1977). A fte r pacemaker im p lanta tion  
every th ir d  beat was a premature beat w ith  an accentuated f i r s t  heart sound, while  in  the 
previous two pacemaker beats mesosystolic sounds were heard and recorded (F ig . 1 .) .
Premature beats could sometimes be reg istered as every second beat w ith  s y s to lic  
pacemaker c l ic k  i f  the magnet mode was employed (F ig . 2 ) .  The dizziness disappeared a f te r  
pacemaker im plantation but the p a tie n t developed dyspnoea and tiredness during and a f te r  exer­
t io n  resp e c tive ly . Although he had been fee ling  a l l  these fo r  4 years, he regu la rly  d id  garden­
ing and drove car. His retrograde conduction and premature beats fa ile d  to respond to  adminis­
t ra t io n  o f beta b lockers. One evening, watching te le v is io n , he died suddenly.
At autopsy the heart was enlarged (480 g) w ith  predominant d ila ta tio n  o f the r ig h t  
appendage and v e n tr ic le . No thrombi were seen in  the chambers. The pacemaker wire was fix e d  a t 
the apex o f the r ig h t  v e n tr ic le  and functioned w e ll. In  the coronaria vessels moderate s c le ro ­
s is  was found w ithout myocardial in fa rc t io n . On the v isce ra  the signs of chronic congestive 
heart fa i lu re  were observed.
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F ig . 3. 6-channel PCG, ECG and DVP re g is tra tio n  — (The PCG was recorded over the le f t  lower
parasternal border.)
A) a t the end o f maximal exsp ira tion B) C) and during gentle in sp ira tio n . — A) Negative P 
waves are at the beginning o f ST segments on ECG lead I I , proving retrograde conduction. Strong 
pacemaker sounds can be recorded in  every frequency-band on PCG. The OVP tra c in g  shows t r i ­
cuspid regu rg ita tion  (Cannon waves). — B) During in sp ira tio n  the strong pacemaker sounds 
change to pacemaker c lic k s . The s y s to lic  murrrur la s tin g  from the f i r s t  heart sound to  the 
m idsysto lic  (s y s to lic  a t r ia l )  sound can be observed b e tte r. — C) Later the pacemaker c lic k s  
disappear but the s y s to lic  murmur and s y s to lic  a t r ia l  sound do not change. 
Abbreviations: ECG = electrocardiogram lead I I ,  see. F ig . 1. Timing: — — 1 s
Case 2. A 48-year-old woman, having experienced dizziness and anginas underwent e lec- 
trophys io log ic  examination and coronarography which revealed sinus-node dysfunction and a 
moderate coronary heart disease. She was given a Medtronic ve n tricu la r demand pacemaker in  the 
Hungarian In s t itu te  o f Cardiology in  Dune 1982. A fte r pacemaker im plantation she developed
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F ig . 4 , ECG, PCG recorded over the le f t  lower parasternal border, and the centra l venous flow  
v e lo c it ie s  in  the beginning o f in fe r io r  vena cava by PDE in  subcostal view. A fte r negative 
P wave o f ECG, s y s to lic  a t r ia l  sound can be recorded on PCG (S) followed by la te  s y s to lic  
reverse flow  (a) on PDE. The d ia s to lic  forward flow (b) is  la rge  and occupies the whole d ia ­
s to le . Two types o f premature beats can be seen: in  the fo u rth  cardiac cycle ( * ) :  premature 
beat w ith  negative P wave and la te  s y s to lic  reverse flow , and in  the tenth cardiac cycle (x x ): 
premature beat w ithout them. Abbreviations: see F ig. 1, ECG I I I  = electrocardiogram lead I I I
d izz iness only ra re ly  but she needed antiangina drugs longer. By evenings she observed minimal 
oedema on her legs. Her auscu lta to ry find ing  was the fo llo w in g : the f i r s t  heart sound comprised 
o f two components over the apex and the le f t  parasternal border. At the time o f the f i r s t  
component a l i t t l e  ske le ta l muscle contraction was seen around the pacemaker ba ttery and in  the 
l e f t  f i f t h  in te rco s ta l reg ion , so i t  was supposed to be a pacemaker sound. (The l i t t l e  ske le ta l 
muscle contraction was not f e l t  by the p a tie n t.)  From the second component of the f i r s t  heart 
sound a s y s to lic  murmur was heard and recorded to the m idsysto lic  sound. Over the greet vessels 
the second heart sound was paradox s p lit te d . PDE showed a p o s itiv e  large wave fo llow ing  the 
s y s to lic  a t r ia l  sound in  the beginning o f the in fe r io r  vena cava, while there was a trace re ­
g u rg ita tio n  ju s t above the tr ic u s p id  valves. These were suggestive o f a pseudotricuspid 
re g u rg ita tio n  (Figs 3, 4 ). The r ig h t  atrium was a b iten  la rg e r (30 x 35 mm) w ith no a n te rio r 
movement o f tr icu sp id  and b icuspid le a f le ts  during a t r ia l  sys to le .
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Despite the above-mentioned minor complaints and the minor signs o f pseudotricuspid 
regu rg ita tion  the p a tie n t was fe e lin g  w e ll, so i t  was not planned to change her VVI pacing 
mode to DDD.
Discussion
Sinus-node dysfunction as indication fo r  primary pacemaker implanta­
tion  made 52% of a l l  cases included in  a survey carried out in  the USA 
during 1985 /12 /. Treatment with conventional ven tricu la r pacing in  patients 
with sinus-node dysfunction can lead to retrograde conduction in 33-100% of 
cases in  which the anterograde conduction is  normal /5 /.  P waves are ty p i­
ca lly  inverted on the ECG’ s ST segments in  cases w ith retrograde ac tiva tion  
(case 2), but they may be of upright form i f  rapid retrograde bypass path­
ways are present /11 / (case 1). Pacemaker-induced retrograde a tr ia l a c tiva ­
tion  has assumed great importance as an inducer of reciprocal or echo beats 
i f  the RP in te rva l is  long enough so the a tr io ve n tr icu la r pathways are not 
in  re fracto ry  phase and the a tr ia l depolarization can generate a ve n tricu la r 
depolarization see Johnson’ s four cases /5 / .  In our two cases th is  poss ib i­
l i t y  could be excluded because the P waves were seen at the beginning of the 
ST segment, namely the RP in terva ls were short, so the a tr ia l depolarization 
could not generate ven tricu la r depolarization. Thus a ventricu lar depolar­
iza tion  ju s t a fte r the paced beat can be in terpre ted as a ven tricu la r pre­
mature beat. Nevertheless, the RP in te rva ls  may change /5 /,  thus rec iproca l 
or echo beats might occur out of the recorded time in  our two cases as w e ll. 
These echo beats may have been dangerous i f  the impulse ran back to  the 
atrium, then to the ve n tr ic le  again, making a macro-reentry tachycardia and 
producing ven tricu la r f ib r i l la t io n .  This p o s s ib il ity  could not be excluded 
in  case 1, in  which at autopsy there were no signs causing the sudden death. 
The prominent d ila ta tio n  o f the r ig h t appendage and ventric le  may contribute 
to the genesis of a malignant tachycardia, fo r  — as known for many years — 
the d ila ta tio n  of cardiac chambers is  a "hotbed" of rhythm abnormalities 
/9 /.  Among 27 patients of Westveer et a l.  in  whom retrograde conduction was 
present a t the time of electrophysiologic study 13 ones displayed retrograde 
conduction fo llow ing ven tricu la r premature beat on routine ECG p r io r  to 
electrophysiologic study /14 /. In our case 1 upright P waves were seen on 
ven tricu la r premature beats’ ST segments, pred icting  that th is  kind of P 
waves would be present during ventricu lar pacing.
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A tr ia l contractions a t the time when the m itra l and tr icu sp id  valves 
are closed may produce a t r ia l  sounds lik e  those described by Benchimol in  
1973 /1 / .  The synchronously-registered jugu la r pulse with large and (o r t a l l  
"cw" would provide a clue to  take d is tin c tio n  of other auscultatory phenom­
ena, such as ejection and nonejection c lic k s , extracardial sounds, e tc . The 
s y s to lic  fourth heart sound (a t r ia l sound) can be a ttributed to e ith e r: 1. 
fo rc e fu l a t r ia l contraction against a closed m itra l and tr icusp id  valve or 
2. a b r ie f  movement o f the m itra l valve apparatus giving rise  to audible and 
recordable v ibrations. Benchimol et a l. /13 / described a case presenting 
a t r ia l  sound and retrograde conduction w ith  a l i t t l e  anterior movement of 
the tr ic u s p id  valve on M-mode echocardiography. In case 2 anterior movement 
o f the tr icusp id  and bicuspid valves could not be demonstrated by two-dimen­
s io n a l echocardiography. So one concludes tha t the systo lic  a t r ia l  sound may 
be produced by the rapid increase of a t r ia l  pressure o rig ina ting  from the 
fo rc e fu l a t r ia l contraction.
Pacemaker-induced pseudotricuspid regurg ita tion  was described a t the 
f i r s t  time in  a 83-year-old female pa tien t, by Kay et a l. /6 /.  The evidence 
o f th is  diagnosis was tha t the hepatic pulsation and the other periphera l 
signs o f tricusp id  regurg ita tion  abolished when the ventricu lar pacing had 
been interrupted and the normal a tr io ve n tr icu la r sequence of ac tiva tio n  was 
res to red . Jacobs et a l.  found, with in fe r io r  vena cava contrast M-mode echo­
cardiography, pseudotricuspid regurg ita tion  in  8 of 20 patients treated with 
permanent ventricu lar pacemaker; none of the 8 patients showed c l in ic a l 
symptoms of tricusp id  regurg ita tion  /4 /.  Kay e t a l. /6 / postulate th a t the 
combination of cannon waves superimposed on an already elevated r ig h t  a t r ia l  
pressure may be the necessary substrate fo r producing these find ings /4 , 6 /. 
In  the two cases described here peripheral symptoms of tricusp id  regurg ita ­
t io n  could not be seen. In case 1 the JVP trac ing  and the prominent enlarge­
ment o f r ig h t appendage and ven tric le  at autopsy were considered to  be t r i ­
cuspid regurg ita tion , whereas in  case 2 the high positive wave fo llow ing  the 
a t r ia l  sound proved pseudotricuspid regu rg ita tion . The forcefu l a t r ia l  con­
tra c t io n  could produce a t r ia l  sound as w ell as the pseudotricuspid regurg i­
ta t io n  r is in g  a fte r the s y s to lic  a t r ia l sound.
Harris was the f i r s t  to state tha t pacemaker c lic k  was an ex tra - 
c a rd ia l c lic k  /3 /. In case 1 the pacemaker c lic k  was heard and recorded 
during the la te  systole and disappeared when i t  f e l l  in  the m id-systole. 
One might say that i t  was a range of systole in  which no pacemaker c lic k  
could come into being. Nager et a l . ,  /10 / who had studied the pacemaker
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sound/click in  d e ta il mentioned the same range. In the case 2, pacemaker 
c lic k  disappeared during insp ira tion , proving i ts  being changeable. The 
appearing and disappearing of a pacemaker c lic k  or sound may vary by a lte ra ­
tio n  of the body’ s position , by resp ira tion  and, perhaps, by the moving of 
tricusp id  valves and a trioven tricu la r groove /2 , 7, 8 /. The movement of the 
tr icusp id  valves and a trioven tricu la r groove may take the pacemaker wire 
in to  a position  in  which the e le c tr ic  stream towards the tho rac ic  muscle 
becomes unfavourable, in terrupting  the rapid skeletal muscle contraction 
that produced the pacemaker click/sound. This is  one of the explanations for 
being of the zone ju s t follow ing the f i r s t  heart sound, a zone in  which 
pacemaker sound/click cannot be orig inated (case 1).
I t  seems that the retrograde a tr io ve n tr icu la r conduction w ith  prema­
ture or echo beats and the sys to lic  a t r ia l  sounds with pseudotricuspid 
regurg ita tion  are symptoms that may occur together at the same tim e, though, 
in our knowledge these four symptoms had not been reported in  the same case. 
Besides th is ,  i f  one can hear a pacemaker click/sound i t  can occur co inc i- 
dently, but i t  is  of in te res t that in  an attempt to assess the occurrence of 
pacemaker c lic k  was more often found in  unfavourable haemodynamic and elec- 
trophysio log ic s itu a tio n , such as: retrograde a trioven tricu la r conduction 
and in the employing of the magnet mode /2 / .
In conclusion, treatment with ven tricu la r pacing in  pa tien ts  with 
sinus-node dysfunction may often lead to  retrograde conduction. Thus treated 
patients deserve carefu l preventive care and attention , especia lly sys to lic  
a t r ia l sound, pacemaker click/sound and the minor échocardiographie signs of 
a pseudotricuspid regurg ita tion are present. The increasing enlargement of 
the r ig h t atrium and peripheral signs of tricusp id  regu rg ita tion  need 
changing to a trio ve n tricu la r sequential pacing. Nevertheless, in  the pa­
tie n ts  w ith sinus-node dysfunction in  whom retrograde conduction exists 
p rio r to  permanent pacemaker implantation physiological pacing modes, such 
as AAI, DVI and DDD may be advisable. The mentioned pacing modes could 
protect also our patients against the described complaints as well as, 
perhaps, against sudden death.
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GASTROENTEROLOGY
PREVALENCE OF ANTIBODY TO HEPATITIS C VIRUS IN BLOOD DONORS, 
HIGH-RISK GROUPS AND PATIENTS WITH LIVER DISEASES IN HUNGARY
A multicentre study using ABBOTT EIA te s t and a comparison w ith  an 
ORTHO ELISA te s t system
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Serum samples from 1183 ind iv idua ls  (blood donors, health-care workers, pa tien ts  on 
haemodialysis, those from other h ig h -risk  groups and those suffering from non-A, non-B hepati­
t i s  or other l iv e r  diseases) were examlnated fo r  antibody to a recombinant HCV antigen. An 
ABBOTT HCV EIA system was used throughout and in  add ition  a p a ra lle l study w ith  ORTHO HCV ELISA 
was done in  380 o f the samples to compare the two anti-HCV tes ts . A confirm atory neu tra liz in g  
ABBOTT ELISA probe was also performed in  45 cases. The anti-HCV te s t was p o s itiv e  in  1.60% of 
the healthy blood donors and in  9% o f subjects excluded from donation fo r elevated aminotrans­
ferase. In  pa tients  on haemodialysis 47%, in  other h igh-risk-group subjects 33% anti-HCV pre­
valence was found. Patients w ith acute and chronic post-transfusion NANB h e p a tit is  showed 40% 
and 70% prevalence, respective ly . The two ELISA te s ts  revealed 95% agreement in  the p a ra lle l 
determ inations. S e ria l e nd -po in t-d ilu tion  studies o f anti-HCV-positive sera suggest th a t the 
ABBOTT te s t was o f superior s e n s it iv ity .  The re s u lts  o f the confirmatory te s t  suggest that 
reactive  (p o s itiv e ) samples o f low o p tica l density near to  the c u t-o ff value, required a con­
firm a tion  w ith  the n a tu ra liza tio n  te s t.  HCV in fe c tio n  seems to  be a common a e tio lo g ic a l fac to r 
in  PT-NANB h e p a tit is  in  Hungary, there fore , screening o f blood donors fo r  anti-HCV may be ju s ­
t i f ie d .
Keywords: h e p a tit is  В v iru s , h e p a tit is  C v iru s , antibody to h e p a tit is  C v iru s , non-A, 
non-B h e p a tit is ,  l iv e r  diseases, h ig h -risk  groups, post-transfusion h e p a tit is .
Abbreviations: anti-HBc = antibody to h e p a tit is  В v irus core, anti-HCV = antibody to 
h e p a tit is  C v iru s , ALT = alanine aminotransferase, AST * aspartate aminotransferase, EIA, 
ELISA = enzyme-linked immunosorbent assay, HBV = h e p a tit is  8 v irus , HCV = h e p a tit is  C v iru s , 
NANB = non-A, non-B, PT = post-transfusion
O ffp r in t requests should be sent to  A. Pár, H-7643 Pécs, Ifjúság  S tr .  13., Hungary
Akadémiai Kiadó, Budapest
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Introduction
In the 15-year h is to ry  of non-A, non-B (NANB) v ira l h epa titis  re­
search (1-3) the discovery of hepa titis  C v irus (HCV) can be regarded as an 
important milestone, as the HCV-related recombinant antigen offered an oppor­
tu n ity  fo r  the detection o f anti-HCV /4 , 5 /. Thus an aetio log ica l diagnosis 
of parentera lly-transm itted NANB hepa titis  has become available. Two in te r ­
nationa l world conferences on HCV /6 , 7/ and many reports indicate how much 
th is  discovery stimulated the studies on blood-borne hepa titis . From Hunga­
ry , in  addition to the early researches on NANB h e p a titis  reported by Hollós 
e t a l.  /8 /  as well as Schaff et a l. /9 / fu rthe r papers have been published 
on th is  subject /10-12/. Recently Héjjas et a l.  /13/ have published the 
f i r s t  resu lts  of anti-HCV research from Hungary. Detection of anti-HCV is  of 
s ign ificance  mostly in  the research of epidemiology, diagnosis and preven­
tio n  o f parentera lly-transm itted NANB h e p a titis , now ten ta tive ly  called 
h e p a tit is  C, through, several unsolved questions have remained to judge the 
rea l value of anti-HCV studies.
The ORTHO Diagnostic System (Raritan, New Yersey, USA) was the f i r s t  
to develop a technique (an ELISA techniqe) fo r detection of anti-HCV. This 
te s t has spread in  a wide range on the world. The f i r s t  Hungarian experi­
ences were obtained by using th is  method /12, 13/. Soon ABBOTT (North Chi­
cago, I I I . )  introduced another system fo r the same purpose. Recently a sec­
ond-generation test is  also available from th is  firm . Last year a nation­
wide m ulticenter screening study was designed in  Hungary, to evaluate the 
c l in ic a l significance of anti-HCV determination. In th is  screening the 
firs t-g e n e ra tio n  ABBOTT EIA tes t was used, p a rtly  in  comparison w ith an 
ORTHO anti-HCV tes t.
The present study was performed in seven in s titu tio n s . Serum samples 
from blood donors, health-care workers, h igh -risk  group of parentera lly- 
transm itted NANB h epa titis  and patients with l iv e r  diseases were examinated.
Patients and methods
P atients
Serum samples from a to ta l o f 1185 subjects were stud ied. The d is tr ib u tio n  o f the 
subjects by diagnosis is  shown in  Table I :  o f the blood donors, 257 have excluded from dona­
tio n  because o f suspicion o f chronic h e p a tit is  or an elevated transaminase le ve l. The hea lth ­
care workers were laboratory technicians or hosp ita l nurses. In  the h igh -risk  group 123 pa-
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t ie n ts  were haemodialysed, 35 were polytransfused, and 10 suffered from haemophilia: 14 pa­
t ie n ts  had undergone open-heart surgery and 5 in d iv id u a ls  were on plasmapheresis. Out o f the 
pa tien ts  w ith  acute NANB h e p a tit is  35 were post-transfus ion  cases, 64 had sporadic NANB hepati­
t i s ,  while out o f the pa tients w ith chronic NANB h e p a tit is  36 had post-transfusion (PT) hepa­
t i t i s  and 91 had sporadic ("cryptogenic") NANB h e p a tit is .  In the group o f the various l iv e r  
diseases, 41 pa tients  had a lcoho lic  h e p a tit is  o r c ir rh o s is ,  13 had HBsAg-positive (B acute and 
5 chronic) h e p a tit is  and 42 pa tients suffered from d iffe re n t hepatob ilia ry  diseases.
Methods
The blood samples were stored a t -20 °C u n t i l  used.
Biochemical l iv e r  te s ts . The necrosis enzymes aminotransferase (ALT/GOT o r AST/GOT) 
were determined by conventional standard methods or an optimalized k in e t ic  technique.
H ep a titis  В v irus  (HBV) markers. HBsAg and anti-HBc were tested w ith  ELISA (ORGANON 
Teknika, Oss, The Netherlands) or w ith  radioimmunoassay (ABBOTT Wiesbaden, Germany, o r SORIN 
Biomedica, Hamburg).
Anti-HCV te s t . The sera were assayed fo r  anti-HCV with the ABBOTT anti-HCV EIA k i t  
(k in d ly  provided by ABBOTT, Wiesbaden); besides 380 o f the sera were tested w ith  the ORTHO HCV 
antibody ELISA te s t system as w e ll. For confirm ation o f pos itive  anti-HCV-reaction, an ABBOTT 
anti-HCV N eu tra liza tion  EIA te s t was used in  45 cases by one of us (M .T .). ( B r ie f ly ,  two 
p a ra lle l samples o f serum were studied: the one was subjected to the screening te s t  as above 
while to  the other a n e u tra liza tio n  reagent — a recombinant HCV antigen — was added. This 
antigen forms an immune complex w ith the anti-HCV antibody present in  serum, thus b lock ing  the 
binding o f the antibody to  the c-100-3 rHCV antigen absorbed on the surface o f beads. As a 
re s u lt ,  the absorption, i . e .  o p tica l density o f the anti-HCV-containing serum samples w i l l  be 
reduced.)
S ta t is t ic a l analyses
* 2 te s t was used fo r  the comparison o f frequency o f positive  sera in  d if fe re n t  groups.
Results
Frequency of hepa titis  markers
The prevalence of the anti-HCV marker and the two HBV markers found 
in  the d iffe re n t study groups is  summarized in  Table I .
Blood donors. A s ig n ifica n t d iffe rence was seen between the healthy 
persons and those who had raised aminotransferase levels or being suspect 
of v ira l hepa titis  had been excluded from donation. In the la t te r  subgroup 
a l l  the three v ira l markers occurred s ig n if ic a n tly  more frequently than in 
the group of healthy donors (P < 0.001 fo r a l l  three markers).
The h igh-risk  group. Haemodialysis patients need special a tte n tio n : 
anti-HBc and anti-HCV were detected w ith s im ila r frequency in  about a ha lf 
of these patients. The rate of anti-HCV se ropos itiv ity  was lower in  patients 
who had undergone open-heart surgery, or who had been polytransfused fo r 
haematological disease.
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Table I
V ira l markers in  blood donors, hea lth-ca re  workers, 
h ig h -r is k  groups and l iv e r  disease
Diagnosis n
HBV HCV
HBsAg anti-HBc anti-HCV
p o s i t i v e  (%)
Blood donors
— healthy 367 3(0.8%) 17/240(7%) 6 /(1 .6%)
— raised ALT 257 28(11%) 61/247(25%) 23(9%)
Health-care workers 43 0 5(12%) 2(5%)
H igh-risk qroups
— haemodialysis 123 17(14%) 61(50%) 58(47%)
— other po lytransfused 64 3(5%) 17(27%) 21(33%)
Acute NANB
— post-transfus ion 35 0 9(26%) 14(40%)
— sporadic 64 0 18(28%) 17(27%)
Chronic NANB
— post-transfus ion 36 0 10(28%) 28(78%)
— sporadic 91 0 26(29%) 31(34%)
Various l iv e r  diseases 96 13(14%) 16(17%) 12(13%)
Out of the 123 haemodialysed patients 30^  were positive for both a n t i-  
HCV and anti-HBc (30.9%). This number represents 65% of the anti-HCV-posi- 
t iv e  haemodialysis cases. Out of the 58 anti-HCV-positive haemodialysis pa­
t ie n ts  9 were HBsAg-positive, that is , 7.3% o f the to ta l haemodialysis cases 
revealed a "double" ca rrie rsh ip .
The NANB h e p a tit is  group. The prevalence o f anti-HCV was higher in  
the parentera lly-transm itted acute and chronic hepa titis  than in  the spo­
rad ic  (cryptogenic) NANB cases, but the d iffe rence  77.8 vs. 34.1% was s ig ­
n if ic a n t (P < 0.001) only in  the chronic forms.
The re lationship between the raised aminotransferase level 
and anti-HCV find ing
As mentioned above in  the group of blood donors anti-HCV seropos itiv - 
i t y  rate was s ig n if ic a n t ly  higher fo r subjects w ith elevated aminotrans­
ferase level than fo r accepted healthy donors. Regarding the haemodialysis 
pa tien ts , a s im ila r re la tionsh ip  was found, namely, 46 of 58 anti-HCV-posi- 
t iv e  dialysed patients (79.3%) had raised aminotransferase levels while only
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22 patients of 65 anti-HCV-negative (33.8%) showed the same. — In the 
chronic NANB hepa titis  group, 23 of 24 anti-HCV-positive (95.8%) while out 
of 17 anti-HCV-negative patients 11 (64.7%) had an elevated ALT a c tiv ity .
Comparison of the ABBOTT EIA and ORTHO ELISA test systems
When 125 serum samples from blood donors with elevated aminotrans­
ferase leve l (and/or w ith suspicion of he p a titis ) were tested simultaneously 
w ith the ABBOTT and ORTHO anti-HCV tes ts , the agreement was 98% (F ig . 1/a).
ORTHO ORTHO
+  -  +
- 120 0 - 162 6
ABBOTT + 3 2
ABbUГТ
4 - 9 78
a) Blood donors w ith 
elevated ALT
b) Patients at high r is k  
or w ith  l iv e r  disease
Fin- 1. P a ra lle l ABBOTT and ORTHO anti-HCV determinations
In another study, 255 patients belonging to d iffe re n t h igh-risk 
groups or with l iv e r  disease were examined pa ra lle l with both te s ts : a 94% 
agreement was found (F ig. 1 /b). The concordance for a l l  the p a ra lle lly -  
tested sera was 362/380 (95%). The s e n s it iv ity  of anti-HCV te s t systems was 
compared by the p a ra lle l tes ting  of se ria l end-poin t-d ilu tion of four an ti- 
HCV-positive sera: in  three of those 4 the ABBOTT test proved to be more 
sensitive than the ORTHO (Table I I ) .
Table I I
Anti-HCV EIA endpoint d ilu t io n  resu lts  
on seropositive serum samples
Reciprocal endpoint d ilu t io n
Patient
ABBOTT ORTHO
1. 0620267 128 48
2. A.B. 128 16
3. V.G. 64 32
4. B.N. 16 64
172 PÁR, A . ,  ILD IKÓ  KÁNTOR
The resu lts  of ABBOTT N eutra liza tion  anti-HCV EIA te s t
A to ta l of 45 confirmatory tests were performed. For th is  purpose, 
sera were derived from 12 patients with acute v ir a l  hepa titis , from 13 with 
chronic hepatitis  and from two patients with other l iv e r  diseases, as well 
as from 18 blood donors. The results are shown in  Table I I I .  Out of the
Table I I I
Confirmatory s tud ies  w ith ABBOTT N eu tra liza tion  anti-HCV EIA
G roup
A n t i  HCV
Screening tes t N eu tra liza tion  te s t
Reactive Negative P os itive Negative False-p.
Acute hepatitis 12 0 6 3 + 3+ 0
Chronic hepatitis 11 2 6 4 + 3+ 0
Other l iv e r  disease 1 1 0 2 0
Blood donors 18 0 11 4 3
Tota l 42 3 23 13 + 6+ 3
+ a f te r  neu tra liza tion  the absorption decreased
i n i t i a l l y  anti-HCV-reactive 12 sera of patients w ith acute hepa titis  6 
proved to be positive in  the confirmatory tes t as w e ll. (Serum samples were 
co llec ted  from the pa tien ts  w ith in  one month a fte r  the onset of the illn e s s  
(two sera) or la te r than one month (four sera). Three of the s ix negative 
sera produced absorption values under the c u t t -o f f ,  but in  the neutra liza­
t io n  te s t the ir op tica l density values were considerably reduced. Otherwise, 
a l l  these three patients had undergone surgery, or had got transfusion, two 
months before the symptoms o f hepatitis . Their sera were obtained from the 
ea rly  stage of in fe c tio n , 5-10 days after the onset of the illn e ss .
Eleven of 13 o f chronic hepatitis  patien ts were reactive in  the 
screening test, six of them proved to be pos itive  w ith the neutra liza tion  
te s t and seven were negative. The absorbance value (o p tica l density) of the 
three negative sera was considerably reduced in  the neutra liza tion  te s t.
Sera of patients w ith  other l iv e r  disease proved to be negative in  
the confirmatory te s t.
Eighteen healthy donors were seropositive in  the screening te s t, 11 
o f them were positive in  the neutra lization te s t. Four were negative and the
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remaining three proved to be fa lse p o s itive , that is , the la t te r  sera were 
strongly reactive both before and a fte r  neutra lization. This phenomenon 
might be a ttr ibu ted  to a h itherto  unknown nonspecific reaction.
Summing up the resu lts of the ABBOTT Neutralization te s t, 42 o f the 
45 tested sera were reactive with the ABBOTT screening test and three were 
negative (the la t te r  sera were pos itive  w ith the ORTHO screening te s t) .  The 
negative sera were поп-reactive in  the neutra liza tion  test as w e ll. Out of 
the 42 o r ig in a lly  reactive sera 23 were pos itive  in the neu tra liza tion  te s t, 
3 proved to be fa lse positive and 16 samples produced negative re su lts . The 
sera, which gave negative resu lts  in  the neutra liza tion  test had low op tica l 
density values in  the screening te s t, ju s t above the cu t-o ff value.
Discussion
Our present study with the ABBOTT anti-HCV EIA tes t resu lted in 
several in te res ting  findings some of which correspond to those obtained with 
the ORTHO HCV antibody ELISA test in  western Europe and Hungary e a r lie r .
We have learned that the anti-HCV seropositiv ity  rate fo r  healthy 
blood donors (determined only with the sole screening test w ithout neu tra l­
iza tion  confirmatory probe) was s im ila r to tha t reported by Héjjas e t a l. 
/13 / the f i r s t  the authors using the ORTHO te s t in Hungary. ( I t  is  conceiv­
able that i f  we had the checked a l l  the anti-HCV-reactive sera of blood 
donors and of other study groups w ith  the neutralization te s t, the true 
prevalence rate would have been much low er.)
Yet, i f  we take in to  account the previous anti-HCV resu lts  as well as 
our recent find ings, the frequency of HCV infection in  Hungary may be 
comparable to that found in the Mediterranean area of Europe /6 , 7/.
The f i r s t  nationwide Hungarian m ulticenter anti-HCV study (using the 
ORTHO te s t) /12/ revealed an anti-HCV p o s it iv ity  in 86% of haemophiliacs, 
27% of patients undergone open-heart surgery, 20% o f haemodialyses cases, 
furthermore, in  34% of acute NANB h e p a titis  patients, 87% of chronic PT NANB 
h epa titis  and 48% of chronic sporadic NANB hepatitis  patients as w e ll as in 
33% of HBsAg-positive chronic h e p a titis  patien ts.
Now, with the ABBOTT te s t, we have found higher se ro p o s itiv ity  rates 
both in  polytransfused and haemodialysed patients, and a s l ig h t ly  lower 
prevalence in  chronic NANB hepa titis  cases, — other findings d id not d if fe r  
from the above-mentioned previous re su lt s ig n ific a n tly .
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I t  is  worth noting tha t in  our haemodialysed patients and elevated 
aminotransferase (ALT/GPT) together with anti-HBc occurred in about a h a lf 
o f the anti-HCV-positive cases, that is , — corresponding to the e a r lie r  
suggestion /14/ — the simultaneous determination of these two "surrogate 
markers" can be able to detect a ha lf of the HCV-infected persons. (Anti-HBc 
can be regarded as a serologic marker of a previous HBV in fection , which 
presumably might occur co inc iden ta lly  with the HCV in fec tion .)
Ihe present study revealed a s lig h tly  higher anti-HCV p o s it iv ity  ra te  
fo r  health-care workers than fo r blood donors. The comparative examinations 
w ith  ABBOTT and ÜRTH0 tes ts  showed an accordance of 95%, while in  the end­
po in t d ilu tio n  study, ABBOTT test appeared to  be more sensitive in  3 out o f 
4 cases. I t  is  no doubt tha t in the future the re a lly  specific , re lia b le  
methods in  the v iro lo g ic a l diagnostic producers w i l l  be based on d ire c t 
detection of v ira l nucleic acids e.g. the polymerase chain reaction. This is  
true  fo r  the HCV tes ting  as well /15 /. U n til such modern techniques w i l l  be 
introduced in  our everyday practice, we can s t i l l  use the classic serological 
methods, that is ,  antibody studies, with su itab le  confirmatory tes ts . Con­
cerning the HCV th is  is  of importance, fo r the fa lse -pos itive  anti-HCV f in d ­
ing reported in  chronic autoimmune hepa titis  /1 6 /. A correlation was also 
observed between serum gamma globulin or IgG le ve l and the optica l density 
o f anti-HCV reaction, furthermore, the anti-HCV reaction became negative 
a fte r  immunosuppressive treatment, with a decrease of the IgG serum leve l 
/17, 18/. I t  was assumed tha t the sera of patien ts with such autoimmune 
l iv e r  diseases might contain a component which can resu lt in  fa lse -pos itive  
anti-HCV reaction. Although these reports were founded on ORTHO anti-HCV 
te s tin g , they have master us cautions at the evaluation of the resu lts  of 
the ABBOTT screening te s t as w ell.
Our neu tra liza tion  te s t studies suggest tha t any anti-HCV p o s it iv ity  
w ith  an absorbance value close to the c u t-o ff ,  should always be confirmed 
by a neu tra liza tion  te s t. I f  the absorption is  considerably reduced during 
the neu tra liza tion  — a new blood sample should be taken for a repeated 
te s t. Since the sera of high absorption values (derived from our h e p a tit is  
pa tien ts ) always proved pos itive  in the neu tra liza tio n  tes t, the confirma­
tio n  of such samples seems to be unnecessary. S im ila rly , the sera found to 
be negative with the screening test do not need fu rthe r study with neural- 
iz a tio n  te s t.
In summary, the ABBOTT anti-HCV EIA together with the neu tra liza tion  
confirmatory test can be re a lly  useful fo r the recognition of the nature of
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parentera lly-transm itted hepa titis  and of "cryptogenic" c irrhos is  cases, as 
well as fo r epidemiological studies in  subjects at high r is k  of PT hepati­
t is .  I f  cost/benefit ca lculations make i t  ju s t if ie d ,  an anti-HCV screening 
of blood donors should be performed.
Although there are controversies in  th is  respect, i t  was stated /19/ 
tha t a 5-12% estimated prevalence of PT-hepatitis could be reduced to 1-2% 
by screening of blood donors fo r anti-HCV.
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Primary cancer o f the parenchymal c e lls  o f the l iv e r  — hepatoce llu lar carcinoma — is  
much more cormcn in  A fr ica  (and Southeast Asia) than in  Europe and North America. The very 
high incidence o f th is  tumour is  one o f the outstanding problems o f medicine in  tro p ic a l 
countries. There is  no doubt th a t i t  was already widespread in  A frica  before u rban ization and 
in d u s tr ia liz a tio n . In  th is  a r t ic le  the cha ra c te ris tics  o f hepatocellu lar cancer in  the tro p ic a l 
(sub-Saharan) part o f A fr ica  are b r ie f ly  reviewed.
Keywords: hepatoce llu lar carcinoma, tro p ic s , A fr ica .
In tro d u c tio n
In sub-Saharan ( tro p ic a l)  A frica HcC is  the most common of a l l  
tumours, accounting fo r 10-30 per cent of a l l  malignancies in  men /13, 20, 
29, 37/.
In Maputo (Mozambique) i t  accounts fo r two-thirds of the tumours in 
men, i .e .  about thousandtimes the incidence in  (most parts o f) Europe /10 /.
A very high rate has also been reported from Senegal /1 2 /.
In much of East A frica  and N igeria, although a common tumour, i t  does 
not reach the high rates seen in  Mozambique and Senegal.
In Uganda, i t  constitutes 7.9 per cent of a l l  tumours, thus, i t  is  
the fourth commonest malignancy recorded in  the Kampala Cancer Registry
Abbreviations: aFp: alpha-Fetoprotein, DNA: Deoxyribonucleic ac id , HBsAg: H e p a titis  В 
surface antigen, HBV: H epa titis  В v iru s , HcC: Hepatocellular carcinoma.
O ffp r in t requests should be sent to : G. A. B a lin t, Semmelweis u. 6 . ,  P.0. Box 397, 
H-6701 Szeged, Hungary.
Akadémiai Kiadó, Budapest
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/1 5 /. The overall annual incidence rate is  2.0 cases per 100000 population. 
In  Kyadondo county (Uganda) — an area best served by medical fa c i l i t ie s  — 
the incidence rate is  5.1 cases per 100 000 women and 11.1 cases per 100 000 
men /14 /.
In Nigeria, the fig u re  is  5.9 per 100000 population. In Ibadan (Nige­
r ia )  144 cases were seen in  a ten-year (1958—68) period. The male/female 
ra t io  was 4:1, and death occurred at a mean time of eleven weeks a fte r the 
f i r s t  symptom had appeared /2 1 /.
In Zimbabwe A fricans, the incidence rate was 20.9 per 100000 popula­
t io n ;  among South African Bantus i t  was 14.0 per 100 000, while in  the most 
a ffected Mozambique the fig u re  generally quoted is  98.2 per 100 000 /38 /.
A high incidence has also been reported from the Sudan. The tumour 
represented 2.0 per cent o f the medical admissions and 40 per cent of a l l  
malignancies. The male to  female ra tio  was 6:1 and the disease seems to be 
more common in Western Sudan than elsewhere in  the country /44/.
In Ethiopia 11.0 per cent, and in Kenya about 5 per cent of the tu ­
mours are HcCs /51 /.
Edington and Th ijs  gave basically the same figures regarding to Ghana 
and Zaire, respectively (c ite d  in  /12 /).
There is  apparently a fiv e -fo ld  varia tion  in  average w ith in the trop­
ic a l part of A frica /12, 19/.
Unlike those fo r more easily biopsied tumours, the true rates are 
undoubtedly underestimated.
I t  is  worth mentioning that cholanqiocellu lar carcinoma is  not more 
common in  Africa than in  the western world /1 / .
Aetiology of HcC
The reasons fo r being so common HcC in  A frica  is  probably related 
mainly to the high c a rr ie r  rate of HBsAg, but there are further factors 
possible:
— relationship to macronodular c irrh o s is ;
— tox ic : A fla tox ins from Aspergillus species are hepatotoxic and car­
cinogenic;
— hormonal: Males are affected more than females;
— n u tr it io n a l;
— genetic and
— others.
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HBV and HcC
There is  a strong epidemiological evidence fo r th is  association /9 , 
41, 42/.
HBV is  highly endemic in  A fr ica ._ Most people are infected in  ch ild ­
hood, resu lting in  the highest incidence of chronic ca rrie rsh ip  in the 
world /49/.
C lin ica l studies also have consistently shown tha t those with HcC 
have a greatly increased prevalence of carrie rsh ip  of HBV /41, 53/. For ex­
ample, about 1 in  500 chronic carrie rs in  Gambia developed HcC /38 /.
I t  seems lik e ly  that v ira l hepa titis  В is  a predisposing factor fo r 
HcC and that the intermediate stage is  usually c irrhos is  /7, 29, 45, 50, 52/.
Duration of chronic l iv e r  disease before HcC was found s ig n if ic a n tly  
shorter in HBsAg-positive than HBsAg-negative patients /24 /.
In a Tanzanian study, performed in  Gar-es-Salaam, 21.0 per cent of 
serum samples from 57 patients with HcC gave pos itive  resu lts  fo r HBsAg, 
while fo r a control group (patients without HcC), rates 5.5 and 1.3 per cent 
fo r  males and females, respectively, were reported /33 /.
In Kenya, HBsAg was present in  21.0 per cent of patients with c i r ­
rhosis and 14.0 per cent o f those with HcC /7 /.
I t  is  worth mentioning that 95 per cent of Africans (and Asians) with 
HcC have antibodies to the hepa titis  core antigen (anti-HBc), too /30 /.
There is  a p o s s ib ility  that the high incidence of HbsAg in  patients 
w ith HcC is  a resu lt of an altered immunological status rendering in fection  
more lik e ly .
I t  is  also possible that a la ten t HBV in fec tion  is  activated by the 
development of HcC /12 /.
Moreover, HcC might have a m u ltifa c to ria l aetio logy: HBV may be one 
of a number of co-carcinogenic factors, including genetic, hormonal, immuno­
log ica l and environmental ones /43 /. Among these p o s s ib ilit ie s  a possible 
HBV-DNA (v irus-host) in te rac tion  needs a special a tten tion  /16, 27/.
Relationship to macronodular c irrhos is
In high-incidence areas 60 to 80 per cent of hepatomas arise in  c i r ­
rh o tic  liv e rs . (In  temperate countries the corresponding figures are 2.5 to 
15.0 per cent.)
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In Kampala (Uganda), 19.0 per cent of c ir rh o t ic  patients (most with 
macronodülar c irrh o s is ), were found at post-mortem to have HcC /46 /. Other 
reports  from Uganda, Ghana and Ethiopia a l l  confirm such an association /12/.
In some areas, although, where c irrhos is  is  common, HcC is  not of 
high incidence. Ihe explanation fo r th is  is  not clear /4 6 /.
The underlying c ir rh o s is  is  usually macronodülar, suggesting that 
l iv e r  c e ll in ju ry , followed by regenerative hyperplasia is  of ae tio log ica l 
importance; further i t  has been suggested that the greater the degree of 
hyperplasia, the greater is  the danger of the development of HcC /4 / .  I t  
seems very lik e ly  tha t c irrh o s is  and hepatoma have s im ila r it ie s  in  th e ir  
ae tio logy /3 /.
Alcoholic c irrhos is  also predisposes to a high incidence of HcC but 
a lcohol basically seems to  be unimportant; hepatoma is  common even in 
Islamic-dominated areas (e .g . N igeria, Saudi Arabia, e tc .)  where l i t t l e  or 
no alcohol is  consumed /5 , 12/.
Relationship to  a fla tox in  and other mycotoxins
Aflatoxins are a group of compounds produced by the moulds Aspergil­
lus  flavus and Aspergillus fumigatus, which read ily  grow on nuts and grains 
in  warm, humid conditions, mainly on damaged groundnuts which have been 
stored fo r a long time at high temperature and humidity /34 /.
In experimental animals (ra ts , ducklings, turkeys, monkeys), a single 
dose o f afla toxin  is  s u f f ic ie n t  to induce h epa titis  and/or l iv e r  cancer 
/20 , 38/.
In A frica, the incidence of c irrhos is  and HcC is  very high; attempts 
have been made to explain the d is tr ib u tio n  in terms of a fla tox ins .
In Swaziland, the incidence of HcC was the highest in  the hot, low- 
ly in g  areas, among immigrants from Mozambique. These people ate groundnuts 
heav ily  contaminated w ith a fla to x in  /23/.
In  Uganda, the incidence was the highest in  poor immigrants from 
Rwanda and Burundi who consumed poor-quality, contaminated grains /2 / .
In Kenya, a s ta t is t ic a l ly  s ig n ifica n t association between the ingest­
ed a fla to x in  and HcC was observed /6 , 28/. S im ilar observation was made in 
N igeria  /34 /.
However, i t  is  d i f f i c u l t  to  evaluate the overa ll ro le  of mycotoxins 
in  HcC in  the trop ics. Whether or not those agents modify the e ffec t of 
other factors, e.g. HBV, m a lnu trition  or others, is  unknown /4 3 /. Although
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some epidemiological and circum stantia l evidences point to th e ir  being 
important, the solution in  man is  s t i l l  unresolved.
Hormonal factors
I t  is  a well-established fact that males are affected by HcC to a 
higher degree than females /17, 32, 38, 54/.
Hyperoestrogenism (gynaecomastia) has also been suggested as a pos­
s ib le  ae tio log ica l facto r of HcC in  Uganda but i t  seems probable that the 
high c ircu la ting  oestrogen concentrations are a re su lt, ra ther than the 
cause, of the liv e r  damage.
N u tritiona l changes
The role of the d ie t in  the production of HcC is  also unclear. HcC is  
also common in  low socio-economic groups where m alnutrition is  common. I t  is  
possible that m alnutrition  merely potentiates the e ffec t of other poten ti­
a l ly  carcinogenic substances in  man.
Possible ro le  of genetic factors
Family c lustering  o f cases together with hepa titis  В ca rrie rsh ip  has 
been reported /22, 38/.
Other possible ae tio log ica l factors
— Schistosomiasis;
— hydatid disease.
Although HcC frequently occurs in  areas where schistosomiasis and/or 
hydatid disease is  a great medical problem, there is  no convincing evidence 
o f cause-effect re la tionsh ip .
Presentation of HcC
Males are involved by the disease four to fiv e  times as often as 
females.
The average age at presentation is  30 to 40 years. Although c irrhos is  
is  often present, the l iv e r  is  otherwise normal in  15 to 20 per cent.
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Excessive alcohol in take is  not a consistent feature and no s ig n if­
ic a n t re lationship to soc ia l class seems to e x is t.
Most patients have a persistent pain in  the r ig h t hypochondrium, 
anorexia and weight-loss a t presentation.
There is  hepatomegaly in  approximately 95 per cent.
In te res ting ly , the m a jo rity  of the patients are aware of the liv e r  
enlargement, and about one quarter of them are jaundiced.
C lin ic a lly , the signs o f c irrhosis may dominate the p icture.
In  about 10 per cent o f the cases, an acute onset with bleeding in to  
the abdominal cavity occurs. In a further 10 per cent, presentation is  as­
sociated with métastasés. Fever may also be present /51 /.
In about ha lf of the patients with hepatoma there is  an audible b ru it 
/5 1 /,  which leaves no reasonable doubt about the diagnosis /48 /.
The presence of (blood-stained) ascites is  often a terminal event.
Hypoglycaemic attacks and polycythaemia may also be present in pa­
t ie n ts  with HcC /31/.
The diagnosis is  nearly always clear and only ra re ly  presents a 
d iffe re n tia l-d ia g n o s tic  problem /36 /.
The most common problem is  to d iffe re n tia te  the tumour from an amoeb­
ic  l iv e r  abscess, or in  ce rta in  countries (e .g . in  E th iop ia), from hydatid 
cysts .
The c lin ic a l cond ition  is  usually so obvious that l i t t l e ,  i f  any, 
in ves tiga tio n  is  required. P rac tica lly  an adult African who has upper ab­
dominal pain and enlarged hard liv e r  should be considered a case of HcC.
For confirmation o f the diagnosis ( i f  i t  is  needed) aFp estimation 
might be performed.
In  HcC, aFp (which is  produced by the tumour c e ll in  abundance) is  
present at very high concentrations in the serum in  50 to 90 per cent of 
the patien ts.
However, one must bear in  mind that even w ith the most sensitive mod­
ern methods, aFp cannot be detected in a proportion of the patients with HcC 
and, on the other hand, there are pathological conditions in  which elevated 
aFp concentrations can be seen without primary hepatoma.
The routinely used l iv e r  function tests do not give the diagnosis, 
nor do they distinguish between some cases of l iv e r  abscess and cancer.
I t  should be noted th a t the more sophisticated diagnostic techniques 
(ultrasonography, MR, radionuclide imaging, e tc .)  usually are not available 
in  most trop ica l countries.
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Death, which is  usually a resu lt of cachexia, takes place w ith in  a 
few weeks of diagnosis; longer survivals occur rare ly and never la s t longer 
than a few months.
Pathology of HcC
The tumours arise from hepatocytes. They may be monocentric or m u lti- 
cen tric  in  o rig in . The rate of growth is  very rapid, and tumours may reach 
an enormous size.
Necrosis, haemorrhage and fa tty  change may be present in  the liv e r .
The tumour is  superimposed on a macronodular c irrhos is  in  about 
three-quarters of the cases.
Métastasés are formed mainly by lymphatic spread (porta hepatis, head 
o f the pancreas). Spread to hepatic veins w ith pulmonary métastasés is  very 
common. Other s ites  of métastasés are: bone, brain, ga ll bladder, diaphragm, 
peritoneum, etc.
H is to log ica lly , there are several types of HcC: adenoid, g ia n t-c e ll,  
anaplastic, pseudoendothelial, miscellaneous and mixed types /1 2 /.
On the u ltra s tru c tu ra l aspects of HcC, Lapis has recently published 
an excellent review /26 /.
Treatment of HcC
This is  uniformly disappointing. L iver cancer is  a fa ta l tumour, i t  
k i l l s  rap id ly . Survival beyond 3 months a fte r diagnosis is  rare.
Methods of treatment include symptomatic care, surgery and drug 
therapy.
Symptomatic care
In most cases i t  is  advisib le to give sedatives and analgetics, in ­
cluding morphine.
Surgery
Most patients with HcC are not f i t  fo r surgery. When the tumour is  
t ru ly  loca lized, p a r t ia l lobectomy provides the only hope fo r complete cure. 
But due to poor fa c i l i t ie s  there are very few surgeons in tro p ic a l countries 
who w i l l  undertake that operation.
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Patients f i t  to  stand surgical exploration, whose tumour is  found to 
be non-resectable, can be treated by hepatic a rte ry  lig a tio n . This procedure 
is  simple and provides comparatively prolonged p a llia t io n  /8 /.
The vast m ajority o f the tumours are too advanced, have m ultip le  foc i 
or have arisen in a c ir rh o t ic  l iv e r ,  therefore, they are not amenable to 
surgery. Neither l iv e r  transplantation is  the so lu tion .
Drug- (chemo) therapy
The use of systemic drug therapy fo r HcC has so fa r given extremely 
low response rates. Many chemotherapeutic agents have been tr ie d  but without 
much success.
The drugs used include 5 -flu o ro u ra c il, methotrexate, thiotepa, mito- 
mycin-C, percutaneous ethanol in jec tion , e tc. A ll have been disappointing 
/38, 40/.
Hepatic a r te r ia l in fus ion  of cytotoxic agents has also been attempt­
ed /18, 47/.
Cochrane et a l.  obtained some improvement in  surviva l by using m u lti­
drug antineoplastic therapy /1 1 /.
Remission can be achieved by doxorubicin ("Adriamycin") in  about one 
th ird  o f the patients /25, 35, 39/.
Combination of doxorubicin with other agents did not improve i t s  
e ffica cy  but increased i t s  to x ic ity .  The response rate to in tra -a r te r ia l 
doxorubicin is  higher in  average than systemic therapy.
At the present moment, doxorubicin is  the only anti-neoplastic drug 
tha t has consistently given objective responses in  patients with HcC.
I t  is  worth mentioning that in assessing the effectiveness of chemo­
therapy i t  is  often d i f f i c u l t  to separate the rea l e ffec t of treatment on 
the tumour from the de te rio ra tion  in the c l in ic a l state associated with the 
c ir rh o s is .
F in a lly , the authors would like  to emphasize that they are fu l ly  
aware o f tha t the problem o f HcC is  much more complex and has many other 
aspects than those dealt w ith  in  th is  short review. They wanted to give an 
account on th is  guestion as i t  is  encountered in  the trop ica l part of 
A fr ic a .
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CHANGES OF MUCOSAL ENDOGENOUS PROSTACYCLIN LEVEL 
IN HUMAN PEPTIC ULCER DISEASE.
THE ROLE OF SMOKING AND SEX DIFFERENCE
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I t  seems th a t in  human gastroduodenal mucosal biopsy specimens from hea lthy persons 
there  is  a d e fin ite  tendency toward a higher endogenous prostacyclin content in  favour of 
women. This discrepancy is  present in  peptic u lc e r disease, too. Smoking exerts an unfavourable 
e f fe c t  on the g a s tr ic  and duodenal mucosa. The ta rg e t o f th is  action is  (among others) the 
endogenous p rostacyclin  content. In  v e n tricu la r as w e ll as duodenal u lce ra tio n  there  is  a 
tendency toward decreased endogenous prostacyclin  a c t iv i ty  but (moderate) smoking, — as a 
continuous stim ulus — seems to be capable o f evoking higher endogenous p ros ta cyc lin  le ve ls . 
This phenomenon, most probably, constitu tes a pa rt o f the reparative reactions against the 
noxa, i . e .  smoking, i t s e l f .  The resu lts  draw a tte n tio n  once again to  a possible ro le  o f smoking 
in  the development and healing o f peptic u lce r disease.
Keywords: pep tic  u lce r disease, endogenous p ros tacyc lin , smoking, sex d iffe re n ce .
In tro d u c tio n
Bálin t et a l.  reported in  a p ilo t-s tu d y  /2 / that in PUD there was a 
d e fin ite  tendency toward decreased end. PG-^ production in  human gastric  
mucosa.
Moreover, they showed that not only among experimental circumstances 
in  ra t but in  c l in ic a l s itua tion  as w e ll, in  humans, cigarette smoke exerted 
an unwanted e ffe c t on the gastric mucosa. The target of th is  action was the
Abbreviations: End.: Endogenous, mucosal, PG-I2 : Prostacyclin; (PG: P rostaglandin), 
PUD: Peptic u lce r disease.
O ffp r in t requests should be sent to : G. A. B a lin t,  H-6701 Szeged, P.0. Box 397. (Sem­
melweis u. 6 .) Hungary.
Akadémiai Kiadó, Budapest
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end. PG-I2  content, which s ig n if ic a n tly  decreased under the e ffec t of c ig ­
a re tte  smoke /4 /.
Taking into consideration that smoking has a positive co rre la tion  
w ith  PUD, too /10/, i t  was an in trigu ing  problem to  investigate the possible 
ro le  o f end. PG-^ in  the pathogenesis of PUD, w ith special reference to 
smoking.
Methods
Investiga tions were ca rr ie d  out in  gastroduodenal mucosal biopsy specimens. The 
b iops ies  were performed in  pa tien ts  who had some g a s tro in te s tin a l complaints but th e ir  c a re fu l 
re tro s p e c tiv e  c l in ic a l check-up fa i le d  to  show peptic u lc e ra tio n , inflammatory g a s tric  diseases 
( g a s t r i t is ,  e tc .)  or tumour. This group o f the pa tients served as con tro l group.
On the other hand, the presence o f active PUD — e ith e r  i t s  gas tric  or the duodenal 
form — was proved by gastroscopy w ith  consecutive h is to lo g ic a l investiga tion  aimed a t exclud­
ing malignancy. (Human In ve s tig a tio n s ’ Review Board’ s Agreement No: 75/1987.)
Before gastroscopy the biopsy donors fasted overn ight w ithout systemic premedication. 
The in v e s tig a tio n  was carried  out w ith  the help o f a gastro-duodeno fiberoscope Olympus GIF-Q 
type.
A sp ir in  and non-stero ida l anti-inflam m atory drug therapy, as w ell as alcohol consump­
t io n  were excluded fo r a week before gastroscopy.
The biopsy donors (p a tie n ts ) were, divided in to  groups on the basis o f th e ir  i l ln e s s ,  
smoking h a b it and sex.
The fo llow ing  groups were formed:
— healthy non-smoker males and females;
— healthy smoker males and females;
— non-smokers (males and females) w ith g a s tric  u lce r disease;
— non-smokers (males and females) w ith duodenal u lc e r disease;
— smokers (males and females) w ith  g as tric  u lce r disease;
— smokers (males and females) w ith  duodenal u lce r disease.
We considered as "smokers" the persons who had smoked 20 or more c igare ttes d a ily  a t 
le a s t over a year.
The biopsy donors’ age was 21 to 64 yrs (males), and 27 to  59 yrs (fem ales).
I t  is  worth mentioning th a t no gastroscopical d iffe rences were present between the 
hea lthy  smokers and non-snukers.
The end. PG-I2 le /e l was determined by radioimmunoassay throughout.
Since 6 - k e to - P G - F is  the s tab le  degradation product o f PG-I2, i t  is  widely accepted 
th a t i t s  changes indicate an a lte ra t io n  o f the la t te r  (1 .1 5 ). Therefore, to  determine the end. 
PG-I2 le v e l we have measured the mucosal leve l o f 6-keto-PG -F^^ . For the determ inations, 
"RK-16" k i t s ,  manufactured by the In s t ,  o f Isotopes o f the Hungarian Academy o f Sciences 
( Iz in ta ,  Budapest) were used.
The c ro ss -re a c tiv ity  o f the k i t s  used a t 50% B/BQ-values was as fo llow s:
6-keto-PG-Fl i t  100.0%
PG-F2oü 0.8% PG-E2 1.4%
PG-Floe 2.0% PG-Ej^  1.2%
The extraction  o f 6-keto-PG-Flf t . from the mucosal biopsy specimens was ca rried  out 
w ith  the  help o f the acetone-petroleum ether-e thylaceta te  method /9 / .
Samples were taken fo r  p ro te in  determination, too /1 1 / .
The recovery o f the e x tra c tio n  procedure reached o r exceeded 90%, while the detection 
l im i t  was 5 pg/mg p ro te in .
MUCOSAL PROSTACYCLIN LEVEL IN  PEPTIC ULCER DISEASE 191
A ll  re su lts  were given in  pg 6-keto-PG-Ej^/mg p ro te in .
In tra -  and in te r-assay coe ffic ie n ts  o f v a r ia tio n  were less than 5%. The "procedure 
blank" (bu ffe r sample subjected to  exactly the same treatm ent as b io log ica l (biopsy) samples) 
used showed no detectable "P G -^ - lik e "  a c t iv ity ,  i . e .  i t  was below the detection l im i t  (5 pg/mg 
p ro te in ) .
W ithin each group mean +_ S.E.M. was ca lcu la ted  and analysed s ta t is t ic a l ly  w ith  the 
help o f analysis o f variances. S ig n ifica n t d iffe rences were assumed when P was less than 0.05.
Results
The resu lts  of the investigation are presented in the Table I .
Table I
Changes o f Mucosal Endogenous Prostacyclin Level in  Human Peptic Ulcer Disease
(mean ±  S.E.M.)
Group/Ulcer n Antrum Fundus
6 -ke to -P G -F^ pg/mg protein
Duodenum
a
MEN, SMOKERS
1. Control 18 344.6+  72,4*su 337 .3+  68.34v 369.9 +_ 80.9x t
2. Gastric 17 355.9+ 85.1xsu 367 .2+  79.14V 440 .0+  97.6t
3. Duodenal 21 409.4 + 83.5s0 403.1 + 80.44V 302.4 + T !.6 m t
MEN, NON-SMOKERS
4. Control 17 467.8+  87.4s 503.6 + 95.6+ 498.4 + 94.2
5. Gastric 14 355.4+ 83.6*su 328.1 + 81.94V 406 .6+  93.2x t
6. Duodenal 18 603.7 + 109.6У§ 583.5 + 106.7+ 330.7 + 75.1wxt
WOMEN, SMOKERS
7. Control 15 605.1 + 103.7Y§ 587.5 + 95.4+ 461.9+  96.1
8. Gastric 11 282.7+ 70.4XSU 299.1 + 61.14V 394.4 е в .б ^ т
9. Duodenal 12 758.4 + 114.0Y§ 665.9 + 104.6+* 667.9 + 108.20Z
WOMEN, NON-SMOKERS
10. Control 17 680.8 + 98.7У§ 671.2 + 107.3+e 641.7 + 101.0OZ
11. Gastric 12 663.2 + 108.5У§ 596.8 + 101.4+ 670.3 + 109.90Z
12. Duodenal 10 339.3 + 55.0XSU 355 .2+  82.24V 375 .8+  83.8wxt
aProstacyclin has been estimated in  6-keto-PG-Floc form.
у = P< 0.05 vs 8. + = PC0.05 vs 8. о = P<0.05 vs 3.
s = P< 0.05 vs 9. q * P< 0.05 vs 9. w = P< 0.05 vs 9.
u = P< 0.05 vs 10. V  = P<0.05 vs 10. t  = P < 0.05 vs 10.
ч = P< 0.05 vs 11. •  = P< 0.05 vs 12. X  = P<0.05 vs 11.
§ = P < 0.05 vs 12. z = P< 0.05 vs 12.
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I t  seems that in  the so-called con tro l s itua tion , i .e .  in  healthy 
(non-PUD) persons, there is  a tendency toward a higher end. PG-I2 le ve l in  
favour o f women, among both non-smokers and smokers.
Moreover, i t  is  evident that smoking generally decreases the end. 
PG-I2 le ve l in both sexes /4 / .
In the case of g a s tr ic  ulceration smoker women showed a s ig n if ic a n t 
decrease o f the antra l end. PG-I2 content, while in  men no change or only a 
s l ig h t  decrease was observed. As compared to  the non-PUD group in  duodenal 
u lce ra tio n  on the other hand, regarding to the antra l end.PG-I2 content, 
there  was a non-sign ificant elevation in  a l l  groups but the group o f non- 
smoker women.
In te res ting ly , in  the fundic mucosa o f men (e ither smokers or non- 
smokers), with any form o f u lceration the end.PG-I2 content did not show 
marked changes but in  smoker women with g as tric  ulcers or in  non-smoker 
women w ith  duodenal u lce r, end.PG-I2 was s ig n if ic a n tly  low.
In the duodenal region the most important changes are in  women, name­
ly ,  in  the case of duodenal u lceration the end.PG-I2 level showed s ig n if ­
ic a n t ly  high values in  smokers, while in  non-smokers i t  showed a s ig n if ic a n t 
decrease as compared to the contro l (non-PUD) value.
Discussion
I t  is  well known th a t several fac to rs , e.g. stress, drugs, may lead 
to  gastro in tes tina l u lce ra tion .
While the ro le  o f some aetio log ic facto rs  has been recognized in  the 
in i t ia t io n  and/or ac tiva tio n  of gastroduodenal ulcers, quite a number of 
o th e r, s t i l l  unknown, fac to rs  are most probably present, and the possible 
in te ra c tio n  of these noxae in  the pathogenesis and/or pathomechanism o f PUD 
is  s t i l l  poorly understood.
One of the loca l facto rs  in  these processes might be an imbalance 
among protective (regenerative) and ulcerogenic reactions in  the mucosa.
Taking into consideration that end.PG-I2 is  one of the most important 
na tu ra l protective substances in the gas tric  mucosa /4 , 5/ we considered an 
inves tiga tio n  of i t s  changes in active PUD to  be an in teresting  problem.
According to the performed investiga tions in human gastroduodenal 
mucosal biopsy specimens, i t  seems that in  healthy persons there is  a def­
in i t e  tendency toward a higher end.PG-I2 content in  favour of women. This is
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in  complete agreement w ith our previous data /7 / ,  i .e .  that s im ila r s itua ­
tio n  was observed in  the case of the colonic mucosa. The cause o f th is  sex 
d ifference as well as i t s  physiological and/or pathological relevance ( i f  
there is  any) is  not understood yet.
Smoking exerts an unfavourable e ffe c t on the gastro in tes tina l tra c t 
as well as on the gastric  and duodenal mucosa of humans /13, 14, 16, 17/. 
One of the targets of th is  action seems to be the endogenous prostaglandin 
content of the mucosa. According to McCready /1 2 /, c igarette smoking reduces 
human gastric  luminal PG-E2 content, while Fedi showed /8 / tha t the same 
noxa increases the luminal PG-F2 level  in  healthy smokers.
In the pertinent l ite ra tu re  only scarce data are available regarding 
to the possible re la tionsh ip  of human gastroduodenal mucosal PG-I2 content 
and smoking in  PUD /6 /.
According to the present investiga tion  i t  seems that an indisputable 
damaging e ffec t of smoking was encountered in  the end. PG-I2 content of 
smoker women with ven tricu la r u lcera tion . In th is  group of patien ts a l l  
investigated parts of the mucosa showed a decreased PG-I2 leve l compared to 
the non-PUD (contro l) values. A s im ila r p ic ture  was obtained, also with 
ve n tricu la r ulcers, in the group of non-smoker men.
In the other groups of the investigated persons only p a r t ia l (a n tra l, 
fundic or duodenal) damages were noticed. (For example: In men w ith  duodenal 
u lce r there was a decrease only in  the duodenal mucosa; in non-smoker women 
w ith  duodenal u lcer, damage in the duodenal region; e tc .)
The cause of the tendency toward a higher end.PG-I2 content in 
smokers (mainly in  women) w ith duodenal u lceration proposes another very 
in te res ting  question.
According to our previous data /4 /  i t  seems that in  ce rta in  circum­
stances smoking — as a repeated and continuous stimulus — is  capable of 
producing such a phenomenon. This reaction seems to be a part o f the general 
defensive mechanism(s) in  the gastroduodenal mucosa toward noxae. I t  was 
established e a rlie r that in  the gastroduodenal mucosa the damaging as well 
as the reparative processes run together simultaneously /3 /.
The above-mentioned data draw a tten tion  once again to the ro le  of 
smoking in  the development and healing o f PUD, pa rticu la rly  i f  we accept the 
hypothesis that end.PG-I2 exerts a cytoprotective e ffect in  the human gas­
troduodenal mucosa, too.
Moreover, the resu lt tha t women have a higher end.PG-I2 leve l in 
th e ir  gastroduodenal mucosa than men, perhaps enlightens — at leas t part-
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ly  --  the fact that PUD is  a more common disease among males than females, 
i . e .  the higher enJ.PG-^ leve l gives a be tte r protection.
Further investiga tions seem to be needed to c la r ify  more precise ly 
the ro le  of end.PG-Ij in  the pathomechanism o f gastroduodenal u lcera tion  in  
due course of PUD --  p a rtic u la r ly  in  that case i f  we take into considera­
tio n  a l l  of the contrad ictions and disputes in  th is  matter.
Acknowledgement. Thanks are due to G. Karácsony, M.D., fo r  the h is to lo g ica l in ves tiga ­
t io n s  performed.
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COLLOÏDAL bism oth  su bc itra te  evokes a da ptive  cytoprotection
IN RAT GASTRIC MUCOSA
G . A . BÁLI NT
Laboratory of C lin ica l Pharmacology, Department of Neurology 
and Psychiatry,
A lbert Szent-Gyhrgyi Medical U n ivers ity , Szeged, Hungary 
(Received: September 12, 1991)
The 6-keto-prostaglandin-F j,c content (as the stable break-down product o f prosta­
cy c lin ) o f ra t  a n tra l and fundic g a s tr ic , as w e ll as o f duodenal mucosa, s ig n if ic a n t ly  in ­
creases a f te r  1, 5 and 10 mg/kg o ra lly  administered c o llo id a l bismuth subc itra te  treatm ent. The 
re s u lts  ind ica te  tha t ( i )  c o llo id a l bismuth subcitrate-induced s tim ula tion  o f endogenous 
p rostacyc lin  content ("adaptive cytop ro tection ") o f ra t  gastroduodenal mucosa may con tribu te  to 
i t s  therapeutic e ffe c t; ( i i )  the e ffe c t o f c o llo id a l bismuth subcitra te is  not due exclus ive ly  
to  the bismuth content o f the molecule, but seems to  be connected w ith the s tru c tu re  o f c o l­
lo id a l bismuth subcitra te  i t s e l f ;  ( i i i )  the e ffe c t seems to be dose-dependent, showing a dose- 
response re la tio n sh ip .
Keywords: C o llo ida l bismuth su b c itra te , adaptive cytoprotection, p ro s ta c y c lin , g a s tric  
and duodenal mucosa, ra t .
In tro d u c tio n
End.PG-l2  plays a s ig n ifica n t ro le  as one of the natura l protective 
substances in  the ra t gastroduodenal mucosa /1 , 2 /. I t  is  known tha t the H2 - 
receptor blockers Cimetidine and ra n itid in e  enhance the end.PG-Ij le ve l /3 , 
4 /. Moreover sucralphate also acts (a t least partly ) via the end.prosta­
glandin system /5 /.
The aim of th is  study was to estab lish the possible e ffe c t o f CBS on 
gastroduodenal end.PG-^ levels in  ra ts .
Abbreviations: BSN: Bismjth subn itra te , CBS: C o llo ida l bismuth s u b c itra te , end: Endo­
genous, mucosal, PG-I2 : P rostacyclin .
O ffp r in t requests should be sent to : G. A. B a lin t, H-6701 Szeged, P.0. Box 397. (Sem­
melweis u. 6 .)  Hungary.
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M a te ria ls  and methods
Female Wistar ra ts  o f  200 to  220 g body weight were used. The animals were fasted 
(allowed water ad lib itu m ) in  wire-bottomed cages fo r  24 h p r io r  to  investiga tion .
CBS (Batch No: 08940, Gist-Brocades N.V., D e lf t ,  The Netherlands) was given o ra lly  
(through a gastric  tube) as an aqueous suspension in  a f ix e d  volume (1 ml/kg) and in  various 
s in g le  doses: 1, 5 and 10 mg/kg, respective ly .
60, 120, 180 and 240 min fo llow ing CBS treatment the animals were k i l le d  and th e ir  
stomach and duodenum removed. The handling o f mucosal samples as w e ll as the deta iled  procedure 
o f  end.PG-l2 estimation was published e a rlie r  /2 / ,  th e re fo re , a b r ie f  account w i l l  on ly be 
given here.
To determine the end.PG-l2 le v e l, the mucosal content o f 6-keto-prostaglandin-F j^ was 
investiga ted  by radioimmunoassay. For determination "RK-16" k i t s ,  manufactured by the In s t ,  o f 
Isotopes o f the Hungarian Academy o f Sciences ( Iz in ta ,  Budapest) were used.
The б-ke to -p rostag land in-F iß  from the mucosal samples was extracted w ith the help o f 
the acetone-petroleum e ther-e thy lace ta te  method /6 / .  Samples were also taken fo r  mucosal DNA 
determ ination /7 , 9 /. The recovery o f the extraction procedure reached or exceeded 90%, while  
the de tection l im it  was 0.5 ng/mg DNA. A ll resu lts  are given in  ng ő-keto-prostaglandin-F^/m g 
DNA.
The in tra -  and in te r-a ssa y  coe ffic ien ts  o f v a r ia tio n  were less than 15%. The "proce­
dure blank" showed no detectable "P G -^ - lik e "  a c t iv ity ,  i . e .  i t  was below the detection l im i t .
A l l  determinations in  each animal were ca rried  out in  t r ip l ic a te ,  the re s u lts  were 
pooled and w ith in  each group (n = 5/group) the means +_ S.E.M. were calculated and analysed s ta ­
t i s t i c a l l y  w ith the help o f ana lys is  o f variances. The d iffe rences  were considered s ig n if ic a n t 
when P was <  0.05.
In  an add itiona l se ries  o f  investigations — under the same experimental cond itions — 
the e f fe c t  o f 1, 5 and 10 mg/kg BSN (BKOH^NOj) was examined.
Results
The experimental re su lts  are presented in  Tables I and I I .
The CBS and the BSN used contains about 35% and 70% bismuth, respec­
t iv e ly .
BSN has a physical structure completely d iffe re n t from that of CBS. 
Therefore, we investigated i t s  e ffect on the end.PG-^ level of ra t gastro­
duodenal mucosa. In th is  way the effect of bismuth and molecular structure 
can be separately analysed.
The experimental re su lts  showed tha t:
( i )  CBS s ig n if ic a n t ly  increases the gastroduodenal mucosal end.PG-^ 
le ve l o f ra ts.
( i i )  BSN exerted the same type of e ffe c t as CBS.
BISMUTH SUBCITRATE EVOKES ADAPTIVE GASTRIC CVTOPROTECTION 199
Table I
The E ffec t o f C o llo id a l Bismuth Subcitrate (CBS) on Gastroduodenal Mucosal Endogenous 
Prostacyclin  Level o f Rat (mean ±  S.E.M.)
Group
6-keto-prostaglandin F j^  ng/mg DNA 
Antrum Fundus Duodenum
1. CONTROL 15.55 i  2.46*§ab 9.44 + 2.01,§ab 2.65 + 0.57*§ab
2. CBS 1 mg — 60 min 65.6B + 17.11**° 74.37 + 20.98* 31 .35+  6.44*°
3. CBS 1 mg — 120 min 69.54 + 12.21**° 58.88+ 7.81* 30.62 + 7.02*°
4. CBS 1 mg — 180 min 44.18 + 9.44 * * ° ab 49.95 + 11.72* 29.97 + 3.39*°
3. CBS 1 mg — 240 min 39.15 + 7.07**5°ab 24.10+ 6.67*§b 18.96 + 5.33*§°
6. CBS 5 mg — 60 min 38.77 +_ 8 .58**5°ab 22.90 i  5 .55*§at> 10.89 + 3.72**ab
7. CBS 5 mg — 120 min 61.88 + 20.Об**0 49.92 + 7.98* 28.34 + 6.51*°
8. CBS 5 mg — 180 min 161.47 + 28.76*§° 49.41 +_ 9.71* 34.80 + 7.31*°
9. CBS 5 mg — 240 min B7.02 + 18.90*° 95.78 + 26.39* 54.86 + 12.36*°ab
10. CBS 10 mg — 60 min 14.17 + 2.78*§ab 25.42 + 9.32§ab 6.72 + 0.94**5ab
11. CBS 10 mg — 120 min 4B.65 +_ 7.27+* oab 31.35+ 7.63*§ 10.73 + 2.05**5b
12. CBS 10 mg — 1B0 min 111.31 + 23.76*° 110.22 + 31.78*° 27 .40+  2.12*5°
13. CBS 10 mg — 240 min 106.00 + 28.79*° 84.75 + 35.05* 33.22 + 9.16*°
+ = P< 0.05 vs Control •  = P<0.05 vs 8. § = P < 0.05 vs 9.
о = P < 0.05 vs 10. a = P< 0.05 vs 12. b = P< 0.05 vs 13.
(W ithin antrum, fundus and duodenum, respective ly .)
Table I I
The E ffec t o f Bismuth Subnitrate (BSN) on Gastroduodenal Mucosal Endogenous
Prostacyclin Level o f Rats (mean ±  S.E.M.)
Group 6-keto-prostaglandin-Flpc ng/mg DNA
Antrum Fundus Duodenum
1. CONTROL 15.94 + 2.82 10.13 + 3.24 2.22 + 0.76
2. BSN 1 mg — 60 min 18.43 + 4.31 15.34 + 3.41 5.35 + 0.97
3. BSN 1 mg — 120 min 23 .69+ 2.96 23.14 + 7.21 7.03 + 1.13*
4. BSN 5 mg — 60 min 31.93 + 7.24 33.27 + 5.93* 16.48 + 3.26*
5. BSN 5 mg — 120 min 52.71 + 11.43* 48.84 + 11.87* 26.04 + 4.18*
6. BSN 10 mg — 60 min 70.17 + 29.85*ab 40.75 i  2 .15*a 24 .16+  5.61*a
7. BSN 10 mg — 120 min 82.77 + 17.40*abc 59.80 + 13.89*a 43.58 + 13.1B*ab
+ = P<0.05 vs Control a = P< 0.05 vs 2. b = P<0.05 vs 3. c = P< 0.05 vs 4.
(W ith in antrum, fundus and duodenum, respective ly .)
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Discussion
Several data suggest tha t d iffe ren t types of an ti-u lce r (cytoprotec- 
t iv e )  drugs exert (a t leas t p a rtly )  the ir mode o f action through stim ulation 
o f end.prostaglandin synthesis, i.e .  via "adaptive cytopro tection".
According to Branski e t a l.  /3 / Cimetidine stimulates end.PG-^ and 
PG-E2  production. R anitid ine has the same e ffec t (Goldin et a l. /4 / ) .  Tar- 
nawski e t a l. /5 / showed th a t end.prostaglandins play a role also in  the 
e ffe c t of sucralphate. Konturek et a l. /10/ and H a ll and van den Hoven /11 / 
have shown that CBS increases the a b il ity  of ra t gas tric  mucosa to syn­
thesize PG-E2 .
CBS precipitates in  acid medium; in  a l l  p ro b a b ility  i t s  bismuth- 
c it r a te  bond opens, and thus various insoluble compounds are formed. A ll 
these structures may bind to  proteins, formings d iffuse  precip ita te  on the 
g a s tr ic  and duodenal mucosa and on the ulcer c ra te r.
A layer of such a p rec ip ita te  acts as a pro tective  coating against 
noxae, therefore, the a n ti-u lc e r a c tiv ity  of CBS is  very l ik e ly  due to the 
form ation of the p ro tective  bismuth coating on the stomach w all. This 
coating supports ulcer healing .
Taking into consideration the p ro te in -p rec ip ita ting  e ffect of CBS 
— which was found about 25% by Hall (personal communication, unpublished) 
in  an in  v itro  system containing only bovine serum albumin — we present a l l  
re s u lts  obtained in  the present work related to the DNA of the mucosa in ­
stead o f i t s  protein content.
Our conclusions are as fo llows:
— In the e ffec t o f CBS not exclusively the bismuth content of the 
molecule is  important, fo r CBS is  poorer in  bismuth than BSN. The end.PG-^- 
e leva ting  effect of CBS is  more pronounced.
— I t  seems that the end.PG-^-elevating e ffe c t o f CBS may contribute 
to  i t s  therapeutic e ffec t in  peptic ulcer disease.
I t  is  worth mentioning that both molecules evoked a dose-dependent 
e f fe c t ,  i .e .  i t  seems tha t there is  a d irec t dose-response re la tionsh ip .
Acknowledgement. We are ob liged  to  the Gist-Brocades N .V ., D e lf t ,  The Netherlands, fo r 
the CBS used in  the present work.
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ME T A B OL I S M
SERUM ELASTASE-TYPE ENZYMES AND THEIR CORRELATION TO BLOOD LIP IDS  
IN MALE PATIENTS WITH ATHEROSCLEROSIS
ANNA L A N DI  1  , MAGDOLNA B I H A R I  - V A R G A 2  , L.  KELLER 1
1ls t  Department of Medicine, St. Stephen Hospita l, Budapest (Hungary), and 
2
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Serum elastase-type a c t iv ity ,  elastase in h ib ito ry  capacity and th e ir  re la t io n  to  
l ip id s  were examined in  140 male patients w ith ischaemic vascular disease (coronary, ce reb ra l, 
periphe ra l) and in  60 co n tro l subjects. Serum e lastase-type a c t iv ity  was found to  be s ig n if ­
ic a n tly  lower, in h ib ito ry  capacity s ig n if ic a n t ly  h ighe r, in  the groups o f pa tients  than in  the 
co n tro ls . HDL- and HDL2 cho lestero l as w e ll as apo A concentration showed s ig n if ic a n t negative 
co rre la tio n  w ith elastase in h ib ito ry  capacity both in  a therosc le ro tic  and in  c o n tro l sub jects.
Keywords : serum elastase-type proteases, e lastase in h ib ito rs , ischaemic vascular d i­
sease, blood lip id s .
In tro d u c tio n
Degradation of the e las tic  fib res  of the a rte r ia l wall seems to take 
an important part in  the m u ltifa c to r ia l events of atherogenesis. Although 
progressive s p lit t in g ,  fragmentation and ly s is  of e lastic  lamellae can be 
observed in  physiological aging as w e ll, the whole process is  accelerated in  
the pathology of atherosclerosis.
Details of the mechanism of e la s tic  tissue destruction are hardly 
known. The e la s tic  fib res  contain two d is t in c t  u ltras truc tu ra l components: 
a m ic ro f ib r il la r  component formed by cross-s tria ted  fibrotubules and an 
amorphous one, e la s tin . From the e a rlie s t phase of atherogenesis plasma low-
Abbreviations: CVO = cerebrovascular disease; IHD = ischaemic heart disease; PVD = pe­
r ip h e ra l vascular disease.
O ffp r in t requests should be sent to  Anna Landi, H-1096 Budapest, Nagyvárad té r  1,
Hungary
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density lipopro te in  enter the a rte r ia l wall and in teract with connective 
tissue  macromolecules, such as glycosaminoglycans, collagen and e la s tin ; 
th is  se lective  in te rac tion  is  considered to be one of the mechanisms of 
l ip id  accumulation in  atherosclerotic lesions /10, 16, 19, 23, 30, 33, 34/. 
The re la tionsh ip  between deposition of l ip id s  and deterioration of e la s tic  
f ib re s  is  s t i l l  not c lear.
The regulation of e las tin  metabolism is  a ttribu ted to humoral and 
tissue  elastases and th e ir  in h ib ito rs . Elastases, a group of p ro te o ly tic  
enzymes, are endopeptidases capable of s o lu b iliz in g  and degrading inso lub le  
e la s tin . Elastases and elastase-type proteases have been iso la ted from 
various sources; th e ir  structure properties and s p e c if ic it ie s  have been par­
t i a l l y  characterized /1 , 3, 6 , 12, 22, 29/ and some of th e ir natura l in ­
h ib ito rs  id e n tif ie d  /1 3 /. There are data ind ica ting  that elastases in h ib it  
the progress of experimental atherosclerosis and enhance lipopro te in  lipase 
a c t iv i ty  /5 , 8 , 17, 32, 35/.
The mechanism of action of elastase consists of the se lective degra­
dation o f lipid-bound e la s tin , by which elastase promotes the biosynthesis 
of newly-formed e las tin  /1 7 /. In the c irc u la tio n  the a c tiv ity  of elastases 
can be modified by high amounts of elastase in h ib ito rs  /9 , 14/. I t  was 
suggested tha t the increase in  e la s tin o ly tic  a c t iv ity  may represent a de­
crease o f the leve l of in h ib ito rs  /11 /. Disturbance of the equilibrium  of 
humoral and tissue proteases and th e ir in h ib ito rs  might lead to connective 
tissue  damage.
Based on the suggestion that changes o f vascular e lastin  metabolism 
may be re flected  in  changes of e lastase-like a c t iv ity  and e las tase -inh ib i- 
to ry  capacity of the serum, the aim of our investigations was to get more 
inform ation about the behaviour of these parameters and the ir re la tionsh ip  
to blood lip id s  in  a therosclerotic patients. Considering that the facto rs  
in fluenc ing  the anatomical loca liza tion  of atherosclerosis have not yet been 
elucidated, i t  seemed to be of in terest to subdivide the group of patien ts 
according to the c l in ic a l ly  dominant areas (coronary, cerebral, pe riphera l).
P a tie n ts  and methods
S election  o f patients
A to ta l o f 140 a thero sc le ro tic  male patients (between 42 and 76 years o f age, mean age 
63.4 years), 60 o f them w ith  ischaemic heart disease (IHO), 40 w ith cerebrovascular disease 
(CVD) and 40 w ith periphera l vascular disease (PVD) were stud ied. The patients in  the three 
groups were p ra c t ic a lly  age-matched. Selection c r i te r ia  fo r  inc lus ion  were: ( i )  fo r  pa tie n ts
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with IHD, ty p ic a l anginal pains and ECG signs o f myocardial ischaemia, or myocardial in fa rc tio n  
in  the case h is to ry  a t le a s t s ix  month p r io r  to  the in ve s tig a tio n ; ( i i )  fo r pa tie n ts  w ith  CVD, 
acute cerebrovascular accident w ith  foca l neuro log ica l signs in  the case h is to ry  a t le a s t 6 
months p r io r  to  the in ve s tig a tion  (the possible in tra c ra n ia l or extracran ia l s ite  o f the patho­
lo g ic a l vascular process leading to stroke has not been taken in to  account); ( i i i )  fo r  pa tients 
w ith PVD, in te rm itte n t c laud ica tion  or res t pain w ith  Doppler signs o f o b lite ra t iv e  a r te r ia l 
disease in  the lower ex trem ities . As contro ls 60 age-matched men without h is to r ie s , symptoms or 
find ings o f ischaemic vascular disease were selected.
Patients w ith  diabetes m e llitu s , chronic rena l or hepatic disease, endocrine d iso r­
ders, primary hyperlip idaem ias, and those treated w ith  drugs a ffec ting  l ip id  metabolism were 
excluded.
Methods
Venous blood was obtained a fte r an overn ight fa s t .  Elastase-type protease a c t iv i t y  and 
pancreas elastase in h ib ito ry  capacity were determined using su cc in o y l-tr ia la n in e -p a ran itro - 
analide (Suc/Ala/PNA; P rec ib io , Rueil-Malmaison, France) as substrate, according to  the methods 
o f B ieth e t a l .  /2 / .
T rig lyce rid e , to ta l cho lestero l, HDL-, HDL2-cho le s te ro l, apo A and apo В contents were 
determined using Boehringer’ s Peridochrom and CHOD-PAP te s t and Sebia’ s Apofilm p la te s , respec­
t iv e ly .  LDL cho les te ro l le ve ls  were estimated by Friedewald’ s form jla  /7 /  only in  p a tie n ts  w ith 
t r ig ly c e r id e  le ve ls  under 4.5 nM/1.
For s ta t is t ic a l  evaluation o f the data S tudent’ s t - te s t ,  "y^-test and regression anal­
ys is  were used.
R esu lts
Ischaemic vascular disease
Average values of serum elastase-type a c tiv ity  and pancreatic elas­
tase in h ib ito ry  capacity, as well as l ip id  leve ls determined from the same 
blood samples are summarized in  Table I .  Elastase-type a c t iv ity  in  each of 
the three groups of ischaemic vascular disease was found to be s ig n if ic a n tly  
lower than in  the contro ls. E lastase-inh ib ito ry capacity proved to  be s ig ­
n if ic a n tly  elevated in  the groups of pa tien ts  compared to the con tro l sub­
je c ts . (No age-variation of elastase a c t iv i ty  or inh ib ito ry  capacity could 
be demonstrated.) In healthy ind iv idua ls  we found a s ig n ifica n t pos itive  
corre la tion  between the elastase-type a c t iv i ty  and e lastase-inh ib ito ry  capa­
c ity  of sera (regression equation; у = 9, 781x + 1120; P ■< 0.001); s im ila r 
corre la tion  could not be established in  the sera of patients w ith  IVD.
From among the serum lip id  and lipop ro te in  parameters the average 
HDL- and HDL^-cholesterol levels in  a l l  three groups of patien ts, the apo A 
content in  IHD and CVD were found to be s ig n if ic a n tly  decreased compared to 
the contro ls . LDL-cholesterol levels were higher in IVD groups than in  the 
con tro l, w ith a s ig n ific a n t difference in  the case of IHD and o f PVD.
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Table I
E lastase a c t iv ity ,  in h ib ito ry  capacity and l ip id s  in  the sera o f a therosclerotic male 
pa tie n ts  and In con tro l subjects
Parameters 
(mean +_ S.D.)
G roup o f  p a t ie n ts
IHD
(n = 60)
CVD
(n = 40)
PVD
(n = 40)
Contro l 
(n = 60)
E lastase a c t iv ity  
(ngml- l  24 1гЪ
7 .5 +  3 .4** В .4 + 3 .7 * 7.8 + 3.B** 10.9 + 4.1
In h ib ito r y  capacity 
(ngml- l  24 h- ^)
44.7 + 11.5** 41.5 + 9.4* 40.8 + 8.9* 32.2 + 7.9
C ho leste ro l
(mmol/1)
5.4 + 1.1 5.4 + 1.3 5.9 + 1.2 5.1 + 1.2
HDL ch o le s te ro l 
(mmol/1)
1 .2 +  0 .3 ** 1.1 + 0 .4 ** 1.3 + 0.3* 1.7 + 0.2
HDI_2 cho les te ro l 
(mmol/1)
0 .8 +  0 .2 ** 0.7 + 0 .1 ** 0.8 + 0.2* 1.2 + 0.2
LDL ch o le s te ro l 
(mmol/1)
3 .2 +  0.9* 3.0 + 0.9 3.5 + 1.0** 2.4 + 1 .1
T rig ly c e r id e s
(mmol/1)
2 .3 +  1.1 2.6 + 1.3 2.4 + 1.2 2.3 + 0.9
Apo A 
( g / l )
1 .3 +  0.3* 1.3 + 0.3* 1.4 + 0.4 1.6 + 0.4
Apo В
( g / l )
1 .3 +  0.4 1.3 + 0.4 1.3 + 0.5 1.1 + 0.4
P value fo r  s ign ificance vs. c o n tro l: * P <  0.05; * * P <  0.01;
IHO = Ischaemic heart disease; CVD = Cerebrovascular disease; PVD = Peripheral vascular disease
Table I I
C o rre la tio n  o f elastase in h ib ito ry  capacity w ith the serum HDL-, HDL^cholesterol and apo A 
concentra tion  in  male pa tients w ith  ischaemic vascular disease (IV0) and in con tro l subjects
Group o f 
p a tie n ts
No. of 
patients
HDL-cholesterol HDl2-cho le s te ro l Apo A
regression equation 
t  P
regression equation 
t  P
regression equation 
t  P
IVD 140
у = -0.0014X + 2.09 
20.4 <  0.001
у = -0.117X + 46,7 
7.37 <0.001
у = -0.0004X + 1.40 
2.89 <0.05
C ontro l 60
у = -0.0019X + 2.06 
14.0 <0.001
у = -0.387X + 59.6 
8.93 <0.001
у = -0.0068X + 4.27 
3.22 <0.01
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HDL-, HDL2 -cholesterol and apo A concentration showed s ig n if ic a n t 
negative corre la tions with e las tase-inh ib ito ry  capacity, both in  IVD and 
contro l subjects (Table I I ) .  Between elas'tase-type a c tiv ity  and l ip id s  no 
s ig n ifica n t re la tionsh ip  could be demonstrated.
Discussion
The de ta ils  of in teraction  between e la s tin  and lipoprote ins are s t i l l  
not c lear. The find ing  of Srinivasan et a l.  /31/ indicated tha t certa in  
regions of plaque e las tin  may have a f f in i t y  fo r apo В-containing lipop ro ­
te ins . According to Kramsch et a l. /19, 20, 21/, with the permeation o f LDL 
in to  a r te r ia l e la s tin  a change of the pro te in  composition of a r te r ia l elas­
t in  takes place in  localized areas; the re s u lt of th is  process w i l l  be fu r ­
ther deposition o f l ip id s  attracted by the foca lly -a lte red  e la s tin  surface. 
Accumulated lip id s  are successively phagocytosed by macrophages; a fte r  hav­
ing been destroyed, these release th e ir  l ip id  contents into the in te rc e llu ­
la r  space, causing damage to both to the external and in terna l e la s tic  mem­
branes of the media. Noma et a l. /24, 25, 26/ presented evidence o f the in  
v it ro  formation of a stable complex between LDL and delipidated a r te r ia l 
e la s tin , and demonstrated the in h ib itio n  of the LDL binding to e la s tin  in 
the presence of HDL.
Contradictory reports have been published about the serum elastase 
a c t iv ity  and in h ib ito ry  capacity in atherosclerosis. In the experiments of 
0-hara et a l. /27 / administration of elastase inh ib ited  the development of 
atherosclerosis produced by cholesterol feeding in  rabbits. Rabaud et a l.  
/28 / reported tha t the "serum in h ib ito ry  power of e lasto lysis" was s ig n i f i ­
cantly higher in  cardiovascular patients than in  controls; the highest 
levels were measured in  the acute phase o f myocardial in fa rc tio n . Hornebeck 
et a l. /14 / fa ile d  to find  s ta t is t ic a lly  s ig n ifica n t differences between 
elastase levels in  the sera of a therosclero tic and control subjects. In a 
previous observation on smaller groups of patients we found the pancreatic 
elastase in h ib ito ry  capacity to have been s ig n if ic a n tly  elevated in  persons 
w ith ischaemic vascular diseases /4 , 18/.
In our investigations a simultaneous determination of elastase-type 
a c t iv ity  and e las tase-inh ib ito ry  capacity of the serum was carried out both 
in  atherosclero tic and control subjects. Based on the close metabolic in te r ­
action between the vessel wall and the c ircu la tin g  blood i t  seemed to be
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p laus ib le  that the observed humoral a lte ra tio n  would also provide some in ­
s igh t in to  the pathological a r te r ia l processes.
Among the investigated l ip id  and lip o p ro te in  components serum HDL- 
and HDL2 -cholestero l and apo A concentration showed a s ign ifican t negative 
co rre la tio n  with elastase in h ib ito ry  capacity. This finding may be re la ted 
to  the observation o f Jacob et a l. /15 / tha t an elastase-type enzyme could 
be iso la ted  and characterized in  close association with apo A of human HDL 
preparation.
In the groups of patients we found the mean serum elastase-type ac­
t i v i t y  s ig n if ic a n tly  lower and the elastase in h ib ito ry  capacity s ig n i f i ­
can tly  elevated compared to  the relevant values o f the control subjects. We 
also demonstrated tha t in  the control group there is  a positive co rre la tion  
between the serum elastase-type enzyme a c t iv ity  and e las tase-inh ib ito ry  
capacity, while in  patients with IVD such co rre la tion  could not be demon­
s tra ted . These find ings point to the p o s s ib il ity  that the lack of the 
balanced p ropo rtion a lity  o f elastase-type enzymes and th e ir in h ib ito rs  may 
be re la ted  to the a therosclero tic  process.
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MEASUREMENT OF COMPLEMENT COMPONENTS AND ALPHA 1-ANTITRYPSIN 
DURING PLASMA EXCHANGE
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Therapeutical plasma exchange can be ca rrie d  out by using blood c e l l  separators based 
upon cen trifuga tion  or in  equipments w ith membranes. We investigated whether a c tiv a tio n  o f the 
complement system took place in  po lyv iny lch lo ride  tubes used in  the blood c e l l  separator. We 
also examined the changes in  the c la ss ica l and a lte rn a tiv e  complement pathways by an analysis 
o f functiona l haemolytic t i t e r s ,  as w ell as the le ve ls  o f C4, C30, C4, albumin and alpha 1-an- 
t i t r y p s in .  No measurable a c tiva tio n  o f the complement system was found. The decreased leve ls  of 
the C3, C3d, C4, albumin and alpha 1 -a n titryp s in  in  the sera a fte r PE could be a consequence of 
the haemodilution.
Keywords : plasma exchange, complement a c tiv a tio n , PVC tubes.
In tro d u c tio n
In the las t twenty years therapeutical plasma exchange (PE) has been 
used in  the treatment of more than 90 diseases / 6 / .  Two forms o f PE are ap­
p lied : ( 1 ) that based upon centrifugation  using blood c e ll separator, ( 2 ) 
membrane plasmapheresis /7 / requiring membranes with larger pore size than 
used in  haemodialysis.
The centrifugation  method is  more time-consuming, and more expensive, 
but safer than the membrane method. Using a r t i f ic ia l  membranes — as i t  is  
well known in  haemodialysis — an ac tiva tion  of the complement system can
Abbreviations: AAT: alpha 1 -a n titryp s in ; PE: plasma exchange; PVC: p o lyv in y lch lo rid e ; 
C3, C3d, C4: complement p ro te ins ; CH5g, AP5q: 50% haemolytic t i te r s  in  c la s s ic a l and a lte r ­
na tive  complement pathways; EDTA: ethylenediam inetetraacetic acid.
O ffp r in t requests should be sent to  I .  Csípő, H-4004 Debrecen, Móricz Zs. u. 22.,
Hungary
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take place /5 /. The po lyv iny lch lo ride  (PVC) membranes were found to be weak­
er activa tors then the polysulfon and ce llu lose  acetate membranes /1 1 /.
The purpose of th is  study was to investiga te  whether an activa tion  of 
the complement system takes place when PVC tubes are used in the blood c e ll 
separator. We examined the changes in both the c lass ica l and a lte rna tive  
complement pathways by an analysis of functiona l haemolytic t i te rs .  Besides, 
the serum levels of C3, C3d, C4, albumin and alpha 1-antitrypsin  were 
determined.
Changes in  serum albumin concentration during PE
About one l i t r e  o f plasma (about 30% o f the o rig ina l to ta l plasma 
volume) was taken from each patient during each PE. In order to contro l the 
re a l value of haemodilution, we chose the serum albumin levels as a marker. 
We found, on the average, 28% decrease in  the le ve l o f albumin at the end of 
22 PE-s (Table I ) .
M a te r ia ls  and methods
Results
Table I
Serum albumin le v e ls  before and a fte r plasma exchange (g/1)
No. of samples
Before treatment 
Mean + S.D.
A fte r treatment 
Mean + S.D.
22 39.1 + 10.93 28.47 + 8.42
22 PE-s were ca rrie d  ou t in  f iv e  patients, in  th ree  w ith  myasthenia g rav is , one w ith  
system ic lupus erythematosus, and a pregnant woman w ith  Rh in co m p a tib ility . PE was performed 
w ith  Haemonetics Modell 30S C e ll Separator. About one l i t r e  o f plasma was removed during each 
trea tm ent. The f i r s t  blood sample was taken 10 min before, and the second, 10 min a fte r  the PE. 
Sera dispensed in  small volumes were stored at minus 30 °C. (Repeated freezings and thawings 
were avoided.)
Functional haemolytic t i t r a t io n s  fo r to ta l c la s s ic a l and a lte rna tive  complement path­
way components were performed as described elsewhere /10, 12 /.
Levels of C3, C3d, C4, albumin and alpha 1 -a n titry p s in  were assayed by ra d ia l immuno­
d if fu s io n .  The slides were prepared w ith  1% agar in  0.02 M b a rb ita l bu ffe r w ith  0.01 M EDTA a t 
pH B.4 /8 ,  9 /.
S ta t is t ic a l ana lys is : We regarded every treatment as a separate case, so we compared 
the p re - and postcen trifugation  re s u lts  using the paired " t "  te s t  and ca lcu la ting the co rre la ­
t io n  c o e ffic ie n ts  ( r ) .
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Classical (CHcq) and a lte rna tive  pathway (AP^q) t i te rs ,  C3, C3d and C4 
leve ls before and a fte r PE
We found s ig n if ic a n t (about 30%) decreases in the t i t e r s  o f both 
c lass ica l (P < 0.001) and a lte rna tive  (P<. 0.01) complement pathways during 
PE (F ig. 1).
The decrease in  the level of the early component of the c lass ica l 
pathway, C4, was 36%, and in  the leve l of central component of both activa­
tio n  pathways, C3, was found to be 33% during PE (Fig. 2).
■ ■ 1________I
p< 0  0 0 1  p < 0 . 0 1
Fia. 1. C lassica l (CH5q) and a lte rn a tive  pathway (AP5g) complement t i t e r s  (n = 13) 
before (Q )  and a fte r  (£§) pE (means + 5 .0 .)
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I__________ I 1_________ I
p <  0 .0 0 1  p < 0.01
F ig . 2, C3 (n = 22) and C4 (n = 13) levels betöre (D) and a f te r  (S) PE (means + S.D.)
The levels of C3d were also examined in  13 cases, and the decrease
measured was about 29%. The values of C3d before and a fte r PE were charac-
2te rize d  by the diameter (d ) of immunodiffusion p rec ip ita tion  rings 
(Table I I ) .
In  these 13 cases we also compared the CH^g, AP^g, C3 and C4 levels 
to  the values of C3d by ca lcu la ting  the co rre la tion  coe ffic ien ts  (Table I I I ) .
Table I I
Serum C3d le v e ls  before and a fte r plasma exchange (mm )^
No. of samples Before treatment A fte r treatment
Mean + S.D. Mean + S.D.
13 63.37 + 21.37 45.05 + 18.03
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Table I I I
Comparison o f co rre la tion  c o e ff ic ie n ts  between
C3d and CHçn. APtn, C3, C4 leve ls
before and a fte r plasma exchanoe
C o r r e la t io n c o e f f i c ie n t
before PE a fte r  PE
C3d C3d
C3 0.58 0.57
C4 0.70 0.56
ch50 0.87 0.87
I» ~0 О 0.59 0.87
Good corre la tions were found between the values of CH^g, AP^ g and C3d before 
and a fte r PE, suggesting that the applied therapeutical method did not 
resu lt in  detectable differences in the ac tiva tion  state of the complement 
system, because the decrease of CH^g, AP^g and C3d are about the same as the 
decrease of the albumin concentration (Table I ) .
Changes in  alpha 1 -an titryps in  levels during PE
The leve ls of acute-phase reactant g lobulin , alpha 1 -an titryps in  
(AAT), were measured before and a fte r PE in  22 cases. The decrease in  serum 
concentration of AAT was 36% (P <  0.01) at the end of PE (Table IV ). This 
rate of decrease was in  accordance with the value of haemodilution, suggest­
ing that no acute phase-reaction had occurred during PE.
Table IV
Serum alpha 1 -an titryps in  content before and a fte r 
plasma exchange (q /1 )
No. o f events
Before treatment A fte r treatment
Mean +_ S.D. Mean +_ S.D.
22 2.67 + 0.84 1.69 + 0.64
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Discussion
The methods of extracorporeal c irc u la tio n  (haemodialysis, card io­
pulmonary bypass, leukapheresis, plasmapheresis) were reviewed by G ardinali 
e t a l.  /5 / .  They found some complement ac tiva tion  in  a l l  methods using a r t i ­
f i c i a l  membranes. McLeod e t a l. /13/ compared the complement ac tiva ting  
properties  of some membranes. Polysulfon and cellulose acetate membranes 
activa ted  complement more markedly than PVC did.
In th is  study our aim was to investiga te  the effects of PVC tubes 
used during the cen trifuga tion  PE method on the complement system and acute 
phase-reaction. ^
Blood samples were taken before and immediately a fte r PE. During PE 
we d id  not take blood samples, fo r the plasma expander Gelifundol (ge la tine ) 
might have an e ffect on the complement system i t s e l f  /4 /.
According to Derksen et a l. a fte r an exchange of 1-2 l i t r e s  o f p las­
ma, the serum concentration of ind iv idua l plasma components (e.g. albumin) 
can show a reduction of 35% to 65% /3 / .  In our practice the exchange of 
about one l i t r e  of plasma caused a 28% decrease in  serum albumin leve l (be­
sides the o rig ina l plasma volume corrected by G elifundol).
We found that each o f CH^g, AP^g, C4, C3, C3d and AAT decreased by 
the same rates (28 to 36%) during PE, suggesting that neither Gelifundol nor 
the PVC tubes can re su lt in  an e ffective  and s ig n ifica n t activa tion  o f the 
complement system or acute-phase reactions, fo r these rates of decrease do 
not an excess the value o f haemodilution (28%). Namely, the decreases s ig ­
n if ic a n t ly  greater than 28 to 36% would mean the signs of complement con­
sumption, derived from the activa tion  of the complement system.
Hypersensitivity reaction (dyspnoe, hypotension, sweating) was ob­
served but rare ly in  our patien ts, whose symptoms could rather be a ttr ib u te d  
to  the e ffec t of ethylene-oxide used fo r s te r il iz a t io n  of sets / 2 /  than to 
the PVC tubes.
In  conclusion, our data support the view that the application of PVC 
tubes in  blood processors is  a rather safe and useful technique, causing 
no ac tiva tio n  of the complement system, acute-phase reactions and/or the 
granulocytes / 1 / .
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A s ig n if ic a n t increase was found in  the number o f white blood c e lls ,  in c lu d in g  neutro­
p h ils ,  in  the periphera l blood o f pa tien ts  during plasma exchange. However, the spontaneous 
chemiluminescence o f periphera l white blood c e lls  (b a s ic a lly  characterized the a c tiva ted  state 
o f neu troph ils ) was not elevated. This fin d in g  suggests a re la tive  defic iency in  the metabolism 
o f neutroph ils during plasma exchange. This idea is  supported by the observation th a t the 
le ve ls  o f malonyldialdehyde in  plasmas, a fte r  plasma exchange, do not increase, in d ic a tin g  tha t 
the a c tiva tio n  dependent lip id p e ro x id a tio n  in  neu troph ils  d id  not take place.
Keywords: plasma exchange■ side e ffe c ts , neu troph ils , chemiluminescence.
In troduction
Therapeutic plasma exchange (PE) has become a rou tine ly  used proce­
dure in  the treatment of diseases caused by autoantibodies and/or immuno- 
complexes / 1 0 , 3 /.
Beside i t s  apparent advantages, l i t t l e  is  known about side e ffè c ts  of 
PE. I t  is  obvious that v e r if ic a tio n  any of i t s  side effects has great theo­
re t ic a l and p rac tica l importance because the patients su ffe ring  from auto­
immune disease, fo r whom PE is  indicated, are usually rather sens itive  to 
in fections.
Abbreviations: PE: plasma exchange, MOA: malonyldialdehyde, PBS: phosphate-buffered 
sa lin e , TBA: th io -b a rb itu r ic  ac id , WBC: white blood c e l l ,  CL: chemiluminescence.
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Therefore, in  th is  study we compared the numbers and activa tion  
s ta tes of peripheral neu troph il granulocytes — playing crucia l roles in  the 
defence against in fec tions  — before and a fte r  PE. We found that PE was 
followed by leukocytosis, bas ica lly , an elevation in  the number of neutro­
p h ils .  At the same time, the spontaneous chemiluminescence (CL) of neutro­
p h ils  did not increase in  proportion with leukocytosis, suggesting a re la ­
t iv e  damage to these c e lls .  The same tendency was observed by the measure­
ment o f the levels o f malonyldialdehyde (MDA) in  the plasmas of patients 
before and after PE.
Materials and methods
Patients: 25 PE-s were ca rrie d  out in  s ix  p a tie n ts  (3 pa tien ts  with systemic lupus 
erythematosus and 3 others w ith  myasthenia g rav is ).
For the PE the Haemonetics 30 S blood c e ll processor was used. The approximately 
30-40% o f the o rig in a l plasma volume was taken out during each treatm ent. C itra te  was used as 
anticoagulant. Venous blood samples (heparinized, c itra te d  and not anticoagulated) were taken 
10 min before PE and 10 min a f te r  fin is h in g  PE. The whole PE procedure lasted 120 minutes in  
genera l. In  each case both the quantita tive  and q u a lita t iv e  WBC count was determined.
Measurement o f spontaneous chemiluminescence o f pe riphe ra l white blood c e lls  in  whole 
b lood: 1.0 ml o f heparinized human whole blood was d ilu te d  to  3 times i t s  o rig in a l volume w ith  
phosphate-buffered sa line (PBS). The CL in tens ity  was measured in  the presence o f 10"^ mol/1 o f 
lum ino l ( f in a l concentration) by a Nuclear Chicago Isocap/300 liq u id  s c in t i l la t io n  counter 
(S e a rl, Ind. USA), in  the o f f  coincidence mode. The to ta l number o f photons measured 3 times 
a t 5-min in te rva ls  was used as a cha rac te ris tic  value fo r  a given sample /1 2 /. The value o f 
the spontaneous CL o f a s in g le  WBC was calculated by the index: CL cpm/nurrber o f WBC in  1 p i .
Determination o f MDA le v e ls  in  c itra ted  plasma samples: l ip id  peroxidation was assayed 
by Ohkawa’ s method (10) w ith  s l ig h t  m odifications. 0.20 ml c it ra te d  plasma was d ilu ted  by addi­
t io n  o f 0.20 ml 8.1% SDS in  d is t i l le d  water. This so lu tio n  was added to  1.50 ml o f 20% ace tic  
ac id  (pH 3.5) together w ith  1.50 ml 0.8% th io b a rb itu ric  ac id  (TBA). A fte r incubation (95 °C, 
60 m in), the TBA reactive  substance (MDA) was extracted by add itio n  o f 4.00 ml o f n-butano l- 
p y rid in e  (15:1) and measured in  a fluorescence spectrophotometer (e x c ita tio n : 532 nm; emission: 
570 nm). The content o f MDA was ca lcu la ted from a standard curve obtained w ith MDA, and was 
expressed as nmoles MDA/ml serum.
Albumin leve ls were determined by rad ia l immunodiffusion /9 / .
The 25 PE-s in  6 p a tie n ts  were carried out a t va rious periods o f time and not a t 
reg u la r in te rva ls . Because o f the re la t iv e ly  long in te rv a ls  (3-4  days) between PE-s, we thought 
i t  would be acceptable, from a s ta t is t ic a l point o f v iew , to  regard every treatment as a 
separate case. Therefore, in  the s ta t is t ic a l  analysis (using Student’ s ^ t-te s t), we compared the 
la bo ra to ry  values before and a f te r  PE.
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Results
Changes in numbers o f white blood ce lls , neutrophils and 
in chemiluminescence before and a fte r PE
Figure 1 shows tha t there are s ig n ifica n t elevations in  numbers of both 
to ta l WBC-s and neutrophils of peripheral blood, measured before and a fte r 
PE in  our cases (q u a lita tiv e  and quantita tive  c e ll counts) (F ig . 1).
At the same time, the spontaneous CL in tens ity  of these c e lls  (char­
acteriz ing basica lly the metabolic a c tiv ity  of neutrophils in  whole pe ri­
pheral blood) (8) does not increase in p a ra lle l with the number o f ce lls . 
The поп-s ig n ifica n t e levation shows or suggests a re la tive  metabolic damage 
of neutrophils during PE (F ig. 2).
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Fig- 1» Total WBC count (empty bars) and number o f neutroph ils (dotted bars) 
before and a fte r PE (means + S.D.)
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F ig . 2. Change o f whole blood chemiluminescence before and a fte r  PE (means +_ S.D.)
Change in  MPA levels during plasma exchange
MDA is  an endproduct of lip idperoxidation /1 , 5 /. I ts  ex trace llu la r 
quan tity  can also be an ind ica to r of the in te n s ity  of energy dependent me­
ta b o lic  processes taking place in  the ce lls  /1 4 /. In our cases, the plasma
Table I
Plasma malonvldialdehyde (nmol/ml) and albumin (g /1 ) leve ls  before and a fte r  PE
Plasma
components
Number o f 
samples
Pre-PE values 
mean +_ S.D.
Post-PE values 
mean +_ S.D.
MDA 14 2.32 1.70
(nmol/m l) 0.95 0.79
Albumin 22 39.11 28.47
( g / l ) 10.93 8.42
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leve ls of MOA decreased a fte r PE only as much as the d ilu tio n  o f plasma 
components took place. Namely, the lower MDA values a fte r PE compared to the 
values before PE are in  accordance w ith the changes in  the plasma albumin 
concentrations, suggesting that an a r t i f i c ia l  d ilu tio n  of proteins and other 
plasma components ( l ik e  MDA) is  taking place during PE (Table I ) .  Our re­
su lts  show that PE does not cause a s ig n if ic a n t increase in the lip id p e r-  
oxidation of blood c e lls  (Table I ) .
Discussion
We tested anticoagulated blood samples (plasma and WBC) taken before 
and a fte r PE. During the procedures we did not measure the samples because 
the gelatine molecules used in plasma expander solution Gelifundol influence 
the function o f leukocytes. Our aim was to compare the metabolic state of 
WBC at the beginning and at the end of the procedures. Therefore, we meas­
ured the spontaneous CL of peripheral WBC /4 / ,  in  which more than 90% of the 
photons were emitted by the neutrophils / 8 / .
Since, the number of neutrophils in  WBC (qua lita tive  c e ll counts) 
changed in p a ra lle l w ith the to ta l number of WBC (quantitative c e ll counts), 
and because 90% of the CL in a sample could come from the neutroph ils , we 
regarded the values of CL as data representing quantita tive ly  the metabolic 
a c t iv ity  of neutrophils in a sample.
The s ig n if ic a n t elevation in number of WBC (including neutrophils) 
can be explained in  our resu lts , supposedly, by the elevation of in te r ­
leukin-1 leve ls, produced during a s lig h t acute phase reaction induced PE 
/ 6 / .  However, we have to mention that c l in ic a l symptoms of a rea l acute 
phase reaction could be rare ly observed. That means that the PE procedure 
— based upon Dideco sets — is  c l in ic a l ly  a well-to lerated medical tre a t­
ment fo r patients.
In our system we have found a decreased spontaneous CL of peripheral 
neurophils calculated upon the increased number of WBC a fte r PE. These 
phenomena can possibly be explained by the mechanical and osmotic stresses 
caused by the PE procedure /7 /. At the same time, the lack of increase in 
plasma MDA leve ls also seems to exclude the p o s s ib ility  of a s ig n ific a n t 
increase in  the lip idperoxidation  (elevated metabolism of peripheral WBC). 
Thus, our data do not support the idea tha t — lik e  during hemodialysis 
/ 2 , 13/ — a prolonged activation of neutrophils occurs.
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PROSTAGLANDIN IN RENAL TRANSPLANT RECIPIENTS
M. M. H. EL-SHARABASV , M. N. EL-NAGGAR
Chemistry Department, Faculty of Science, Mansoura U nivers ity ,
Egypt
(Received: August 7, 1991)
Prostaglandin E2 (PGE2) ,  sodium, potassium and creatin ine were determined in  the blood 
and u rine  o f 50 rena l transp lant rec ip ien ts  trea ted  fo r  a t least one year post transp lan ta tion  
w ith  cyclosporine A o r azathioprine as immunosuppressive agent. Fourteen healthy subjects were 
used as a con tro l group. The u rinary  PGE2 excre tion was s ig n if ic a n tly  decreased in  the renal 
transp lan t rec ip ien ts  on azathioprine therapy while  i t  was unchanged in  the p a tie n ts  treated 
w ith  cyclosporine A. At the same tim e, a s ig n if ic a n t decrease in  urinary excre tion  o f sodium 
and potassium was found. On the other hand, a high e levation of blood PGE2 concentration was 
observed while no s ig n if ic a n t changes were seen in  sodium and potassium in  the blood o f these 
rena l transp lant re c ip ie n ts . I t  is  suggested th a t an association e x is ts  between u rina ry  PGE2 
reduction and immunosuppressive treatments in  rena l transplant rec ip ien ts  and th a t PGE2 may 
regu la te  in tra rena l haemodynamics and in fluence rena l tubular e le c tro ly te  excre tio n . F in a lly , 
u rina ry  PGE2 can be used as an in d ica to r o f successful renal transp lanta tion.
Keywords: prostaglandin E2 , sodium, potassium, crea tin ine , renal tran sp la n t rec ip ­
ie n ts , cyclosporine A and aza thriop rine .
In tro d u c tio n
Prostaglandin are synthesized in  many tissues in minute amounts. They 
are highly active pharmacologically causing, e .g ., contraction o f smooth 
muscle — of the uterus among them — vasodilation and p la te le ts  aggregation 
/2 /. In addition, prostaglandins are important intrarenal hormone involved in 
the regulation of renal blood flow , renal haemodynamics and water d iuresis 
/ 3 / .  Since urinary prostaglandins E2  (PGE2) concentration was found in -
O ffp rin t requests should be sent to  M. M. H. El-Sharabasy, Chem. D ept., Faculty of 
Science, Mansoura U n ive rs ity , Egypt
Akadémiai Kiadó, Budapest
226 EL-SHARABASV, M. M. H . ,  EL-NAGGAR, M . M.
creased 1 to 7 days before any changes in the conventional biochemical in d i­
cators of acute re je c tio n , measurement of u rinary PGE2  may be a useful and 
early  indicator of acute renal transplant re je c tio n  /9 / .  Furthermore, a high 
increase in  urinary PGE2  excretion, but no or minimal increase in  the to ta l 
excretion rates was observed in patients w ith acute o ligu ria  renal fa ilu re  
immediately a fte r the transplantation. In th is  respect, re jection crises 
were characterized by a two-fold increase in  PGE2  excretion with a sub­
sequent f a l l  induced by ste ro id  treatment, and the PGE2  excretion correlated 
closer with urinary sodium excretion than d iu res is  / 6 / .  This prompted us to 
study the urinary excretion of PGE2 , sodium and potassium, as well as the 
concentration of these agents in the blood of renal transplant recip ients 
under immunosuppressive therapy. Cyclosporine A or other conventional thera­
py, e.g. azathioprine was applied for at least one year post renal trans­
p lan ta tion .
Table I
Mean values o f PGEo, sodium and potassium in  u rine  o f con tro ls  and of renal 
transp lan t re c ip ie n ts  treated with immunosuppressive agents
Group
pge2
ng/g.
creatin ine
Sodium
mEq/g.
c rea tin in e
Potassium
mEq/g.
creatin ine
Healthy subiects 
Mean +_ S.D. 6327 + 2823 129.0 + 60.2 32.0 + 16.40
n = 13 14 14
Renal transplant 
rec ip ien ts  
Mean +_ S.D. 5294 + 2324 90.5 + 42.6* 18 .0+  8.73s®*
n = 40 42 41
Cyclosporine A 
rec ip ien ts  
Mean +_ S.D. 6229 + 3460 99.4 + 38.9х 29.4 + 17.50
n = 25 27 25
Conventional therapy
rec ip ien ts
Mean + S.D. 4720 + 2163 95.2 + 33.3х 21 .4+  8.67x
n = 15 15 16
X = P < 0 .0 5  
XX = P C  0.001
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This study was ca rrie d  out on 50 adu lt pa tien ts , 32 males and 18 females, a t least one 
year a fte r  successful rena l transp lanta tion a t the Urology and Nephrology Center, Mansoura 
U n ive rs ity , Egypt. Patients were divided in to  two groups according to the treatm ents immuno­
suppressive agent: 30 pa tien ts  were treated w ith  cyclosporine A and 20 pa tien ts  w ith  azathio­
p rine . A l l  patients received long-term immunosuppressive therapy. Fourteen healthy persons 
(8 males and 6 females) were used as a group fo r comparison. Blood and urine samples were taken 
from both patients and con tro ls  in  a fas ting  s ta te .
The radioimnunoassay method o f Oaf fa  and Parker /5 / ,  the atomic absorption spectro- 
photometric method o f W il l is  /1 1 / and the method o f Van Pilsum and Bovis /1 0 / was used fo r 
determination o f PGE2, sodium and potassium, and c rea tin in e , respective ly . Serum and urine 
samples were tested. The s ta t is t ic a l analyses were performed according to Snedecor’ s method/8/.
Results
The mean value of the urinary PGE2  excretion was s ig n if ic a n t ly  de­
creased (P <  0.05) in  the renal transplant recipients as compared to the 
mean control value (Table I ) .  This reduction was accompanied by a highly
Table I I
Mean values o f PGE2, sodium, potassium and crea tin ine  in  the blood serum o f hea lthy subjects
and renal transplant rec ip ien ts
PGE2 Sodium Potassium Creatinine
(ng%) (п£д%) (mEq%) (mg%)
Healthy subjects
Mean +_ S. D. 3150 + 1767.6 146.9 + 14.36 4.67 + 0.71 0.52 + 0.18
n = 12 14 14 13
Renal transplant rec ip ien ts
Mean +_ S.D. 5808 + 2446.7** 145.0 + 10.78 4.27 + 0.83 1.03 *_ 0.65**
n = 25 28 28 29
Recipients on cyclosporine
A therapy
Mean +_ S.D. 5489 + 2914.0** 147.4 + 11.94 4.32 + 0.94 1.07 + 0.58**
n = 14 16 15 15
Recipients on conventional
therapy
Mean + S.D. 6327 + 2363.7** 144.0 + 8.08 4.42 + 0.86 1.22 +_ 0.61**
n = 11 17 17 15
X = P <  0.05
XX = P <  0.001
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s ig n if ic a n t decrease (P К. 0.001) in  the concentrations of sodium, potassium 
and creatin ine in  the urine o f the same patients. At the same time, the con­
cen tra tion  of PGE2  was s ig n if ic a n t ly  increased (P 0.05) in  the blood of 
renal transplant re c ip ie n ts , rather than the corresponding mean value of 
co n tro ls . Blood creatin ine was also increased, but w ith in  the normal range 
(Table I I ) .  Moreover, no s ig n ific a n t changes were observed in the blood 
concentrations of sodium and potassium (Table I I ) .
The results obtained from the two groups o f renal transplant rec ip ­
ie n ts  were sim ilar to each other (Tables I  and I I ) .
Discussion
The renal prostaglandin system has proved to partic ipa te  in  some 
rena l disorders, we investiga ted the behaviour o f PGEj and i t s  influence on 
sodium and potassium le ve ls  in  the urine and blood of renal transplant 
re c ip ie n ts  treated w ith immunosuppressive agents. The urinary PGE2  excretion 
was decreased in a l l  o f our renal transplant rec ip ien ts  and i t s  decrease was 
accompanied by a marked decrease in urinary excretion of sodium and potas­
sium. These findings can be explained by assuming that prostaglandins are 
im portant intrarenal hormones concerned with the regulation of renal blood 
flow  and e lectro ly te  excre tion  and that th is  is  so not only in some kidney 
d isorders but also in  renal transplant recip ients treated with cyclosporine 
A or being on some other conventional therapy / 2 / . These assumptions are in  
agreement with other previous findings, v iz . ,  tha t in  patients w ith hyper- 
c a lc iu r ia ,  prostaglandin synthetase in h ib itio n  w ith indomethacin is  followed 
by a marked reduction o f calcium and sodium. These observations are related 
to  an evidence that renal prostaglandin a c t iv ity  is  an important facto r in 
the mechanism of hyperca lc iuria  / 1 / .
Haylor and Lote /4 /  provided an evidence fo r a d irec t tubular action 
o f endogenous prostaglandins on distal-nephron sodium excretion. There is  
also good circumstantial evidence to suggest tha t prostaglandins may in ­
fluence calcium reabsorption by the kidney and prostaglandins have been 
shown to a lte r water, sodium and calcium transport across frog skin /7 / .  In 
our immunosuppressived re c ip ie n ts  the reduction o f the urinary PGE2  excre­
t io n  followed a marked decrease in  urinary sodium and potassium excretion 
may determine the renal handling of sodium and potassium by con tro lling  the 
tu b u la r function; furthermore, the reduction in  PGE2  excretion was a t t r ib u t-
ed to an impaired kidney function. This is  supported by the s ig n if ic a n t 
elevation of blood creatin ine concentration. Besides, the elevation of PGE2  
in  the blood of renal transplant rec ip ien ts  can be attributed to the kidney 
dysfunction which enables secretion of th is  prostaglandin in  the urine ; 
moreover, th is  elevation of PGE2  mainly due to  the possible a c tiva tio n  of 
monocytes by immunosuppressive agents used as treatment fo r renal transplant 
re jec tion .
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ACTIVATION TO ACQUISITION: Functional Aspects of the Basal Forebrain
Cholinergic System 
Edited by Russell T. Richardson 
(Birkhäuser, Boston 1991) Price: 168 Swiss Francs
The chapters of th is  book — w ritten  by leading investigators of the 
f ie ld  — provide an excellent review of the current knowledge and hypotheses 
about the ro le  of the basal forebrain cholinergic system (BFCS). Contribu­
tions from most d isc ip lines  of the neurosciences can be found in  the book, 
which allow the reader to gain a broad understanding of the anatomy, physio­
logy and behavioural im plications of th is  system.
The functional importance of the cholinergic basal forebrain neurons 
began to be recognized in  the mid-1970s, when these neurons were discovered 
to  provide a d iffuse  innervation of the e n tire  co rtica l mantle. Later they 
were shown i )  to represent the la s t l in k  in  the ascending re t ic u la r  a c tiva t­
ing system of Moruzzi and Magoun (1949), i i )  to have a powerful influence on 
the p la s tic  properties of co rtic a l neurons during development as w e ll as in 
the adult (learning and memory), and i i i )  to  play a c ruc ia l ro le  in  the 
pathogenesis of Alzheimers’ disease. Due to these fundamental functiona l and 
pathophysiological im plications, the BFCS has become a focus of research in 
many laboratories over the past decade. This book represents the most com­
p le te  account to date of the huge body of information accumulated during 
th is  period about the BFCS.
In the f i r s t  chapter the ed ito r summarizes the aims of the book, and 
presents the question which had to be addressed by a l l  contribu tors: "Based 
on your c r i t ic a l  evaluation of relevant studies, what is  the most l ik e ly  
function of the basal forebrain cholinergic system?". A b r ie f but comprehen­
sive summary is  given about the several functiona l processes suggested to 
involve the BFCS. The proposed hypotheses are not mutually exclusive, in 
almost a l l  in te rp re ta tions acetylcholine (ACh) is  considered a neuromodula­
to r .  The view which appears to emerge from a l l  chapters is  that the cho lin ­
ergic system is  a lte ring  the functional properties of other brain structures 
over time (from transient to permanent e ffe c ts ), which may involve selected 
target neurons, selected target areas, or even the entire  cerebral cortex.
The follow ing three chapters describe the c lassica l and chemical 
neuroanatomy of the basal forebrain with pa rticu la r emphasis on the func­
tio n a l im plications of charac te ris tic  s tru c tu ra l features. A chapter by 
Koliatsos and Price gives a h is to r ic a l overview, and summarizes our present 
knowledge of the a fferent and efferent connections, local c irc u its ,  neuro- 
transm itters, and nerve growth factor (NGF) receptor content of the BFCS. In 
the next, rather short chapter Mesulam reviews recent work on the topograph­
ic a l organization of the cholinergic basal forebrain-neocortex p ro jection  in 
primates, and describes the spec ific  behavioural and neurophysiological 
aspects of th is  organization. More detailed anatomy, based la rge ly  on tra c ­
ing studies, is  provided by Price and Carnes, who conclude the chapter by 
speculating about the functional im plications of the spec ific  input-output 
re la tionships of BFCS neurons.
The next four chapters are based p rim arily  on e lectrophysio log ica l 
studies of the ro le of the BFCS in  c o rtic a l activa tion , learning and memory. 
The a c t iv ity  state of the cerebral cortex is  e ither aroused (open-loop, or
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in te ra c tive  s ta te ), or поп-activated (closed-loop, or non-interactive 
s ta te ) . What is  the b io lo g ica l significance of th is  dichotomy of states? 
Why must the cereoral cortex be aroused to in te ra c t with the environment? 
"Why is  the brain not hard-wired exclusively fo r the information-processing 
mode as seen in computers? What are the neurophysiological mechanisms in ­
volved in  the switching between the d iam etrica lly  opposite functiona l 
states?" In th e ir chapter Buzsáki and Gage attempt to answer the la s t ques­
t io n ,  and at least to discuss the other basic neurobiological questions 
through th e ir own studies on the BFCS. They hypothesize that the basal fo re - 
b ra in  cholinergic neurons play a crucia l ro le  in  c o rtic a l arousal via a dual 
mechanism: i )  they enhance the efficacy of spec ific  thalamic affe rents to 
d rive  th e ir  c o rtica l ta rge t neurons (d ire c t c o r t ic a l e ffe c t) , and i i )  they 
suppress the rhythmic o sc illa tio n s  of the thalamic "pacemaker" neurons by 
th e ir  axons innervating the re ticu la r nucleus o f the thalamus, thus, allow­
ing the relay of sp e c ific  information to the neocortex. The possible ro le  of 
BFCS neurons in learning and memory is  analysed in  a chapter by Richardson 
and DeLong, who review th e ir  studies on the f i r in g  properties of single 
basal forebrain neurons during d iffe ren t behavioural paradigms, and describe 
a model how cholinerg ic neurons may fa c i l i ta te  associative learning. The 
re la tio n s  of condition ing, d iffe re n t forms o f long-term potentia tion (LTP), 
and cholinergic fa c i l i ta t io n  of glutamatergic transmission are summarized in 
a chapter by Gorman and Woody. The cholinergic modification of in tra c e llu la r  
responses and e x c ita b il i ty ,  and i t s  ultimate e ffe c t on receptive f ie ld  plas­
t i c i t y  in  a behavioural state-dependent manner is  the subject of a chapter 
by Ashe and Weinberger, who present a hypothetical model of "adaptive in ­
formation processing" fo r the auditory cortex.
Learning and memory are the focus of the two subsequent chapters (by 
Oltón e t a l. and Kesner and Johnson), but from more o f a behavioural view­
po in t in  which the re la tio n s  of the BFCS to other brain structures and th e ir  
functions is  analysed.
In the subsequent, most fascinating, two chapters the ro le  of the 
cho line rg ic  afferents in  the regulation of sensory receptive f ie ld s  is  
reviewed. Kasamatsu and Imamura emphasise the necessity of an integrated 
cho line rg ic  noradrenergic action in the regulation of visual c o rtic a l plas­
t i c i t y  during development (e .g . the formation o f ocular dominance columns). 
In  th e ir  chapter Dykes e t a l.  summarize th e ir  work on long lasting  enhance­
ment o f co rtica l responses evoked by sensory s tim u li. They conclude that 
c o r t ic a lly  released ACh fa c il ita te s  synaptic m odification, and tha t the 
mechanisms of co rtic a l p la s t ic ity  are fundamentally s im ila r in  a l l  areas of 
sensory neocortex at a l l  postnatal ages.
In the las t chapter by Woolf and Butcher a h ighly speculative model 
is  presented addressing "the basic computation s ty le  that cholinergic basal 
fo rebra in  ce lls  could use in  order to perform cognitive operations". The 
cho line rg ic  neurons are suggested to be involved in  cognition by a lte rin g  
the anatomical connections among d iffe re n t groups of neurons representing 
sp e c ific  b its  of in form ation.
This book consists o f thorough reviews of anatomical, electrophysio- 
lo g ic a l and behavioural data on the BFCS, and, in  addition, the author of 
a l l  chapters share th e ir  personal views and hypotheses about the possible 
functions of th is  system. According to John P la tt ,  strong inference is  the 
most e ffec tive  method fo r making progress in  science, since i t  resu lts  in  
the formulation of m u ltip le , testable hypotheses. The book contains a most 
fasc ina ting  co llec tion  o f such hypotheses. I t  is  h ighly recommended to 
neuroscientists involved in  studies of the BFCS, the cerebral cortex, learn­
ing and memory, and cogn itive  processes.
TAMÁS FREUND
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Adrenoreceptors: structure, mechanisms, function 
(Edited by E. Szabadi and C. M. Bradshaw, 
Birkhäuser Verlag, Basel—Boston—Berlin)
408 pages. Price: 98 Swiss Francs
The material of th is  volume was presented at the Symposium on the 
pharmacology of adrenoreceptors (June 1990, University of Manchester), the 
th ird  of the symposia organized as a s a te ll i te  of a Word Congress o f Pharma­
cology (IUPHAR Congress in  Amsterdam, 1990.). I t  re fle c ts  the immense devel­
opment in  th is  f ie ld  o f science during the four-year period tha t has elapsed 
since the preceding symposium.
The structure of adrenoreceptors has been revealed in  the la s t 5 to 6  
years, and our view has been greatly modified due to the new knowledge. The 
existence of fu rthe r subtypes of the alpha}, alpha2 , beta} and beta 2  adreno­
receptors, a question much debated before, has been proved. The d iv e rs ity  of 
the receptors has been suggested by new data obtained w ith the c lassica l 
techniques on the one hand, and numerous subtypes were id e n tif ie d  by means 
of methods of molecular biology on the other. Newly-discovered agonists and 
antagonists have contributed to the recognition of the exact /physio log ica l 
ro le  of the receptor types (and subtypes)/.
The newly-described subtypes of receptors suggest tha t soon drugs 
were selective than those available today w i l l  be developed fo r  use in 
therapy.
Much has been recognized of the molecular mechanism activated by 
adrenergic receptors. For beta and alpha2  receptors various elements of the 
G protein family (Gs and G}, respectively) play the mediator ro le , whereas 
fo r alpha} receptors the phosphoinozitol pathway which is  activated via 
phospholipase C is  involved in  the usual biochemical mechanism.
As to the adrenergic receptors in  the cardiovascular system, i t  
should be taken in to  account that the receptors of various vascular areas 
may behave d if fe re n tly , and that th e ir  d ive rs ity  is  a general ru le .
Changes in  adrenergic receptors may play an important ro le  in  some 
c lin ic a l conditions. I t  has been shown that a las ting  r ise  in  the plasma 
catecholamine leve l is  associated with a decrease in  number o f beta adreno­
receptors in the cardiovascular system. In contrast, an increase in  the sen­
s i t i v i t y  of alpha and beta receptors should be reckoned w ith when the auto­
nomous regulation involves a lasting  decrease in the plasma catecholamine 
leve l.
This book should be read by those who are dealing w ith the pharmaco­
logy and/or physiology of adrenoreceptors or meet these receptors in the 
course of th e ir research work.
G. B. MAKARA
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New Perspectives in Histamine Research 
(Ed. H. Timmerman, H. van der Groot).
Agents and Actions Supplements, vol. 33. A s a te l l i te  symposium of the X lth 
In te rna tion a l Congress o f Pharmacology of IUPHAR, July 6 —8 , 1990, Noord- 
w ijke rhout, the Netherlands. Birkhäuser Verlag, Basel, Boston, Berlin , 1991, 
434 pages. Price: 128 Swiss Francs
There is  a long h is to ry  of histamine research, s t i l l  th is  f ie ld  of 
research is  always f u l l  o f exc iting  new find ings. Histamine has been known 
as a neurotransmitter, inflammatory mediator and a facto r in  anaphylaxis, as 
w e ll as in  cardiac and gastro in tes tina l functions. In addition to these, 
some new roles of histamine were presented at th is  Symposium, e.g. i t s  ro le  
as an immune modulatory autacoid or as a mediator o f the mitogenic response. 
The book contains 34 papers presented at the Symposium dealing with nearly 
a l l  aspects of the ro le  o f histamine in the regulation of physiological 
processes.
Japanese authors (Wada et a l. ,  Osaka, Japan) have id e n tif ie d  the 
histam inergic neuron system in  ra t brain by immunocytochemical techniques 
using antibodies against h is tid in e  decarboxylase or histamine i t s e l f .  The 
histam inergic neurons are located exclusively in  the tuberomamillary nucleus 
in  the posterior basal hypothalamus and send th e ir  varicose fib res  to almost 
a l l  regions of the brain.
Histamine has a s tim u la to ry , but in d ire c t, e ffe c t on the release of 
p itu ita r y  derived pro-opiomelanocortin peptides: ACTH, Ki-endorphin, ,6 -mela­
nocyte stimulating hormone (Knigge et a l. ,  Copenhagen, Denmark) that occurs 
by stim ula tion  of H]^  and H2  receptors and seems to  be mediated via release 
o f co rtico trop in -re leas ing  hormone.
One of the newest find ings was presented by the researchers of the 
Unité de Neurobiologie et Pharmacologie, INSERM, Paris (Arrang et a l . ) ,  who 
id e n tify in g  among a series o f methylated histamine derivatives (R)rf, (S )$,- 
dimethyl histamine as a novel potent and se lective H3  receptor agonist. The 
drug seems to display a very low animal to x ic ity ,  i t  might find  various 
c l in ic a l  applications. The same group (Ruât et a l . )  designed the f i r s t  
la be lled  probes spec ific  fo r  the H]^  and H2  receptors. The reversible 1 2 ^ I-  
probes allowed them to extend the pharmacology o f these receptors in  several 
b io lo g ic a l preparations and to  establish th e ir  in te rac tion  with G prote in.
Barnes P. (London, U.K.) summarized the ro le  of d iffe re n t histamine 
receptors in  mediating a lle rg ic  airway disease.
The association of histamine receptors w ith  the in tra c e llu la r  second 
messenger systems is  discussed by S. J. H i l l  (Nottingham, U.K.). H2  recep­
to rs  are coupled via a Gg regulatory protein to adenylate cyclase and stim­
u la te  c y c lic  AMP formation, while H^  receptors mediate many of th e ir  e ffects  
via the products of in o s ito l phospholipid hydro lysis. I t  is  becoming clear 
tha t there is  a substantia l "cross-ta lk" between these in tra c e llu la r  second 
messenger systems in a number of tissues.
The problem of a preoperative histamine H^  + H2  prophylaxis was 
tackled by Lorenz et a l.  (Marburg, Germany) includ ing randomized controlled 
c l in ic a l  t r ia ls  and cross-sectioned studies w ith plasma histamine measure­
ments and administration o f H  ^ + H2  antagonist.
The use of histamine H2 ~agonists seems to be a new promising approach 
to  the treatment of congestive heart fa ilu re . Buschauer and Baumann (B erlin  
and München, Germany) developed a potent H2  agonist, a guanidine derivative 
having a potent positive inotrope e ffect.
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Brandes e t a l.  (Winnipeg, Canada) provided evidence tha t the h is ta ­
mine mobilized from cytoplasmic stores is  a mediator of the mitogenic re­
sponse to concavalin A in  mouse spleen c e lls .
Khan and Melmon (Stanford, CA, USA) summarized our knowledge of the 
function of histamine and i ts  congener derivatives as immune modulators. 
The receptors fo r histamine are non-randomly d istributed on lymphocytes. 
Suppressor T c e lls  can control the expression of histamine receptors on 
helper and c y to ly t ic  T ce lls . Histamine regulates lymphokine release and 
vice versa histamine release is  influenced by lymphokines.
The book is  highly recommended fo r pharmacologists and biochemists 
involved in  monoamine studies.
KATALIN SZ. SZALAY
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For more inform ation, contact SMRM, 1918 U n ive rs ity  Avenue, Suite 3C, Berkeley, CA 94704, USA. 
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— AN INTERNATIONAL COURSE—
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150, cours A lbe rt Thomas 
F-69372 Lyon Cedex 08
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US, CT and MRI in  th e  1990’ s
M a rrio tt ’ s Tenaya Lodge a t Yosemite, CA 
May 18-22 , 1992
For fu rth e r in form ation, please contact: 
Radiology Postgraduate Education 
Room C-324
U n ive rs ity  o f C a lifo rn ia  School o f Medicine 
San Francisco, C a lifo rn ia  94143-0628
INTERVENTIONAL HEPATOBILIARY RADIOLOGY :
PERCUTANEOUS PORTACAVAL SHUNTS, BILIARY STENTS, TUMOR CHEM0EMB0LIZATI0N,
LITHOTRIPSY
R itz-Carlton, San Francisco, California 
June 4—6, 1992
For fu rth e r in form ation, please contact:
Radiology Postgraduate Education 
Room C-324
U n ive rs ity  o f C a lifo rn ia  School o f Medicine 
San Francisco, C a lifo rn ia  94143-0628
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